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Abstract 
The first section of this thesis describes the development of a one-pot Pd(II)-
catalysed Overman rearrangement, Ru(II)-catalysed ring closing enyne metathesis 
reaction and a hydrogen bond-directed Diels-Alder reaction for the 
diastereoselective synthesis of C-5 substituted aminobicyclo[4.3.0]nonanes in 
good yields. To explore the late stage diversification of these compounds, further 
work investigated a one-pot synthesis of a benzyldimethylsilyl-derived analogue. 
The synthetic utility of this compound was demonstrated using C–C bond coupling 
reactions, for the late stage synthesis of a range of sp3-rich bicyclononane 
scaffolds with up to six stereogenic centres. 
 
 
 
The second section of this thesis describes the development of a one-pot two-step 
procedure for aryl C–H amination using iron and copper catalysis. Firstly, a mild 
and highly regioselective method for the bromination (and chlorination) of arenes 
via iron(III) triflimide activation of N-bromosuccinimide (or N-chlorosuccinimide) 
was developed. The scope of both processes was explored for the synthesis of a 
wide range of aromatic compounds and natural products. The one-pot iron(III)-
catalysed bromination/Cu(I)-catalysed N-arylation was then studied. After 
optimisation, the one-pot two-step process allowed the synthesis of a large library 
of para-aminated aryl compounds in high yields as single regioisomers.  
 
OH
5
NHO
Cl3C
R1
R1
H
i. Cl3CCN, DBU
ii. PdCl2(MeCN)2
(10 mol %)
toluene, rt
iii. Grubbs II
(7 mol %), 90 °C
1,7-octadiene
NH
R1
CCl3
O
R3
R2R3R2
iv. hydroquinone
75 °C
14 examples
40−76% overall yield
R1 = Me, Ph, p-NO2-Ph
     p-MeO-Ph, BnMe2Si
R R
Br
H–NR1R2
CuI (10 mol %)
R
NR1R2H
NBS
toluene, rt to 40 °C
24 examples
51-88% overall yield
FeCl3 (2.5 mol %)
[BMIM]NTf2 (7.5 mol %)
DMEDA (20 mol %)
Cs2CO3, water
 3 
Table of Contents 
Abstract .................................................................................................................. 2	
Acknowledgements ............................................................................................... 6	
Author’s Declaration ............................................................................................. 7	
Abbreviations ......................................................................................................... 8	
1.0 Introduction .................................................................................................... 13	
1.1 Claisen Rearrangement ............................................................................. 13	
1.2 Overman rearrangement ........................................................................... 14	
1.2.1 Thermal Overman Rearrangement ........................................................ 15	
1.2.2 Metal catalysed Overman rearrangements ........................................... 19	
1.2.2.1 Mercury (II)-catalysed Overman rearrangement ............................. 19	
1.2.2.2 Palladium (II)-catalysed Overman rearrangement .......................... 20	
1.2.3 Asymmetric Overman Rearrangement .................................................. 23	
1.2.4 Substrate directed palladium(II)-catalysed Overman rearrangement .... 29	
1.2.5 Applications of the Overman rearrangement ......................................... 32	
1.2.6 Conclusions ........................................................................................... 37	
1.3 One-pot multi-step processes .................................................................. 38	
1.3.1 Domino/cascade catalysis ..................................................................... 39	
1.3.2 Tandem catalysis ................................................................................... 41	
1.3.3 Classical one-pot multi-step process ..................................................... 43	
1.3.4 One-pot process initiated by Overman rearrangement ......................... 44	
1.3.5 One-pot process initiated by metathesis reaction .................................. 47	
1.3.6 Conclusions ........................................................................................... 50	
2.0 Results and Discussion ................................................................................ 51	
2.1 One-Pot multi-bond forming reactions for the diastereoselective 
synthesis of aminobicyclo[4.3.0]nonanes ..................................................... 51	
2.1.1 Previous work within the Sutherland group ........................................... 51	
2.1.2 Aims ....................................................................................................... 56	
2.1.3 Synthesis of allylic alcohols ................................................................... 58	
2.1.4 Investigation of the palladium(II)-catalysed Overman rearrangement ... 60	
2.1.5 Development of the one-pot multi-step process .................................... 61	
2.1.6 Functionalisation of bicyclo[4.3.0]nonane 201 ....................................... 68	
2.1.7 Conclusions ........................................................................................... 70	
2.2 The development of a one-pot process for the synthesis of vinylsilyl 
derived aminobicyclo[4.3.0]nonanes, synthetic intermediates for a late-
stage incorporation of substituents ............................................................... 72	
2.2.1 Aims ....................................................................................................... 72	
 4 
2.2.2 Development of a one-pot process using a tert-butyldimethylsilylalkynyl-
derived allylic alcohol ...................................................................................... 75	
2.2.2.1 Synthesis of allylic alcohol .............................................................. 75	
2.2.2.2 One-pot palladium(II)-catalysed Overman rearrangement ............. 76	
2.2.2.3 One-pot RCEYM/Diels-Alder reaction ............................................. 77	
2.2.2.4 Attempted one-pot four-step synthesis of aminobicyclo[4.3.0]nonane 
227 .............................................................................................................. 77	
2.2.3 Development of a one-pot process using a benzyldimethylsilylalkynyl-
derived allylic alcohol ...................................................................................... 78	
2.2.3.1 Synthesis of allylic alcohol .............................................................. 78	
2.2.3.2 One-pot multi-step synthesis of aminobicyclo[4.3.0]nonane 235 .... 79	
2.2.4 Protodesilylation reaction ...................................................................... 81	
2.2.4.1 Functionalisation of aminobicyclo[4.3.0]nonane 236 ...................... 82	
2.2.5 Attempted Hiyama-Denmark cross coupling ......................................... 83	
2.2.6 Iododesilylation reaction ........................................................................ 84	
2.2.6.1 Suzuki cross-coupling reaction ....................................................... 85	
2.2.6.2 Sonogashira cross-coupling reaction .............................................. 87	
2.2.7 Conclusions ........................................................................................... 89	
2.2.8 Future work ............................................................................................ 89	
2.3 Development of a one-pot two-step procedure for aryl C-H amination 
using iron and copper catalysis ..................................................................... 92	
2.3.1 Introduction and previous work within the Sutherland group ................. 92	
2.3.2 Bromination of arenes using iron(III) triflimide ....................................... 94	
2.3.2.1 Aims ................................................................................................ 94	
2.3.2.2 Substrate scope .............................................................................. 95	
2.3.3 One-pot iron-catalysed bromination and copper(I)-catalysed N-arylation 
of aromatic compounds .................................................................................. 97	
2.3.3.1 Introduction and aims ...................................................................... 97	
2.3.3.2 Optimisation .................................................................................... 98	
2.3.3.3 Substrate scope ............................................................................ 101	
2.3.3.4 Limitations ..................................................................................... 105	
2.3.4 One-pot iron(III)-catalysed iodination and copper(I)-catalysed N-arylation 
of aromatic compounds ................................................................................ 106	
2.3.5 Conclusions and future work ............................................................... 107	
2.4 Iron(III)-catalysed chlorination of activated arenes .............................. 109	
2.4.1 Introduction and aims .......................................................................... 109	
2.4.2 Optimisation ......................................................................................... 110	
2.4.3 Substrate scope ................................................................................... 111	
 5 
2.4.4 The development of tandem dihalogenation processes ...................... 115	
2.4.4.1 Application of 2-bromo-4-chloroanisole (250d) in the synthesis of 
biologically important targets .................................................................... 116	
2.4.5 Attempted one-pot iron(III)-catalysed chlorination and Grignard cross-
coupling reaction .......................................................................................... 117	
2.4.6 Conclusions ......................................................................................... 119	
3.0 Experimental ................................................................................................ 120	
4.0 References ................................................................................................... 221	
5.0 Appendices .................................................................................................. 233	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
Acknowledgements 
First of all, I would like to thank my supervisor Dr Andy Sutherland, for giving me 
the opportunity to undertake this PhD programme within his research group. I am 
very appreciative of all his help, advice, guidance and encouragement throughout 
my PhD. 
Thanks to the technical staff in the Joseph Black Building for their assistance 
throughout my PhD: Dr Claire Wilson (X-ray crystallography), Dr David Adam 
(NMR), Jim and Andy (Mass Spec), Stuart and Arlene (IT), Ted (Stores) and Frank 
McGeoch. 
I would also like to thank all the members of the Sutherland group past and 
present: Adele, Mark, Filip, Ewen, Tomas, Salaheddin, Alex, Nikki, Kerry, Tim, 
Réka, Johnny, Lewis, Martyn, Maria and Holly for the good time in the Loudon lab 
and also for the great support. Thanks also to all members of the Hartley group, in 
particular Dr Stuart Caldwell. I would like to thank my project students: Angus and 
Rosalind, it was a nice experience working with both of you. 
Finally, special thanks to my family: my Mum (Safia) and my wife (Manal) for their 
love, support and prayers throughout my study, also to my sons: Abdulhamid and 
Mahmoud who are making my life more wonderful. I would like also to thank all my 
brothers, sisters and friends for their encouragement and support. 
Financial funding and support from the Libyan government and University of Omar 
Al-Mukhtar is gratefully acknowledged. 
 
 
 
 
 
 7 
Author’s Declaration 
I declare that, except where explicit reference is made to the contribution of others, 
this thesis represents the original work of Mohamed A. B. Mostafa and has not 
been submitted for any other degree at the University of Glasgow or any other 
institution. The work upon which it is based was carried out at the University of 
Glasgow in the Loudon Laboratory under the supervision of Dr Andrew Sutherland 
between April 2014 and May 2017. Aspects of the work described herein have 
previously been published elsewhere as stated below. 
M. A. B. Mostafa, M. W. Grafton, C. Wilson and A. Sutherland, Org. Biomol. 
Chem., 2016, 14, 3284.  
M. A. B. Mostafa, E. D. D. Calder, D. T. Racys and A. Sutherland, Chem. Eur. J., 
2017, 23, 1044. 
M. A. B. Mostafa, A. E. McMillan and A. Sutherland, Org. Biomol. Chem., 
2017, 15, 3035.  
M. A. B. Mostafa, R. M. Bowley, D. T. Racys, M. C. Henry and A. Sutherland, J. 
Org. Chem. 2017, 82, 7529. 
 
 
 
 
 
Signature   _________________________ 
Printed name _________________________  
 8 
Abbreviations 
µW    Microwave 
Δ    Reflux 
Ac   Acetyl 
Ar    Aromatic 
BDMS   Benzyldimethylsilyl 
BHT   Butylated hydroxytoluene (2,6-Di-tert-butyl-4-methylphenol) 
BINAP  (2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl) 
[BMIM]NTf2  1-Butyl-3-methyl-imidazolium bis(trifluoromethylsulfonyl)imide 
Bn   Benzyl 
Boc   tert-Butyloxycarbonyl 
br   Broad 
Bu   Butyl 
°C   Degrees Centigrade 
Cat.   Catalyst 
Cbz   Carboxybenzyl 
CI   Chemical Ionisation 
Conc.   Concentrated 
COP    Cobalt Oxazoline Palladacycle 
COSY   Correlated Spectroscopy 
Cy   Cyclohexyl 
 9 
d   Doublet 
DABCO  1,4-Diazabicyclo[2.2.2]octane  
dba   Dibenzylideneacetone 
DBU    1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCE   1,2-Dichloroethane 
DDQ   2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DIBAL-H   Diisobutylaluminium Hydride 
DIP-Cl  (–)-Diisopinocamphenyl Chloroborane   
DIPEA  N,N-Diisopropylethylamine 
DMAP   4-Dimethylaminopyridine 
DMEDA  N,N’-Dimethylethylenediamine 
DMF   N,N-Dimethylformamide 
DMP   Dess-Martin Periodinane 
DMSO   Dimethyl Sulfoxide 
dppf   Diphenylphosphinoferrocene 
dr   Diastereomeric Ratio 
EDG   Electron Donating Group 
ee   Enantiomeric Excess 
EI   Electron Ionisation 
endo   Endocyclic 
equiv.   Equivalents 
 10 
er   Enantiomeric Ratio 
ESI   Electrospray ionisation 
Et   Ethyl 
EWG   Electron Withdrawing Group 
exo   Exocyclic 
FOP    Ferrocenyl Oxazoline Palladacycle 
g   Gram 
h   Hour 
Hex  Hexyl 
HWE    Horner-Wadsworth-Emmons 
Hz    Hertz 
IR    Infrared 
LDA   Lithium Diisopropylamide 
m-    Meta- 
M    Molar 
m-CPBA  meta-Chloroperbenzoic Acid 
Me   Methyl 
MEM   Methoxyethoxymethyl 
mg   Milligrams 
mL    Millilitres 
mmol    Millimoles 
 11 
mol    Mole 
mol. sieves  Molecular Sieves 
MOM    Methoxymethyl 
Mp   Melting Point 
Ms   Methanesulfonyl 
HMDS  bis(Trimethylsilyl)amide (Hexamethyldisilazide) 
NBS   N-Bromosuccinimide 
NCS   N-Chlorosuccinimide 
NIS   N-Iodosuccinimide 
NMR    Nuclear Magnetic Resonance 
NOE    Nuclear Overhauser Effect 
o-    Ortho- 
p-    Para- 
ppm   Parts Per Million 
Ph   Phenyl 
ppm    Parts Per Million 
Pr   Propyl 
Py   Pyridine 
q   Quartet 
quin   Quintet 
RCEYM  Ring Closing Enyne Metathesis 
 12 
RCM   Ring Closing Metathesis 
ROM   Ring Opening Metathesis 
rt   Room Temperature 
s   Singlet 
SET   Single Electron Transfer 
SIPr.HCl  1,3-bis-(2,6-Diisopropylphenyl)imidazolinium Chloride 
t   Triplet 
TBAF   Tetrabutylammonium Fluoride 
TBDMS   tert-Butyldimethyl Silyl 
tert    Tertiary 
Tf    Triflate 
TFA   Trifluoroacetic Acid  
THF    Tetrahydrofuran 
TLC    Thin Layer Chromatography 
TMEDA  N,N,N′,N′-Tetramethylethylenediamine 
TMS   Trimethylsilyl 
Tr   Triphenylmethyl 
Ts   4-Toluenesulfonyl 
XPhos  2-Dicyclohexylphosphino-2,4,6-triisopropylbiphenyl 
 
 
 
 13 
1.0 Introduction 
1.1 Claisen Rearrangement 
[3,3]-Sigmatropic rearrangements are a class of pericyclic reactions that possess a 
cyclic transition state in which bond-breaking and bond-making take place in one 
step. Among several types of sigmatropic rearrangements, the Claisen 
rearrangement, discovered by Ludwig Claisen in 1912,1 has become a widely 
used reaction in synthetic organic chemistry.2 This is due to its importance in the 
construction of a new carbon-carbon bond, as well as giving the desired products 
in high yields under relatively mild conditions. It is also especially useful because 
of the formation of a new carbonyl group as well as the generation of new 
stereocentres. The Claisen reaction was first defined as the “thermal 
isomerisation" of allyl vinyl ether 1 (when X = O) to form the γ,δ-unsaturated 
carbonyl product 2 (Scheme 1).1,2 
 
Scheme 1: A general Claisen rearrangement. 
The first reported Claisen rearrangement described a thermal [3,3]-sigmatropic 
rearrangement of β-allyloxy-α,β-unsaturated ester 3 to form ethyl 2-
allylacetoacetate (4) in the presence of ammonium chloride (Scheme 2).1,2  
 
Scheme 2: The first reported Claisen rearrangement. 
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1.2 Overman rearrangement 
One important variant of this reaction is the aza-Claisen rearrangement, which 
involves the formation of protected allylic amines via a [3,3]-sigmatropic 
rearrangement of allylic imidates containing nitrogen and oxygen. This reaction 
was first discovered by Mumm and Möller in 1937, who investigated the 
rearrangement of the allylic benzimidate 5 to form the corresponding allylic 
benzamide 6 (Scheme 3).3 However, this method has limited application in 
synthetic chemistry, due to low yields obtained for the formation of the allylic 
imidate substrates, and harsh conditions required for the [3,3]-rearrangement.4 
 
Scheme 3: Aza-Claisen rearrangement of allylic benzimidate to allylic benzamide. 
In 1974, Larry Overman reported the first [3,3]-sigmatropic rearrangement of allylic 
trichloroacetimidates to corresponding allylic trichloroacetamides.4 This 
transformation involves the reaction of allylic alcohol 7 with trichloroacetonitrile in 
the presence of catalytic amounts of base to form the allylic trichloroacetimidate 8. 
This can be then directly converted to the allylic trichloroacetamide 9 through a 
[3,3]-sigmatropic rearrangement, which can be carried out either thermally or 
catalysed by transition metal complexes (known as the Overman rearrangement) 
(Scheme 4). Due to the ease of preparation of allylic trichloroacetimidates as well 
as the high yields obtained for the final allylic amide products, this process has 
become an attractive and useful methodology in synthetic organic chemistry. 
Moreover, removal of the trichloroacetyl-protecting group to form allylic amines 
would allow access to wide variety of nitrogen-containing products including 
natural products, amino acids, amino sugars, peptides, modified nucleotides and 
other N-heterocycles.5 
 
O
NPh
Ph
O
NPh
Ph
215 °C, 3 h
5 6
 15 
 
Scheme 4: Overman rearrangement. 
1.2.1 Thermal Overman Rearrangement 
The Overman rearrangement can be carried out either thermally or catalysed by 
transition metals such as Hg(II) or Pd(II).4,6 Under thermal conditions, the 
rearrangement is usually performed in solvents such as p-xylene at elevated 
temperatures.4 Several studies have shown the broad scope of the thermal 
Overman rearrangement, in which the process can be applied to a wide range of 
primary, secondary and tertiary allylic alcohols. Temperatures required for these 
reactions are highly dependent on the structure of the imidates.6 For example, the 
imidic esters of primary allylic alcohols can be isomerised at 140 ºC, while the 
tertiary imidates rearrange at 80 ºC.   
Similar to other pericyclic reactions, the [3,3]-sigmatropic rearrangement follows 
the Woodward-Hoffmann rules in which the rearrangement proceeds via a 
suprafacial process, thus it is thermally allowed.7 As proposed by Shimoda and co-
workers, the mechanism of this transformation proceeds via chair-type transition 
structure 11 in a concerted process, which means complete transfer of chirality 
from the allylic imidate to the allylic amide can be achieved.8 In this process a new 
carbon-nitrogen bond is formed from the same face as the carbon-oxygen bond 
that is broken (Scheme 5). 
 
Scheme 5: Thermal Overman rearrangement. 
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The rearrangement process is normally conducted in aprotic aromatic solvents 
such as xylene or toluene. However, more polar solvents such as DMF are 
preferred in some cases.9 For example, the rearrangement of dissaccharide 
trichloroacetimidate 13 proceeded with 27% yield using xylene, whereas the yield 
dramatically increased to 80% when the reaction was carried out in DMF (Scheme 
6).9 The higher yield in this transformation is due to the use of DMF as a more 
polar and basic solvent which reduces the acid-catalysed decomposition of the 
imidate and enhances the reaction rate. 
 
Scheme 6: Solvent effects on the yield of Overman rearrangement. 
In 1998, Isobe and co-workers showed that the decomposition of the imidate could 
be avoided by adding small quantities of base to the reaction mixture.10 They 
found that at high temperatures, the presence of small amounts of acidic by-
products caused decomposition of the imidate starting material. This issue was 
avoided by adding a small quantity of potassium carbonate (2 mg/mL), resulting in 
an increase of yield (Scheme 7). Since then, these have become the most 
commonly used conditions for the thermal Overman rearrangement. 
	
Scheme 7: Thermal Overman rearrangements of 15 with and without base. 
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The thermal Overman rearrangement can be influenced by the halogen 
substituent on the imidate. For example, the rearrangement of trichloroacetimidate 
analogue 17a can provide the trichloroacetamide product 18a in high yield, 
whereas a lower yield is observed for the trifluoroacetamide analogue 18b 
(Scheme 8).10,11 However, this is not always the case. In other examples, the 
trifluoro analogues can rearrange faster and more efficient than the trichloro 
derivatives. 
 
Scheme 8: Effects of halogen substituent on the thermal Overman rearrangement. 
The presence of substituents on the gamma carbon of the imidate can play an 
important role on the thermal rearrangement. The example below shows the 
difference in yields between the rearrangements of para- and ortho-substituted 
aromatic trichloroacetimidates 19a–b (Scheme 9).12 While the para-substituted 
analogue rearranges to 20a in 82% yield after 12 hours, the ortho-substituted 
amide 20b is formed in a much lower yield (30%) and longer time (24 hours). The 
difference in reactivity between both reactions was due to steric hindrance effects 
between the γ-methyl group and the ortho-chlorine during rearrangement. 
 
Scheme 9: Steric effects on the rearrangement of 19a–b. 
In terms of regioselectivity, the thermal rearrangement of an imidate having two 
different double bonds normally gives a mixture of two regioisomers. For example, 
the rearrangement of dienyl imidate derived from allylic alcohol 21 leads to a 
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mixture of both amides 22a and 22b in a ratio of 60:40 (Scheme 10).6 The slight 
observed preference may due to faster rearrangement at the less hindered alkene. 
 
Scheme 10: Regioselectivity in the Overman rearrangement. 
The use of the [3,3]-sigmatropic rearrangement is especially important because it 
allows access to wide range of allylic amides with a complete transfer of chirality 
from the allylic imidate starting materials. This was first demonstrated by Shimoda 
and co-workers, who subjected the E-trichloroacetimidate 10 to a thermal 
Overman rearrangement to give the corresponding trichloroacetamide 12 in a 74% 
yield with no loss of chirality (Scheme 5).8 This was a consequence of the reaction 
progressing via a chair-like transition state 11. This feature can also be observed 
in the rearrangement of allylic trichloroacetimidates with a Z-geometry, such as 24 
(Scheme 11).13 
 
Scheme 11: Chirality transfer in the thermal rearrangement of 24. 
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1.2.2 Metal catalysed Overman rearrangements 
The Overman rearrangement of allylic trihaloacetimidates can be catalysed using 
various transition metals such as Hg(II), Pd(II), Au(I) or Pt(II).2b,4,6,14 Therefore, this 
reaction can be carried out under mild conditions using low temperature, and 
sometimes resulting in higher yields and cleaner reactions.6 
1.2.2.1 Mercury (II)-catalysed Overman rearrangement 
The first catalysed [3,3]-sigmatropic rearrangement of allylic trichloroacetimidates 
using mercuric salts such as mercuric trifluoroacetate (or mercuric nitrate) was 
reported by Overman in 1974.4 It was shown that using mercury(II) as a catalyst 
increased the reaction rate by up to 1012, allowing the reaction to proceed at room 
temperature. Therefore, allylic trichloroacetimidate 26 was rearranged to the 
corresponding allylic trichloroacetamide 28 using Hg(II) as a catalyst under mild 
conditions (Scheme 12). This transformation involves a two step mechanism in 
which Hg(II) coordinates to the alkene first, allowing the mercurinium ion to be 
formed, which then forms intermediate 27 by generation of a Hg–C sigma bond. 
Secondly, cleaving the C–O bond of the intermediate leads to the formation of the 
amide product 28.4 
 
Scheme 12: Mechanism of Hg(II)-catalysed Overman rearrangement. 
It has been demonstrated that the catalysed reaction is dependent on the allylic 
trichloroacetimidate structure, in which the presence of an R group attached to the 
imidate can promote nucleophilic attack of the imino nitrogen to the C-3 carbon 
atom.6 For example, C3-substituted allylic trichloroacetimidates 29 and 31 
rearranged successfully to allylic trichloroacetamides 30 and 32 in higher yields at 
low temperatures, compared to the harsh conditions used for the thermal 
rearrangement (138 °C) of the same substrates (Scheme 13). 
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Scheme 13: Early reported examples of Hg(II)-catalysed Overman rearrangement. 
However, the scope of the mercuric-catalysed process is limited for other allylic 
substrates bearing terminal vinyl groups such as 33, in which the intramolecular 
nucleophilic addition of the imino nitrogen at C-3 fails to rearrange (Scheme 14).6 
Therefore, the formation of allylic trichloroacetamide 34 is disfavoured, as the 
imino nitrogen will more likely attack at C-2 position. For the same reason, the 
Hg(II)-catalysed rearrangement of the cyclic allylic imidate 35 was unsuccessful. 
 
Scheme 14: Limitation of Hg(II)-catalysed Overman rearrangement. 
1.2.2.2 Palladium (II)-catalysed Overman rearrangement 
Palladium (II)-complexes have become the most successful catalysts since the 
first reported use of mercuric trifluoroacetate for [3,3]-sigmatropic rearrangements, 
allowing previously difficult transformations to be performed at room temperature 
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with lower catalyst loading and minimal amounts of by-products.15 The Pd(II)-
catalysed rearrangement is believed to proceed via a cyclisation-induced 
mechanism, which is similar to that previously proposed by Henry for the Pd(II)-
catalysed rearrangement of allylic acetates.16 This mechanism involves a stepwise 
pathway, in which the palladium coordinates to the allylic double bond of imidate 
37 to initially form complex 38 (Figure 1). This coordination activates the alkene 
and promotes cyclisation via nucleophilic attack by the imidate nitrogen to form the 
cyclic carbocation intermediate 39. Cleavage of the Pd−C sigma bond completes 
the final stage to give acetamide product 40 and regenerates the catalyst.15−18 
 
Figure 1: Mechanism of Pd(II)-catalysed Overman rearrangement. 
Similar to the thermal reaction, Schenck and Bosnich suggested that the catalytic 
reaction also proceeds via a chair-like transition state (e. g. 41), in which the 
palladium catalyst at C2 is placed in the equatorial position, leading to the most 
stable intermediate.18 This transition state explains the complete transfer of 
chirality from the starting imidate to the amide product, as the C−N bond forming 
takes place on the same face as the cleavage of the C−O bond (Scheme15). The 
metal catalysis of the Overman rearrangement mainly generates a single [3,3]-
sigmatropic product when metal complexes such as Hg(CF3CO2), PdCl2(CH3CN) 
and H2[PtCl6] are employed. However, the use of zero-valent metal complexes 
such as Pd(PPh3)4 and Pt(PPh3)4 promotes the formation of the [1,3]-rearranged 
product (anti-Claisen) in a competing non-concerted process.18  
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Scheme 15: Mechanisms of [3,3]- and [1,3]-rearrangements. 
Recently, palladium (II)-complexes, PdCl2(PhCN)2 and PdCl2(CH3CN)2 have 
become the most widely used catalysts, which were successfully employed in the 
rearrangement of wide range of allylic imidates. In 1992, Metz and co-workers 
reported the Pd(II)-catalysed Overman rearrangement of different secondary allylic 
trichloroacetimidates.19 For example, in the presence of PdCl2(PhCN)2, allylic 
trichloroacetimidates 42 and 44 rearranged to the desired amide products 43 and 
45 in high yields with complete transfer of chirality (Scheme 16). 
 
Scheme 16: Pd(II)-Catalysed Overman rearrangement of secondary allylic 
trichloroacetimidates. 
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1.2.3 Asymmetric Overman Rearrangement 
After the success of the metal-catalysed trichloroacetimidate rearrangements, 
significant attention turned to the development of chiral palladium (II)-catalysts to 
produce an asymmetric Overman rearrangement. This could then be utilised in the 
synthesis of important enantiopure nitrogen-containing compounds. During the 
asymmetric rearrangement process, the catalyst coordinates to one face of the 
alkene allowing the intramolecular nucleophilic attack by the imino nitrogen to 
occur at the other unhindered face.20,21 This then leads to the formation of a single 
stereoisomer of the desired allylic acetamide. 
In 1997, Overman and co-workers reported the first successful application of 
Pd(II)-complexes for the asymmetric rearrangement of different prochiral allylic 
imidates.20 The cationic palladium diamine complex 48 was easily synthesised in 
four-steps from (S)-proline. This catalyst was utilised as an enantioselective 
catalyst for the rearrangement of various N-arylbenzimidates, including 46 to 
amides such as 47, in good yield and modest enantiomeric excess (Scheme 17). 
Hayashi and co-workers then reported a series of cationic oxazoline palladium 
catalysts for the rearrangement of 46, and this gave 47 in moderate yields and 
enantioselectivities (41% yield, 76% ee).22 
 
Scheme 17: The first diamine catalyst for enantioselective Overman rearrangement. 
However, catalyst 48 failed to rearrange other substrates, e.g. 49 when X= CCl3 or 
CF3, in the same way, and resulted in the formation of the [1,3]-rearranged side-
product 50, as well as other elimination products (Scheme 18).20 
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Scheme 18: [1,3]- and [3,3]-rearrangements pathways. 
One of the main issues with the cationic complexes was the competing elimination 
reaction that occurs due to the coordination between the imidate nitrogen and the 
cationic Pd. To overcome this issue, Overman and co-workers reported the first 
neutral chiral catalyst, ferrocenyl palladacycle 51.23 This catalyst proved to be 
more effective for the [3,3]-sigmatropic rearrangement of the same benzimidate 
substrate 46 to benzamide 47, in greater yield (98%), without the formation of any 
side-products. However, the enantioselectivity remained moderate (61% ee) 
(Scheme 19).  
 
Scheme 19: The first reported neutral chiral catalyst, ferrocenyl palladacycle 51. 
In an attempt to enhance the enantioselectivity, Donde and Overman developed 
various ferrocenyl oxazoline palladacycles (FOP) catalysts, including 54, for the 
rearrangement of several E- and Z-allylic N-arylbenzimidates, such as 52.24 
Among all the catalysts, only 54 was found to effectively catalyse the 
rearrangement and gave benzamide product 53 in excellent yield and greatly 
improved enantiomeric excess (96% ee) (Scheme 20). However, the scope of the 
rearrangement using these catalysts was limited to benzimidate substrates only. 
Thus, this transformation is not useful for the preparation of the corresponding 
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allylic amines as the 4-methoxyphenyl and benzoyl groups are difficult to remove 
from the resulting N-arylbenzamides. 
 
Scheme 20: Asymmetric Overman rearrangement using FOP catalyst 54. 
Other ferrocenyl catalysts, such as 55 (Figure 2) were synthesised by Kang and 
co-workers and applied to the rearrangement of various allylic benzimidate 
substrates with E- and Z-geometry, such as 52, giving the desired amides in 
excellent yields and enantioselectivities (53, 91% yield and 92% ee) in a shorter 
reaction time of 0.5 hours.25 Again, this catalyst was only applicable for 
benzimidate substrates, which limited the scope of the rearrangement process. 
 
Figure 2: Neutral ferrocenyl catalyst 55. 
More recently, the cobalt oxazoline palladacycles (COP-Cl 56 and 57, Figure 3) 
have emerged as the most useful asymmetric catalysts to date. Kang and co-
workers reported the first use of silver-activated COP-complex (generated in situ 
from the reaction of COP complex 56 and 2 equivalents of silver trifluoroacetate) 
for the rearrangement of allylic Z-benzimidates 58 (Scheme 21).26 This gave the 
corresponding rearranged amides 59 in excellent yields and enantioselectivities. 
On the other hand, moderate yields and enantioselectivities were obtained for the 
rearrangement of the corresponding allylic E-imidates, with the reactions 
proceeding more slowly. 
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Figure 3: (S)- and (R)-COP-Cl catalysts. 
 
Scheme 21: Asymmetric rearrangement of allylic Z-benzimidates using silver-
activated COP Catalyst. 
At the same time, Overman and Richards reported the use of COP-Cl complex 56 
in the enantioselective rearrangement of E-trifluororoacetimidates 60, giving the 
rearranged (S)-trifluororoacetamide products 61 in excellent yields and high 
enantioselectivities (Scheme 22).21 Interestingly, it was found that the COP-Cl 
catalysts could achieve optimal results for the rearrangement process without pre-
activation with silver salts. Moreover, these catalysts also proved to be highly 
efficient towards other substrates such as E-allylic trichloroacetimidates 62, 
providing excellent results for the allylic trichloroacetamide products 63.27 The 
allylic trichloroacetimidates are preferred substrates because they can be easily 
prepared from readily available allylic alcohols in high yields. Also, the 
trichloroacetyl-protecting group can be removed under basic conditions to form the 
corresponding chiral allylic amines. However, the COP-catalysed process was not 
successful with the Z-configured imidates, and also when the olefin substituents 
are bulky (such as tert-butyl group) or aryl derived.27 
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Scheme 22: Enantioselective (S)-COP-Cl catalysed Overman rearrangement. 
More recently, Peters and co-workers reported the synthesis of novel chiral 
ferrocenyl-imidazoline palladacycle complexes 64a−c and bispalladacycle catalyst 
65 (Figure 4).28,29 These palladacycles were found to be excellent chiral catalysts 
for the rearrangement of Z- and E-configured imidates. Also, they could be a 
suitable alternative to the COP-Cl complexes, in terms of their efficiency in the 
rearrangement of Z-imidate substrates. 
These catalysts were successfully applied to the enantioselective rearrangement 
of various Z- and E-configured N-para-methoxyphenyl-trifluoroacetimidates 60, 
affording the corresponding allylic trifluoroacetamides 61 in excellent yields and 
enantioselectivities (Table 1). Complex 64c was found to be most effective for the 
rearrangement of allylic E-imidates.28 With the Z-configured substrates; excellent 
results were obtained using palladacycles 64a and 64b or bispalladacycle 65.28,29 
In contrast to other catalysts, it is possible to lower the catalyst loading to 0.05 
mol%, without affecting the reaction outcome. However, these catalysts still 
require pre-activation with silver salts. 
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Figure 4: Chiral ferrocenyl-imidazoline palladacycle 64a−c and bispalladacycle 65. 
 
Entry R Geometry 
Catalyst 
(mol %) 
Temp. 
(°C) 
Yield 
(%) 
ee 
(%) 
1 n-Pr Z 64a, 5 20 75 89 (S) 
2 (CH2)2Ph Z 64a, 5 20 70 90 (S) 
3 i-Bu Z 64a, 5 20 69 96 (S) 
4 n-Pr Z 64b, 5 40 72 93 (S) 
5 (CH2)2Ph Z 64b, 5 40 95 95 (S) 
6 i-Bu Z 64b, 5 40 82 96 (S) 
7 n-Pr E 64c, 0.05 40 95 95 (R) 
8 n-Pr Z 64c, 5.0 40 36 85 (S) 
9 Me E 64c, 0.05 40 98 92 (R) 
10 (CH2)2Ph E 64c, 0.05 40 99 98 (R) 
11 i-Bu E 64c, 0.2 40 96 98 (R) 
12 n-Pr Z 65, 1.0 20 96 98 (S) 
13 Me Z 65, 1.0 20 94 96 (S) 
14 (CH2)2Ph Z 65, 1.0 20 99 96 (S) 
15 i-Bu Z 65, 1.0 20 87 98 (S) 
Table 1: Enantioselective rearrangement results with palladacycle catalysts 64a−c 
and 65. 
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1.2.4 Substrate directed palladium(II)-catalysed Overman rearrangement 
A substrate-directed Overman rearrangement is an important approach that can 
be used to introduce stereoselectivity without employing a chiral catalyst. This 
involves the use of an imidate substrate bearing a chiral directing group adjacent 
to the alkene. This chiral functionality can be used to direct the catalyst to one face 
of the alkene, allowing nucleophilic attack by the imidate nitrogen to take place at 
the least hindered face of the substrate. This then leads to stereochemical control 
during the rearrangement process. 
In 1993, Belluš and co-workers reported the first example of a substrate directed 
Overman rearrangement for the synthesis of 1,2-diamines.30 In this example, 
allylic trichloroacetimidate 69 was first prepared in 96% yield from allylic alcohol 68 
(containing chiral a Boc-protected amine in the vicinity of the alkene) (Scheme 23). 
This amine-directing group was successfully utilised in the Pd-catalysed 
rearrangement of 69 to give the anti-diastereomer 71 as a major product in 
excellent diastereoselectivity and modest yield. The high diastereoselectivity was 
explained using a chair-like transition state 70, with the palladium coordinating to 
the amine nitrogen and the alkene. 
 
Scheme 23. The first example of a substrate directed Overman rearrangement. 
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The substrate directed process was further investigated within the Sutherland 
research group using different ether chiral directing groups. Work by Jamieson 
and Sutherland showed that unhindered ether directing groups could be effectively 
used to direct the palladium catalyst in a similar way to that described above by 
Bellûs.31 In this study, a number of allylic trichloroacetimidates 72 having different 
ether groups were synthesised and then subjected to Pd-catalysed Overman 
rearrangement (Table 2). The methoxymethyl (MOM) group was found to be the 
most effective directing group to give the anti-diastereomer 73a as a major product 
in 10:1 ratio with 64% yield (entry 5). The higher observed diastereoselectivity was 
attributed to the catalyst coordinating to both oxygen atoms of the MOM group. On 
the other hand, bulky ether groups prevented coordination of the metal catalyst to 
the alkene and gave products in poor selectivities (entries 1, 2, 3). 
 
Entry R Yield (%) Ratio (73a:73b) 
1 TBDMS 68 2:1 
2 Tr 70 3:1 
3 Bn 62 3:1 
4 Me 49 7:1 
5 MOM 64 10:1 
6 MEM 60 8:1 
Table 2: Substrate directed rearrangement of allylic trichloroacetimidate 72 
containing different ethers. 
Using the MOM-ether as a directing group, Sutherland and co-workers further 
expanded the scope of this process.32 Several allylic trichloroacetimidates 74 with 
a variety of side chains were synthesised and subjected to the substrate directed 
rearrangement process. This allowed the formation of the desired anti-
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diastereomers 75a in good yield with excellent diastereoselectivity (Table 3, 
entries 1, 2 and 3). It was noticed that trace amounts of the [1,3]-rearranged 
product 57c was formed. As previously demonstrated by Ikariya and Bosnich, this 
by-product is normally observed when palladium(0) catalyst exists in the reaction 
mixture.17,18 The Pd(0) was believed to be formed due to the slower 
rearrangement of the bulkier substrates, via a competing β-elimination process. 
This issue was overcome by the addition of p-benzoquinone, a re-oxidant used to 
convert Pd(0) to Pd(II). This effectively suppressed the formation of [1,3]-products 
and led to the desired [3,3]-products more cleanly (entries 4, 5 and 6). Further 
oxidation and deprotection of the resulting allylic trichloroacetamides 75a led to the 
corresponding β-hydroxy-α-amino acids. More recently, the Sutherland group also 
examined the ether-directed Overman rearrangement process using a variety of 
metal catalysts and solvents. The best results were achieved using Pd(II) or Pt(II) 
catalysts in THF or toluene.33   
 
Entry R Additive Yield (%)a 
Ratio 
(75a:75b:75c) 
1 i-Bu - 60 14:1:1 
2 PhCH2 - 54 12:1:0 
3 PhCH2CH2 - 65 9:1:4 
4 i-Bu p-benzoquinone 73 14:1:0 
5 PhCH2 p-benzoquinone 70 12:1:0 
6 PhCH2CH2 p-benzoquinone 69 9:1:0 
Table 3: Scope of MOM-ether directed Overman rearrangement. aIsolated combined 
yields of 75a, 75b and 75c from allylic alcohol. 
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1.2.5 Applications of the Overman rearrangement 
The Overman rearrangement has found widespread application in synthetic 
organic chemistry.34 As previously mentioned, this is due to the relative ease of 
preparation of the allylic trichloroacetimidates from readily available allylic alcohols 
as well as the high yields obtained for the final allylic amide products. The 
Overman rearrangement is especially important because of its ability to generate 
new stereocentres. Also it can provide products in high stereoselectivity, due to 
the complete transfer of chirality from allylic alcohols to the new C−N bond. 
Moreover, removal of the trichloroacetyl-protecting group to form allylic amines 
has then allowed access to wide variety of nitrogen-containing products including 
natural products, amino acids, amino sugars, peptides, modified nucleotides and 
other N-heterocycles.5,34 
For example, (–)-agelastatin A (84), a marine alkaloid was isolated from axinellid 
sponge Agelas dendromorpha.35 It is identified as an antimetastatic and 
antineoplastic agent and also shows insecticidal properties.36−38 In 2009, Chida 
and co-workers reported the use of a cascade thermal Overman rearrangement as 
a key transformation for the synthesis of this target (Scheme 24).39 In this 
synthesis, allylic diol 77 was first prepared in multiple steps from a commercially 
available (–)-2,3-O-isopropylidene-D-threitol (76). In the presence of 
trichloroacetonitrile and base, allylic vicinal diol 77 was converted to the 
corresponding allylic bistrichloroacetimidate 78, which then underwent a 
sequential thermal Overman rearrangement to produce the bistrichloroacetamide 
80 in 58% overall yield. The observed transfer of chirality from allylic alcohol 77 to 
the new C−N bond was a direct consequence of the concerted nature of the 
Overman rearrangement. A Mislow-Evans rearrangement was then employed to 
produce the hydroxyl group at the C5 carbon. Subsequent ring closing metathesis 
of 81 gave cyclopentene 82, which upon treatment with methanesulfonic 
anhydride afforded the oxazoline 83 in 58% yield over three steps. Further 
functionalisation of oxazoline 83 to install the piperazinone ring completed the 
synthesis of (–)-agelastatin A (84).  
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Scheme 24: The total synthesis of (–)-agelastatin A (84) using a cascade thermal 
Overman rearrangement. 
Within the Sutherland research group, the palladium(II)-catalysed MOM-ether 
directed Overman rearrangement has been employed for the stereoselective 
synthesis of several biologically active molecules and natural products.32,40−43 For 
example, (+)-monanchorin (90), a guanidine alkaloid isolated from the sponge 
Monanchora ungiculata.44 The Pd(II)-catalysed Overman rearrangement was used 
as a key step to generate the second stereogenic centre. Initially, the desired 
allylic alcohol 85a was prepared and then treated with trichloroacetonitrile and 
DBU to obtain allylic trichloroacetimidate precursor 86a (Scheme 25).41 The 
imidate 86a was then subjected to the Pd-catalysed MOM-ether directed Overman 
rearrangement. This gave the corresponding trichloroacetamide 87a in 84% yield 
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with a 12:1 diastereomeric ratio between the anti and syn [3,3]-products. p-
Benzoquinone was added to the reaction mixture to inhibit the formation of the 
[1,3]-by-product, resulting in an improved yield of the major anti-diastereomer. The 
amine of the major diastereomer 87a was then re-protected as benzyloxy 
carbamate. This was followed by a cross metathesis with 2-vinyl-1,3-dioxolane 
and then hydrogenation to form the amine 88. Coupling of amine 88 with a 
commercially available guanylation reagent gave 89 in 87% yield. Finally, 
treatment of 89 with TFA completed the synthesis of the natural product (+)-
monanchorin (90). 
More recently, the Sutherland group utilised the same methodology for the 
synthesis of clavaminols A (93), C (94) and H (95) (Scheme 25).42 Clavaminols 
are a class of amino alcohols isolated from the Mediterranean ascidian Clavelina 
phlegraea.45,46 These compounds, in particular (–)-clavaminol A, have shown 
cytotoxic properties against a number of cancer cell types such as breast, lung 
and gastric.46 In this synthesis, the Pd(II)-catalysed Overman rearrangement of 
allylic trichloroacetimidate 86b gave the anti-product 87b as a major diastereomer 
in 13:1 ratio. The anti-diastereomer 87b was isolated in 70% yield. Under 
reductive conditions, ozonolysis of the allylic trichloroacetamide 87b gave alcohol 
91 in 88% yield. Reduction of the trichloroacetyl group of 91 using n-tributyltin 
hydride followed by selective deprotection of the MOM group gave the desired (+)-
clavaminol H (95). To form the methyl side-chain, alcohol 91 was converted to the 
corresponding bromide 92. Cleavage of the C−Br bond and reduction of the 
trichloroacetyl group in a one-pot reaction, followed by selective deprotection of 
the MOM group gave (+)-clavaminol C (94). Removal of both protecting groups 
gave (–)-clavaminol A (93). 
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Scheme 25: Pd(II)-Catalysed MOM-ether directed Overman rearrangement for the 
stereoselective synthesis natural products 90, 93, 94 and 95. 
In 2003, Overman and co-workers reported the successful use of a chiral 
palladium catalyst [(S)-COP-Cl 56] for the enantioselective synthesis of various 
allylic trichloroacetimidates to the corresponding allylic trichloroacetamides 
(Scheme 22).27 In the same paper, they applied this methodology for the synthesis 
of the natural product (S)-vigabatrin (96) (Scheme 26). Initially, asymmetric Pd(II)-
catalysed Overman rearrangement of 62 using (S)-COP-Cl 56 gave allylic 
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trichloroacetamide 63 in 73% yield and 95% ee which was then after treatment 
with 6 N HCl gave (S)-vigabatrin (96) in 75% yield. 
 
Scheme 26: Asymmetric synthesis of (S)-vigabatrin using (S)-COP-Cl. 
Since then there have been only a few examples appeared in the literature for 
using COP catalysts in natural products synthesis. One of these was reported by 
Han and co-workers for their synthesis of the trisubstituted piperidine (+)-iso-6-
cassine (101), which is an important core structure of several biologically active 
compounds (Scheme 27).47 An asymmetric Overman rearrangement of 99 using 
(S)-COP-Cl 56 was carried out to form allylic trichloroacetamide 100. The 
Overman rearrangement was essential to generate the second stereocentre of the 
target compound. An intramolecular amidomercuration reaction to establish the 
third stereocentre followed by cross metathesis to attach the side-chain then gave 
compound 101. 
 
Scheme 27: Synthesis of (+)-iso-6-cassine using a (S)-COP-Cl catalysed Overman 
rearrangement. 
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1.2.6 Conclusions 
The Overman rearrangement has been used as a key step in the synthesis of a 
wide range of nitrogen-containing products including natural products, amino acids 
and other N-heterocycles. This reaction can provide products in high yields and 
stereoselectivity and it is especially important because of its ability to generate 
new stereocentres. Recently, advances have been made toward the synthesis of 
chiral palladium catalysts such as the COP-Cl catalysts. These catalysts have 
been successfully employed in natural products synthesis. In addition, substrate-
directed Overman rearrangement has been recently developed as an alternative 
way to introduce stereoselectivity without employing a chiral catalyst. This 
approach has been successfully employed in the synthesis of a variety of amino 
acids, amino alcohols and alkaloid natural products. 
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1.3 One-pot multi-step processes 
Enhancing the efficiency and handling of waste are two major issues in modern 
organic chemistry. These concepts should be considered carefully during the 
design of any synthetic process.48 In other words, these can be described in terms 
of reducing the number of synthetic steps to a target compound (step economy),49 
incorporating all atoms of each reagent into the final product (atom economy),50,51 
and avoiding isolation and purification of intermediates as necessary by carrying 
out as many sequential transformations in the same reactor (pot economy).52 This 
in turn means reducing the amount of reagents and solvents, leading to significant 
reduction of waste which would lead to greener synthetic methods. To meet this 
aim, organic chemists have recently turned attention to the development of one-
pot multi-bond forming processes as efficient synthetic methodologies that allows 
the synthesis of complex structures from simple and readily available starting 
materials.48,53,54 
Generally, the term “one-pot process” refers to a process in which multiple 
transformations and bond-forming steps can take place in a single reaction vessel, 
without isolation or purification of intermediates.53,54–57 This makes dealing with 
unstable, toxic, volatile and sensitive intermediates easier. The use of these 
processes helps to minimise the amount of solvents and reagents as well as 
reducing waste, which can lead to great benefits for the environment. Other 
advantages of developing one-pot processes are reduction of cost and time and 
also increasing the chemical yield. In general; the one-pot process is an effective 
way to make the chemical reaction more efficient. One-pot processes can be 
generally classified into three different terminologies: domino/cascade, tandem or 
classical one-pot multi-step process.57 
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1.3.1 Domino/cascade catalysis 
The domino reaction, sometimes identified as a cascade reaction, is an important 
approach in organic chemistry for the synthesis of complex structures. This type of 
reaction was defined, by Tietze, as “a process involving two or more bond-forming 
transformations which take place under the same reaction conditions, without 
adding additional reagents and catalysts, and in which the subsequent reactions 
result as a consequence of the functionality formed in the previous step” (Scheme 
28).58 Faber has further added that “both individual reactions belong tightly 
together and are rather difficult to perform in a stepwise fashion. As a 
consequence, the intermediate between both steps is likely to be unstable and 
eludes isolation and characterisation”.59 Fogg additionally stated that all 
transformations are involved in a single reaction mechanism.57 The cascade type 
catalysis was defined by Fogg as multiple (≥3) domino reactions.57  
 
Scheme 28: Illustration of domino/cascade process. 
Palladium catalysed transformations are of great importance for the construction of 
carbon−carbon bond and have been widely utilised in domino and cascade 
catalysis. In 2003, Larock and co-workers reported a typical example of a domino 
reaction for the synthesis of tetrasubstituted alkene 105 (Scheme 29).60 The first 
step of this transformation is a regioselective carbopalladation of 103 with an aryl 
palladium intermediate generated from the oxidative addition of aryl halide 102 
with Pd(0), to form the vinylic palladium intermediate 104. Subsequent Suzuki-type 
transmetalation followed by reductive elimination gave tetrasubstituted alkene 
product 105 in 94% yield. 
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 40 
 
Scheme 29: Palladium catalysed synthesis of tetrasubstituted alkene 105. 
An example of cascade reactions using ruthenium complexes was reported by 
Phillips and Pfeiffer who utilised a two directional metathesis cascade process in 
their synthesis of the natural product (+)-cyanthiwigin U (110) (Scheme 30).61 Bis-
enone 107 was first prepared from dialdehyde 106, and then treated with Grubbs 
second-generation catalyst (Grubbs II) to initiate the ring-opening metathesis 
(ROM) reaction and produce intermediate 108. This was followed by two 
sequential ring-closing metathesis (RCM) reactions to give tricyclic core 109 in 
43% overall yield from dialdehyde 106. A five further steps completed the total 
synthesis of 110. 
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Scheme 30: Cascade ROM/RCM process for the synthesis of (+)-cyanthiwigin U 
(110). 
1.3.2 Tandem catalysis 
The term tandem catalysis was described as a multiple catalysis process in which 
sequential reactions of the substrate take place via two or more distinct 
mechanisms (Scheme 31).56,57 In this process, intermediates are more likely to be 
stable. According to Fogg’s classification, the tandem catalysis was further divided 
into three different categories: orthogonal, auto- and assisted tandem catalysis.57 
Orthogonal catalysis involves two (or more) distinct and non-interfering catalysts, 
each of them catalyses an independent transformation and all must be present 
(with any other required reagents) from the reaction outset.56,57,62 In the auto-
tandem catalysis, only a single catalyst is used to effect two (or more) distinct 
transformations in two different mechanisms, without adding reagents to prompt 
any change in mechanism.56,57,63,64 In a similar way, a single catalyst is still 
employed in the assisted catalysis, except that after the completion of the first 
cycle, reagents must be added to trigger a change in the catalyst and start another 
cycle.56,57 
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Scheme 31: Illustration of tandem catalysis. 
One of the most popular uses of the tandem catalysis has been in the synthesis of 
heterocyclic scaffolds using different metal-ligand combinations. Recently, Lautens 
and co-workers reported the synthesis of dihydroquinolines 113 via a 
rhodium/palladium-catalysed orthogonal tandem process (Scheme 32).65 The 
process started with a Rh-catalysed alkyne arylation of disubstituted alkyne 111 to 
form the phenylallyl 112. This was followed by a Pd-catalysed C−N coupling 
reaction to furnish the desired dihydroquinoline 113. Control experiments were 
carried out to investigate the catalyst−ligand compatibility. It was found that Rh/X-
Phos and Pd/BINAP display low reactivity for the arylation reaction (5% yield with 
partial decomposition of starting material 111) and no reaction for the C−N 
coupling. Ligand-free arylation only led to decomposition of 111. The authors also 
found that palladium can bind equally and competitively to both ligands. To 
overcome this issue, catalysts were premixed with their specified ligands and then 
added to the reaction mixture to enable the formation of the final product in high 
overall yield.     
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Scheme 32: Rh/Pd-catalysed orthogonal tandem process for the synthesis of 
dihydroquinoline 113. 
1.3.3 Classical one-pot multi-step process 
Classical one-pot multi-step process (one-pot synthesis) can simply combine all 
previous terminologies (domino/cascade and tandem) except that catalysts and 
reagents can be added any time during the one-pot process as needed, which 
make these processes easier to develop and can have broader scope.54,57,66   
The concept “pot economy”, which was proposed by Clarke, is based on carrying 
out several sequential transformations in the same reactor without isolation or 
purification of intermediates.52 This pot economic approach has been effectively 
demonstrated in the total synthesis of natural products and medicinally important 
compounds.67–71 For example, Hayashi and Umemiya employed a three-pot 
process in their synthesis of prostaglandin E1 (PGE1) methyl ester (123) (Scheme 
33).71 The first one-pot reaction started with an asymmetric Michel addition of 
succinaldehyde 114 and nitroalkene 115 using organocatalyst 116, followed by an 
intramolecular Henry reaction to obtain the cyclopentane 117. Subsequent Horner-
Wadsworth-Emmons reaction then afforded the prostaglandin skeleton 118 in 81% 
yield over the four-step process with high diastereoselectivity. As 117 is unstable, 
it was important to carry out the HWE reaction in the same pot, where in an 
attempt to isolate 117, the yield was low. A diastereoselective reduction of ketone 
118 in a single pot using (–)-diisopinocamphenyl chloroborane (DIPCl) gave allylic 
alcohol 119 in 68% yield. In a second one-pot process, further functionalisation of 
the cyclopentyl ring completed the synthesis of PGE1 methyl ester 123 in 14% 
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overall yield. 
 
Scheme 33: Three-pot synthesis of PGE1 methyl ester (123). 
1.3.4 One-pot process initiated by Overman rearrangement 
The Overman rearrangement is an important tool in C–N bond formation, and has 
been extensively used as a single step in the total synthesis of natural products, 
and other valuable compounds.34 This reaction can be also combined with other 
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transformations in one-pot processes. For example, a mercury(II)-mediated one-
pot tandem Overman rearrangement/intramolecular amidomercuration process 
was reported by Han and Singh for the synthesis of trans-2,6-dialkylpiperidine 127 
(Scheme 34).72 The tandem process was initiated by treatment of allylic 
trichloroacetimidate 124 with mercury(II) catalyst to form allylic amide 125 which 
then underwent an intramolecular amidomercuration reaction to produce the 
desired piperidine product 126 in 90% yield. In another one-pot process, 
demercuration of 126 followed by reprotection of the amine group gave 127 in 
70% yield. 
 
Scheme 34: A mercury(II)-mediated tandem Overman rearrangement/intramolecular 
amidomercuration reaction for the synthesis of trans-2,6-dialkylpiperidine 127. 
Another example of one-pot reactions initiated by Overman rearrangement was 
reported by Chida and co-workers for the synthesis of the natural product (–)-
stemoamide (134) (Scheme 35).73 In the presence of DBU and ZnCl2 (catalytic), 
allylic diol 128 was treated with trichloroacetonitrile to form cyclic orthoamide 129. 
The use of ZnCl2 was important to prevent the formation of the undesired bis-
trichloroacetimidate. Compound 129 was then heated to initiate the ring opening 
and generate imidate 130. In the same pot, compound 130 was subjected to the 
Overman rearrangement to form allylic amide 131. Allylic alcohol of 131 then 
underwent a Johnson-Claisen rearrangement using triethyl orthoacetate and 2-
nitrophenol to form the rearranged product 132 as a single diastereomer in 47% 
overall yield. Furthermore, both esters of 132 were hydrolysed to the 
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corresponding acids and then selectively cyclised to form the lactone and lactam 
rings of 133. Further transformations to install the third ring completed the 
synthesis of (–)-stemoamide (134). 
 
Scheme 35: Development of a one-pot Overman/Johnson-Claisen rearrangement 
for the synthesis of (–)-stemoamide (134). 
Within the Sutherland group, a number of previous projects have focused on the 
development of one-pot processes involving Overman rearrangement in 
combination with ring closing metathesis (RCM) or ring closing enyne metathesis 
(RCEYM) reactions for the synthesis of biologically active compounds and other 
important synthetic intermediates.74 One of these was the synthesis of 3-
aminoazepane 138 using a one-pot three-step process (Scheme 36).75 Allylic 
alcohol 135 (with alkene side chain) was first converted into allylic 
trichloroacetimidate 136 and then subjected to the Pd-catalysed Overman 
rearrangement to furnish diene 137. This was followed by RCM using Grubbs 
second-generation catalyst to give 2,3,6,7-tetrahydro-3-amidoazepine 138 in 79% 
overall yield. With the use of chiral palladium catalysts (56 and 57) the 3-
Cl3CCN, DBU
ZnCl2 (cat.)
OH
OH
EtO2C
O
O
EtO2C
NH2
CCl3
CH2Cl2, 0 °C
92%
O
OH
EtO2C
CCl3
HN
OH
EtO2C
HN
EtO2C
NHO
CCl3
EtO2C
OBn OBn
OBnOBn
O
CCl3
OBn
O
O
N
O
O
OBn
N
H
OH
H
H
H
H
H
O
BHT(cat.)
t-BuPh, 160 °C
128 129
130131
132 133 134
(–)-Stemoamide
MeC(OET)3, BHT
140 °C, 47%
 47 
aminoazepane 138 was generated in high yields (92%) and high 
enantioselectivities (92% ee). 
 
Scheme 36: One-pot three-step synthesis of 3-aminoazepane 138. 
1.3.5 One-pot process initiated by metathesis reaction 
The ruthenium-catalysed reactions, which are mostly based on metathesis, have 
emerged as important tools in organic synthesis for the construction of new 
carbon−carbon bonds. Since the discovery of molybdenum and ruthenium 
complexes (Figure 5) by Schrock and Grubbs in the early 1990’s,76–78 reactions 
such as ring-opening metathesis (ROM), cross-metathesis (CM), ring-closing 
metathesis (RCM) and ring-closing enyne metathesis (RCEYM) have been 
extensively used in the total synthesis of natural products and medicinally 
important compounds.79–82 The products generated from the metathesis reactions 
are well-known precursors for a number of transformations such as olefin 
hydrogenation, olefin dehydrogenation, olefin isomerisation, cycloaddition, 
cyclopropanation, cyclisation and others.59,83–89 Therefore, due to the ability of 
ruthenium complexes to also catalyse these transformations, the metathesis 
products could be combined with these reactions in one-pot processes. 
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Figure 5: Structures of Schrock and Grubbs catalysts. 
An example of this was used in the synthesis of gaur acid (141).90 Evans and co-
workers reported the synthesis of 140 using a one-pot RCM/hydrogenation 
process (Scheme 37). The RCM of diene 139 with Grubbs second-generation 
catalyst afforded the desired cyclic ether. Subsequent hydrogenation with addition 
of H2 at 70 °C followed by deprotection of TBS group gave product 140 in 75% 
yield. 
 
Scheme 37: One-pot RCM/hydrogenation process for the synthesis of gaur acid 
(141). 
In 2011, Shuto and co-workers reported a one-pot RCM/oxidation process for the 
synthesis of 2-quinolone 144 (Scheme 38).91 Diene 142 was subjected to a RCM 
reaction using Grubbs second-generation catalyst to obtain 1,2-dihydroquinoline 
143. Treatment of 143 with tert-butyl hydroperoxide produced 2-quinolone 144 in 
84% yield. To study the effect of ruthenium catalyst on the oxidation reaction, 
dihydroquinoline 143 was isolated and subjected to the oxidation conditions. 
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However, this attempt failed to give any quinolone product 144. This suggested 
that the presence of ruthenium catalyst was essential to effect the oxidation step. 
This may due to the conversion of the ruthenium catalyst to another active 
species, which assisted the oxidation reaction. 
 
Scheme 38: One-pot RCM/oxidation process for the synthesis of 2-quinolone 144. 
Enyne metathesis is one of the main types of olefin metathesis. It was described 
as a bond reorganisation reaction, in which all atoms of the starting material are 
present in the final product, thus it is an economical process.92 In enyne 
metathesis, the combination of both alkyne and alkene species generates a new 
functionality, a 1,3-diene, which is a useful intermediate that can be used in a wide 
range of applications. A number of reports have shown that this 1,3-diene can be 
combined with other reactions (e.g. Diels-Alder) in one-pot tandem processes. 
This was demonstrated by Pérez-Castle and co-workers who developed a one-pot 
RCEYM/Diels-Alder reaction for the construction of polycyclic frameworks.93 
Enyne 145 was subjected to a RCEYM reaction to generate the 1,3-diene 146 
which was reacted with maleic anhydride in a one-pot process to produce the 
endo-Diels-Alder product 147 in 68% overall yield (Scheme 39). 
 
Scheme 39: One-pot RCEYM/Diels-Alder reaction. 
An example of utilising the 1,3-diene product in a tandem one-pot process 
involving an intermolecular cross-metathesis reaction followed by a Diels-Alder 
reaction and then an aromatisation reaction was reported by Reddy and co-
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workers for the synthesis of the natural product, isofregenedadiol (153) (Scheme 
40).94 By subjecting 1,7-enyne 148 to a tandem RCEYM/cross metathesis process 
using olefin 149 as a cross-metathesis partner, the 1,3-diene 150 was generated. 
This was followed by the addition of alkyne dienophile 151 to form the Diels-Alder 
product which was then aromatised using DDQ to give the desired polycycle 
product 152 in 42% overall yield.  
 
Scheme 40: One-pot four-step process involving RCEYM/cross-metathesis reaction 
followed by a Diels-Alder and then aromatisation reactions for the synthesis of 153. 
1.3.6 Conclusions 
One-pot multi-step processes (domino, cascade, tandem or classical one-pot 
synthesis) are highly effective methods for the synthesis of highly functionalised 
molecules from simple and readily available starting materials. Carrying out a 
number of transformations in the same reaction vessel without isolation and 
purification of intermediates has a number of advantages over step-wise methods. 
These include the reduction of the amount of reagents and solvents and other 
chemical waste, which lead to more friendly methods to the environment. Many of 
these methods also allow the more efficient synthesis of target compounds 
compared to step-wise approach. 
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2.0 Results and Discussion 
2.1 One-Pot multi-bond forming reactions for the diastereoselective 
synthesis of aminobicyclo[4.3.0]nonanes 
2.1.1 Previous work within the Sutherland group  
In order to develop efficient methods for the synthesis of important organic 
compounds and their intermediates, one-pot multi-bond forming reactions have 
been an area of interest in the Sutherland research group over the past 
decade.74,95−101 In particular, the focus has been on development of one-pot 
processes involving Overman rearrangements in combination with ring closing 
metathesis (RCM) or ring closing enyne metathesis (RCEYM) reactions, followed 
by Diels-Alder reaction. In 2007, the group published the first example of a one-pot 
Overman rearrangement/RCM process for the diastereoselective synthesis of 
different cyclic allylic amides from readily available alkene derived allylic 
alcohols.95 The required allylic alcohol substrates were prepared in a three-step 
route from commercially available alken-1-ols 154a–d (Scheme 41). These alken-
1-ols substrates 154a–d were first converted to (E)-α,β-unsaturated esters 155a–d 
via a one-pot Swern oxidation and a Horner-Wadsworth-Emmons (HWE) reaction. 
The combination of both reactions in a one-pot process allowed the formation of 
esters 155a–d in high yields, and this was due to avoiding the isolation of the 
volatile aldehyde intermediate as well as using the mild Masamune–Roush 
conditions for the HWE reaction. Reduction of the resulting esters 155a–d with 
DIBAL-H gave allylic alcohols 156a–d in excellent yields. 
 
Scheme 41: Synthesis of allylic alcohols 156a–d. 
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Treatment of allylic alcohol precursors 156a–d with trichloroacetonitrile and a 
catalytic amount of DBU afforded the corresponding allylic trichloroacetimidates 
(Scheme 42). These allylic trichloroacetimidates were then subjected to 
palladium(II)-catalysed Overman rearrangements followed by ring-closing 
metathesis reactions to synthesise a small library of five-, six-, seven- and eight-
membered cyclic trichloroacetamides 157a–d in high yields over the three-step 
processes.95 
 
Scheme 42: First developed one-pot synthesis of carbocyclic amides 157a–d. 
In order to develop a general procedure that can be used in the synthesis of 
natural products, further work showed that an asymmetric version of the one-pot 
process could be achieved.95 For example, the use of chiral palladium catalysts 
such as (S)-COP-Cl 56 and (R)-COP-Cl 57 for the Overman rearrangement step 
allowed stereoselective synthesis of cyclic amide analogues 158a and 158b in 
high yields and enantiomeric excesses (Scheme 43). 
 
Scheme 43: Asymmetric one-pot synthesis of cyclic amide analogues 158a and 
158b using chiral palladium catalysts 56 and 57. 
Following the successful development of the one-pot two step process, the group 
applied this methodology to the stereoselective preparation of the natural product, 
(+)-physoperuvine (162).96 The synthesis began with the conversion of allylic 
alcohol 156c to the corresponding allylic trichloroacetimidate (Scheme 44). This 
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was then subjected to a one-pot asymmetric Overman rearrangement/RCM 
reaction to give the desired cycloheptyl amide 159 in 82% yield and 84% ee. With 
the present trichloroacetyl-protecting group, the methylation of 159 was 
unsuccessful. Therefore, the amine of 159 was reprotected as a Boc-carbamate in 
a one-pot reaction, and then methylated to give 160 in 84% yield. Allylic oxidation 
of 160 gave the corresponding α,β-unsaturated ester. This was followed by 
hydrogenolysis of the alkene to afford the desired oxo-carbamate 161 in a good 
yield. Finally, the total synthesis of (+)-physoperuvine 162 was completed with 
amine deprotection of 161 under acidic conditions, which allowed cyclization to the 
final product.     
 
Scheme 44: Asymmetric synthesis of (+)-physoperuvine (162) using one-pot multi-
reaction process. 
This methodology was further extended to present a four-step sequence of the 
one-pot process for the synthesis of more-complex bicyclic systems. For example, 
bicyclic γ-lactams 163a–c were synthesised in high yields through a one-pot four-
step tandem process involving palladium(II)-catalysed Overman rearrangement, 
RCM and Kharasch cyclisation (Scheme 45).97 The synthesis began as described 
in Scheme 42 to form the carbocyclic amides 157a–c, which were then cyclised by 
Ru(II)-Kharasch reaction to form the desired products 163a–c. The use of chiral 
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palladium catalysts allowed the asymmetric formation of these bicyclic γ-lactams in 
excellent enantioselectivites.98 
 
Scheme 45: One-pot tandem process for the synthesis of bicyclic γ-lactams 163a–c. 
In 2012, the Sutherland group developed another efficient one-pot four-step 
process involving a thermal Overman rearrangement, RCEYM reaction, and Diels-
Alder reaction for the diastereoselective synthesis of various amino-substituted 
multi-cyclic scaffolds (Scheme 46).99 The one-pot processes were performed using 
readily available allylic alcohols bearing alkyne side-chains. These allylic alcohols 
were first converted to the corresponding alkyne-derived allylic 
trichloroacetimidates, which then underwent a one-pot thermal Overman 
rearrangement followed by a RCEYM reaction to form the corresponding cyclic 
exo-diene. Finally, a hydrogen bond directed Diels-Alder reaction of the formed 
diene with various dienophiles gave a small library of amino substituted 
bicyclo[4.4.0]decanes and bicyclo[4.3.0]nonanes in good yields over the four-step 
process. 
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Scheme 46: Development of a one-pot four-step process for the synthesis of amino 
substituted bicyclo[4.4.0]decanes and bicyclo[4.3.0]nonanes scaffolds. 
More recently, the group expanded the scope of this process and developed a 
one-pot five-step tandem process to include a cross metathesis step, resulting in 
the formation of a library of C-4 substituted polycyclic compounds in good overall 
yields, using different dienes for the cross metathesis step and different 
dienophiles for the Diels-Alder reaction (Scheme 47).101 Interestingly, all products, 
with up to five stereogenic centres, were isolated as single diastereomers. 
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Scheme 47: One-pot tandem process synthesis of C-4 substituted 
bicyclo[4.4.0]decanes and bicyclo[4.3.0]nonanes. 
2.1.2 Aims 
The aim of this project was to extend and explore the previously developed one-
pot four-step process to involve a Pd-catalysed Overman rearrangement in place 
of the thermal rearrangement, to enable diastereoselective and stereoselective 
synthesises of highly substituted aminobicyclo[4.3.0]nonanes (Scheme 48). From 
the previously mentioned studies (Scheme 46 and 47), it was found that some of 
these one-pot reactions required harsher conditions (140 °C) and slightly longer 
reaction times (36 h) due to the difficulty of the thermal Overman rearrangement. 
Previous studies in the group showed the feasibility of the palladium(II)-catalysed 
Overman step for the mono-substituted alkyne derived allylic trichloroaceimidate 
(R = H). However, due to the palladium binding to the alkyne moiety, the reaction 
was slow and gave a low yield. Therefore, it was proposed that the use of 
disubstituted alkynes with bulkier substituents would hinder the alkyne binding to 
the catalyst, allowing effective palladium catalysis of the Overman rearrangement 
n
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to take place. This would lead to the formation of a new library of C-5 substituted 
aminobicyclo[4.3.0]nonanes with range of substituents. Another aim of this project 
was to investigate the effects of electronic properties of the alkyne substituents on 
the outcome of the one-pot process. Finally, the development of a one-pot 
process, involving a Pd-catalysed Overman rearrangement, would allow 
asymmetric synthesis of these compounds using chiral palladium catalysts such 
as (S)-COP-Cl 56 and (R)-COP-Cl 57. 
 
Scheme 48: Proposed one-pot process involving a Pd(II)-catalysed Overman 
rearrangement. 
On development of an asymmetric one-pot process, this would allow the 
preparation of saturated and partially saturated bicyclic nonanes that have found 
widespread applications due to their biological activities. In particular, amino 
substituted bicyclo[4.3.0]nonanes are of interest, because they can be found in 
wide range of natural products and medicinally important compounds. Examples 
include the guanidine alkaloid, netamine A (164),102 (+)-ptilocaulin (165),103 which 
is an antitumour antibiotic, rasagiline (166),104 a compound used for the treatment 
of Parkinson’s disease and (+)-indatraline (167),105 a monoamine transporter 
inhibitor (Figure 6).  
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Figure 6: Examples of biologically active C-1 amino bicyclo[4.3.0]nonanes.  
2.1.3 Synthesis of allylic alcohols  
The first stage of this project was the preparation of range of disubstituted alkyne 
derived allylic alcohol precursors to investigate the Pd(II)-catalysed Overman 
rearrangement. In a four step route, the desired allylic alcohols were synthesised 
from commercially available pent-4-yn-1-ol (168).106 Firstly, a Sonogashira 
coupling was used to attach the phenyl group and other derivatives to the alkyne 
side-chain of pent-4-yn-1-ol (168), in the presence of 
bis(triphenylphosphine)palladium(II) dichloride catalyst (1 mol %) and copper 
iodide (2 mol %) (Scheme 49). Using iodobenzene as a coupling partner, 5-
phenylpent-4-yn-1-ol (169) was formed in a 95% yield. To investigate the 
electronic effects on the one-pot reactions, other disubstituted alkynes bearing 
electron-rich (p-methoxyphenyl) and electron-deficient (p-nitrophenyl) groups (170 
and 171) were also prepared in excellent yields under the same conditions. 
 
Scheme 49: Sonogashira reaction for the synthesis of disubstituted alkynes 169–
171. 
The preparation of alkyl analogue 173 (R = Me) was achieved in 92% yield 
through an isomerisation reaction of commercially available hex-5-yn-1-ol (172) 
using potassium tert-butoxide in dimethyl sulfoxide (Scheme 50).107 
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Scheme 50: Preparation of hex-4-yn-1-ol 173. 
As well as the mono-substituted alkyne 168 (R = H), the disubstituted alkynes 
169–171 and 173 were all subjected to one-pot Swern oxidation/Horner-
Wadsworth-Emmons reactions under Masamune–Roush conditions to form the 
corresponding (E)-α,β-unsaturated esters 174–178 in almost quantitative yields 
(Table 4). This one-pot reaction has been developed and successfully utilised in 
many synthetic transformations within the Sutherland research group.31,95−97,99−101 
In particular, the mild Swern oxidation is useful, because in some cases the 
aldehyde intermediate is unstable or volatile, and so handling is minimised using 
the one-pot process. During the HWE transformation, the mild Masamune–Roush 
conditions are designed for base sensitive substrates. In this reaction, a mild 
Lewis acid such as lithium chloride is used to increase the acidity of the triethyl 
phosphonoacetate and therefore a mild base such as 1,8-
diazabicyclo(5.4.0)undec-7-ene (DBU) can be employed. The use of a stabilised 
phosphonate ester that reacts with the aldehyde in the presence of lithium chloride 
gives only E-alkenes. The formation of E-isomers of all (E)-α,β-unsaturated esters 
formed were analysed by 1H NMR spectroscopy which showed large coupling 
constants of ~15.7 Hz between the alkene hydrogen atoms. Finally, reduction of 
esters 174–178 with DIBAL-H led to the formation of the desired C-7 substituted 
hept-2-en-6-yn-1-ols 179–183 in excellent yields. 
Me
t-BuOK, DMSO
rt, 2 h
92%
172 173
OH
OH
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Entry R Yield (%) Yield (%) 
1 H, 168 174, 91 179, 87 
2 Me, 173 175, 95 180, 87 
3 Ph, 169 176, 95 181, 98 
4 p-NO2-Ph, 170 177, 95 182, 83 
5 p-MeO-Ph, 171 178, 94 183, 94 
Table 4: Synthesis of allylic alcohols 179–183. 
2.1.4 Investigation of the palladium(II)-catalysed Overman rearrangement 
Having the required C-7 substituted hept-2-en-6-yn-1-ols 179–183 in hand, the 
next stage of this study was to investigate their abilities to undergo a Pd(II)-
catalysed Overman rearrangement (Table 5). Initially, the mono-substituted alkyne 
(2E)-hept-2-en-6-yn-1-ol (179) was treated with trichloroacetonitrile and a catalytic 
amount of DBU to form the corresponding allylic trichloroacetimidate. The imidate 
was then subjected to a Pd(II)-catalysed Overman rearrangement under standard 
conditions of 10 mol % catalyst loading at room temperature.108 However, minimal 
conversion (less than 10 %) to the amide product 184 was observed after 24 h 
(entry 1). As mentioned earlier, the low conversion was associated with the 
palladium catalyst binding to the alkyne side-chain. By heating the reaction to 40 
°C and adding an extra batch of the catalyst (10 mol %), the amide product 184 
was afforded in 34% yield after 48 h (entry 2). The rearrangement using 
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Et3N
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disubstituted alkyne-derived allylic alcohols 180–183 was next investigated. It was 
notably found that when a small substituent such as the methyl group was 
attached to the alkyne, the corresponding allylic trichloroacetamide 185 was 
formed in modest yield at room temperature using only 10 mol % of the catalyst 
(entry 3). More bulky aryl substituents having different electronic properties were 
then tested and proved to be more effective, allowing the formation of amides 
186–188 in high yields and shorter reaction times (entries 4, 5 and 6). From these 
results, it was proposed that the electronic properties of the substituents have no 
effects on the reaction outcome, and only steric bulk was responsible for impeding 
the catalyst binding to the alkyne. 
 
Entry R Temp. (°C) Catalyst load. (mol %) Time (h) Yield
a (%) 
1 H, 179 20 10 24 184, <10b 
2 H, 179 40 10 + 10 48 184, 34 
3 Me, 180 20 10 24 185, 55 
4 Ph, 181 20 10 12 186, 81 
5 p-NO2-Ph, 182 20 10 12 187, 76 
6 p-MeO-Ph, 183 20 10 12 188, 83 
Table 5: Palladium(II)-catalysed Overman rearrangement. aIsolated yields from 
allylic alcohols 179–183, bConversion calculated by 1H NMR spectroscopy of crude 
reaction mixture. 
2.1.5 Development of the one-pot multi-step process 
After identifying the optimal conditions for the Pd(II)-catalysed Overman 
rearrangement step, attention was then turned to the RCEYM reaction. Previous 
work within the group showed that the RCEYM reaction of the mono-substituted 
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alkyne could be effectively performed using Grubbs first-generation catalyst to give 
the desired 1,3-diene with full conversion (Scheme 46).99 However, preliminary 
study on the preparation of 1,3-diene 189 using Grubbs first- or second-generation 
catalysts proved unsuccessful, with the reactions proceeding with low conversions 
(Table 6, entries 1 and 2).108 The low reactivity of the Grubbs catalysts was 
associated with the disubstituent alkyne with a bulky phenyl group attached. A 
range of conditions were then investigated to optimise the reaction, and the best 
results were obtained using Grubbs second-generation catalyst (7 mol %) in 
combination with octa-1,7-diene 190 and an increase of temperature to 90 °C 
(entry 4). 
 
Entry Catalyst 
Loading     
(mol %) 
Additive 
Temp. 
(°C) 
Time     
(h) 
Conversiona 
(%) 
1 Grubbs 1st 10 - 75 48 <10 
2 Grubbs 2nd 10 - 75 48 <20 
3 Grubbs 2nd 10 octa-1,7-diene 190 75 18 100 
4 Grubbs 2nd 7 octa-1,7-diene 190 90 18 100 
Table 6: RCEYM reaction for the formation of 1,3-diene 189. aConversion calculated 
by 1H NMR spectroscopy of crude reaction mixture. 
As developed by Fustero et al., octa-1,7-diene can be used to accelerate RCEYM 
reactions by forming ethylene in situ.109 This method is safer than using ethylene 
gas which is highly flammable and difficult to handle. The possible mechanism of 
the RCEYM reaction using octa-1,7-diene is shown below (Scheme 51).110−113 The 
first stage is a RCM reaction between the ruthenium catalyst 191 and octa-1,7-
diene 190 to form the activated ruthenium carbene 192 and cyclohexene 193. The 
NH
Ph
NH
Ph
CCl3
O O
CCl3
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toluene
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activated ruthenium species 192 can either react with alkyne or alkene moieties, 
leading to two possible mechanisms. The reaction of ruthenium species 192 with 
the alkyne side-chain (called ‘yne-then-ene pathway’) can proceed via [2+2] 
cycloaddition to form ruthenacyclobutene 194, which then can undergo ring-
opening to afford ruthenium carbene complex 195. This would then react with 
alkene moiety to produce ruthenacyclobutane 196. Subsequent ring-opening of 
196 gives 1,3-diene (exo-product) 197 and the activated ruthenium carbene 192. 
In terms of the reaction of 192 with the alkene moiety (called ‘ene-then-yne 
pathway’), the alkylidene 198 would be formed and then undergo a ring closure to 
generate ruthenacyclobutene 199. Ring-opening of 199 affords ruthenium carbene 
200. Finally, the reaction of 200 with a second equivalent of 193 leads to the exo-
product 197 and regeneration of the alkylidene intermediate 198. 
 
Scheme 51: RCEYM reaction mechanism using octa-1,7-diene. 
Using these optimised conditions for both steps, the one-pot four-step process 
was attempted (Scheme 52). The process was initially performed using alkyne-
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derived allylic alcohol 181 with the phenyl group as an alkyne substituent. This 
allylic alcohol was first treated with trichloroacetonitrile and a catalytic amount of 
DBU to form the corresponding allylic trichloroacetimidate. This was then 
subjected to a one-pot Pd(II)-catalysed Overman rearrangement followed by a 
RCEYM reaction to form the required cyclic exo-diene. Finally, a hydrogen 
bonding directed Diels-Alder reaction of the 1,3-diene with N-phenylmaleimide as 
a dienophile gave the desired amino-substituted bicyclo[4.3.0]nonane 201 in 51% 
yield as a single diastereomer. During the Diels-Alder reaction, hydroquinone was 
added to the reaction mixture to prevent radical polymerisation of the dienophile 
that is known to occur at high temperature.114,115 The stereochemistry of 
compound 201 was proven by NOE studies where a syn relationship was 
observed between the hydrogen atoms at C8, C8a, C8b and C3a. In comparison, 
allylic alcohol 180 with a methyl group attached to the alkyne was subjected to the 
one-pot process, and gave only a 25% yield of the corresponding bicyclic 
compound 202. As mentioned earlier (Table 5, entry 3), this was due to a less 
efficient Overman rearrangement step. 
 
Scheme 52: One-pot four-step process using allylic alcohols 181 and 180. 
Having successfully developed the four-step one-pot process for the synthesis of 
bicyclic compound 201, the scope of the process was explored. Alkyne-derived 
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allylic alcohol 181 was further subjected to the one-pot process with the use of 
other dienophiles for the final Diels-Alder reaction (Scheme 53). With a less 
reactive diene, it was found that only strongly electron-deficient dienophiles could 
provide the desired products in good yields. The use of other symmetrical 
dienophiles such as 4-phenyl-1,2,4-triazole-3,5-dione and tetracyanoethylene 
allowed the successful synthesis of indane compounds 203 and 204 as single 
diastereomers in good yields (40% and 65%, respectively). To investigate the 
compatibility of the one-pot process with other dienophiles, the Diels-Alder 
reaction using methyl acrylate as a nonsymmetrical dienophile was conducted. 
This gave the corresponding aminobicyclo[4.3.0]nonane 205 in 46% yield. It is 
worth noting that compound 205 was isolated as a single regioisomer, and this is a 
consequence of the Diels-Alder reaction proceeding via a hydrogen bonding 
directed endo transition state. 
Another important objective of this study was to use alkyne substituents with 
different electronic properties to investigate this effect on the outcome of the 
RCEYM step. Alkyne-derived allylic alcohol 182 bearing an electron-deficient aryl 
group was subjected to the one-pot multi-step process (Scheme 53). Using N-
phenylmaleimide as a dienophile, the desired 4-nitrophenyl substituted 
bicyclo[4.3.0]nonane 206 was synthesised as a single diastereomer in 69% yield. 
Other dienophiles such as 4-phenyl-1,2,4-triazole-3,5-dione, tetracyanoethylene 
and methyl acrylate were employed in the final Diels-Alder reaction and 
successfully generated the corresponding 4-nitrophenyl substituted 
bicyclo[4.3.0]nonanes 207–209 in good overall yields (63%, 73% and 46%, 
respectively). In general, it was found that the electron-deficient allylic 
trichloroacetamide 187 was able to undergo a more effective RCEYM reaction 
under these conditions. This is due to the presence of the electron withdrawing p-
NO2-group enhancing the reaction between the alkyne component and the 
electron rich Ru-alkylidene.  
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Scheme 53: Synthesis of a library of phenyl and 4-nitrophenyl substituted 
bicyclo[4.3.0]nonanes 203–209 through one-pot multi-step processes. aDiels-Alder 
reaction was performed at 111 °C for 5 days. 
In comparison, when electron-rich (2E)-7-(4’-methoxyphenyl)hept-2-en-6-yn-1-ol 
(183) was employed in the one-pot process under the same conditions using N-
phenylmaleimide and 4-phenyl-1,2,4-triazole-3,5-dione as dienophiles, low yields 
were obtained for the corresponding 4-methoxyphenyl substituted 
bicyclo[4.3.0]nonanes 210 and 211 (Figure 7). 
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Figure 7: 4-Methoxyphenyl substituted bicyclo[4.3.0]nonanes 210 and 211. 
Reactions of the one-pot process involving allylic alcohol 183 were then re-
investigated to ensure each step went to completion. As mentioned in Table 5, 
allylic alcohol 183 underwent an efficient one-pot Pd-catalysed Overman 
rearrangement and gave the allylic amide 188 in 83% yield. In this case, it seemed 
that the problem was associated with the RCEYM reaction as there should not be 
any problem with a Diels-Alder reaction of an electron-rich diene with electron 
deficient dienophiles. Analysis of the 1H NMR spectrum of the crude RCEYM 
reaction showed that the cyclopentyl exo-diene compound was successfully 
formed. However, it seemed that the high temperature (90 °C) of the RCEYM 
reaction resulted in partial decomposition of this highly reactive diene.  
The RCEYM reaction of the 1,6-enyne 188 was then reinvestigated with Grubbs 
second-generation catalyst and octa-1,7-diene at various temperatures. It was 
found that the reaction went to completion after 18 h at much lower temperature of 
40 ºC. To avoid any issues during the purification step, it was proposed that the 
Diels-Alder reaction could take place in the same pot. N-Phenylmaleimide was 
then added and the reaction mixture was stirred for 24 h at 75 ºC, giving the 
desired product 210 in 65% yield (Scheme 54). Under these optimised conditions 
of the low temperature RCEYM step, allylic alcohol 183 was re-subjected to the 
one-pot four-step process. However, all attempts ended with low yields. Therefore, 
with this particular analogue, it was decided that the synthesis of 210–213 would 
be carried out using two separate one-pot processes. Initially, imidate formation 
and then a Pd(II)-catalysed Overman rearrangement was used to form the allylic 
trichloroacetamide 188. Using various electron-deficient dienophiles, the allylic 
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H
N
N
NHO
Cl3C
NPh
O
O
211, 23%
H
OMe OMe
 68 
trichloroacetamide 188 was then subjected to a one-pot two-step process involving 
the RCEYM and Diels-Alder reactions. This allowed the formation of 4-
methoxyphenyl substituted bicyclo[4.3.0]nonanes 210–213 in good overall yields. 
 
Scheme 54: One-pot two-step synthesis of 4-methoxyphenyl substituted 
bicyclo[4.3.0]nonanes 210–213. aDiels-Alder reaction was performed at 111 °C for 5 
days. 
2.1.6 Functionalisation of bicyclo[4.3.0]nonane 201 
After the success of the one-pot process for the synthesis of a novel library of 
bicyclo[4.3.0]nonanes, the next aim was to explore functionalisation of these 
compounds. Initial efforts were made to reduce the alkene of bicyclo[4.3.0]nonane 
201 using 10% palladium on carbon under an atmosphere of hydrogen. 
Unfortunately, this attempt failed and only 71% conversion to the 
dichloroacetamide 214 was observed (48% isolated yield) (Scheme 55). It was 
proposed that this was due to the hindered nature of the tetra-substituted alkene. 
Although the reduction of 201 was challenging, oxidation of the alkene was 
successful. For example, dihydroxylation of compound 201 under Donohoe's 
conditions,116,117 using osmium tetroxide and N,N,N′,N′-
O
NH
O
Cl3C
H
ii. dienophile, hydroquinone
75 °C, 24 h
NHO
Cl3C
NPh
O
O N
N
NHO
Cl3C
NPh
O
O
NHO
Cl3C
210, 65% 213, 65%a211, 76% 212, 57%
OMe OMe OMe
i. Grubbs II (7 mol %)
1,7-Octadiene, 40 °C, 20 h
OMe
HN
CCl3
OMe
R2
R1
H HH
188
NHO
Cl3C
CN
CN
CN
NC
OMe
H
CO2Me
 69 
tetramethylethylenediamine (TMEDA) in dichloromethane  at –78 °C gave 
dihydroxy derivative 216 as a single diastereomer in quantitative yield. In this 
method, the combination of TMEDA and OsO4 is used to enhance the reactivity of 
the catalyst by forming a more electron-rich bidentate complex. This newly formed 
complex then reacted with the alkene of 201 to form the osmate ester 215 which 
after hydrolysis gave the desired dihydroxylated product 216. Based on the curved 
shape of 201, it was expected that the catalyst would attack from the less hindered 
top face of the molecule. In a similar way, an epoxidation reaction of amino 
bicyclo[4.3.0]nonane 201 with meta-chloroperoxybenzoic acid (m-CPBA) gave 
epoxide 217 in 65% yield. The epoxide derivative 217 was formed as major 
diastereomer in a 4:1 ratio. 
 
Scheme 55: Reduction, dihydroxylation and epoxidation reactions of 
aminobicyclo[4.3.0]nonane 201.  
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The relative stereochemistry of the dihydroxy product 216 was confirmed by X-ray 
crystallography (Figure 8). The X-ray structure also proved the relative 
stereochemistry of the product of the one-pot process 210, and showed the syn 
relationship of the hydrogen atoms around the stereogenic centres.  
 
Figure 8: View showing the structure of one of the crystallographically independent 
molecules of 216. 
2.1.7 Conclusions 
In conclusion, a library of C-5 substituted aminobicyclo[4.3.0]nonanes has been 
successfully prepared through a one-pot four-step process involving Pd(II)-
catalysed Overman rearrangement, Ru(II)-catalysed RCEYM and hydrogen 
bonding Diels-Alder reactions. The study began with the preparation of series of 
disubstituted alkyne-derived allylic alcohols using a one-pot Swern oxidation and 
HWE reaction as the key steps. These compounds were then used to investigate 
the palladium catalysis of the Overman rearrangement and then utilised in a one-
pot multi-step process. The effect of the electronic properties of the aryl 
substituents on the outcome of the one-pot process was also examined. The 
electron-deficient 4-nitrophenyl analogue proved to be an effective substrate 
enabling the synthesis of the corresponding aminobicyclo[4.3.0]nonanes in high 
overall yield. On the other hand, the electron-rich 4-methoxyphenyl analogue 
underwent partial decomposition during the RCEYM reaction at high temperature. 
To overcome this issue, the synthesis of 4-methoxyphenyl substituted 
bicyclo[4.3.0]nonanes were carried out in two separate one-pot processes. Finally, 
the phenyl substituted bicyclo[4.3.0]nonane analogue was further functionalised 
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yielding highly substituted sp3-rich, polycyclic scaffolds with up to six stereogenic 
centres. 
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2.2 The development of a one-pot process for the synthesis of vinylsilyl 
derived aminobicyclo[4.3.0]nonanes, synthetic intermediates for a late-stage 
incorporation of substituents 
2.2.1 Aims 
As described in the previous section, a one-pot multi-bond forming process has 
been successfully developed for the synthesis of a library of C-5 substituted 
aminobicyclo[4.3.0]nonanes 201–213 in good yields. This study has clearly shown 
that the presence of simple aryl groups was necessary to block the alkyne and 
allow an effective Pd(II)-catalysed Overman rearrangement to proceed under mild 
conditions. Also, the use of a disubstituted alkyne did not significantly retard the 
following RCEYM reaction. However, the C-5 structural diversity of these 
compounds was introduced via a Sonogashira cross coupling during the first step. 
This required the formation of a series of disubstituted alkynes from the first step 
and for each of them to be transformed through the entire route to each final 
compound. To overcome this limitation, the aim of this project was to incorporate 
an alkyne substituent that would allow the late-stage introduction of groups at C-5. 
It was proposed that a silyl protecting group could facilitate a Pd(II)-catalysed 
Overman rearrangement and this would be then utilised in a one-pot process 
including RCEYM and Diels-Alder reactions (Scheme 56). Once the one-pot 
process has been fully optimised, the C-5 silyl substituted bicyclic product could be 
functionalised via cross coupling reactions such as a Hiyama-Denmark coupling. 
This would allow the late-stage synthesis of C-5 substituted bicyclo[4.3.0]nonane 
compounds with a wide range of substituents in a single step. Another objective of 
using this newly developed process would be removal of the silyl group to allow 
the formation of the non-substituted analogue.118 
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Scheme 56: Proposed one-pot synthesis and functionalisation of C-5 substituted 
aminobicyclo[4.3.0]nonanes. 
In this project, four major factors were considered. 
1. The stability of the silyl group for preparation of the allylic alcohol precursor, 
as well as the conditions of the one-pot multi-step process. 
2. The ability of the silyl group to hinder the catalyst binding to the alkyne and 
facilitate the palladium(II)-catalysed Overman rearrangement (Scheme 57). 
3. To be aware that the silyl group may hinder the RCEYM reaction. 
4. The reactivity of the vinylsilane functionality towards palladium-catalysed 
cross-coupling reactions. 
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Scheme 57: One-pot Pd(II)-catalysed Overman rearrangement/ RCEYM using silyl-
derived alkyne. 
In recent years, a wide range of silanes have been used in palladium-catalysed 
cross-coupling reactions and successfully utilised in many important synthetic 
applications.119–121 In this project, two different silyl groups were chosen. Initially, 
the tert-butyldimethylsilyl (TBDMS) group will be used to investigate the steric 
requirements for the one-pot process. Having successfully tested the optimal 
conditions of the process using the TBDMS group, the synthetic route will then be 
repeated using benzyldimethylsilyl (BDMS) group, as this group would be stable 
during the synthesis of the aminobicyclo[4.3.0]nonane, and could be used for 
Hiyama-Denmark cross-coupling reactions. 
In 2003, Trost and co-workers reported the BDMS group as a suitable coupling 
partner that can lead to cross-coupled products under mild conditions.122 For 
example, treatment of disubstituted vinylsilane 218 and phenyl iodide with tetra-n-
butylammonium fluoride (TBAF) in the presence of 
tris(dibenzylideneacetone)dipalladium(0) gave coupled product 219 in 97% yield at 
room temperature (Scheme 58) . Using various disubstituted vinylsilanes with 
different electrophilic partners, the scope of this method was explored and resulted 
in the formation of the corresponding cross-coupled products in high yields. 
 
Scheme 58: A literature example of Hiyama-Denmark coupling of vinylsilyl 218. 
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In 2010, Junker et al. reported another example of using the BDMS group in 
Hiyama-Denmark coupling reaction.123 Under similar reaction conditions, 
compound 220 reacted with iodobenzene and gave product 221 in 70% yield 
(Scheme 59).  
 
Scheme 59: Formation of 221 via Hiyama-Denmark cross-coupling reaction. 
2.2.2 Development of a one-pot process using a tert-
butyldimethylsilylalkynyl-derived allylic alcohol 
2.2.2.1 Synthesis of allylic alcohol 
The synthetic route began with the conversion of pent-4-yn-1-ol (168) to its C-
silylated derivative 222, using n-butyllithium and two equivalents of tert-
butyldimethylsilyl chloride.124 This was followed by addition of aqueous 
hydrochloric acid to cleave the silyl ether and form alcohol 222 (Scheme 60). 
Under these conditions, the product 222 was formed in 31% isolated yield. Efforts 
were made to improve the outcome of this reaction, by increasing the equivalents 
of the reagents or changing the base to LDA or NaHMDS. However, all attempts 
ended with no reaction or forming a mixture of the product, the di-silylated 
intermediate and starting material. To improve the yield of this reaction, it would be 
better to initially protect the alcohol and then attach the silyl group.  
 
Scheme 60: Formation of pent-4-yn-1-ol bearing a C-5 TBDMS group. 
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Disubstituted alkyne 222 was then subjected to a one-pot Swern oxidation and 
Horner-Wadsworth-Emmons reaction, again under mild Masamune-Roush 
conditions. This exclusively allowed the formation of the corresponding (E)-α,β-
unsaturated ester 223 in 80% yield. Reduction of 223 with DIBAL-H gave the 
alkynylsilyl-derived allylic alcohol 224 in 92% yield (Scheme 61).  
 
Scheme 61: Synthesis of allylic alcohol 224. 
2.2.2.2 One-pot palladium(II)-catalysed Overman rearrangement 
Before attempting the one-pot process, each stage was investigated separately. 
Starting with the Overman rearrangement, allylic alcohol 224 was reacted with 
trichloroacetonitrile and a catalytic amount of DBU to form the corresponding allylic 
trichloroacetimidate 225. Without further purification, compound 225 was 
subjected to a Pd(II)-catalysed Overman rearrangement. This allowed the 
formation of allylic trichloroacetamide 226 in 80% yield (Scheme 62). This result 
supported the previous hypothesis that the steric bulk was responsible for 
preventing the coordination of the catalyst to the alkyne, and enabling the Pd(II)-
catalysed Overman rearrangement to proceed. 
 
Scheme 62: A one-pot Pd-catalysed Overman rearrangement. 
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2.2.2.3 One-pot RCEYM/Diels-Alder reaction 
Attention was then turned to the RCEYM reaction of allylic trichloroacetamide 226. 
The RCEYM reaction was carried out as previously described for similar 
substrates using Grubbs second-generation catalyst (10 mol %) and octa-1,7-
diene at 90 °C  (Scheme 63). Under these conditions, the reaction was slow and 
proceeded with poor conversion after 60 h. A second portion of Grubbs catalyst 
was added (10 mol %), and the reaction was left stirring at the same temperature 
for further 60 h. After consumption of all starting materials, N-phenylmaleimide and 
hydroquinone were added to the same pot, and the Diels-Alder reaction was 
completed in 18 h to give the desired TBDMS-derived aminobicyclo[4.3.0]nonane 
227 as a single diastereomer in 20% yield over the one-pot, two-step process. The 
low yield was attributed to the ineffective RCEYM reaction, where the presence of 
the bulky TBDMS group obstructed the reaction of the alkyne, resulting in a slower 
reaction. The low yield may also due to decomposition of the formed diene at high 
temperature and long reaction time, which has been observed before with similar 
substrates. 
 
Scheme 63: One-pot RCEYM/Diels-Alder reaction of 226. 
2.2.2.4 Attempted one-pot four-step synthesis of aminobicyclo[4.3.0]nonane 
227 
Allylic alcohol 224 was then subjected to the one-pot four-step process, using 
more forcing conditions for the RCEYM step of 20 mol % catalyst loading and 
performing the reaction at 110 °C. This gave the TBDMS-derived 
aminobicyclo[4.3.0]nonane 227 in 19% yield over the four steps (Scheme 64). 
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The work shows that while the bulky TBDMS group was sufficient to prevent the 
catalyst binding to the alkyne and enable the Pd(II)-catalysed Overman 
rearrangement, it had a detrimental effect on the following RCEYM reaction. 
 
Scheme 64: Synthesis of 227 via one-pot multi-reaction process. 
2.2.3 Development of a one-pot process using a benzyldimethylsilylalkynyl-
derived allylic alcohol 
2.2.3.1 Synthesis of allylic alcohol 
Having probed the steric requirements for the one-pot process, it was proposed 
that the less bulky BDMS group would allow a more efficient one-pot process. As 
usual, the synthetic route started with the preparation of the required allylic 
alcohol. To avoid any issues of side-reactions during the silylation step, the 
incorporation of the BDMS group was carried out stepwise. The hydroxyl group of 
pent-4-yn-1-ol (168) was first protected as a THP ether, giving 1-(tetrahydropyran-
2-yloxy)-4-pentyne (228) in quantitative yield  (Scheme 65). Compound 228 was 
then silylated with benzyldimethylsilyl chloride to give 229. Finally, THP 
deprotection of 229 with p-toluenesulfonic acid in methanol gave 5-
(benzyldimethylsilyl )pent-4-yn-1-ol (230) in quantitative yield.125 
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Scheme 65: Formation of BDMS-analogue 230. 
The BDMS-derived disubstituted alkyne 230 was then subjected to a one-pot 
Swern oxidation and Horner-Wadsworth-Emmons reaction under Masamune–
Roush conditions, allowing the formation of the (E)-α,β-unsaturated ester 231 in 
92% yield. Reduction of the ester 231 with DIBAL-H gave desired allylic alcohol 
232 in 98% yield (Scheme 66). 
 
Scheme 66: Synthesis of allylic alcohol 232. 
2.2.3.2 One-pot multi-step synthesis of aminobicyclo[4.3.0]nonane 235 
With allylic alcohol 232 in hand, the one-pot Pd-catalysed Overman rearrangement 
was first attempted. Under standard conditions, allylic trichloroacetamide 233 was 
successfully formed in 68% yield (Scheme 67). Allylic trichloroacetamide 233 was 
then subjected to a RCEYM reaction in the presence of Grubbs second generation 
catalyst (7 mol %) and octa-1,7-diene at 90 °C. As expected, the 1H NMR 
spectrum of the crude RCEYM reaction showed the clean conversion of allylic 
trichloroacetamide 233 to the diene 234 after 18 hours. N-Phenylmaleimide as a 
dienophile was then added and the final BDMS-derived aminobicyclo[4.3.0]nonane 
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235 was isolated as a single diastereomer in 66% yield.  
 
Scheme 67: Two-pot synthesis of aminobicyclo[4.3.0]nonane 235. 
Starting from allylic alcohol 232, the one-pot four-step process involving Pd(II)-
catalysed Overman rearrangement, RCEYM and Diels-Alder reaction was then 
performed. This gave final product 235 in 57% overall yield (Scheme 68). The 
relative stereochemistry of diastereomer 235 was confirmed by NOE experiments 
which showed the syn-relationship of the hydrogen atoms at C-3a, C-8, C-8a and 
C-8b. 
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Scheme 68: One-pot four-step synthesis of aminobicyclo[4.3.0]nonane 235. 
2.2.4 Protodesilylation reaction 
Having identified a suitable silane for the one-pot process and successfully 
prepared the desired vinylsilyl derived aminobicyclo[4.3.0]nonane 235, attention 
then turned to using this vinylsilane for a late stage synthesis of various 
derivatives. Initially, removal of the BDMS group to form the non-substituted 
analogue was investigated. Under standard fluoride conditions, treatment of 
vinylsilane 235 with TBAF at room temperature showed no reaction (Table 7, entry 
1). Using more forcing conditions by increasing the temperature (up to 60 °C) and 
the reaction time (24 h) only led to decomposition with no starting materials or 
product recovered (entry 2). Alternatively, attempts were made to cleave the C−Si 
bond under acidic conditions. Starting with 2 M hydrochloric acid and methanol 
(1:1 ratio), there was no reaction at room temperature after 24 h (entry 3). Using a 
more concentrated acid (4 M HCl) and by performing the reaction at 45 °C, a 42% 
conversion to 236 was observed after 48 h (entry 4). Finally, the synthesis of the 
non-substituted aminobicyclo[4.3.0]nonane 236 was achieved in 74% yield using 6 
M HCl at 60 °C (entry 5). These results showed that the BDMS group is stable to 
protodesilylation under fluoride and mild acidic conditions. 
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Entry Reagent Conditions Conversion (%) Yield (%) 
1 TBAF, THF 20 °C, 6 h No reaction - 
2 TBAF, THF 60 °C, 24 h Decomposition - 
3 2 M HCl, MeOH (1:1), THF 20 °C, 24 h No reaction - 
4 4 M HCl, MeOH (1:1), THF 45 °C, 48 h 42 - 
5 6 M HCl, MeOH (1:1), THF 60 °C, 18 h 100 74 
Table 7: Protodesilylation reaction to form non-substituted analogue 236. 
2.2.4.1 Functionalisation of aminobicyclo[4.3.0]nonane 236 
The next stage of this project was to investigate the reactivity of the tri-substituted 
alkene component of compound 236 toward oxidation reactions. Firstly, under 
Donohoe's conditions using osmium tetroxide and TMEDA,116,117 dihydroxylation of 
236 gave the desired diol derivative 237 in 86% yield as a single diastereomer 
(Scheme 69). Similarly, an epoxidation reaction of 236 with m-CPBA was carried 
out and gave epoxide 238 as a major diastereomer in 73% yield. Diol derivative 
237 was formed as a single diastereomer in contrast to the epoxidation reaction 
that gave 238 as a major diastereomer in a 5:1 ratio. Due to the small-scale 
reaction, the minor epoxide diastereomer was difficult to isolate after column 
chromatography. The selectivity observed for these reactions was due to the 
curved shape of the tricyclic core of 236, which allowed the reactions to take place 
on the less hindered top face of the molecule. The facial selectivity of these type of 
reactions with aminobicyclo[4.3.0]nonanes such as 237 has been confirmed by the 
X-ray crystal structure of a similar molecule 216 (see figure 8, section 2.1.6). 
Finally, attempts were made to reduce the alkene of bicyclo[4.3.0]nonane 236 
using 10% palladium on carbon under an atmosphere of hydrogen. The alkene 
NH
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O NH
O
Cl3C
NPh
O
O
235 236
H
H
fluoride or
acidic conditions
 83 
was resistant to hydrogenation and the reaction produced only dichloroacetamide 
analogue 239 in 85% yield. 
 
Scheme 69: Functionalisation of the tri-substituted alkene of compound 236. 
2.2.5 Attempted Hiyama-Denmark cross coupling 
One of the main aims of this project was to enable the palladium catalysis of the 
Overman rearrangement to take place during the one-pot process. Therefore, the 
asymmetric synthesis of this aminobicyclo[4.3.0]nonane core could be achieved 
using chiral palladium catalysts such as (S)-COP-Cl 56 and (R)-COP-Cl 57. The 
previous study showed that the use of disubstituted alkynes with an aryl group 
attached was necessary to hinder the coordination of the palladium catalyst to the 
alkyne side-chain and facilitate the Pd(II)-catalysed Overman rearrangement. This 
allowed the formation of a library of aminobicyclo[4.3.0]nonanes 201–213 
diastereoselectively in good overall yields. However, there were only two ways to 
introduce the diversity of this process, either via a Sonogashira cross coupling 
before the synthesis of the allylic alcohol precursors or a Diels-Alder reaction at 
the final stage of this process using different dienophiles. To overcome this 
limitation, another one-pot process using BDMS-derived allylic alcohol was 
developed and successfully led to the synthesis of vinylsilyl derived 
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aminobicyclo[4.3.0]nonane 235 in a good yield. The use of the vinylsilane 
functionality in cross coupling reactions was then investigated to allow the late-
stage diversification to various aminobicyclo[4.3.0]nonanes.   
Under standard conditions, a Hiyama-Denmark reaction was attempted to couple 
the vinylsilyl derived aminobicyclo[4.3.0]nonane 235 with iodobenzene in the 
presence of tris(dibenzylideneacetone)dipalladium(0) (2.5 mol %) and TBAF 
(Scheme 70).122 However, all attempts failed and neither product nor starting 
material was recovered. Other conditions, such as increasing the catalyst loading 
(up to 10 mol %) and the temperature (40, 60 and 80 °C), or using electron rich (4-
iodoanisole) and electron poor (1-iodo-4-nitrobenzene) coupling partners were 
investigated, but all efforts ended with decomposition of vinylsilane 235. 
 
Scheme 70: Attempted Hiyama-Denmark cross coupling reaction of 235. 
2.2.6 Iododesilylation reaction 
In a similar fashion to the protodesilylation reaction and to overcome the issue with 
the Hiyama-Denmark reaction, it was found that the vinylsilane 235 could undergo 
an iododesilylation reaction to form the corresponding vinyl iodide 240.126,127 Using 
iodine monochloride at −78 °C, the vinylsilane 235 was transformed into the vinyl 
iodide 240 in a 88% yield (Scheme 71). The successful synthesis of vinyl iodide 
240 was promising, as this could be used to explore other palladium-catalysed 
cross-coupling reactions such as Suzuki and Sonogashira reactions. 
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Scheme 71: Synthesis of vinyl iodide 240 via iododesilylation reaction. 
2.2.6.1 Suzuki cross-coupling reaction 
Following the issues encountered with the Hiyama-Denmark coupling, the first 
suggestion was to attempt a Suzuki coupling reaction using vinyl iodide 240. 
Initially, compound 240 was subjected to a Suzuki coupling reaction with 
phenylboronic acid in the presence of [1,1’-
bis(diphenylphosphino)ferrocene]palladium(II) dichloride (5 mol %) and cesium 
fluoride (Table 8, entry 1). With these conditions, the reaction proceeded with low 
conversion and gave the product 201 along with the dechlorinated compound 214 
as a by-product in a 4:1 ratio, respectively. Changing the base to cesium 
carbonate gave a better conversion, but again produced by-product 214 (entry 2). 
Using bis(triphenylphosphine)palladium(II) dichloride as a catalyst and shorter 
reaction times, with different catalyst loading gave coupled product 201 and 
compound 214 in low yield (entries 3, 4 and 5). Decomposition was observed 
when tetrakis(triphenylphosphine)palladium(0) was used as the catalyst with 
cesium fluoride or potassium carbonate as bases in 1,4-dioxane or DMF (entries 6 
and 7). Fortunately, when the solvent system was changed to toluene and 
methanol with potassium carbonate as a base and Pd(PPh3)4 as the catalyst, a 
high yield was obtained for both compounds with the ratio of 1:2 of the target 
product 201 and the by-product 214, respectively (entry 8). Monitoring the reaction 
progress by 1H NMR spectroscopy showed that the dechlorination happened 
immediately after the formation of the product 201. To increase the reaction rate, a 
higher catalyst loading of 10 mol% was trialed, hoping that the target product 201 
would be formed quickly before the dechlorination started. This led to the 
formation of compound 201 in a better ratio (2:1) (entry 9). Finally, using increased 
equivalents of base (4 equiv.) and 10 mol% of the catalyst gave the cross-coupled 
ICl, −78 °C, 3 h
88%
NHO
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NHO
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product 201 in 76% yield as a major product (entry 10). During the optimisation of 
this reaction, it was thought that the problem could be associated with the 
palladium catalyst. Therefore, further investigation was carried out using other 
transition metal catalysts, such as (1,3-bis(diphenylphosphino)propane)nickel(II) 
dichloride. However, this led to no reaction. 
 
Entry Catalyst (mol %) Base, Solvent, Time 
Conversion (%)a 
Ratio (201:214:240) 
Yield (%)b 
201:214 
1 PdCl2(dppf) (5) 
CsF, 1,4-dioxane, 
24 h 
22 
(4:1:13) 
- 
2 PdCl2(dppf) (5) 
CsCO3, 1,4-dioxane/H2O,  
24 h 
69 
(2.4:1:2) 
- 
3 PdCl2(PPh3)2 (5) 
K2CO3, 1,4-dioxane/H2O,  
4 h 
100 
(2:1:0) 
32:15 
4 PdCl2(PPh3)2 (2.5) 
K2CO3, 1,4-dioxane/H2O,  
7 h 
88 
(4.2:2:1) 
20:10 
5 PdCl2(PPh3)2 (10) 
K2CO3, 1,4-dioxane/H2O,  
3 h 
87 
(4:1.7:1) 
- 
6 Pd(PPh3)4 (5) 
CsF, 1,4-dioxane, 
5 h 
Decomposition 
7 Pd(PPh3)4 (5) 
K2CO3, DMF/H2O 
18 h 
Decomposition 
8 Pd(PPh3)4 (5) 
K2CO3, toluene/MeOH 
48 h 
100 
(1:2:0) 
32:53 
9 Pd(PPh3)4 (10) 
K2CO3, toluene/MeOH 
48 h 
100 
(2:1:0) 
- 
10c Pd(PPh3)4 (10) 
K2CO3, toluene/MeOH 
48 h 
92 76:5 
Table 8: Optimisation of Suzuki coupling reaction. aCalculated from 1H NMR spectra 
of crude reaction mixture, bIsolated yield after purification. cThe reaction was 
performed using four equivalents of K2CO3. 
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Having established the required conditions for the Suzuki coupling to form 201 
using phenylboronic acid as a coupling partner, attention was then turned to 
electron-rich and electron-deficient variants (Scheme 72). Under the optimised 
conditions, reaction of vinyl iodide 240 with 4-methoxyphenylboronic acid gave the 
corresponding coupled product 210 in a 53% yield. As observed during the 
synthesis of 201, small amounts of the dichloroacetamide analogue 210b were 
detected (10%). The mono-dechlorinated product was still observed in high 
amounts during the reaction of compound 240 with electron-deficient 4-
fluorophenylboronic acid. However, the formation of this by-product was reduced 
to less than 10% by using a shorter reaction time. This allowed the synthesis of 
the aminobicyclo[4.3.0]nonane analogue 241 in a 46% yield in 12 h. 
 
Scheme 72: Suzuki cross-coupling reaction of 240 with electron electron-rich and 
electron-deficient coupling partners. 
2.2.6.2 Sonogashira cross-coupling reaction 
The late-stage diversity of aminobicyclo[4.3.0]nonanes was further expanded with 
the coupling of other groups at the C-5 position via a Sonogashira reaction. This 
work was carried out by Angus McMillan, a project student in the group. Under 
standard conditions, the reaction was performed using phenylacetylene 242 as a 
coupling partner in the presence of bis(triphenylphosphine)palladium dichloride (1 
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mol %) and copper iodide (2 mol %) in triethylamine and DMF as a co-solvent 
(Scheme 73).128 This gave a mixture of dechlorinated starting material and couple 
of different unidentified by-products. Increasing the catalyst loading to 10 and 20 
mol % of the palladium and copper catalysts allowed the synthesis of the 
dechlorinated C-5 substituted product 243 in a 48% yield. It should be mentioned 
that after two hours, the 1H NMR spectra of the crude reaction mixture showed the 
consumption of all starting material 240 and the formation of a mixture of both the 
expected coupled product and the mono-dechlorinated product 243. Because of 
the rapid transformation to both products, the reaction was left stirring for an 
additional hour to exclusively form compound 243. This was the best result 
obtained from different attempts using various catalysts and bases. 
 
Scheme 73: Sonogashira cross-coupling reaction of 240. 
The proposed mechanism for the formation of dichloroacetamide 243 is shown in 
Scheme 74. It was believed that the dechlorination occurred via a single electron 
transfer (SET) mechanism similar to what has been previously observed for 
platinum-catalysed dechlorination of the trichloromethylcarbonyl group.129 This 
observation was supported by Liu, Dong and co-workers who described a similar 
SET mechanism for palladium catalysts.130 
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Scheme 74: Proposed dechlorination mechanism. 
2.2.7 Conclusions 
In conclusion, two silyl substituted hep-2-en-6-yn-ols have been prepared and 
examined as substrates for the one-pot multi-step synthesis of novel vinylsilyl 
derived aminobicyclo[4.3.0]nonanes. Initially, a TBDMS group was used to 
investigate the steric requirements for the one-pot process. It was found that while 
the presence of this group was effective to perform the Pd-catalysed Overman 
rearrangement, it hindered the following RCEYM reaction. Alternatively, the less 
bulky BDMS group was then examined and successfully led to the formation of the 
corresponding aminobicyclo[4.3.0]nonane 235 in a good yield over the four-step 
process. The resulting vinylsilane 235 was then submitted to protodesilylation and 
iododesilylation reactions leading to the synthesis of the non-substituted 236 and 
vinyl iodide 240 derivatives. Next, the reactivity of compounds 236 and 240 
towards oxidation and cross-coupling reactions was investigated and led to the 
late stage synthesis of various sp3-rich aminobicyclo[4.3.0]nonanes. 
2.2.8 Future work 
During this course of study, a one-pot four-step process was successfully 
developed for the diastereoselective synthesis of a novel BDMS-derived 
aminobicyclo[4.3.0]nonane 235 in a good overall yield. This one-pot process 
involved a Pd(II)-catalysed Overman rearrangement, Ru(II)-catalysed RCEYM and 
hydrogen bonding Diels-Alder reactions. To examine the requirements for the one-
pot process, this work focused only on using N-phenylmaleimide as a dienophile 
for the Diels-Alder reaction. Exploring the scope of dienophile during the Diels-
Alder reaction will be the next stage of this project (Scheme 75). This could be 
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achieved by using different dienophiles such as 4-phenyl-1,2,4-triazole-3,5-dione, 
tetracyanoethylene and methyl acrylate during the final step.   
 
Scheme 75: Exploring the scope of the process using different dienophiles. 
Having successfully synthesised the vinylsilyl derivatives 244–246, these would be 
then undergo iododesilylation reactions to form the corresponding vinyl iodide. By 
utilising these vinyl iodides in different cross coupling reactions, such as Suzuki, 
Sonogashira and Stille reactions, the scope of this study would be further 
expanded for the late-stage generation of a large library of analogues (Scheme 
76). 
 
Scheme 76: Exploring the scope of the process using different dienophiles. 
After the successful development of the one-pot multi-reaction process involving a 
Pd(II)-catalysed Overman rearrangement for the diastereoselective synthesis of 
various aminobicyclo[4.3.0]nonanes, the final stage of this project will be the 
asymmetric synthesis of these compounds. This could be achieved by using a 
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chiral palladium catalyst such as (S)-COP-Cl 56 during the Overman 
rearrangement step (Scheme 77). Once the reaction has been fully optimised, this 
will be then utilised in a one-pot process including RCEYM and Diels-Alder 
reactions to synthesise the corresponding chiral vinylsilyl. 
 
Scheme 77: Proposed asymmetric Overman rearrangement using chiral catalyst. 
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2.3 Development of a one-pot two-step procedure for aryl C-H amination 
using iron and copper catalysis 
2.3.1 Introduction and previous work within the Sutherland group 
Aryl halides are highly useful synthetic intermediates in organic synthesis, used in 
several synthetic transformations, such as the construction of C–C, C–N, C–O and 
C–S bonds via Pd-, Ni- and Cu-catalysed cross coupling reactions, the formation 
of organometallic reagents and also as precursors for nucleophilic aromatic 
substitution reactions.131−133 These compounds also have great importance in 
medicinal chemistry, because of their applications in understanding diseases with 
the use of aryl compounds containing radioactive halogen isotopes.134,135 
Generally, aryl iodides and bromides have better reactivity than aryl chlorides and 
fluorides, and can be used in different chemical reactions, because of their weaker 
C-X bonds. Several methods have been developed for preparing this important 
class of compounds. These include metal-catalysed halogen exchange, the 
Sandmeyer reaction and most commonly, electrophilic aromatic 
halogenation.136−140 However, most of these methods require the use of expensive 
and toxic transition metals, harsh conditions and sometimes give products with 
poor regioselectivity. 
In order to develop an alternative cost-efficient catalytic method, Racys and 
Sutherland have developed an important and highly regioselective iodination 
method of activated arenes via iron(III)-catalysed activation of N-iodosuccinimide 
(NIS).141a This work investigated a general aryl iodination method using iron(III) 
triflimide, which is a strong Lewis acid generated in situ from the reaction of  
iron(III) chloride and triflimide-based ionic liquid, 1-butyl-3-methyl-imidazolium 
bis(trifluoromethylsulfonyl)imide ([BMIM]NTf2). The use of the inexpensive, non-
pollutant and non-toxic iron(III) chloride catalyst and a cheap and recyclable ionic 
liquid have made this method very efficient, enabling rapid reactions to proceed 
under mild conditions using low catalyst loading. It was clearly noticed that the 
ionic character of the ionic liquid produces high cohesive pressure,141b which 
increased the reaction rate, in particular with substrates containing strong 
deactivating groups. 
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For example, the iodination of substrates such as anisole with FeCl3 (5 mol %) and 
NIS in dichloromethane as a solvent gave 4-iodoanisole in a 86% yield in 1.5 h 
(Scheme 78).141a On the other hand, when [BMIM]NTf2 was used as a solvent, 
89% yield was achieved in 0.5 h. In comparison, with less reactive substrates such 
as 2-methoxybenzaldehyde, it was found that a higher catalyst loading (100 mol 
%) of FeCl3 was required to give 90% of 2-methoxy-5-iodobenzaldehyde in 6 h, 
when the reaction was performed in dichloromethane. Alternatively, the use of a 
catalytic amount of FeCl3 (5 mol %) in ionic liquid gave 2-methoxy-5-
iodobenzaldehyde in 88% yield and a decreased reaction time of 2.5 h. Therefore, 
in this process, the ionic liquid was used as a solvent and as a source of triflimide 
to activate the iron catalyst. The process was then applied to a wide range of 
substrates tolerating different activating and deactivating groups, resulting in the 
formation of a library of iodinated arenes in high yields under mild conditions and 
short reaction times. During this work, it was also shown that the iodination 
proceeds via a two-electron transfer mechanism, and this was proven by adding 
the radical scavenger (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO), which had 
no effect on the reaction outcome. It is believed that higher para selectivity is due 
to the greater frontier orbital coefficient for the HOMO of the para position which is 
estimated to be 0.47 compared to 0.31 for the HOMO of the ortho position.141c This 
was shown by Leblanc and Boudreault for the amination of anisole.141d The 
regiochemistry observed for this reaction is similar to that seen in other 
halogenation reactions of activated aryl compounds.141e−g 
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Scheme 78: Iron triflimide catalysed iodination of activated arenes. 
The process was successfully used to synthesise important medicinal compounds. 
For example, the preparation of PIMBA (247) which is a compound used for 
imaging breast tumors,142 was achieved in 84% yield (Figure 9). Other targets 
such as (–)-IBZM (248), a SPECT imaging agent and a human D2 receptor,143 and 
8-iodoharmaline (249), a monoamine oxidase inhibitor,144 were synthesised in 
47% and 73% yield, respectively.141a 
 
Figure 9: Examples of medicinal compounds prepared by iron triflimide catalysed 
iodination. 
2.3.2 Bromination of arenes using iron(III) triflimide 
2.3.2.1 Aims 
The first aim of this project was to investigate the iron(III)-catalysed bromination of 
activated arenes using N-bromosuccinimide (NBS) as the brominating reagent in 
the triflimide based ionic liquid, [BMIM]NTf2 (Scheme 79).145 
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Scheme 79: Iron triflimide catalysed bromination of activated arenes. 
2.3.2.2 Substrate scope 
Using a similar procedure to that described in Scheme 78, the scope of the iron(III) 
triflimide activation of N-bromosuccinimide (NBS) was evaluated. This 
transformation was found to be applicable to a wide range of anisole, aniline and 
alcohol derivatives (Scheme 80). Bromination of substrates with electron donating 
group such as anisole gave 4-bromoanisole (250a) in excellent yield with a 95:5 
ratio of p- and o-isomers. Apart from anisole, all other aryl bromides were 
generated as single monobrominated regioisomers. Arenes with strong 
deactivating groups attached were also tested. For example, 4-nitroaniline was 
brominated in 2 h, and gave product 250n in 80% yield. Substrates with a carboxyl 
group such as 4-methoxybenzoic acid and 2,4-dimethoxybenzoic acid were also 
examined and gave products 250e and 250f in 83% and 65% yields, respectively. 
The bromination process was also applied to highly active phenol substrates such 
as phenol, 2-fluorophenol, 2,4-dimethoxy-6-hydroxybenzaldehyde and 2-naphthol, 
affording the corresponding brominated products (250i–k and 250v) in high yields. 
The scope of the process was further explored to include other active substrates 
such as 1-methoxynaphthalene, 2-methoxynaphthalene and 2,3-
dihydrobenzofuran, giving the corresponding products 250t, 250u, and 250w in 
excellent yields. From this study, it was found that the bromination using this 
method was more efficient than iodination, in terms of reaction times and isolated 
yields. The iron(III)-catalysed bromination method was also used to prepare 3,5-
dibromo-4-hydroxybenzonitrile (bromoxynil) (250x), which is a mass produced 
herbicide, used to control weeds in corn, cereals and other vegetables.146 The 
synthesis of 250x was achieved in 91% yield from the reaction of 4-cyanophenol 
with 2 equivalent of NBS in 2.5 h. 
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Scheme 80: Scope of iron triflimide catalysed bromination process. aA 95:5 ratio of 
p- and o-isomers. 
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The only limitation observed with this iron(III) catalysed method was the 
bromination of aniline which gave a mixture of the mono-, di- and tri-brominated 
anilines 251a–251c in a 2:1:1 ratio (Scheme 81). The bromination was found to be 
very rapid at room temperature. In an attempt to slow the reaction, the 
temperature was lowered to 0 °C or –10 °C. However, this gave the same mixture 
of compounds. 
 
Scheme 81: Attempted bromination of aniline. 
2.3.3 One-pot iron-catalysed bromination and copper(I)-catalysed N-arylation 
of aromatic compounds 
2.3.3.1 Introduction and aims 
The formation of aryl C–N bonds is of great importance in medicinal chemistry and 
natural product synthesis.147−149 Various metal-catalysed methods have been 
developed for the selective synthesis of this valuable motif. These include the use 
of copper- (Ullman-Goldberg and Cham-Lam coupling)150−153 or palladium- 
(Buchwald-Hartwig coupling)154−157 catalysed amination or amidation of aryl 
(pseudo)-halides. However, these methods require prefunctionalisation or 
preoxidation of either one of the cross-coupling partners. Recently, a new class of 
transition-metal-catalysed amination methods which involve C–H/N–H bond 
activation have been reported.158−164 Significant progress has been made towards 
the metal-catalysed cross-dehydrogenative ortho-amination coupling for the direct 
formation of C–N bonds.164 However, only few examples have been reported for 
meta- and para-amination processes.165,166 
The aim of this project was to develop a one-pot, two-step method for amination of 
para-C–H bonds using a combination of iron(III)- and copper(I)-catalysis (Scheme 
BrFeCl3 (5 mol %)NBS
H2N H2N
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H2N
Br
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Br Br
Br
+ +
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82). The one-pot process involves an iron(III)-catalysed bromination of activated 
arenes followed by a copper(I)-catalysed N-arylation reaction. 
 
Scheme 82: One-pot para-C–H/N–H coupling using a combination of iron(III)- and 
copper(I)-catalysis. 
2.3.3.2 Optimisation 
After identifying the optimal conditions for the bromination step, the next stage of 
this study was to include a copper(I)-catalysed N-arylation coupling. Anisole was 
chosen as a model substrate. The process started with the bromination of anisole 
with NBS in the presence of FeCl3 (5 mol %) in [BMIM]NTf2 as a solvent (Scheme 
83). After completion of the first step, indole as a nucleophilic partner, copper(I) 
oxide, N,N’-dimethylethylenediamine as a ligand, and potassium phosphate were 
then added. Unfortunately, with these conditions, there was no reaction for the 
second step after stirring at 130 °C for 24 h. Changing the copper source to 
copper(I) iodide and the base to potassium carbonate or cesium carbonate gave 
the same result. 
 
Scheme 83. First attempted one-pot process in [BMIM]NTf2. 
It was proposed that the problem of N-arylation reaction could be associated with 
using the ionic liquid as a solvent. This may be due to the triflimide ion acting as a 
ligand and coordinating to the copper centre, which prevented the catalyst ligation 
to the arene. To overcome this issue, the bromination step was further 
investigated using catalytic amounts of the ionic liquid and other solvents. As 
previously mentioned in Scheme 80, anisole was brominated to 250a in 82% yield 
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using [BMIM]NTf2 as a solvent in 1.5 h (Table 9, entry 1). It was also found that 
bromination of anisole can be carried out using FeCl3 (5 mol %) and a catalytic 
amount of [BMIM]NTf2 (15 mol %) in N,N-dimethylformamide or toluene, giving 
250a in excellent yield with an increased reaction time of 2.5 h (entries 2 and 3). 
The reaction could be also performed with lower catalyst loading. For example, 
using FeCl3 (2.5 mol %) and [BMIM]NTf2 (7.5 mol %) in toluene gave 4-
bromoanisole (250a) in 79% yield (entry 4). 
 
Entry FeCl3 (mol %) [BMIM]NTf2 (mol %) Solvent Time (h) Yield (%)  
1 5 --- [BMIM]NTf2 1.5 82 
2 5 15 DMF 2.5 84 
3 5 15 toluene 2.5 86 
4 2.5 7.5 toluene 4 79 
Table 9. Fe(III)-catalysed bromination of anisole in different solvents. 
The N-arylation coupling step was then investigated. In toluene, a 30% conversion 
to 252a was observed, when 4-bromoanisole (250a) was reacted with indole in the 
presence of FeCl3 and Cu2O (5 mol % each) at 110 °C (Table 10, entry 1). 
Increasing the catalyst loading to 10 mol % and the temperature to 130 °C, gave 
compound 252a in 48% yield (entry 2). By changing the copper source to CuI and 
the base to cesium carbonate, a vastly improved yield of 95% for product 252a 
was obtained (entry 3). The use of Fe(NTf2)3 is essential for effective bromination, 
especially with substrates containing strong deactivating groups. Therefore, the 
reaction was repeated using a catalytic amount of ionic liquid to examine its effect 
on the N-arylation reaction. In the presence of 30 mol % of [BMIM]NTf2, compound 
252a was obtained in 78% yield (entry 4). 
solvent, 40 °C
Brcatalyst, NBS
MeO MeO
250a
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Entry FeCl3 
(mol %) 
CuX 
(mol %) 
[BMIM]NTf2 
(mol %) 
Base 
(2 equiv.) 
Conv. 
(%)a 
Yield 
(%) 
1b 5 Cu2O (5) --- K3PO4 30 --- 
2 10 Cu2O (10) --- K3PO4 63 48 
3 10 CuI (10) --- Cs2CO3 100 95 
4 10 CuI (10) 30 Cs2CO3 100 78 
Table 10. Optimisation of Cu(I)-catalysed N-arylation reaction. aCalculated from 1H 
NMR spectrum of crude reaction mixture. bThe reaction was performed at 110 °C. 
Using these optimised conditions, the one-pot two-step process was attempted. 
Firstly, anisole was brominated in 2 h using FeCl3 (10 mol %) and [BMIM]NTf2 (30 
mol %) in toluene. After completion, the Cu(I)-catalysed N-arylation reaction was 
performed. However, only 14% conversion was observed for the coupled product 
252a (Table 11, entry 1). Further reduction of the catalyst loading of FeCl3 and 
[BMIM]NTf2 in DMF or toluene led to improved conversions (entries 2 and 3). It 
was also noticed that the conversion remained the same when the reaction was 
left stirring for another 24 h. During the one-pot reaction, it was found that there 
was a solubility issue of the base in the reaction mixture. To solve this issue, water 
as a co-solvent was added to the reaction mixture. This allowed a better solubility 
of the base and all other reagents, giving the coupled product 252a in nearly 
quantitative conversion (60% overall yield) (entry 4). Finally, by lowering the 
catalyst loading of FeCl3 (2.5 mol %) and [BMIM]NTf2 (7.5 mol %), a significant 
increase of yield (78%) to 252a was obtained (entry 5). 
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Entry FeCl3 (mol %) [BMIM]NTf2 (mol %) Solvent Conv. (%)a Yield (%)  
1 10 30 toluene 14 --- 
2 5 15 DMF 39 --- 
3 5 15 toluene 45 --- 
4b 5 15 toluene 95 60 
5b 2.5 7.5 toluene 95 78 
Table 11. Optimisation of the one-pot p-amination process. aCalculated from 1H 
NMR spectrum of crude reaction mixture. bWater (40% reaction volume) was added 
to the second step. 
2.3.3.3 Substrate scope 
Having identified the optimal conditions for the one-pot, two-step synthesis of 
product 252a, the scope of the process was explored (Scheme 84). The 
bromination step was carried out using NBS in the presence of FeCl3 (2.5 mol %) 
and [BMIM]NTf2 (7.5 mol %). After completion, the nucleophilic partner, copper(I) 
iodide (10 mol %) as the catalyst, DMEDA (20 mol %) as the ligand and cesium 
carbonate were then added. Firstly, the scope of the one-pot process was 
explored using anisole with various N-heterocycles (e.g. indole, pyrazole, 
imidazole, pyrrole and pyrrolidin-2-one), amides and sulfonamides. This led to the 
formation of the corresponding p-aminated coupled products 252a–i in excellent 
overall yields as single regioisomers. It was also found that pyrazole 252b could 
be prepared in a multigram scale in almost quantitative yield.  
FeCl3, NBS
[BMIM]NTf2
MeO
N
252a
MeO
indole, CuI 
DMEDA  (20 mol%)
solvent
40 °C, 4 h
250a
MeO Cs2CO3130 °C, 18 h
Br
 102 
 
Scheme 84: Scope of the one-pot p-amination process with anisole (250a). aN-
Arylation reaction was performed at 150 °C for 24 h. bN-Arylation reaction was 
performed at 150 °C for 36 h. 
The scope of the one-pot process was further expanded to include different aryl 
substrates using pyrazole, benzamide and indole as nucleophilic partners 
(Scheme 85). High yields of the para-aminated products 253a–n were afforded 
when the process was applied to aryl substrates such as anisole, phenol, aniline 
and acetanilide derivatives, in the presence of electron-donating or electron-
withdrawing substituents. In addition, with substrates containing nucleophilic 
function groups (e.g., phenols and anilines), the process was found to be efficient 
and cleanly formed the N-coupled products in high yields as single regioisomers. 
For example, the one-pot synthesis of pyrazole 253d, which contains a strong 
electron-deactivating group and also a nucleophilic function group, was achieved 
in 65% yield. 
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Scheme 85: Scope of the one-pot p-amination process with different aryl 
substrates. 
Another aim of this study was to investigate the one-pot ortho-bromination/N-
arylation reaction (Scheme 86). More forcing conditions were required for both 
bromination and amination steps when the process was applied to 4-chloroanisole, 
giving the ortho-aminated coupled product 253o in a 53% yield over the two-step 
process. In another attempt to include other substrates, a similar one-pot 
procedure was applied to 4-nitroaniline. However, this gave an inseparable 
mixture of both 4-nitroaniline starting material and the coupled product 253p in a 
1:2 ratio. Analysis of the 1H NMR spectrum of the crude bromination reaction 
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showed complete conversion to the 2-bromo-4-nitroaniline (250n). However, the 
slower N-arylation reaction resulted in reduction of the organcopper intermediate 
of 250n and led to regeneration of 4-nitroaniline. It was proposed that this could be 
assisted by the presence of the adjacent amine group.  
 
Scheme 86: Preliminary study of a one-pot ortho-amination process. 
Various methods have been reported for N-arylation reactions of aromatic halides 
with a wide range of N-nucleophiles using metal catalysts (most commonly 
copper).150−153  Recently, Correa and Bolm have shown that iron(III) catalysts 
could influence the N-arylation reactions.167,168 However, two years later Buchwald 
and Bolm reported that the reaction was essentially catalysed by copper 
contaminants.169 Another study by Taillefer and co-workers has shown that both 
metals are essential for effective N-arylation reaction in an iron–copper co-
catalysed process, in which neither of them could be used individually to effect the 
process.170 To probe the role of each catalyst during the N-arylation reaction, 4-
bromoanisole (250a) was subjected to series of reactions using pyrazole as a 
nucleophile (Table 12). It was found that less than 5% conversion was observed 
when iron(III) triflimide was employed individually as the catalyst (entry 1), while a 
92% yield obtained for the coupled product 252b with copper iodide (entry 2). By 
employing both catalysts, compound 252b was afforded in 87% yield (entry 3). 
These results strongly confirmed the role of copper iodide to effect the N-arylation 
reaction. 
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Entry Catalyst Yield (%) 
1 FeCl3 (2.5 mol %) <5 
2 CuI (10 mol %) 92 
3 FeCl3 (2.5 mol %)/CuI (10 mol %) 87 
Table 12: Investigation of the role of iron and copper catalysts during the N-arylation 
reaction. 
2.3.3.4 Limitations 
Limitations of this one-pot process were observed when using nitrogen nucleophiles 
such as morpholine (254a), succinimide (254b), 1H-1,2,3-triazole (254c), acetamide 
(254d), 2-aminothiazole (254e) and other nucleophiles with strong electron 
withdrawing group such as 4-(trifluoromethyl)benzamide (254f) (Figure 10). These 
attempts gave no products even when increasing temperature (150 °C), reaction 
time (up to 72 h), catalyst loading (up to 50 mol %) or using other ligands. Other 
nucleophiles such as benzyl carbamate (254g) gave traces of the coupled product 
(<10% conversion) with other unidentified by-products. Attempts were made to 
include oxygen (254h) or sulfur nucleophiles (254i). However, only de-bromination 
was observed. 
 
Figure 10: Unsuccessful nucleophiles. 
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2.3.4 One-pot iron(III)-catalysed iodination and copper(I)-catalysed N-
arylation of aromatic compounds 
Having had success with the one-pot para-amination process with a wide range of 
aromatic substrates and nucleophiles, another study was undertaken involving 
iodination of arenes with NIS followed by the C–N coupling reaction (Scheme 87). 
It was proposed that the weaker carbon-iodine bond could improve the efficiency 
of the one-pot process and further expand the scope. Using similar conditions to 
that described in Scheme 84, this modified one-pot process was initially applied to 
anisole and other aromatic substrates with different N-nucleophiles, giving the 
coupled products 252 and 253 in excellent yields. One of the advantages of using 
the iodination over the bromination was the formation of the para-aminated 
products in higher yields. For example, the one-pot iodination/N-arylation of 
anisole using indole or p-toluamide as nucleophiles gave 252a and 252g in 89% 
(previously, 78%) and 99% (previously, 88%) yields, respectively. Moreover, the 
one-pot iodination/N-arylation of aniline gave the coupled product 253q in a 92% 
yield as a single regioisomer. It is worth mentioning that the bromination of aniline 
gave a mixture of mono-, di- and tri-brominated products (Scheme 81), while the 
iodination gave a single mono-iodinated regioisomer. During the one-pot ortho-
bromination/N-arylation of 4-nitroaniline, an inseparable mixture of the coupled 
product 253p and 4-nitroaniline starting material was formed (Scheme 86). 
However, by using the one-pot iodination/N-arylation process, compound 253p 
was effectively and cleanly obtained in 76% yield. Work is underway by another 
PhD student (Martyn Henry) to further optimise the one-pot process to include 
other nucleophiles such as aliphatic amines, carbamates and intramolecular 
cyclisation for the N-arylation reaction. 
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Scheme 87: Scope of the one-pot iron-catalysed iodination and copper(I)-catalysed 
N-arylation process. 
2.3.5 Conclusions and future work 
In conclusion, an efficient and highly regioselective method for the bromination of 
arenes via iron(III) triflimide activation of NBS has been developed. This process 
was carried out using 5 mol % loading of inexpensive and environmentally friendly 
iron(III) chloride catalyst, as well as the use of a cheap and recyclable ionic liquid 
which acts as a solvent and as a source of triflimide to activate the iron catalyst. 
The use of this combination allowed the synthesis of a large library of brominated 
arenes 250 tolerating electron-rich and electron-deficient groups, in a short time 
under mild conditions. 
Another aim of this study was to develop a one-pot two-step p-amination process 
involving the standard bromination method (FeCl3 (5 mol %) in [BMIM]NTf2 as a 
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solvent) in combination with a copper(I)-catalysed N-arylation reaction. However, 
no aminated products were detected. As the issue with the N-arylation reaction 
was associated with the use of ionic liquid as a solvent, a modified version of the 
bromination reaction using catalytic amounts of both FeCl3 and [BMIM]NTf2 in 
toluene was then developed. Combination of this modified transformation with the 
N-arylation reaction has allowed the synthesis of a large library of aminated aryl 
compounds (252 and 253) using different aryl substrates with a wide range of N-
nucleophiles in high yields as single regioisomers. 
Limitations of this one-pot process were observed when using other nitrogen 
nucleophiles such as aliphatic amines and carbamates. Therefore, another one-pot 
process was developed, which involved iodination of arenes with NIS followed by 
the C-N coupling reaction. Initially, this modified one-pot was applied to similar 
substrates and nucleophiles and allowed the synthesis of the coupled products in 
higher yields. Work is underway by another PhD student (Martyn Henry) to further 
optimise the one-pot process to include other nitrogen and oxygen nucleophiles and 
most importantly the development of a one-pot intramolecular amination and 
etherification process (Scheme 88). 
 
Scheme 88: A one-pot iodination and amination or etherification process. 
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2.4 Iron(III)-catalysed chlorination of activated arenes 
2.4.1 Introduction and aims 
Aromatic chlorides are important synthetic blocks in organic synthesis, used as 
precursors for coupling and substitution reactions.171–176 These compounds were 
found in a wide range of natural products,177,178 e.g. nitrofungin (255),179 2,4-
dichlorophenol (256)180 and helitenuone (257),181,182 and as a structural 
component in a number of medicinal compounds and agrochemicals, such as the 
antiseptic agent chloroxylenol (258),183,184 the pesticide chloroxynil (259)185,186 and 
the cholinesterase inhibitor 260 (Figure 11).187 
 
Figure 11: Biologically active chloroarenes. 
It was previously shown (Section 2.3) the ability of iron triflimide, as a powerful 
Lewis acid, to activate NIS and NBS for a mild, efficient and highly regioselective 
halogenation of a wide range of aromatic compounds.141a,145 It was proposed that 
this method could be further modified for chlorination of a variety of activated 
arenes. The first aim of this project was to develop an iron(III)-catalysed 
chlorination method using N-chlorosuccinimide (NCS) as the chlorinating reagent 
(Scheme 89). After exploring the scope of this transformation, the next aim of this 
study would be the development of a one-pot dihalogenation method of aromatic 
compounds. Based on the reactivity differences of carbon-halogen bonds, the 
synthetic utility of these dihalogenated products would then be examined in the 
synthesis of natural products and biologically important targets.   
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Scheme 89: Iron(III) triflimide catalysed chlorination. 
2.4.2 Optimisation 
The study started with screening the chlorination of anisole in different solvents 
(Table 13). It was previously shown the iron(III)-catalysed bromination of anisole 
using iron(III) chloride (5 mol %) in [BMIM]NTf2 as a solvent (also as a source of 
triflimide to activate the iron(III) chloride catalyst). This transformation required a 
temperature of 40 °C and reaction time of 1.5 h. The same methodology was 
applied to the chlorination of anisole with NCS. It was found that a higher 
temperature of 50 °C and an increased reaction time of 5 h were required to give 
complete conversion to 4-chloroanisole (261a) (entry 1). This is due to the 
stronger nitrogen-chlorine bond of NCS. During previous investigation of the one-
pot amination process (Section 2.3.3.2, Table 9), a modified procedure of the 
iron(III) triflimide bromination reaction using catalytic amounts of both FeCl3 and 
[BMIM]NTf2 in toluene or DMF was developed. Using a similar strategy, it was 
proposed that a catalytic version of the chlorination procedure could be achieved. 
Initially, anisole was subjected to chlorination reaction using iron(III) chloride (2.5 
mol %) and [BMIM]NTf2 (7.5 mol %) in tert-butyl methyl ether. However, this 
showed no conversion after stirring for 24 h at 50 °C (entry 2). Although the use of 
the ionic liquid as a solvent is essential for faster halogenation, the catalytic 
chlorination in toluene or THF gave 261a in good conversion (60% and 75%, 
respectively) after 24 h (entry 3 and 4). It was noticed that there was a solubility 
issue of the NCS reagent in toluene, which resulted in low conversion to 261a  
(compared to THF), even when increasing the temperature to 60 °C and reaction 
time to 48 h. On the other hand, with the use of THF as a solvent and a higher 
temperature of 60 °C, compound 261a was formed in a 100% conversion after 18 
h (entry 5). It was also found that the chlorination reaction could be completed in a 
R R
Cl
N OO
FeCl3 + [BMIM]NTf2
Fe(NTf2)3
ClH
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shorter reaction time (8 h) using higher catalyst loading of both FeCl3 (5 mol %) 
and [BMIM]NTf2 (15 mol %) (entry 6). 
 
Entry FeCl3 (mol %) 
[BMIM]NTf2 
(mol %) Solvent 
Temperature   
(°C) 
Time 
(h) 
Conversion 
(%)a 
1 5 --- [BMIM]NTf2 50 5 100 
2 2.5 7.5 t-BuOMe 50 24 --- 
3 2.5 7.5 toluene 50 24 60 
4 2.5 7.5 THF 50 24 75 
5 2.5 7.5 THF 60 18 100 
6 5 15 THF 60 8 100 
Table 13. Optimisation of the iron(III) triflimide catalysed chlorination of anisole. 
aCalculated from 1H NMR spectrum of crude reaction mixture. 
2.4.3 Substrate scope 
Having successfully optimised the conditions for the synthesis of 4-chloroanisole 
(261a), the scope of the process was then evaluated (Scheme 90). In general, the 
use of FeCl3 (2.5 mol %) and [BMIM]NTf2 (7.5 mol %) was found to be sufficient for 
effective chlorination of a wide range of compounds such as anisole, phenol and 
aniline derivatives, affording the corresponding chlorinated products in high yields. 
The only issue observed with this method was the chlorination of monosubstituted 
substrates such as aniline, acetanilide and phenol which gave the ortho-
chlorinated regioisomer as a byproduct. In comparison to the iron(III)-catalysed 
bromination which only produced para-products. This is because of the smaller 
size of the chlorinating reagent compared to bromine, as well as the higher 
temperature used for this chlorination. However, the major para-products (261f, 
261k and 261l) were easily separated from the side-products in good yields (53%, 
78% and 75%, respectively), by column chromatography. Chlorination of 
multisubstituted substrates, naphthalenes and 2,3-dihydrobenzofuran produced 
the corresponding products (e.g. 261b–e, 261g, 261n–p and 261q) in excellent 
MeO MeO
ClFeCl3, NCS[BMIM]NTf2
solvent
H
261a
 112 
yields (77–97% yield) as single regioisomers. In addition, chlorination of substrates 
such as 4-nitroaniline gave the corresponding ortho-chlorinated product 261j in 
high yield (89%). Other arenes with strong electron deactivating groups such as 2-
(trifluoromethyl)aniline and 4-aminobenzonitrile required more forcing conditions 
{FeCl3 (5 mol %) and [BMIM]NTf2 (15 mol %), with a higher temperature of 70 °C} 
to give products 261h and 261i in full conversion. This method was then applied 
for the synthesis of important chlorine-containing compounds. For example, 4-
chloro-2-methylphenol (261m),188,189 a precursor used for the synthesis of 2-
methyl-4-chlorophenoxyacetic acid (MCPA) and methyl chlorophenoxypropionic 
acid (MCPP) herbicides and the antiseptic agent, 4-chloro-3,5-dimethylphenol 
(chloroxylenol)183,184 (258), were synthesised in 81% and 76% yields, respectively. 
Dichlorinated compounds could also be prepared using this method. For example, 
2,4-dichlorophenol (256), a compound used as a growth hormone (isolated from 
soil Penicillium) and also a precursor of the herbicide, 2,4-dichlorophenoxy acetic 
acid (2,4-D), was synthesised in 81% yield from the reaction of phenol with two 
equivalents of NCS.180 
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Scheme 90: Scope of the iron(III)-catalysed chlorination process. a30% conversion 
to ortho-Cl isomer. bReaction was performed at 70 °C using FeCl3 (5 mol %) and 
[BMIM]NTf2 (15 mol %). c20% conversion to ortho-Cl isomer. dReaction was 
performed using 2 equivalent of NCS. e15% conversion to ortho-Cl isomer. 
With substrates containing strong electron-withdrawing groups, low conversions 
were observed when using the previous procedure with a catalytic amount of 
[BMIM]NTf2. As mentioned before, the electronic nature of the ionic liquid 
produces high cohesive pressure, which resulting in a faster reaction, in particular, 
with the chlorination of substrates containing deactivating groups. Therefore, an 
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alternative procedure of using FeCl3 (5 mol%) and [BMIM]NTf2 as a solvent was 
utilised (Scheme 91). These conditions were found to fully chlorinate the 
deactivated substrates and gave the monochlorinated products 261r–v in high 
yields at a higher temperature of 70 °C. Using this alternative method, the 
synthesis of 3-chloro-4-methoxybenzaldehyde (261t),190 a metabolite isolated from 
soil Lepista nuda, and 2-chloro-4-nitrophenol (nitrofungin) (255),179 an antimycotic 
drug was previously used in the treatment of fungal infections (isolated from 
Stephanospora caroticolor), were achieved in 83% and 74% yield, respectively. 
Under the same conditions, dichlorination of 4-hydroxybenzonitrile gave 
chloroxynil (259),185,186 a commercially used nitrile herbicide in 73% yield after 36 
h. 
 
Scheme 91: Iron(III) triflimide catalysed chlorination of substrates containing 
deactivating groups in [BMIM]NTf2 as a solvent. 
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2.4.4 The development of tandem dihalogenation processes 
Another aim of this study was the development of a one-pot dihalogenation 
procedure for the synthesis of important intermediates for the preparation of 
biologically active compounds and natural products. As shown in Scheme 91, the 
iron(III) triflimide catalysed process was successfully used to prepare the 
dichlorinated product chloroxynil (259) cleanly in high yield. In a similar fashion, it 
was proposed that a single portion of iron(III) triflimide catalyst could be used to 
effect multiple halogenation reactions in a one-pot process. To investigate this 
procedure, anisole was initially subjected to a bromination reaction in the presence 
of FeCl3 (5 mol %) and [BMIM]NTf2 as the solvent (Scheme 92). This allowed the 
synthesis of 4-bromoanisole after 1.5 h. To the reaction mixture, NCS was then 
added and the reaction was left stirring at 70 °C for 24 h, giving the desired ortho-
chlorinated product 262 in 89% overall yield. Another one-pot process initiated by 
a chlorination reaction and followed by bromination was also developed. The 
chlorination of anisole was performed at a 60 °C to cleanly form 4-chloroanisole. 
This was followed by the addition of NBS to give 2-bromo-4-chloroanisole (250d) 
in 81% yield as a single regioisomer. The synthesis of 250d was also performed 
on a multigram scale using the one-pot two-step approach. 
 
Scheme 92: One-pot iron(III)-catalysed dihalogenation processes. 
 
[BMIM]NTf2
60 ºC, 6 h
OMe
OMe
Br
Cl
Cl
NCS
FeCl3 (5 mol %)
OMe
OMe
Br
NBS
FeCl3 (5 mol %)
[BMIM]NTf2
40 ºC, 1.5 h
NCS
70 ºC, 24 h
89%
262
OMe
Cl
BrNBS
40 ºC, 18 h
81%
250d
 116 
2.4.4.1 Application of 2-bromo-4-chloroanisole (250d) in the synthesis of 
biologically important targets 
After the successful preparation of 250d through the one-pot tandem process, the 
next stage of this study was to use this compound as a key building block in the 
synthesis of biologically important targets (Scheme 93). This could be achieved 
through selective functionalisation of the C–Br bond, relying on the difference in 
reactivity with the C–Cl bond. During previous investigation of the ortho-amination 
process (Section 2.3.3.3, Scheme 86), it was shown the ability of ortho-brominated 
products to effectively undergo a copper(I)-catalysed N-arylation reaction. Under 
similar conditions and by using 4-chlorobenzenesulfonamide as a nucleophile, 4-
bromo-2-chloroanisole (250d) was successfully aminated to give the antibacterial 
compound 263,191 in 65% yield. A similar reaction of 250d with 
benzenesulfonamide gave 264 in 67% yield. Compound 264 then underwent a N-
methylation reaction to produce cholinesterase inhibitor 260 in 93% yield.187 The 
synthetic utility of 4-bromo-2-chloroanisole (250d) was further explored for the 
synthesis of helitenuone (257),181 a compound isolated from Helichrysum species. 
The synthesis of 257 began with a Suzuki-Miyaura reaction of 4-bromo-2-
chloroanisole (250d) with commercially available 5-acetylthiophene-2-boronic acid 
(265), giving 266 in 79% yield. The hydroxyl group of 266 was then deprotected 
using boron tribromide to complete the synthesis of helitenuone (257) in 87% 
yield. The total synthesis of the natural product 257 was achieved in 56% overall 
yield from anisole, compared to the only reported method by Bohlmann and co-
workers, which involved a six-step route and 7% overall yield.182 
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Scheme 93: Exploring the synthetic utility of 2-bromo-4-chloroanisole (250d) in the 
synthesis of natural products and biologically active targets. 
2.4.5 Attempted one-pot iron(III)-catalysed chlorination and Grignard cross-
coupling reaction 
Iron as an environmentally friendly catalyst has drawn attention of chemists, as a 
good alternative to other toxic and expensive late-transition metals, in cross-
coupling reactions.192–194 The next aim of this study was to develop a one-pot 
process, involving iron(III) triflimide catalysed chlorination and Grignard cross-
coupling of arenes. In 2006, Bica and Gaertner showed that an iron-containing 
ionic liquid, [BMIM]FeCl4, could be used to catalyse aryl Grignard cross-coupling 
with various alkyl halides (Scheme 94).195 
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Scheme 94: Grignard cross-coupling reaction using iron-containing ionic liquid. 
In a similar way, it was proposed that Fe(NTf2)3 (generated in situ from the 
reaction of FeCl3 and [BMIM]NTf2) could be used to effect both chlorination and 
Grignard cross-coupling reactions in a one-pot process. In an attempt to use 
similar conditions, anisole was first subjected to a chlorination reaction using FeCl3 
(2.5 mol %) and [BMIM]NTf2 (7.5 mol %) in THF. After completion, 
phenylmagnesium bromide was added at 0 °C. However, this showed no reaction 
(Scheme 95). 
 
Scheme 95: First attempted one-pot process involving chlorination and Grignard 
cross-coupling reaction. 
An optimisation of the Grignard cross-coupling reaction using 4-chloroanisole 
(261a) was then carried out (Table 14). In 2014, Chua and Duong reported a 
successful Grignard cross-coupling reaction using various iron catalysts in the 
presence of 1,3-bis-(2,6-diisopropylphenyl)imidazolinium chloride (SIPr.HCl) as a 
ligand and sodium tert-butoxide as a base.196 During the optimisation of the 
Grignard reaction, the effect of the ionic liquid and N-succinimide (generated from 
the chlorination reaction) was investigated. Under similar conditions,196 it was 
found that there were no conversion observed to 267 when both the ionic liquid 
and N-succinimide (one equivalent) existed in the reaction mixture (entries 1, 2 
and 3). The use of only FeCl3 (2.5 mol %) gave biaryl 267 in 62% conversion 
(entry 4). The reaction was further improved when doubling the catalyst loading to 
5 mol %, giving 267 in 80% yield (entry 5). As a result, it was found that there was 
no way to perform the one-pot process, as the [BMIM]NTF2 is essential for the 
chlorination reaction, as well as the issue with N-succinimide that is generated 
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from the chlorination reaction. 
 
Entry 
FeCl3 
(mol %) 
[BMIM]NTF2 
(mol %) 
Additives 
Conversion 
(%) 
Yield 
(%) 
1 2.5 7.5 N-succinimide No reaction --- 
2 2.5 7.5 --- No reaction --- 
3 2.5 --- N-succinimide No reaction --- 
4 2.5 --- --- 62 --- 
5 5 --- --- 89 80 
Table 14: Attempted Grignard cross-coupling reaction of 4-chloroanisole (261a). 
2.4.6 Conclusions  
In conclusion, a highly regioselective chlorination method of aromatic compounds 
via iron(III) triflimide activation of NCS have been developed. In general, the use of 
catalytic amounts of both FeCl3 (2.5 mol %) and [BMIM]NTf2 (7.5 mol %) was 
found to be sufficient for effective chlorination of most substrates with a wide range 
of functional groups, giving the chlorinated products in high yields. Chlorination of 
deactivated substrates required more forcing conditions (higher catalyst loading, 5 
mol %, and the use of the ionic liquid as a solvent), with a higher temperature of 
70 °C. In addition, one-pot iron(III)-catalysed dihalogenation procedures for 
efficient preparation of dihalogenated products 250d and 262 were developed. 
The synthetic utility of compound 250d was demonstrated with the synthesis of 
chlorine-containing natural products, 257, 260 and 263. Finally, a one-pot iron(III)-
catalysed chlorination and Grignard cross-coupling reaction was attempted. 
However, this failed to give any coupled products. The issue with this process was 
associated with the use of the ionic liquid, as well as the N-succinimide that was 
generated from the chlorination reaction. 
261a 267
MeO MeO
PhCl
PhMgBr, catalyst
SIPr.HCl (15 mol %)
NaOtBu (18 mol %)
THF, 60 °C, 18 h
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3.0 Experimental 
General Experimental 
All reagents and starting materials were obtained from commercial sources and 
used as received. All dry solvents were purified using a PureSolv 500 MD solvent 
purification system. All reactions were performed under an atmosphere of argon 
unless otherwise mentioned. Flash column chromatography was carried out using 
Fisher matrix silica 60. Macherey-Nagel aluminium-backed plates pre-coated with 
silica gel 60 (UV254) were used for thin layer chromatography and were visualised 
by staining with KMnO4. 1H NMR and 13C NMR spectra were recorded on a Bruker 
DPX 400 or 500 spectrometer with chemical shift values in ppm relative to 
tetramethylsilane (δH 0.00 and δC 0.0) or residual chloroform (δH 7.26) and CDCl3 
(δC 77.2) as standard. Proton and carbon assignments are based on two-
dimensional COSY and DEPT experiments, respectively. Mass spectra were 
obtained using a JEOL JMS-700 spectrometer for EI and CI or a Bruker Microtof-q 
for ESI. Infrared spectra were obtained neat using a Shimadzu IRPrestige-21 
spectrometer. Melting points were determined on a Reichert platform melting point 
apparatus. 
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5-Phenylpent-4-yn-1-ol (169)197 
 
Bis(triphenylphosphine)palladium(II) dichloride (0.022 g, 0.031 mmol) and copper 
iodide (0.012 g, 0.062 mmol) were dissolved in triethylamine (43 mL) and 
iodobenzene (0.42 mL, 3.7 mmol) was added and stirred at room temperature for 
0.1 h. 4-Pentyn-1-ol (168) (0.26 g, 3.1 mmol) was added and the reaction mixture 
was stirred at room temperature for 48 h. The reaction mixture was concentrated 
in vacuo. Purification of the resulting residue by flash column chromatography 
(petroleum ether/ethyl acetate, 3:1) gave 5-phenylpent-4-yn-1-ol (169) (0.48 g, 
95%) as a colourless oil. Spectroscopic data was consistent with the literature.197 
δH (400 MHz, CDCl3) 1.59 (1H, br s, OH), 1.86 (2H, quin, J 6.5 Hz, 2-H2), 2.54 
(2H, t, J 6.5 Hz, 3-H2), 3.82 (2H, t, J 6.5 Hz, 1-H2), 7.24–7.30 (3H, m, 3 × ArH), 
7.36–7.42 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 16.0 (CH2), 31.4 (CH2), 61.7 
(CH2), 81.1 (C), 89.4 (C), 123.8 (C), 127.7 (CH), 128.2 (2 × CH), 131.6 (2 × CH); 
m/z (CI) 161 (MH+. 100%), 133 (20), 117 (28), 113 (13), 85 (28), 69 (39). 
5-(4’-Nitrophenyl)pent-4-yn-1-ol (170)198 
 
5-(4’-Nitrophenyl)pent-4-yn-1-ol (170) was synthesised as described for 5-
phenylpent-4-yn-1-ol (169) using 4-pentyn-1-ol (168) (0.260 g, 3.09 mmol) and 4-
iodo-1-nitrobenzene (0.920 g, 3.71 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 3:1) gave 5-(4’-nitrophenyl)pent-4-
yn-1-ol (170) (0.627 g, 99%) as an orange solid. Mp 30–32 °C; Spectroscopic data 
was consistent with the literature.198 δH (500 MHz, CDCl3) 1.44 (1H, br t, J 6.8 Hz, 
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OH), 1.89 (2H, quin, J 6.8 Hz, 2-H2), 2.59 (2H, t, J 6.8 Hz, 3-H2), 3.82 (2H, q, J 6.8 
Hz, 1-H2), 7.49–7.54 (2H, m, 2’-H and 6’-H), 8.13–8.18 (2H, m, 3’-H and 5’-H); δC 
(126 MHz, CDCl3) 16.1 (CH2), 31.1 (CH2), 61.3 (CH2), 79.5 (C), 95.9 (C), 123.4 (2 
× CH), 130.9 (C), 132.2 (2 × CH), 146.5 (C); m/z (ESI) 228 (MNa+. 100%), 199 
(11), 176 (14), 166 (15), 152 (37), 144 (22), 138 (16), 102 (15). 
5-(4’-Methoxyphenyl)pent-4-yn-1-ol (171)199 
 
5-(4’-Methoxyphenyl)pent-4-yn-1-ol (171) was synthesised as described for 5-
phenylpent-4-yn-1-ol (169) using 4-pentyn-1-ol (168) (0.260 g, 3.09 mmol) and 4-
iodoanisole (0.870 g, 3.71 mmol). Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 1:1) gave 5-(4’-methoxyphenyl)pent-4-yn-1-ol (171) 
(0.576 g, 95%) as a colourless oil. Spectroscopic data was consistent with the 
literature.199 δH (400 MHz, CDCl3) 1.54 (1H, br t, J 6.8 Hz, OH), 1.85 (2H, quin, J 
6.8 Hz, 2-H2), 2.52 (2H, t, J 6.8 Hz, 3-H2), 3.80 (3H, s, OCH3), 3.82 (2H, q, J 6.8 
Hz, 1-H2), 6.78–6.84 (2H, m, 3’-H and 5’-H), 7.30–7.35 (2H, m, 2’-H and 6’-H); δC 
(126 MHz, CDCl3) 15.9 (CH2), 31.5 (CH2), 55.2 (CH3), 61.4 (CH2), 80.8 (C), 87.9 
(C), 113.9 (2 × CH), 116.0 (C), 132.9 (2 × CH), 159.1 (C); m/z (EI) 190 (M+. 
100%), 159 (24), 145 (75), 134 (55), 115 (38), 83 (59), 75 (23), 47 (16). 
Hex-4-yne-1-ol (173)107 
 
To a solution of 5-hexyn-1-ol (172) (0.200 g, 2.04 mmol) in dimethyl sulfoxide (7 
mL) was added potassium tert-butoxide (0.460 g, 4.08 mmol). The reaction 
mixture was stirred at room temperature for 3 h. The reaction was quenched by 
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the addition of 2 M hydrochloric acid and then extracted with diethyl ether (4 × 25 
mL). The organic layers were combined, dried (MgSO4), filtered and concentrated 
in vacuo. Flash column chromatography (petroleum ether/ethyl acetate, 8:2) gave 
hex-4-yne-1-ol (173) (0.185 g, 92%) as a yellow oil. Spectroscopic data was 
consistent with the literature.107 δH (400 MHz, CDCl3) 1.56 (1H, br s, OH), 1.73 
(2H, quin, J 6.2 Hz, 2-H2), 1.78 (3H, t, J 2.6 Hz, 6-H3), 2.22–2.29 (2H, m, 3-H2), 
3.75 (2H, t, J 6.2 Hz, 1-H2); δC (126 MHz, CDCl3) 3.4 (CH3), 15.3 (CH2), 31.5 
(CH2), 61.7 (CH2), 76.1 (C), 78.5 (C); m/z (CI) 99 (MH+. 100%), 81 (10), 73 (15), 
71 (8), 69 (7). 
Ethyl (2E)-hept-2-en-6-ynoate (174)200 
 
Dimethyl sulfoxide (3.16 mL, 44.5 mmol) was added to a stirred solution of oxalyl 
chloride (2.11 mL, 25.0 mmol) in dichloromethane (90 mL) at −78 °C. The mixture 
was stirred for 0.3 h before 4-pentyn-1-ol (168) (1.50 g, 17.8 mmol) in 
dichloromethane (20 mL) was slowly added. The mixture was stirred for a further 
0.3 h before triethylamine (12.5 mL, 89.0 mmol) was added. This reaction mixture 
was stirred for 0.5 h at −78 °C and then allowed to warm to room temperature and 
stirred for a further 3 h. A solution of lithium chloride (1.36 g, 32.0 mmol), triethyl 
phosphonoacetate (6.35 mL, 32.0 mmol) and 1,8-diazabicyclo[5,4,0]undec-7-ene 
(4.79 mL, 32.0 mmol) in acetonitrile (60 mL) was then prepared and stirred for 1 h. 
The Swern solution was concentrated in vacuo, then the Horner Wadsworth 
Emmons solution was added and the reaction mixture was stirred at room 
temperature overnight. The reaction was quenched with a saturated solution of 
ammonium chloride (45 mL) and concentrated to give an orange residue, which 
was then extracted with diethyl ether (4 × 60 mL). The organic layers were 
combined, dried (MgSO4), filtered and concentrated to give an orange oil. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 7:3) 
gave ethyl (2E)-hept-2-en-6-ynoate (174) (2.45 g, 91%) as a yellow oil. 
Spectroscopic data was consistent with the literature.200 δH (400 MHz, CDCl3) 1.30 
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(3H, t, J 7.1 Hz, OCH2CH3), 2.01 (1H, t, J 2.5 Hz, 7-H), 2.34–2.39 (2H, m, 5-H2), 
2.41–2.48 (2H, m, 4-H2), 4.20 (2H, q, J 7.1 Hz, OCH2CH3), 5.90 (1H, dt, J 15.7, 
1.5 Hz, 2-H), 6.97 (1H, dt, J 15.7, 6.7 Hz, 3-H); δC (126 MHz, CDCl3) 14.3 (CH3), 
17.4 (CH2), 31.0 (CH2), 60.3 (CH2), 69.4 (CH), 82.7 (C), 122.6 (CH), 146.3 (CH), 
166.4 (C); m/z (CI) 153 (MH+. 100%), 139 (5), 113 (10), 97 (5), 81 (15), 69 (15). 
Ethyl (2E)-oct-2-en-6-ynoate (175) 
 
Ethyl (2E)-oct-2-en-6-ynoate (175) was synthesised as described for ethyl (2E)-
hept-2-en-6-ynoate (174) using hex-4-yne-1-ol (173) (0.170 g, 1.68 mmol). 
Purification by flash column chromatography (petroleum ether/diethyl ether, 8:2) 
gave ethyl (2E)-oct-2-en-6-ynoate (175) (0.266 g, 95%) as a colourless oil. 
νmax/cm−1 (neat) 2921 (CH), 1721 (C=O), 1657, 1368, 1265, 1157, 1039, 975; δH 
(400 MHz, CDCl3) 1.29 (3H, t, J 7.1 Hz, OCH2CH3), 1.77 (3H, t, J 2.3, 8-H3), 2.25–
2.32 (2H, m, 5-H2), 2.34–2.41 (2H, m, 4-H2), 4.19 (2H, q, J 7.1 Hz, OCH2CH3), 
5.87 (1H, dt, J 15.7, 1.5 Hz, 2-H), 6.98 (1H, dt, J 15.7, 6.6 Hz, 3-H); δC (126 MHz, 
CDCl3) 3.4 (CH3), 14.2 (CH3), 17.7 (CH2), 31.6 (CH2), 60.2 (CH2), 76.6 (C), 77.5 
(C), 122.1 (CH), 147.1 (CH), 166.5 (C); m/z (ESI) 189.0883 (MNa+. C10H14NaO2 
requires 189.0886). 
Ethyl (2E)-7-phenylhept-2-en-6-ynoate (176)201 
 
Ethyl (2E)-7-phenylhept-2-en-6-ynoate (176) was synthesised as described for 
ethyl (2E)-hept-2-en-6-ynoate (174) using 5-phenylpent-4-yn-1-ol (169) (0.640 g, 
3.96 mmol). Purification by flash column chromatography (petroleum ether/diethyl 
ether, 17:3) gave ethyl (2E)-7-phenylhept-2-en-6-ynoate (176) (0.858 g, 95%) as a 
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yellow oil. Spectroscopic data was consistent with the literature.201 δH (400 MHz, 
CDCl3) 1.30 (3H, t, J 7.1 Hz, OCH2CH3), 2.47–2.61 (4H, m, 4-H2 and 5-H2), 4.20 
(2H, q, J 7.1 Hz, OCH2CH3), 5.93 (1H, dt, J 15.7, 1.5 Hz, 2-H), 7.04 (1H, dt, J 
15.7, 6.6 Hz, 3-H), 7.26–7.31 (3H, m, 3 × ArH), 7.36–7.41 (2H, m, 2 × ArH); δC 
(101 MHz, CDCl3) 14.3 (CH3), 18.4 (CH2), 31.4 (CH2), 60.2 (CH2), 81.7 (C), 88.3 
(C), 122.5 (CH), 123.6 (C), 127.8 (CH), 128.2 (2 × CH), 131.6 (2 × CH), 146.6 
(CH), 166.3 (C); m/z (CI) 229 (MH+. 100%), 155 (7), 113 (13), 81 (25), 69 (34). 
Ethyl (2E)-7-(4’-nitrophenyl)hept-2-en-6-ynoate (177) 
 
Ethyl (2E)-7-(4’-nitrophenyl)hept-2-en-6-ynoate (177) was synthesised as 
described for ethyl (2E)-hept-2-en-6-ynoate (174) using 5-(4’-nitrophenyl)pent-4-
yn-1-ol (170) (0.460 g, 2.24 mmol). Purification by flash column chromatography 
(petroleum ether/diethyl ether, 8:2) gave ethyl (2E)-7-(4’-nitrophenyl)hept-2-en-6-
ynoate (177) (0.582 g, 95%) as a yellow solid. Mp 56–58 ºC; νmax/cm−1 (neat) 2960 
(CH), 1714 (C=O), 1591 (C=C), 1509, 1340, 1154, 854, 750; δH (400 MHz, CDCl3) 
1.30 (3H, t, J 7.1 Hz, OCH2CH3), 2.50–2.57 (2H, m, 4-H2), 2.60–2.66 (2H, m, 5-
H2), 4.21 (2H, q, J 7.1 Hz, OCH2CH3), 5.94 (1H, dt, J 15.7, 1.5 Hz, 2-H), 7.02 (1H, 
dt, J 15.7, 6.7 Hz, 3-H), 7.49–7.54 (2H, m, 2’-H and 6’-H), 8.14–8.18 (2H, m, 3’-H 
and 5’-H); δC (101 MHz, CDCl3) 14.3 (CH3), 18.6 (CH2), 30.9 (CH2), 60.4 (CH2), 
80.3 (C), 94.3 (C), 122.8 (CH), 123.5 (2 × CH), 130.6 (C), 132.3 (2 × CH), 146.0 
(CH), 146.8 (C), 166.3 (C); m/z (ESI) 296.0881 (MNa+. C15H15NNaO4 requires 
296.0893). 
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Ethyl (2E)-7-(4’-methoxyphenyl)hept-2-en-6-ynoate (178)201 
 
Ethyl (2E)-7-(4’-methoxyphenyl)hept-2-en-6-ynoate (178) was synthesised as 
described for ethyl (2E)-hept-2-en-6-ynoate (174) using 5-(4’-methoxyphenyl)pent-
4-yn-1-ol (171) (0.550 g, 2.89 mmol). Purification by flash column chromatography 
(petroleum ether/diethyl ether, 8:2) gave ethyl (2E)-7-(4’-methoxyphenyl)hept-2-
en-6-ynoate (178) (0.702 g, 94%) as a yellow oil. Spectroscopic data was 
consistent with the literature.201 δH (400 MHz, CDCl3) 1.29 (3H, t, J 7.1 Hz, 
OCH2CH3), 2.46–2.59 (4H, m, 4-H2 and 5-H2), 3.80 (3H, s, OCH3), 4.20 (2H, q, J 
7.1 Hz, OCH2CH3), 5.92 (1H, dt, J 15.7, 1.5 Hz, 2-H), 6.79–6.84 (2H, m, 3’-H and 
5’-H), 7.03 (1H, dt, J 15.7, 6.5 Hz, 3-H), 7.30–7.35 (2H, m, 2’-H and 6’-H); δC (126 
MHz, CDCl3) 14.3 (CH3), 18.4 (CH2), 31.5 (CH2), 55.2 (CH3), 60.3 (CH2), 81.4 (C), 
86.7 (C), 113.8 (2 × CH), 115.7 (C), 122.4 (CH), 132.9 (2 × CH), 146.8 (CH), 159.2 
(C), 166.4 (C); m/z (EI) 258 (M+. 22%), 230 (20), 185 (27), 145 (100), 130 (6), 102 
(13), 83 (11). 
(2E)-Hept-2-en-6-yn-1-ol (179)202a 
 
Ethyl (2E)-hept-2-en-6-ynoate (174) (2.28 g, 15.0 mmol) was dissolved in diethyl 
ether (80 mL) and cooled to −78 °C. DIBAL-H (1 M in hexane) (33.0 mL, 33.0 
mmol) was added dropwise and the reaction mixture was stirred at −78 °C for 3 h, 
before warming to room temperature overnight. The solution was cooled to 0 °C 
and quenched by the addition of a saturated solution of Rochelle salt (50 mL) and 
warmed to room temperature with vigorous stirring for 1 h, producing a white 
precipitate that was filtered through a pad of Celite® and washed with diethyl ether 
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(3 × 75 mL). The filtrate was then dried (MgSO4), filtered and concentrated in 
vacuo. Purification by flash column chromatography (petroleum ether/diethyl ether, 
1:1) gave (2E)-hept-2-en-6-yn-1-ol (179) (1.44 g, 87%) as a pale yellow oil. 
Spectroscopic data was consistent with the literature.202a δH (500 MHz, CDCl3) 
1.42 (1H, br s, OH), 1.99 (1H, t, J 2.5 Hz, 7-H), 2.28–2.33 (4H, m, 4-H2 and 5-H2), 
4.14 (2H, d, J 4.0 Hz, 1-H2), 5.70–5.81 (2H, m, 2-H and 3-H); δC (126 MHz, CDCl3) 
18.5 (CH2), 31.1 (CH2), 63.5 (CH2), 68.8 (CH), 83.7 (C), 130.5 (CH), 130.6 (CH); 
m/z (CI) 111 (MH+. 3%), 107 (15), 93 (100), 81 (10), 69 (10). 
(2E)-Oct-2-en-6-yn-1-ol (180)202b 
 
(2E)-Oct-2-en-6-yn-1-ol (180) was synthesised as described for (2E)-hept-2-en-6-
yn-1-ol (179) using ethyl (2E)-oct-2-en-6-ynoate (175) (0.558 g, 3.36 mmol). 
Purification by flash column chromatography (petroleum ether/diethyl ether, 1:1) 
gave (2E)-oct-2-en-6-yn-1-ol (180) (0.363 g, 87%) as a colourless oil. νmax/cm−1 
(neat) 3337 (OH), 2919 (CH), 1436, 1082, 1000, 968; δH (500 MHz, CDCl3) 1.24–
1.29 (1H, m, OH), 1.78 (3H, t, J 2.4 Hz, 8-H3), 2.18–2.27 (4H, m, 4-H2 and 5-H2), 
4.11 (2H, t, J 5.3 Hz, 1-H2), 5.66–5.79 (2H, m, 2-H and 3-H); δC (126 MHz, CDCl3) 
3.4 (CH3), 18.8 (CH2), 31.7 (CH2), 63.5 (CH2), 76.0 (C), 78.5 (C), 130.1 (CH), 
131.3 (CH); m/z (ESI) 147.0782 (MNa+. C8H12NaO requires 147.0780), 135 (13%), 
91 (22). 
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(2E)-7-Phenylhept-2-en-6-yn-1-ol (181)101 
 
(2E)-7-Phenylhept-2-en-6-yn-1-ol (181) was synthesised as described for (2E)-
hept-2-en-6-yn-1-ol (179) using ethyl (2E)-7-phenylhept-2-en-6-ynoate (176) 
(0.670 g, 3.00 mmol). Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 13:7) gave (2E)-7-phenylhept-2-en-6-yn-1-ol (181) (0.545 g, 
98%) as a colourless oil. Spectroscopic data was consistent with the literature.101 
δH (400 MHz, CDCl3) 1.29 (1H, br s, OH), 2.33–2.40 (2H, m, 4-H2), 2.50 (2H, t, J 
6.8 Hz, 5-H2), 4.13 (2H, br s, 1-H2), 5.72–5.87 (2H, m, 2-H and 3-H), 7.25–7.32 
(3H, m, 3 × ArH), 7.36–7.42 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 19.5 (CH2), 
31.5 (CH2), 63.5 (CH2), 81.2 (C), 89.4 (C), 123.9 (C), 127.7 (CH), 128.2 (2 × CH), 
130.5 (CH), 130.9 (CH), 131.6 (2 × CH); m/z (EI) 186 (M+. 13%), 167 (12), 155 
(11), 142 (16), 128 (9), 115 (100), 105 (10), 84 (14). 
(2E)-7-(4’-Nitrophenyl)hept-2-en-6-yn-1-ol (182) 
 
 (2E)-7-(4’-Nitrophenyl)hept-2-en-6-yn-1-ol (182) was synthesised as described for 
(2E)-hept-2-en-6-yn-1-ol (179) using ethyl (2E)-7-(4’-nitrophenyl)hept-2-en-6-
ynoate (177) (0.670 g, 2.45 mmol). Purification by flash column chromatography 
(petroleum ether/diethyl ether, 6:4) gave (2E)-7-(4’-nitrophenyl)hept-2-en-6-yn-1-ol 
(182) (0.469 g, 83%) as a dark green solid. Mp 64–66 ºC; νmax/cm−1 (neat) 3374 
(OH), 2924 (CH), 1593 (C=C), 1516, 1341, 855, 750; δH (400 MHz, CDCl3) 1.35 
(1H, br s, OH), 2.35–2.42 (2H, m, 4-H2), 2.54 (2H, t, J 7.1 Hz, 5-H2), 4.14 (2H, d, J 
3.2 Hz, 1-H2), 5.72–5.85 (2H, m, 2-H and 3-H), 7.49–7.54 (2H, m, 2’-H and 6’-H), 
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8.13–8.18 (2H, m, 3’-H and 5’-H); δC (101 MHz, CDCl3) 19.6 (CH2), 31.1 (CH2), 
63.5 (CH2), 79.8 (C), 95.6 (C), 123.5 (2 × CH), 130.4 (CH), 130.8 (CH), 130.9 (C), 
132.3 (2 × CH), 146.7 (C); m/z (ESI) 254.0784 (MNa+. C13H13NNaO3 requires 
254.0788), 227 (9%), 199 (9). 
(2E)-7-(4’-Methoxyphenyl)hept-2-en-6-yn-1-ol (183) 
 
 (2E)-7-(4-Methoxyphenyl)hept-2-en-6-yn-1-ol (183) was synthesised as described 
for (2E)-hept-2-en-6-yn-1-ol (179) using ethyl (2E)-7-(4’-methoxyphenyl)hept-2-en-
6-ynoate (178) (0.435 g, 1.68 mmol). Purification by flash column chromatography 
(petroleum ether/diethyl ether, 1:1) gave (2E)-7-(4’-methoxyphenyl)hept-2-en-6-yn-
1-ol (183) (0.340 g, 94%) as a yellow oil. νmax/cm−1 (neat) 3368 (OH), 2916 (CH), 
1607 (C=C), 1508, 1244, 831; δH (400 MHz, CDCl3) 1.43 (1H, br s, OH), 2.30–2.41 
(2H, m, 4-H2), 2.47 (2H, t, J 7.1 Hz, 5-H2), 3.79 (3H, s, OCH3), 4.12 (2H, d, J 4.5 
Hz, 1-H2), 5.69–5.85 (2H, m, 2-H and 3-H), 6.78–6.83 (2H, m, 3’-H and 5’-H), 
7.29–7.34 (2H, m, 2’-H and 6’-H); δC (101 MHz, CDCl3) 19.5 (CH2), 31.6 (CH2), 
55.2 (CH3), 63.2 (CH2), 80.9 (C), 87.9 (C), 113.9 (2 × CH), 116.0 (C), 130.4 (CH), 
130.7 (CH), 132.9 (2 × CH), 159.1 (C); m/z (EI) 216.1153 (M+. C14H16O2 requires 
216.1150), 172 (17%), 145 (100), 130 (7), 102 (15). 
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3-(2’,2’,2’-Trichloromethylcarbonylamino)hept-1-en-6-yne (184)101 
 
(2E)-Hept-2-en-6-yn-1-ol (179) (0.110 g, 1.00 mmol) was dissolved in 
dichloromethane (20 mL) and cooled to 0 °C. To the solution was added 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.0300 mL, 0.200 mmol) and trichloroacetonitrile 
(0.150 mL, 1.50 mmol). The reaction mixture was allowed to warm to room 
temperature before stirring for 3 h. The reaction mixture was filtered through a 
short pad of silica gel and the filtrate concentrated in vacuo to give the allylic 
trichloroacetimidate, which was used without further purification. The allylic 
trichloroacetimidate was dissolved in toluene (21 mL) under an argon atmosphere. 
Bis(acetonitrile)palladium chloride (0.0260 g, 0.100 mmol) was then added to the 
solution and the reaction mixture was stirred at 40 °C for 24 h. To the reaction 
mixture, an additional portion of bis(acetonitrile)palladium chloride (0.0260 g, 0.100 
mmol) was added and the reaction was stirred at 40 °C for 24 h and the solvent 
was evaporated. Flash column chromatography using silica (petroleum 
ether/diethyl ether 10:1) gave 3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-
yne (184) (0.086 g, 34%) as a white solid. Mp 35–37 °C; Spectroscopic data was 
consistent with the literature.101 δH (500 MHz, CDCl3) 1.84–2.00 (2H, m, 4-H2), 
2.05 (1H, t, J 2.7 Hz, 7-H), 2.26–2.39 (2H, m, 5-H2), 4.56–4.63 (1H, m, 3-H), 5.27 
(1H, d, J 10.5 Hz, 1-HH), 5.30 (1H, d, J 17.2 Hz, 1-HH), 5.82 (1H, ddd, J 17.2, 
10.5, 5.6 Hz, 2-H), 6.93 (1H, br s, NH); δC (126 MHz, CDCl3) 14.8 (CH2), 32.5 
(CH2), 53.0 (CH), 69.9 (CH), 83.1 (C), 92.7 (C), 116.9 (CH2), 135.4 (CH), 161.3 
(C); m/z (CI) 254 (MH+. 72%), 220 (55), 186 (42), 184 (37), 132 (12), 89 (100), 69 
(27). 
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3-(2’,2’,2’-Trichloromethylcarbonylamino)oct-1-en-6-yne (185) 
 
3-(2’,2’,2’-Trichloromethylcarbonylamino)oct-1-en-6-yne (185) was synthesised as 
described for 3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne (184), 
except using (2E)-oct-2-en-6-yn-1-ol (180) (0.040 g, 0.34 mmol) and a single 
portion of bis(acetonitrile)palladium chloride (0.0090 g, 0.034 mmol). The reaction 
was performed at 20 °C for 24 h. Purification by flash column chromatography 
(petroleum ether/diethyl ether, 7:3) gave 3-(2’,2’,2’-
trichloromethylcarbonylamino)oct-1-en-6-yne (185) (0.050 g, 55%) as a colourless 
oil. νmax/cm−1 (neat) 3331 (NH), 2920 (CH), 1694 (C=O), 1516 (C=C), 1441, 1250, 
926, 822; δH (400 MHz, CDCl3) 1.73–1.95 (5H, m, 4-H2 and 8-H3), 2.20–2.30 (2H, 
m, 5-H2), 4.51–4.62 (1H, m, 3-H), 5.19–5.30 (2H, m, 1-H2), 5.79 (1H, ddd, J 17.2, 
10.4, 5.4 Hz, 2-H), 7.14 (1H, d, J 5.4 Hz, NH); δC (101 MHz, CDCl3) 3.7 (CH3), 
14.9 (CH2), 32.7 (CH2), 53.2 (CH), 77.3 (C), 78.0 (C), 92.8 (C), 116.4 (CH2), 135.6 
(CH), 161.2 (C); m/z (ESI) 289.9865 (MNa+. C10H1235Cl3NNaO requires 289.9877). 
7-Phenyl-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne (186) 
 
7-Phenyl-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne (186) was 
synthesised as described for 3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-
yne (184), except using (2E)-7-phenylhept-2-en-6-yn-1-ol (181) (0.080 g, 0.44 
mmol) and a single portion of bis(acetonitrile)palladium chloride (0.012 g, 0.044 
mmol). The reaction was performed at 20 °C for 12 h. Flash column 
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chromatography (petroleum ether/diethyl ether, 1:1) gave 7-phenyl-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (186) (0.12 g, 81%) as a colourless 
oil. νmax/cm−1 (neat) 3304 (NH), 2955 (CH), 2362, 1714 (C=O), 1511, 1265, 1175; 
δH (400 MHz, CDCl3) 1.90–2.09 (2H, m, 4-H2), 2.48–2.61 (2H, m, 5-H2), 4.60–4.69 
(1H, m, 3-H), 5.27 (1H, d, J 10.4 Hz, 1-HH), 5.32 (1H, d, J 17.2 Hz, 1-HH), 5.85 
(1H, ddd, J 17.2, 10.4, 5.6 Hz, 2-H), 6.98 (1H, d, J 7.4 Hz, NH), 7.26–7.32 (3H, m, 
3 × ArH), 7.37–7.44 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 15.9 (CH2), 32.8 
(CH2), 53.2 (CH), 82.0 (C), 88.4 (C), 92.7 (C), 116.9 (CH2), 123.4 (C), 128.0 (CH), 
128.3 (2 × CH), 131.7 (2 × CH), 135.6 (CH), 161.4 (C); m/z (ESI) 352.0019 (MNa+. 
C15H1435Cl3NNaO requires 352.0033). 
7-(4”-Nitrophenyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne 
(187) 
 
7-(4”-Nitrophenyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne (187) 
was synthesised as described for 3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-
en-6-yne (184), except using (2E)-7-(4’-nitrophenyl)hept-2-en-6-yn-1-ol (182) 
(0.060 g, 0.26 mmol) and a single portion of bis(acetonitrile)palladium chloride 
(0.0080 g, 0.026 mmol). The reaction was performed at 20 °C for 12 h. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 8:2) gave 7-(4”-
nitrophenyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne (187) (0.074 
g, 76%) as a yellow oil. νmax/cm−1 (neat) 3339 (NH), 2932 (CH), 1697 (C=O), 1514 
(C=C), 1341, 1107, 852, 820; δH (400 MHz, CDCl3) 1.93–2.08 (2H, m, 4-H2), 2.50–
2.64 (2H, m, 5-H2), 4.58–4.68 (1H, m, 3-H), 5.25–5.36 (2H, m, 1-H2), 5.85 (1H, 
ddd, J 17.2, 10.4, 5.7 Hz, 2-H), 6.80 (1H, d, J 7.9 Hz, NH), 7.50–7.55 (2H, m, 2”-H 
and 6”-H), 8.12–8.17 (2H, m, 3”-H and 5”-H); δC (101 MHz, CDCl3) 16.2 (CH2), 
32.7 (CH2), 53.0 (CH), 80.4 (C), 92.7 (C), 94.3 (C), 117.2 (CH2), 123.5 (2 × CH), 
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130.5 (C), 132.4 (2 × CH), 135.5 (CH), 146.8 (C), 161.4 (C); m/z (ESI) 396.9873 
(MNa+. C15H1335Cl3N2NaO3 requires 396.9884). 
7-(4”-Methoxyphenyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-
yne (188) 
 
7-(4”-Methoxyphenyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne 
(188) was synthesised as described for 3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (184), except using (2E)-7-(4’-
methoxyphenyl)hept-2-en-6-yn-1-ol (183) (0.11 g, 0.49 mmol) and a single portion 
of bis(acetonitrile)palladium chloride (0.014 g, 0.049 mmol). The reaction was 
performed at 20 °C for 12 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 8:2) gave 7-(4”-methoxyphenyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (188) (0.15 g, 83%) as a colourless 
oil. νmax/cm−1 (neat) 3340 (NH), 2925 (CH), 1697 (C=O), 1509 (C=C), 1246, 1173, 
831; δH (400 MHz, CDCl3) 1.89–2.08 (2H, m, 4-H2), 2.45–2.62 (2H, m, 5-H2), 3.80 
(3H, s, OCH3), 4.59–4.69 (1H, m, 3-H), 5.24–5.35 (2H, m, 1-H2), 5.85 (1H, ddd, J 
17.1, 10.4, 5.5 Hz, 2-H), 6.79–6.84 (2H, m, 3”-H and 5”-H), 7.02 (1H, d, J 8.0 Hz, 
NH), 7.30–7.36 (2H, m, 2”-H and 6”-H); δC (126 MHz, CDCl3) 15.8 (CH2), 32.8 
(CH2), 53.2 (CH), 55.3 (CH3), 81.9 (C), 86.8 (C), 92.7 (C), 113.9 (2 × CH), 115.4 
(C), 116.7 (CH2), 133.0 (2 × CH), 135.6 (CH), 159.3 (C), 161.4 (C); m/z (ESI) 
382.0120 (MNa+. C16H1635Cl3NNaO2 requires 382.0139). 
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(3aS*,8R*,8aS*,8bR*)-2,5-Diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(201)101 
 
Method A- (2E)-7-Phenylhept-2-en-6-yn-1-ol (181) (0.120 g, 0.640 mmol) was 
dissolved in dichloromethane (16 mL) and cooled to 0 °C. To the solution, 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.0200 mL, 0.0130 mmol) and trichloroacetonitrile 
(0.100 mL, 0.966 mmol) were added. The reaction mixture was allowed to warm to 
room temperature and stirred for 3 h. The reaction mixture was filtered through a 
short pad of silica gel with diethyl ether (300 mL) and the filtrate concentrated in 
vacuo to give the allylic trichloroacetimidate, which was used without further 
purification. The allylic trichloroacetimidate was dissolved in toluene (16 mL) and 
bis(acetonitrile)palladium chloride (0.0180 g, 0.0640 mmol) was then added and 
the reaction mixture was stirred at room temperature for 12 h. Grubbs second 
generation catalyst (0.0400 g, 0.0500 mmol) was added with 1,7-octadiene (0.390 
mL, 2.58 mmol) and the reaction mixture was stirred for 18 h at 90 °C. N-Phenyl 
maleimide (0.170 g, 0.960 mmol) was added with hydroquinone (0.008 g, 0.080 
mmol). The reaction mixture was stirred for 18 h at 75 °C. The reaction mixture 
was then cooled and the solvent was evaporated. Flash column chromatography 
(petroleum ether/diethyl ether, 7:3) gave (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-
3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(0.166 g, 51%) as a yellow solid. Mp 151–153 °C; Spectroscopic data was 
consistent with the literature.101 δH (400 MHz, CDCl3) 1.75 (1H, dq, J 12.3, 10.2 
Hz, 7-HH), 2.10–2.20 (1H, m, 7-HH), 2.53–2.66 (3H, m, 4-HH and 6-H2), 3.12 (1H, 
dd, J 9.1, 5.8 Hz, 8a-H), 3.30 (1H, dd, J 15.2, 1.4 Hz, 4-HH), 3.46–3.56 (2H, m, 
3a-H and 8b-H), 4.88–5.01 (1H, m, 8-H), 7.06–7.10 (2H, m, 2 × ArH), 7.23–7.47 
8a 8b
4
56
7
8
NHO
Cl3C
1
N 2
3
O
O
H
 135 
(8H, m, 8 × ArH), 8.96 (1H, d, J 9.6 Hz, NH); δC (126 MHz, CDCl3) 28.4 (CH2), 
29.9 (CH2), 31.6 (CH2), 40.3 (CH), 41.7 (CH), 43.7 (CH), 52.8 (CH), 92.9 (C), 
126.5 (2 × CH), 127.2 (CH), 127.5 (2 × CH), 128.5 (2 × CH), 129.2 (CH), 129.4 (2 
× CH), 130.3 (C), 131.4 (C), 139.0 (C), 139.6 (C), 162.3 (C), 178.5 (C), 179.7 (C); 
m/z (ESI) 525 (MNa+. 100%), 481 (18), 454 (7), 413 (7), 345 (24), 323 (21), 297 
(9), 236 (11), 218 (7). 
Method B- To a solution of (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-
iodo-2-phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (240) (0.025 g, 0.045 mmol) in a 5:1 mixture of 
toluene/methanol (3 mL) at room temperature was added phenylboronic acid 
(0.0080 g, 0.070 mmol), tetrakis(triphenylphosphine)palladium(0) (0.0050 g, 
0.0050 mmol) and potassium carbonate (0.025 g, 0.18 mmol). The reaction 
mixture was heated to 70 °C and stirred for 48 h. The mixture was allowed to cool 
to room temperature and then concentrated in vacuo. The residue was dissolved 
in ethyl acetate (5 mL), washed with water (5 mL), brine (5 mL), dried (MgSO4), 
and then concentrated in vacuo. Flash column chromatography (petroleum 
ether/diethyl ether, 7:3) gave (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-
hexahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (201) (0.017 g, 76%) as a yellow solid. Spectroscopic data was 
as described above. 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-methyl-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (202) 
 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-methyl-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (202) was 
synthesised as described for (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-
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hexahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (201) (Method A) using  (2E)-oct-2-en-6-yn-1-ol (180) (0.050 g, 
0.36 mmol). Purification by flash column chromatography (petroleum ether/diethyl 
ether, 7:3) gave (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-methyl-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (202) (0.040 g, 25%) as a white solid. Mp 126–128 °C; νmax/cm−1 (neat) 
3303 (NH), 2928 (CH), 1696 (C=O), 1518 (C=C), 1389, 1188, 736; δH (400 MHz, 
CDCl3) 1.69–1.81 (4H, m, 7-HH and 5-CH3), 2.09–2.22 (2H, m, 6-HH and 7-HH), 
2.26–2.35 (1H, m, 4-HH), 2.45–2.55 (1H, m, 6-HH), 2.69 (1H, dd, J 14.8, 1.4 Hz, 
4-HH), 2.84–2.91 (1H, m, 8a-H), 3.31 (1H, ddd, J 8.6, 7.1, 1.4 Hz, 3a-H), 3.38 (1H, 
dd, J 8.6, 6.2 Hz, 8b-H), 4.76–4.89 (1H, m, 8-H), 7.11–7.15 (2H, m, 2 × ArH), 
7.38–7.50 (3H, m, 3 × ArH), 8.97 (1H, d, J 9.6 Hz, NH); δC (101 MHz, CDCl3) 19.3 
(CH3), 26.1 (CH2), 31.6 (CH2), 31.9 (CH2), 39.9 (CH), 41.4 (CH), 42.5 (CH), 53.1 
(CH), 92.9 (C), 126.2 (C), 126.4 (2 × CH), 129.1 (CH), 129.3 (2 × CH), 131.6 (C), 
136.3 (C), 162.2 (C), 178.5 (C), 179.9 (C); m/z (ESI) 463.0350 (MNa+. 
C20H1935Cl3N2NaO3 requires 463.0353). 
(9R*,9aS*)-2,6-Diphenyl-7,8,9,9a-tetrahydro-9-(2’,2’,2’- 
trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-
a]pyridazine-1,3(2H)-dione (203) 
 
(9R*,9aS*)-2,6-Diphenyl-7,8,9,9a-tetrahydro-9-(2’,2’,2’-
trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-a]pyridazine-
1,3(2H)-dione (203) was synthesised as described for (3aS*,8R*,8aS*,8bR*)-2,5-
diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(Method A) using (2E)-7-phenylhept-2-en-6-yn-1-ol (181) (0.080 g, 0.40 mmol) and 
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4-phenyl-1,2,4-triazole-3,5-dione (0.13 g, 0.72 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 1:1) gave (9R*,9aS*)-2,6-
diphenyl-7,8,9,9a-tetrahydro-9-(2’,2’,2’-trichloromethylcarbonylamino)-1H,5H-
cyclopent[c][2,4,10]triazolo[1,2-a]pyridazine-1,3(2H)-dione (203) (0.080 g, 40%) as 
a dark yellow solid. Mp 176–178 °C; νmax/cm−1 (neat) 3405 (NH), 2925 (CH), 1714 
(C=O), 1704 (C=O) 1503 (C=C), 1420, 752; δH (400 MHz, CDCl3) 2.14–2.29 (2H, 
m, 8-H2), 2.44– 2.54 (1H, m, 7-HH), 2.60–2.71 (1H, m, 7-HH), 4.40 (1H, ddd, J 
16.6, 5.3, 2.3 Hz, 5-HH), 4.54 (1H, ddd, J 16.6, 5.3, 2.9 Hz, 5-HH), 4.57–4.61 (1H, 
m, 9a-H), 4.90–4.95 (1H, m, 9-H), 6.73 (1H, d, J 6.0 Hz, NH), 7.28–7.56 (10H, m, 
10 × ArH); δC (101 MHz, CDCl3) 24.4 (CH2), 27.8 (CH2), 45.6 (CH2), 52.5 (CH), 
59.9 (CH), 92.7 (C), 125.5 (2 × CH), 127.7 (2 × CH), 128.4 (CH), 128.7 (CH), 
128.7 (C), 128.9 (2 × CH), 129.2 (2 × CH), 130.9 (C), 132.3 (C), 136.3 (C), 151.7 
(C), 152.7 (C), 161.3 (C); m/z (ESI) 527.0395 (MNa+. C23H1935Cl3N4NaO3 requires 
527.0415). 
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-phenyl-6,6,7,7-tetracyano-1-(2’,2’,2’- 
trichloromethylcarbonylamino)indene (204) 
 
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-phenyl-6,6,7,7-tetracyano-1-(2’,2’,2’- 
trichloromethylcarbonylamino)indene (204) was synthesised as described for 
(3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(Method A) using (2E)-7-phenylhept-2-en-6-yn-1-ol (181) (0.0600 g, 0.320 mmol) 
and tetracyanoethylene (0.250 g, 1.93 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 10:1) gave (1R*,7aR*)-
2,3,5,6,7,7a-hexahydro-4-phenyl-6,6,7,7-tetracyano-1-(2’,2’,2’-
trichloromethylcarbonylamino)indene (204) (0.083 g, 56%) as a yellow solid. Mp 
136–138 °C; νmax/cm−1 (neat) 3347 (NH), 2927 (CH), 1705 (C=O), 1517 (C=C), 
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1218, 823, 769; δH (400 MHz, CDCl3) 1.90–2.03 (1H, m, 2-HH), 2.33–2.47 (2H, m, 
2-HH and 3-HH), 2.63–2.74 (1H, m, 3-HH), 3.31 (1H, dt, J 16.4, 1.7 Hz, 5-HH), 
3.46–3.56 (2H, m, 5-HH and 7a-H), 4.41–4.53 (1H, m, 1-H), 6.92 (1H, J 7.6 Hz, 
NH), 7.17–7.22 (2H, m, 2 × ArH), 7.35–7.47 (3H, m, 3 × ArH); δC (126 MHz, 
CDCl3) 26.3 (CH2), 29.0 (CH2), 37.5 (CH2), 39.7 (C), 41.4 (C), 49.7 (CH), 54.9 
(CH), 91.8 (C), 108.2 (C), 110.5 (C), 110.8 (C), 110.8 (C), 127.1 (2 × CH), 127.8 
(C), 129.0 (CH), 129.2 (2 × CH), 131.4 (C), 136.4 (C), 162.5 (C); m/z (ESI) 
480.0133 (MNa+. C21H1435Cl3N5NaO requires 480.0156). 
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-phenyl-1-(2’,2’,2’- 
trichloromethylcarbonylamino)indene-7-carboxylate (205) 
 
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-phenyl-1-(2’,2’,2’- 
trichloromethylcarbonylamino)indene-7-carboxylate (205) was synthesised as 
described for (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-
(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(201) (Method A) using (2E)-7-phenylhept-2-en-6-yn-1-ol (181) (0.0900 g, 0.480 
mmol) and methyl acrylate (0.130 mL, 1.44 mmol). The Diels-Alder reaction was 
stirred for 5 days at 111 °C. Purification by flash column chromatography 
(petroleum ether/diethyl ether, 8:2) gave methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-
hexahydro-4-phenyl-1-(2’,2’,2’-trichloromethylcarbonylamino)indene-7-carboxylate 
(205) (0.090 g, 46%) as a yellow oil; νmax/cm−1 (neat) 3414 (NH), 2952 (CH), 1712 
(C=O), 1511 (C=C), 1200, 822, 757; δH (500 MHz, CDCl3) 1.65–1.77 (1H, m, 2-
HH), 1.95–2.10 (2H, m, 2-HH and 6-HH), 2.22–2.38 (3H, m, 3-HH, 5-HH and 6-
HH), 2.40–2.49 (1H, m, 3-HH), 2.50–2.62 (1H, m, 5-HH), 3.00 (1H, q, J 4.5 Hz, 7-
H), 3.04–3.12 (1H, m, 7a-H), 3.72 (1H, s, OCH3), 4.63 (1H, qd, J 8.6, 5.0 Hz, 1-H), 
7.16–7.26 (3H, m, 3 × ArH), 7.29–7.36 (2H, m, 2 × ArH), 7.68 (1H, d, J 8.6 Hz, 
NH); δC (126 MHz, CDCl3) 26.4 (CH2), 27.8 (CH2), 28.9 (CH2), 31.7 (CH2), 39.5 
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(CH), 43.9 (CH), 52.1 (CH), 53.2 (CH3), 92.9 (C), 126.6 (CH), 127.6 (2 × CH), 
128.1 (2 × CH), 130.0 (C), 136.0 (C), 141.9 (C), 161.7 (C), 175.5 (C); m/z (ESI) 
438.0381 (MNa+. C19H2035Cl3NNaO3 requires 438.0401). 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-(4”-nitrophenyl)-2-phenyl-8-
(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (206) 
 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-(4”-nitrophenyl)-2-phenyl-8-
(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(206) was synthesised as described for (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-
3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(Method A) using  (2E)-7-(4’-nitrophenyl)hept-2-en-6-yn-1-ol (182) (0.050 g, 0.20 
mmol). Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 7:3) gave (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(4”-
nitrophenyl)-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (206) 
(0.076 g, 69%) as a yellow solid. Mp 160–162 °C; νmax/cm−1 (neat) 3306 (NH), 
2956 (CH), 1695 (C=O), 1513 (C=C), 1344, 1191, 821, 753; δH (400 MHz, CDCl3) 
1.79 (1H, qd, J 12.4, 8.0 Hz, 7-HH), 2.16–2.26 (1H, m, 7-HH), 2.50–2.70 (3H, m, 
4-HH and 6-H2), 3.17 (1H, dd, J 9.5, 6.1 Hz, 8a-H), 3.33 (1H, dd, J 14.8, 1.0 Hz, 4-
HH), 3.53–3.59 (2H, m, 3a-H and 8b-H), 4.90–5.02 (1H, m, 8-H), 7.02–7.08 (2H, 
m, 2”-H and 6”-H), 7.37–7.49 (5H, m, 5 × ArH), 8.16–8.27 (2H, m, 3”-H and 5”-H), 
8.93 (1H, d, J 9.5 Hz, NH); δC (126 MHz, CDCl3) 28.6 (CH2), 31.3 (CH2), 31.7 
(CH2), 40.2 (CH), 41.4 (CH), 44.2 (CH), 52.6 (CH), 92.8 (C), 123.8 (2 × CH), 126.4 
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(2 × CH), 128.2 (2 × CH), 128.9 (C), 129.4 (CH), 129.5 (2 × CH), 131.2 (C), 143.7 
(C), 145.4 (C), 146.7 (C), 162.4 (C), 178.3 (C), 179.3 (C); m/z (ESI) 570.0347 
(MNa+. C25H2035Cl3N3NaO5 requires 570.0361). 
(9R*,9aS*)-6-(4”-Nitrophenyl)-2-phenyl-7,8,9,9a-tetrahydro-9-(2’,2’,2’- 
trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-
a]pyridazine-1,3(2H)-dione (207) 
 
(9R*,9aS*)-6-(4”-Nitrophenyl)-2-phenyl-7,8,9,9a-tetrahydro-9-(2’,2’,2’- 
trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-a]pyridazine-
1,3(2H)-dione (207) was synthesised as described for (3aS*,8R*,8aS*,8bR*)-2,5-
diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(Method A) using  (2E)-7-(4’-nitrophenyl)hept-2-en-6-yn-1-ol (182) (0.070 g, 0.30 
mmol) and 4-phenyl-1,2,4-triazole-3,5-dione (0.060 g, 0.36 mmol). Purification by 
flash column chromatography (petroleum ether/ethyl acetate, 1:1) gave 
(9R*,9aS*)-6-(4”-nitrophenyl)-2-phenyl-7,8,9,9a-tetrahydro-9-(2’,2’,2’-
trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-a]pyridazine-
1,3(2H)-dione (207) (0.11 g, 63%) as a yellow solid. Mp 160–162 °C; νmax/cm−1 
(neat) 3398 (NH), 2925 (CH), 1711 (C=O), 1515 (C=C), 1420, 1343, 854, 751; δH 
(400 MHz, CDCl3) 2.22–2.33 (2H, m, 8-H2), 2.45–2.56 (1H, m, 7-HH), 2.60–2.72 
(1H, m, 7-HH), 4.41 (1H, dq, J 16.0, 4.0 Hz, 5-HH), 4.52 (1H, dq, J 16.0, 4.0 Hz, 5-
HH), 4.57–4.62 (1H, m, 9a-H), 4.86–4.93 (1H, m, 9-H), 6.77 (1H, d, J 5.8 Hz, NH), 
7.33–7.54 (7H, m, 7 × ArH), 8.24–8.31 (2H, m, 3”-H and 5”-H); δC (101 MHz, 
CDCl3) 24.9 (CH2), 27.6 (CH2), 45.3 (CH2), 52.6 (CH), 60.4 (CH), 92.6 (C), 124.2 
(2 × CH), 125.5 (2 × CH), 126.5 (C), 128.6 (CH), 128.7 (2 × CH), 129.3 (2 × CH), 
9a
N
N 4
5
67
8
9
NHO
Cl3C
1
N 2
3
O
O
1"
2"
3"
4"
5"
6"
NO2
H
 141 
130.7 (C), 136.0 (C), 142.9 (C), 147.6 (C), 151.8 (C), 152.8 (C), 161.5 (C); m/z 
(ESI) 572.0239 (MNa+. C23H1835Cl3N5NaO5 requires 572.0266). 
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-(4”-nitrophenyl-6,6,7,7-tetracyano-1-
(2’,2’,2’- trichloromethylcarbonylamino)indene (208) 
 
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-(4”-nitrophenyl-6,6,7,7-tetracyano-1-(2’,2’,2’- 
trichloromethylcarbonylamino)indene (208) was synthesised as described for 
(3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201)  
(Method A) using  (2E)-7-(4’-nitrophenyl)hept-2-en-6-yn-1-ol (182) (0.070 g, 0.30 
mmol) and tetracyanoethylene (0.23 g, 1.8 mmol). Purification by flash column 
chromatography (petroleum ether/diethyl ether, 6:4) gave (1R*,7aR*)-2,3,5,6,7,7a-
hexahydro-4-(4”-nitrophenyl-6,6,7,7-tetracyano-1-(2’,2’,2’- 
trichloromethylcarbonylamino)indene (208)  (0.11 g, 73%) as a yellow solid. Mp 
128–130 °C; νmax/cm−1 (neat) 3334 (NH), 2924 (CH), 1709 (C=O), 1520 (C=C), 
1347, 1218, 855, 757; δH (400 MHz, CDCl3) 1.98–2.09 (1H, m, 2-HH), 2.31–2.46 
(2H, m, 2-HH and 3-HH), 2.65–2.74 (1H, m, 3-HH), 3.29–3.37 (1H, m, 5-HH), 
3.50–3.58 (2H, m, 5-HH and 7a-H), 4.43–4.52 (1H, m, 1-H), 6.95 (1H, d, J 8.3 Hz, 
NH), 7.39–7.44 (2H, m, 2”-H and 6”-H), 8.29–8.34 (2H, m, 3”-H and 5”-H); δC (101 
MHz, CDCl3) 26.4 (CH2), 28.8 (CH2), 37.0 (CH2), 39.6 (C), 41.3 (C), 49.8 (CH), 
54.8 (CH), 91.7 (C), 108.1 (C), 110.2 (C), 110.5 (C), 110.5 (C), 124.5 (2 × CH), 
126.0 (C), 128.6 (2 × CH), 134.0 (C), 142.8 (C), 148.0 (C), 162.7 (C); m/z (ESI) 
524.9983 (MNa+. C21H1335Cl3N6NaO3 requires 525.0007), 357 (21%), 303 (22), 
289 (29), 253 (25), 235 (8). 
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Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-(4”-nitrophenyl)-1-(2’,2’,2’- 
trichloromethylcarbonylamino)indene-7-carboxylate (209) 
 
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-(4”-nitrophenyl)-1-(2’,2’,2’- 
trichloromethylcarbonylamino)indene-7-carboxylate (209) was synthesised as 
described for (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-
(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(201) (Method A) using (2E)-7-(4’-nitrophenyl)hept-2-en-6-yn-1-ol (182) (0.070 g, 
0.29 mmol) and methyl acrylate (0.080 mL, 0.87 mmol). The Diels-Alder reaction 
was stirred for 5 days at 111 °C. Purification by flash column chromatography 
(petroleum ether/diethyl ether, 8:2) gave methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-
hexahydro-4-(4”-nitrophenyl)-1-(2’,2’,2’- trichloromethylcarbonylamino)indene-7-
carboxylate (209) (0.062 g, 46%) as a colourless oil; νmax/cm−1 (neat) 3389 (NH), 
2930 (CH), 1710 (C=O), 1514 (C=C), 1344, 821, 752; δH (400 MHz, CDCl3) 1.71–
1.84 (1H, m, 2-HH), 1.95–2.15 (2H, m, 2-HH and 3-HH), 2.24–2.61 (5H, m, 3-HH, 
5-H2 and 6-H2), 3.04 (1H, q, J 4.2 Hz, 7-H), 3.09–3.15 (1H, m, 7a-H), 3.72 (1H, s, 
OCH3), 4.66 (1H, qd, J 9.0, 7.2 Hz, 1-H), 7.32–7.38 (2H, m, 2”-H and 6”-H), 7.58 
(1H, d, J 9.0 Hz, NH), 8.16–8.22 (2H, m, 3”-H and 5”-H); δC (101 MHz, CDCl3) 
26.5 (CH2), 27.3 (CH2), 29.4 (CH2), 31.8 (CH2), 39.2 (CH), 44.2 (CH), 52.2 (CH), 
52.9 (CH3), 92.7 (C), 123.5 (2 × CH), 127.8 (C), 128.4 (2 × CH), 139.5 (C), 146.4 
(C), 148.7 (C), 161.8 (C), 175.5 (C); m/z (EI) 460.0359 (M+. C19H1935Cl3N2O5 
requires 460.0360), 299 (100%), 240 (71), 194 (16), 165 (12), 83 (17). 
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(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-(4”-methoxyphenyl)-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (210) and (3aS*,8R*,8aS*,8bR*)-(4”-methoxyphenyl)-2-
phenyl-3a,4,6,7,8a,8b-hexahydro-8-(2′,2′-
dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(210b) 
 
Method A- (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-(4”-
methoxyphenyl)-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (210) was 
synthesised as described for (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-
hexahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (201) (Method A) using (2E)-7-(4’-methoxyphenyl)hept-2-en-6-
yn-1-ol (183) (0.065 g, 0.30 mmol). Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 8:2) gave (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-
hexahydro-5-(4”-methoxyphenyl)-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (210) 
(0.054 g, 34%) as a yellow solid. Mp 115–117 °C; νmax/cm−1 (neat) 3308 (NH), 
2959 (CH), 1698 (C=O), 1512 (C=C), 1391, 1247, 823; δH (400 MHz, CDCl3) 1.66–
1.81 (1H, m, 7-HH), 2.09–2.19 (1H, m, 7-HH), 2.52–2.62 (3H, m, 4-HH and 6-H2), 
3.10 (1H, dd, J 8.9, 6.3 Hz, 8a-H), 3.27 (1H, dd, J 15.2, 1.2 Hz, 4-HH), 3.44–3.54 
(2H, m, 3a-H and 8b-H), 3.81 (3H, s, OCH3), 4.87–4.99 (1H, m, 8-H), 6.85–6.92 
(2H, m, 3”-H and 5”-H), 7.04–7.09 (2H, m, 2 × ArH), 7.17–7.23 (2H, m, 2”-H and 
6”-H), 7.34–7.46 (3H, m, 3 × ArH), 8.97 (1H, d, J 9.6 Hz, NH); δC (101 MHz, 
CDCl3) 28.3 (CH2), 31.6 (CH2), 31.7 (CH2), 40.3 (CH), 41.7 (CH), 43.7 (CH), 52.9 
(CH), 55.3 (CH3), 92.9 (C), 113.8 (2 × CH), 126.5 (2 × CH), 128.7 (2 × CH), 129.1 
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(CH), 129.4 (2 × CH), 129.8 (C), 131.4 (C), 131.5 (C), 138.1 (C), 158.7 (C), 162.3 
(C), 178.6 (C), 179.8 (C); m/z (ESI) 555.0599 (MNa+. C26H2335Cl3N2NaO4 requires 
555.0616). 
Method B- 7-(4”-Methoxyphenyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-
en-6-yne (188) (0.043 g, 0.12 mmol) was dissolved in toluene (3 mL) and Grubbs 
second generation catalyst (0.0070 g, 0.0080 mmol) was added with 1,7-octadiene 
(0.070 mL, 0.48 mmol) and the reaction mixture was stirred for 20 h at 40 °C. N-
Phenyl maleimide (0.030 g, 0.18 mmol) was added with hydroquinone (0.003 g, 
0.030 mmol). The reaction mixture was stirred for 24 h at 75 °C. The reaction 
mixture was then cooled and the solvent was evaporated. Purification by flash 
column chromatography (petroleum ether/diethyl ether, 8:2) gave 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(4”-methoxyphenyl)-2-phenyl-
8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(210) (0.042 g, 65%) as a yellow solid. Spectroscopic data was as described 
above. 
Method C- (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-(4”-
methoxyphenyl)-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (210) was 
synthesised as described for 3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-
hexahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (201) (Method B) using (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-
hexahydro-5-iodo-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (240) 
(0.025 g, 0.045 mmol) and 4-methoxyphenylboronic acid (0.010 g, 0.070 mmol) 
and performed at 70 °C for 36 h. Flash column chromatography (petroleum 
ether/diethyl ether, 8:2) gave (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-
(4”-methoxyphenyl)-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (210) 
(0.013 g, 53%) as a yellow solid. Spectroscopic data was as described above. 
Further elution (petroleum ether/diethyl ether 6:4) gave (3aS*,8R*,8aS*,8bR*)-(4”-
methoxyphenyl)-2-phenyl-3a,4,6,7,8a,8b-hexahydro-8-(2′,2′-
 145 
dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (210b) (2.4 
mg, 10%) as a white solid. Mp 110–112 °C; νmax/cm−1 (neat) 3334 (NH), 2935 
(CH), 1702 (C=O), 1513 (C=C), 1391, 1249, 1181, 909, 773, 732; δH (400 MHz, 
CDCl3) 1.66–1.78 (1H, m, 7-HH), 2.06–2.13 (1H, m, 7-HH), 2.49–2.61 (3H, m, 4-
HH and 6-H2), 3.06 (1H, dd, J 8.5, 6.6 Hz, 8a-H), 3.26 (1H, dd, J 15.0, 1.1 Hz, 4-
HH), 3.43–3.54 (2H, m, 3a-H and 8b-H), 3.81 (3H, s, OCH3), 4.89–4.99 (1H, m, 8-
H), 5.98 (1H, s, CHCl2), 6.85–6.91 (2H, m, 3”-H and 5”-H), 7.06–7.10 (2H, m, 2 × 
ArH), 7.17–7.22 (2H, m, 2”-H and 6”-H), 7.36–7.46 (3H, m, 3 × ArH), 8.66 (1H, d, J 
9.7 Hz, NH); δC (101 MHz, CDCl3) 28.3 (CH2), 31.6 (CH2), 31.7 (CH2), 40.4 (CH), 
41.7 (CH), 43.7 (CH), 51.6 (CH), 55.3 (CH3), 66.7 (CH), 113.8 (2 × CH), 126.6 (2 × 
CH), 128.7 (2 × CH), 129.1 (CH), 129.3 (2 × CH), 129.6 (C), 131.4 (C), 131.5 (C), 
138.3 (C), 158.6 (C), 164.5 (C), 178.7 (C), 179.7 (C); m/z (ESI) 521.0982 (MNa+. 
C26H2435Cl2N2NaO4 requires 521.1005). 
(9R*,9aS*)-6-(4”-Methoxyphenyl)-2-phenyl-7,8,9,9a-tetrahydro-9-(2’,2’,2’- 
trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-
a]pyridazine-1,3(2H)-dione (211) 
 
Method A- (9R*,9aS*)-6-(4”-Methoxyphenyl)-2-phenyl-7,8,9,9a-tetrahydro-9-
(2’,2’,2’- trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-
a]pyridazine-1,3(2H)-dione (211) was synthesised as described for 
(3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(Method A) using (2E)-7-(4’-methoxyphenyl)hept-2-en-6-yn-1-ol (183) (0.060 g, 
0.28 mmol) and 4-phenyl-1,2,4-triazole-3,5-dione (0.059 g, 0.34 mmol). 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 6:4) 
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gave (9R*,9aS*)-6-(4”-methoxyphenyl)-2-phenyl-7,8,9,9a-tetrahydro-9-(2’,2’,2’-
trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-a]pyridazine-
1,3(2H)-dione (211) (0.032 g, 23%) as a dark yellow solid. Mp 154–156 °C; 
νmax/cm−1 (neat) 3406 (NH), 2932 (CH), 1774 (C=O), 1715 (C=O), 1703 (C=O), 
1510 (C=C), 1420, 1250, 821, 734; δH (400 MHz, CDCl3) 2.12–2.30 (2H, m, 8-H2), 
2.44–2.56 (1H, m, 7-HH), 2.61–2.71 (1H, m, 7-HH), 3.85 (3H, s, OCH3), 4.36 (1H, 
ddd, J 16.0, 4.8, 2.6 Hz, 5-HH), 4.49–4.61 (2H, m, 5-HH and 9a-H), 4.92 (1H, q, J 
5.8 Hz, 9-H), 6.70 (1H, d, J 5.8 Hz, NH), 6.93–6.99 (2H, m, 3”-H and 5”-H), 7.22–
7.56 (7H, m, 7 × ArH); δC (101 MHz, CDCl3) 24.5 (CH2), 27.9 (CH2), 45.5 (CH2), 
52.3 (CH), 55.4 (CH3), 59.8 (CH), 92.6 (C), 114.3 (2 × CH), 125.5 (2 × CH), 128.2 
(C), 128.4 (CH), 128.4 (C), 128.9 (2 × CH), 129.2 (2 × CH), 130.9 (C), 131.1 (C), 
151.7 (C), 152.6 (C), 159.8 (C), 161.2 (C); m/z (ESI) 557.0510 (MNa+. 
C24H2135Cl3N4NaO4 requires 557.0521). 
Method B- (9R*,9aS*)-6-(4”-Methoxyphenyl)-2-phenyl-7,8,9,9a-tetrahydro-9-
(2’,2’,2’- trichloromethylcarbonylamino)-1H,5H-cyclopent[c][2,4,10]triazolo[1,2-
a]pyridazine-1,3(2H)-dione (211) was synthesised as described for 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(4”-methoxyphenyl)-2-phenyl-
8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(210) (Method B) using 7-(4”-methoxyphenyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (188) (0.033 g, 0.090 mmol) and 4-
phenyl-1,2,4-triazole-3,5-dione (0.020 g, 0.11 mmol). The Diels-Alder reaction was 
stirred for 24 h at 75 °C. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 6:4) gave (9R*,9aS*)-6-(4”-methoxyphenyl)-2-phenyl-7,8,9,9a-
tetrahydro-9-(2’,2’,2’-trichloromethylcarbonylamino)-1H,5H-
cyclopent[c][2,4,10]triazolo[1,2-a]pyridazine-1,3(2H)-dione (211) (0.037 g, 76%) as 
a dark yellow solid. Spectroscopic data was as described above. 
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(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-(4”-methoxyphenyl-6,6,7,7-tetracyano-1-
(2’,2’,2’-trichloromethylcarbonylamino)indene (212) 
 
(1R*,7aR*)-2,3,5,6,7,7a-Hexahydro-4-(4”-methoxyphenyl-6,6,7,7-tetracyano-1-
(2’,2’,2’-trichloromethylcarbonylamino)indene (212) was synthesised as described 
for (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(4”-methoxyphenyl)-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (210) (Method B) using 7-(4”-methoxyphenyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (188) (0.036 g, 0.10 mmol) and 
tetracyanoethylene (0.080 g, 0.60 mmol). The Diels-Alder reaction was stirred for 
24 h at 75 °C. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 6:4) gave (1R*,7aR*)-2,3,5,6,7,7a-hexahydro-4-(4”-methoxyphenyl-
6,6,7,7-tetracyano-1-(2’,2’,2’-trichloromethylcarbonylamino)indene (212) (0.03 g, 
57%) as a yellow solid. Mp 116–118 °C; νmax/cm−1 (neat) 3370 (NH), 2935 (CH), 
1711 (C=O), 1513 (C=C), 1248, 1178, 824; δH (400 MHz, CDCl3) 1.88–2.02 (1H, 
m, 2-HH), 2.33–2.47 (2H, m, 2-HH and 3-HH), 2.64–2.77 (1H, m, 3-HH), 3.24–
3.33 (1H, m, 5-HH), 3.44–3.54 (2H, m, 5-HH and 7a-H), 3.84 (3H, s, OCH3), 4.39–
4.51 (1H, m, 1-H), 6.91–6.97 (3H, m, 3”-H, 5”-H and NH), 7.11–7.15 (2H, m, 2”-H 
and 6”-H); δC (101 MHz, CDCl3) 26.4 (CH2), 29.1 (CH2), 37.6 (CH2), 39.7 (C), 41.4 
(C), 50.0 (CH), 54.9 (CH), 55.4 (CH3), 91.7 (C), 108.2 (C), 110.4 (C), 110.7 (C), 
110.8 (C), 114.5 (2 × CH), 127.5 (C), 128.4 (2 × CH), 128.6 (C), 130.5 (C), 159.9 
(C), 162.5 (C); m/z (ESI) 510.0253 (MNa+. C22H1635Cl3N5NaO2 requires 510.0262). 
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Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-(4”-methoxyphenyl)-1-
(2’,2’,2’-trichloromethylcarbonylamino)indene-7-carboxylate (213) 
 
Methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-(4”-methoxyphenyl)-1-(2’,2’,2’-
trichloromethylcarbonylamino)indene-7-carboxylate (213) was synthesised as 
described for (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(4”-
methoxyphenyl)-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (210) 
(Method B) using 7-(4”-methoxyphenyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (188) (0.040 g, 0.11 mmol) and 
methyl acrylate (0.030 mL, 0.33 mmol). The Diels-Alder reaction was stirred for 5 
days at 111 °C. Purification by flash column chromatography (petroleum 
ether/diethyl ether, 7:3) gave methyl (1R*,7S*,7aS*)-2,3,5,6,7,7a-hexahydro-4-(4”-
methoxyphenyl)-1-(2’,2’,2’-trichloromethylcarbonylamino)indene-7-carboxylate 
(213) (0.028 g, 59%) as a pale yellow oil; νmax/cm−1 (neat) 3350 (NH), 2935 (CH), 
1712 (C=O), 1608, 1510 (C=C), 1246, 1175, 1035, 822, 737; δH (400 MHz, CDCl3) 
1.64–1.76 (1H, m, 2-HH), 1.93–2.08 (2H, m, 2-HH, and 6-HH), 2.21–2.38 (3H, m, 
3-HH, 5-HH and 6-HH), 2.40–2.59 (2H, m, 3-HH and 5-HH), 2.99 (1H, q, J 4.6 Hz, 
7-H), 3.03–3.11 (1H, m, 7a-H), 3.71 (1H, s, OCH3), 3.81 (1H, s, OCH3), 4.63 (1H, 
qd, J 9.0, 6.9 Hz, 1-H), 6.84–6.89 (2H, m, 3”-H and 5”-H), 7.10–7.16 (2H, m, 2”-H 
and 6”-H), 7.68 (1H, d, J 9.0 Hz, NH); δC (101 MHz, CDCl3) 26.4 (CH2), 27.8 
(CH2), 29.0 (CH2), 31.6 (CH2), 39.5 (CH), 43.9 (CH), 52.1 (CH), 53.2 (CH3), 55.3 
(CH3), 92.9 (C), 113.4 (2 × CH), 128.7 (2 × CH), 129.4 (C), 134.3 (C), 135.1 (C), 
158.3 (C), 161.7 (C), 175.5 (C); m/z (ESI) 468.0486 (MNa+. C20H2235Cl3NNaO4 
requires 468.0507). 
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(3aS*,8R*,8aS*,8bR*)-2,5-Diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2′,2′-
dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (214)  
 
To a solution of (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-
(2′,2′,2′-trichloromethylcarbonylamino)cyclopent[e]iso-indole-1,3(2H,3aH)-dione 
(201) (0.080 g, 0.16 mmol) in ethyl acetate (4 mL) was added 10% palladium on 
charcoal (0.020 g). The mixture was stirred under an atmosphere of hydrogen at 
room temperature for 48 h. The reaction mixture was filtered through a short pad 
of Celite® with diethyl ether (80 mL) and the solvent was removed in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 7:3) 
gave (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2′,2′-
dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (214) 
(0.036 g, 48%) as a white solid. Mp 138–140 °C; νmax/cm−1 (neat) 3323 (NH), 2922 
(CH), 1690 (CO), 1524 (C=C), 1497, 1389, 1196, 808, 734; δH (400 MHz, CDCl3) 
1.66–1.80 (1H, m, 7-HH), 2.05–2.15 (1H, m, 7-HH), 2.52–2.64 (3H, m, 4-HH and 
6-H2), 3.07 (1H, dd, J 8.7, 6.4 Hz, 8a-H), 3.29 (1H, dd, J 15.3, 2.9 Hz, 4-HH), 
3.44–3.54 (2H, m, 3a-H and 8b-H), 4.89–5.01 (1H, m, 8-H), 5.99 (1H, s, CHCl2), 
7.06–7.12 (2H, m, 2 × ArH), 7.22–7.53 (8H, m, 8 × ArH), 8.66 (1H, d, J 9.7 Hz, 
NH); δC (126 MHz, CDCl3) 28.4 (CH2), 31.7 (2 × CH2), 40.3 (CH), 41.7 (CH), 43.7 
(CH), 51.6 (CH), 66.7 (CH), 126.6 (2 × CH), 127.2 (CH), 127.5 (2 × CH), 128.4 (2 
× CH), 129.1 (CH), 129.4 (2 × CH), 130.1 (C), 131.5 (C), 139.0 (C), 139.9 (C), 
164.6 (C), 178.6 (C), 179.7 (C); m/z (EI) 468.1012 (M+. C25H2235Cl2N2O3 requires 
468.1007), 341 (100%), 194 (71), 167 (34), 152 (11), 77 (11). 
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(3aS*,5R*,5aR*,8R*,8aR*,8bR*)-5,5a-Dihydroxy-2,5-diphenyl-
3a,4,5,5a,6,7,8a,8b-octahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (216) 
 
(3aS*,8R*,8aS*,8bR*)-2,5-Diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201)  
(0.040 g, 0.080 mmol) was dissolved in dichloromethane (2 mL) at –78 ºC. 
Tetramethylethylenediamine (0.013 mL, 0.090 mmol) was added and the reaction 
mixture stirred for 0.1 h, before the addition of osmium tetroxide (0.020 g, 0.090 
mmol). The dark coloured solution was stirred for 1 h at –78 ºC before warming to 
room temperature and then stirred for 2 h. The solvent was removed in vacuo and 
the dark coloured solid was dissolved in methanol (2 mL). 12 M Hydrochloric acid 
(0.5 mL) was added and the reaction stirred for a further 2 h. The solvent was 
removed in vacuo to afford a dark solid. Flash column chromatography (petroleum 
ether/ethyl acetate, 4:1) gave  (3aS*,5R*,5aR*,8R*,8aR*,8bR*)-5,5a-dihydroxy-
2,5-diphenyl-3a,4,5,5a,6,7,8a,8b-octahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (216) 
(0.040 g, 100%) as a white solid. Mp 164–166 °C; νmax/cm–1 (neat) 3475 (NH/OH), 
2931 (CH), 1698 (C=O), 1500 (C=C), 1380, 1216, 818, 753; δH (500 MHz, CD3OD) 
1.13–1.23 (1H, m, 6-HH), 1.86–2.06 (2H, m, 6-HH and 7-HH), 2.14–2.30 (2H, m, 
4-HH and 7-HH), 2.58 (1H, dd, J 14.3, 12.5 Hz, 4-HH), 2.87–2.93 (1H, m, 8a-H), 
3.41–3.49 (2H, m, 3a-H), 3.59 (1H, t, J 7.6 Hz, 8b-H), 5.10 (1H, dt, J 10.8, 7.6 Hz, 
8-H), 7.21–7.27 (1H, m, ArH), 7.29–7.38 (4H, m, 4 × ArH), 7.40–7.46 (1H, m, 
ArH), 7.47–7.58 (4H, m, 4 × ArH); δC (126 MHz, CD3OD) 27.8 (CH2), 30.6 (CH2), 
36.2 (CH2), 39.9 (CH), 41.6 (CH), 46.0 (CH), 52.0 (CH), 74.5 (C), 83.7 (C), 92.7 
(C), 126.4 (2 × CH), 126.7 (CH), 126.8 (2 × CH), 127.3 (2 × CH), 128.4 (CH), 
128.7 (2 × CH), 132.0 (C), 143.5 (C), 162.0 (C), 178.7 (C), 178.8 (C); m/z (ESI) 
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559.0564 (MNa+. C25H2335Cl3N2NaO5 requires 559.0565). 
(3aS*,5R*,5aR*,8R*,8aR*,8bR*)-5,5a-Epoxy-2,5-diphenyl-3a,4,5,5a,6,7,8a,8b-
octahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (217) 
 
3-Chloroperbenzoic acid (0.030 g, 0.18 mmol) was added to a stirred solution of 
(3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(0.020 g, 0.044 mmol) in dichloromethane (2 mL) at 0 °C. The reaction mixture 
was warmed from 0 °C to room temperature over 18 h then cooled to 0 °C before 
3-chloroperbenzoic acid (0.030 g, 0.18 mmol) was added. The reaction mixture 
was stirred for a further 24 h at room temperature, quenched by the addition of a 
saturated solution of sodium sulfite (3 mL) and extracted with dichloromethane (2 
× 3 mL). The combined organic layers were washed with a saturated solution of 
sodium hydrogen carbonate (3 × 6 mL), water (6 mL), brine (6 mL), then dried 
(MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/diethyl ether, 1:1) gave 
(3aS*,5R*,5aR*,8R*,8aR*,8bR*)-5,5a-epoxy-2,5-diphenyl-3a,4,5,5a,6,7,8a,8b-
octahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (217) (0.015 g, 65%) as a white solid. Mp 142–144 °C; 
νmax/cm−1 (neat) 3340 (NH), 2921 (CH), 1701 (C=O), 1514 (C=C), 1390, 1192, 
821, 756; δH (400 MHz, CDCl3) 1.58−1.71 (1H, m, 6-HH), 1.85−1.99 (2H, m, 6-HH 
and 7-HH), 2.23−2.33 (2H, m, 4-HH and 7-HH), 2.75 (1H, dd, J 9.0, 7.1 Hz, 8a-H), 
3.22 (1H, dd, J 15.9 Hz, 1.3, 4-HH), 3.40 (1H, dd, J 9.3, 7.1 Hz, 8b-H), 3.49 (1H, 
td, J 9.3, 1.3 Hz, 3a-H), 5.02−5.13 (1H, m, 8-H), 7.11−7.15 (2H, m, 2 × ArH), 
7.21−7.37 (5H, m, 5 × ArH), 7.42−7.55 (3H, m, 3 × ArH), 8.52 (1H, d, J 9.3 Hz, 
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NH); δC (101 MHz, CDCl3) 25.1 (CH2), 29.5 (CH2), 33.0 (CH2), 38.3 (CH), 40.0 
(CH), 45.5 (CH), 52.0 (CH), 61.6 (C), 71.8 (C), 92.7 (C), 126.0 (2 × CH), 126.5 (2 
× CH), 128.1 (CH), 128.5 (2 × CH), 129.4 (CH), 129.5 (2 × CH), 131.2 (C), 136.9 
(C), 162.0 (C), 178.5 (C), 178.9 (C); m/z (ESI) 541.0450 (MNa+. 
C25H2135Cl3N2NaO4 requires 541.0459). 
5-(tert-Butyldimethylsilyl)pent-4-yn-1-ol (222)203 
 
n-Butyllithium (0.520 mL, 1.31 mmol, 2.5 M in hexane) was added dropwise to a 
solution of 4-pentyn-1-ol (168) (0.0500 g, 0.590 mmol) in tetrahydrofuran (20 mL) 
at −78 °C. The reaction mixture was stirred for 0.75 h at −78 °C. tert-
Butyldimethylsilyl chloride (0.220 g, 1.48 mmol) was then added. The reaction 
mixture was allowed to warm to room temperature and stirred for 18 h. A 1 M 
aqueous solution of hydrochloric acid (2 mL) was then added and the mixture was 
stirred for 2 h. The resulting mixture was diluted with ethyl acetate (10 mL), 
washed with water (2 × 15 mL) and a saturated solution of sodium bicarbonate (15 
mL). The aqueous layers were washed with ethyl acetate (2 × 15 mL), and the 
combined organic phase was washed with brine (20 mL), dried (MgSO4), filtered 
and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave 5-(tert-butyldimethylsilyl)pent-4-yn-1-ol 
(222) (0.036 g, 31%) as a colourless oil. Spectroscopic data was consistent with 
the literature.203 δH (400 MHz, CDCl3) 0.06 (6H, s, Si(CH3)2), 0.90 (9H, s, 
SiC(CH3)3), 1.75 (2H, quin, J 6.5 Hz, 2-H2), 1.99 (1H, br s, OH), 2.34 (2H, t, J 6.5 
Hz, 3-H2), 3.74 (2H, t, J 6.5 Hz, 1-H2); δC (101 MHz, CDCl3) −4.5 (2 × CH3), 16.5 
(C), 16.5 (CH2), 26.1 (3 × CH3), 31.3 (CH2), 61.8 (CH2), 83.3 (C), 107.2 (C); m/z 
(ESI) 221 (MNa+. 100%). 
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Ethyl (2E)-7-(tert-butyldimethylsilyl)hept-2-en-6-ynoate (223) 
 
Ethyl (2E)-7-(tert-butyldimethylsilyl)hept-2-en-6-ynoate (223) was synthesised as 
described for ethyl (2E)-hept-2-en-6-ynoate (174) using 5-(tert-butyldimethylsilyl)-
pent-4-yn-1-ol (222) (0.196 g, 0.990 mmol). Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) gave ethyl (2E)-7-(tert-
butyldimethylsilyl)hept-2-en-6-ynoate (223) (0.211 g, 80%) as a colourless oil. 
νmax/cm−1 (neat) 2929 (CH), 2364, 1723 (C=O), 1472, 1250, 1040, 837; δH (400 
MHz, CDCl3) 0.07 (6H, s, Si(CH3)2), 0.91 (9H, s, SiC(CH3)3), 1.28 (3H, t, J 7.1 Hz, 
OCH2CH3), 2.34–2.45 (4H, m, 4-H2 and 5-H2), 4.18 (2H, q, J 7.1 Hz, OCH2CH3), 
5.88 (1H, d, J 15.7 Hz, 2-H), 6.97 (1H, dt, J 15.7, 6.6 Hz, 3-H); δC (101 MHz, 
CDCl3) −4.6 (2 × CH3), 14.2 (CH3), 16.4 (C), 18.8 (CH2), 26.0 (3 × CH3), 31.3 
(CH2), 60.2 (CH2), 84.0 (C), 105.8 (C), 122.5 (CH), 146.5 (CH), 166.3 (C); m/z 
(ESI) 289.1590 (MNa+. C15H26NaO2Si requires 289.1594). 
(2E)-7-(tert-Butyldimethylsilyl)hept-2-en-6-yn-1-ol (224) 
 
(2E)-7-(tert-butyldimethylsilyl)hept-2-en-6-yn-1-ol (224) was synthesised as 
described for (2E)-hept-2-en-6-yn-1-ol (179) using ethyl (2E)-7-(tert-
butyldimethylsilyl)hept-2-en-6-ynoate (223) (0.165 g, 0.620 mmol). Purification by 
flash column chromatography (petroleum ether/ethyl acetate, 8:2) gave (2E)-7-
(tert-butyldimethylsilyl)hept-2-en-6-yn-1-ol (224) (0.128 g, 92%) as a colourless oil. 
νmax/cm−1 (neat) 3332 (OH), 2929 (CH), 2174, 1472, 1250, 1007, 968, 837, 825, 
774; δH (400 MHz, CDCl3) 0.07 (6H, s, Si(CH3)2), 0.92 (9H, s, SiC(CH3)3), 1.32 
(1H, br s, OH), 2.23–2.39 (4H, m, 4-H2 and 5-H2), 4.09 (2H, br t, J 4.6 Hz, 1-H2), 
5.66–5.78 (2H, m, 2-H and 3-H); δC (101 MHz, CDCl3) −4.5 (2 × CH3), 16.5 (C), 
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19.9 (CH2), 26.0 (3 × CH3), 31.5 (CH2), 63.5 (CH2), 83.1 (C), 107.0 (C), 130.4 
(CH), 130.8 (CH); m/z (ESI) 247.1479 (MNa+. C13H24NaOSi requires 247.1489). 
7-(tert-Butyldimethylsilyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-
6-yne (226) 
 
7-(tert-Butyldimethylsilyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne 
(226) was synthesised as described for 3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (184), except using (2E)-7-(tert-
butyldimethylsilyl)hept-2-en-6-yn-1-ol (224) (0.052 g,0.23 mmol) and a single 
portion of bis(acetonitrile)palladium chloride (0.0060 g, 0.023 mmol). The reaction 
was performed at 20 °C for 12 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 8:2) gave 7-(tert-butyldimethylsilyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (226) (0.068 g, 80%) as a 
colourless oil. νmax/cm−1 (neat) 3331 (NH), 2928 (CH), 1695 (C=O), 1516 (C=C), 
1250, 837, 824, 775, 681; δH (400 MHz, CDCl3) 0.08 (6H, s, Si(CH3)2), 0.92 (9H, s, 
SiC(CH3)3), 1.82–1.98 (2H, m, 4-H2), 2.27–2.41 (2H, m, 5-H2), 4.48–4.57 (1H, m, 
3-H), 5.22–5.32 (2H, m, 1-H2), 5.81 (1H, ddd, J 17.0, 10.4, 5.8 Hz, 2-H), 6.68 (1H, 
d, J 7.0 Hz, NH); δC (101 MHz, CDCl3) −4.5 (2 × CH3), 16.5 (CH2), 16.5 (C), 26.1 
(3 × CH3), 33.2 (CH2), 53.2 (CH), 84.2 (C), 92.7 (C), 105.9 (C), 116.9 (CH2), 135.6 
(CH), 161.2 (C); m/z (ESI) 390.0568 (MNa+. C15H2435Cl3NNaOSi requires 
390.0585). 
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(3aS*,8R*,8aS*,8bR*)-5-(tert-Butyldimethylsilyl)-3a,4,6,7,8a,8b-hexahydro-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (227) 
 
Method A- (3aS*,8R*,8aS*,8bR*)-5-(tert-Butyldimethylsilyl)-3a,4,6,7,8a,8b-
hexahydro-2-phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (227) was synthesised as described for (3aS*,8R*,8aS*,8bR*)-
3a,4,6,7,8a,8b-hexahydro-5-(4”-methoxyphenyl)-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (210) 
(Method B) using 7-(tert-butyldimethylsilyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (226) (0.044 g, 0.12 mmol), except 
that the reaction mixture was stirred with Grubbs second generation catalyst 
(0.010 g, 0.012 mmol) and 1,7-octadiene (0.071 mL, 0.48 mmol) for 60 h at 90 °C. 
A second portion of Grubbs second generation catalyst (0.010 g, 0.012 mmol) was 
added with 1,7-octadiene (0.071 mL, 0.48 mmol) and the reaction mixture was 
stirred for further 60 h at 90 °C. N-Phenyl maleimide (0.031 g, 0.18 mmol) was 
added with hydroquinone (0.002 g, 0.020 mmol). The reaction mixture was stirred 
for 18 h at 75 °C. The reaction mixture was then cooled and the solvent was 
evaporated. Flash column chromatography (petroleum ether/ethyl acetate, 8:2) 
gave (3aS*,8R*,8aS*,8bR*)-5-(tert-butyldimethylsilyl)-3a,4,6,7,8a,8b-hexahydro-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (227) (0.013 g, 20%) as a yellow oil.	νmax/cm−1 (neat) 3319 (NH), 2954 (CH), 
1699 (C=O), 1517 (C=C), 1388, 1199, 827, 755; δH (400 MHz, CDCl3) 0.08 (3H, s, 
SiCH3), 0.15 (3H, s, SiCH3), 0.86 (9H, s, SiC(CH3)3), 1.83 (1H, ddd, J 18.6, 12.4, 
7.6 Hz, 7-HH), 2.12–2.21 (2H, m, 4-HH and 7-HH), 2.24–2.38 (1H, m, 6-HH), 2.65 
(1H, dd, J 16.5, 7.6 Hz, 6-HH), 2.92–2.98 (1H, m, 8a-H), 3.01 (1H, dd, J 14.8, 1.3 
Hz, 4-HH), 3.32 (1H, ddd, J 8.9, 7.2, 1.3 Hz, 3a-H), 3.40 (1H, dd, J 8.9, 6.3 Hz, 8b-
H), 4.77–4.88 (1H, m, 8-H), 7.12–7.17 (2H, m, 2 × ArH), 7.37–7.50 (3H, m, 3 × 
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ArH), 8.84 (1H, d, J 9.6 Hz, NH); δC (126 MHz, CDCl3) −5.1 (CH3), −4.2 (CH3), 
18.3 (C), 26.8 (3 × CH3), 30.3 (CH2), 30.5 (CH2), 31.9 (CH2), 39.3 (CH), 40.6 (CH), 
43.1 (CH), 52.3 (CH), 92.9 (C), 126.4 (2 × CH), 128.8 (C), 129.0 (CH), 129.3 (2 × 
CH), 131.5 (C), 156.1 (C), 162.3 (C), 178.1 (C), 179.8 (C); m/z (ESI) 563.1045 
(MNa+. C25H3135Cl3N2NaO3Si requires 563.1062). 
Method B- (3aS*,8R*,8aS*,8bR*)-5-(tert-Butyldimethylsilyl)-3a,4,6,7,8a,8b-
hexahydro-2-phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (227) was synthesised as described for (3aS*,8R*,8aS*,8bR*)-
2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(Method A) using (2E)-7-(tert-Butyldimethylsilyl)hept-2-en-6-yn-1-ol (224) (0.054 g, 
0.24 mmol), except that the reaction mixture was stirred with Grubbs second 
generation catalyst (0.040 g, 0.048 mmol) and 1,7-octadiene (0.142 mL, 0.960 
mmol) for 120 h at 110 °C. N-Phenyl maleimide (0.062 g, 0.36 mmol) was added 
with hydroquinone (0.003 g, 0.030 mmol). The reaction mixture was stirred for 18 
h at 75 °C. The reaction mixture was then cooled and the solvent was evaporated. 
Flash column chromatography (petroleum ether/ethyl acetate, 8:2) gave 
(3aS*,8R*,8aS*,8bR*)-5-(tert-butyldimethylsilyl)-3a,4,6,7,8a,8b-hexahydro-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (227) (0.025 g, 19%) as a yellow oil. Spectroscopic data was as described 
above. 
1-(Tetrahydropyran-2’-yloxy)-4-pentyne (228)204 
 
To a solution of 4-pentyn-1-ol (168) (0.900 g, 10.8 mmol) and a catalytic amount of 
p-toluenesulfonic acid monohydrate (0.020 g) in dichloromethane (25 mL) at 0 °C 
was added 3,4-dihydro-2H-pyran (2.71 g, 32.2 mmol). The reaction mixture was 
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allowed to warm to room temperature and stirred for 2.5 h. Ethyl acetate (50 mL) 
was then added and the solution was poured into a solution of sodium hydrogen 
carbonate (100 mL). The mixture was then extracted with ethyl acetate (3 × 50 
mL). The organic layers were combined, washed with brine (100 mL), dried 
(MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/diethyl ether, 10:1) gave 1-(tetrahydropyran-2’-
yloxy)-4-pentyne (228) (1.81 g, 100%) as a colourless oil. Spectroscopic data was 
consistent with the literature.204 δH (400 MHz, CDCl3) 1.46−1.86 (8H, m, 2-H2, 3’-
H2, 4’-H2 and 5’-H2), 1.94 (1H, t, J 2.7 Hz, 5-H), 2.28−2.35 (2H, m, 3-H2), 
3.45−3.55 (2H, m, 1-HH and 6’-HH), 3.80−3.91 (2H, m, 1-HH and 6’-HH), 4.60 
(1H, t, J 3.3 Hz, 2’-H); δC (101 MHz, CDCl3) 15.1 (CH2), 19.2 (CH2), 25.4 (CH2), 
28.6 (CH2), 30.4 (CH2), 61.7 (CH2), 65.4 (CH2), 68.5 (CH), 83.6 (C), 98.4 (CH); 
m/z (EI) 168 (M+. 4%), 149 (8), 125 (11), 111 (12), 84 (74), 67 (28), 49 (100). 
5-(Benzyldimethylsilyl)-1-(tetrahydropyran-2’-yloxy)pent-4-yne (229)205 
 
n-Butyllithium (2.56 mL,  6.40 mmol, 2.5 M in hexane) was slowly added to a 
stirred solution of 1-(tetrahydropyran-2’-yloxy)-4-pentyne (228) (0.980 g, 5.82 
mmol) in tetrahydrofuran (28 mL) at −78 °C. The resulting solution was stirred at –
78 °C for 0.5 h at which time benzyldimethylsilyl chloride (1.16 mL, 6.40 mmol) 
was added. The resulting solution was stirred at –78 °C for 5 h. The reaction was 
quenched with a saturated solution of ammonium chloride (20 mL) and extracted 
with diethyl ether (3 × 20 mL). The combined organic layers were dried (MgSO4), 
filtered, and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether/diethyl ether, 8:2) gave 5-(benzyldimethylsilyl)-1-
(tetrahydropyran-2’-yloxy)-4-pentyne (229) (1.84 g, 100%) as a colourless oil. 
Spectroscopic data was consistent with the literature.205 δH (400 MHz, CDCl3) 0.10 
(6H, s, Si(CH3)2), 1.47−1.87 (8H, m, 2-H2, 3’-H2, 4’-H2 and 5’-H2), 2.18 (2H, s, 
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SiCH2), 2.35 (2H, t, J 7.1 Hz, 3-H2), 3.42−3.54 (2H, m, 1-HH and 6’-HH), 
3.79−3.91 (2H, m, 1-HH and 6’-HH), 4.60 (1H, t, J 3.3 Hz, 2’-H), 7.05−7.12 (3H, m, 
3 × ArH), 7.19−7.25 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 0.0 (2 × CH3), 18.7 
(CH2), 21.4 (CH2), 27.4 (CH2), 28.4 (CH2), 30.7 (CH2), 32.6 (CH2), 64.0 (CH2), 67.7 
(CH2), 85.0 (C), 100.6 (CH), 110.2 (C), 126.2 (CH), 130.0 (2 × CH), 130.3 (2 × 
CH), 141.1 (C); m/z (ESI) 339 (MNa+. 100%). 
5-(Benzyldimethylsilyl)pent-4-yn-1-ol (230)125 
 
p-Toluenesulfonic acid monohydrate (8.00 mg, 0.042 mmol) was added to a 
solution of 5-(benzyldimethylsilyl)-1-(tetrahydropyran-2’-yloxy)pent-4-yne (229) 
(85.0 mg, 0.270 mmol) in methanol (3 mL). The resulting solution was stirred at 
room temperature for 18 h. The reaction was quenched by addition of brine (50 
mL). The aqueous layer was extracted with ethyl acetate (3 × 50 mL). The 
combined organic layers were dried (MgSO4), filtered, and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 1:1) 
gave 5-(benzyldimethylsilyl)pent-4-yn-1-ol (230) (0.065 g, 100%) as a colourless 
oil. Spectroscopic data was consistent with the literature.125 δH (400 MHz, CDCl3) 
0.12 (6H, s, Si(CH3)2), 1.76 (2H, quin, J 6.5 Hz, 2-H2), 1.86 (1H, s, OH), 2.19 (2H, 
s, SiCH2), 2.35 (2H, t, J 6.5 Hz, 3-H2), 3.72 (2H, t, J 6.5 Hz, 1-H2), 7.06–7.13 (3H, 
m, 3 × ArH), 7.21–7.27 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 0.0 (2 × CH3), 18.4 
(CH2), 28.4 (CH2), 33.0 (CH2), 63.6 (CH2), 85.5 (C), 110.0 (C), 126.2 (CH), 130.0 
(2 × CH), 130.3 (2 × CH), 141.1 (C); m/z (ESI) 255 (MNa+. 100%). 
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Ethyl (2E)-7-(benzyldimethylsilyl)hept-2-en-6-ynoate (231) 
 
Ethyl (2E)-7-(benzyldimethylsilyl)hept-2-en-6-ynoate (231) was synthesised as 
described for ethyl (2E)-hept-2-en-6-ynoate (174) using 5-
(benzyldimethylsilyl)pent-4-yn-1-ol (230) (0.990 g, 4.28 mmol).  Purification by 
flash column chromatography (petroleum ether/diethyl ether, 8:2) gave ethyl (2E)-
7-(benzyldimethylsilyl)hept-2-en-6-ynoate (231) (1.19 g, 92%) as a colourless oil. 
νmax/cm−1 (neat) 2958 (CH), 1720 (C=O), 1656 (C=C), 1494, 1249, 1154, 1039, 
833, 758; δH (400 MHz, CDCl3) 0.10 (6H, s, Si(CH3)2), 1.29 (3H, t, J 7.1 Hz, 
OCH2CH3), 2.18 (2H, s, SiCH2), 2.34–2.45 (4H, m, 4-H2 and 5-H2), 4.20 (2H, q, J 
7.1 Hz, OCH2CH3), 5.87 (1H, dt, J 15.7, 1.4 Hz, 2-H), 6.97 (1H, dt, J 15.7, 6.6 Hz, 
3-H), 7.03–7.12 (3H, m, 3 × ArH), 7.19–7.25 (2H, m, 2 × ArH); δC (101 MHz, 
CDCl3) 0.0 (2 × CH3), 16.3 (CH3), 20.8 (CH2), 28.3 (CH2), 33.1 (CH2), 62.2 (CH2), 
86.3 (C), 108.8 (C), 124.5 (CH), 126.3 (CH), 130.1 (2 × CH), 130.3 (2 × CH), 141.0 
(C), 148.4 (CH), 168.2 (C); m/z (ESI) 323.1422 (MNa+. C18H24NaO2Si requires 
323.1438). 
(2E)-7-(Benzyldimethylsilyl)hept-2-en-6-yn-1-ol (232) 
 
(2E)-7-(Benzyldimethylsilyl)hept-2-en-6-yn-1-ol (232) was synthesised as 
described for (2E)-hept-2-en-6-yn-1-ol (179) using ethyl (2E)-7-
(benzyldimethylsilyl)hept-2-en-6-ynoate (231) (1.35 g, 4.49 mmol). Purification by 
flash column chromatography (petroleum ether/ethyl acetate, 9:1) gave (2E)-7-
(benzyldimethylsilyl)hept-2-en-6-yn-1-ol (232) (1.14 g, 98%) as a colourless oil. 
νmax/cm−1 (neat) 3367 (OH), 2922 (CH), 2175, 1494, 1249, 838, 762, 698; δH (500 
MHz, CDCl3) 0.11 (6H, s, Si(CH3)2), 1.43 (1H, br s, OH), 2.18 (2H, s, SiCH2), 
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2.23–2.34 (4H, m, 4-H2 and 5-H2), 4.10 (2H, d, J 4.4 Hz, 1-H2), 5.65–5.76 (2H, m, 
2-H and 3-H), 7.06–7.12 (3H, m, 3 × ArH), 7.20–7.25 (2H, m, 2 × ArH); δC (101 
MHz, CDCl3) 0.0 (2 × CH3) 21.8 (CH2), 28.4 (CH2), 33.2 (CH2), 65.4 (CH2), 85.5 
(C), 109.9 (C), 126.2 (CH), 130.0 (2 × CH), 130.3 (2 × CH), 132.3 (CH), 132.6 
(CH), 141.1 (C); m/z (ESI) 281.1323 (MNa+. C16H22NaOSi requires 281.1332). 
7-(Benzyldimethylsilyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-
yne (233) 
 
7-(Benzyldimethylsilyl)-3-(2’,2’,2’-trichloromethylcarbonylamino)hept-1-en-6-yne 
(233) was synthesised as described for 3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (184), except using (2E)-7-
(benzyldimethylsilyl)hept-2-en-6-yn-1-ol (232) (0.11 g, 0.43 mmol) and a single 
portion of bis(acetonitrile)palladium chloride (0.011 g, 0.043 mmol). The reaction 
was performed at 20 °C for 12 h. Purification by flash column chromatography 
(petroleum ether/diethyl ether, 8:2) gave 7-(benzyldimethylsilyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (233) (0.116 g, 68%) as a 
colourless oil. νmax/cm−1 (neat) 3345 (NH), 2961 (CH), 1696 (C=O), 1514 (C=C), 
1494, 1250, 832, 822, 797, 763, 699; δH (400 MHz, CDCl3) 0.12 (3H, s, SiCH3), 
0.12 (3H, s, SiCH3), 1.81–1.97 (2H, m, 4-H2), 2.19 (2H, s, SiCH2), 2.27–2.41 (2H, 
m, 5-H2), 4.47–4.56 (1H, m, 3-H), 5.23–5.31 (2H, m, 1-H2), 5.81 (1H, ddd, J 17.2, 
10.4, 5.8 Hz, 2-H), 6.72 (1H, d, J 7.7 Hz, NH), 7.04–7.12 (3H, m, 3 × ArH), 7.19–
7.25 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 0.0 (CH3), 0.0 (CH3), 18.4 (CH2), 28.3 
(CH2), 34.7 (CH2), 55.1 (CH), 86.5 (C), 94.7 (C), 108.8 (C), 118.8 (CH2), 126.3 
(CH), 130.1 (2 × CH), 130.3 (2 × CH), 137.5 (CH), 141.0 (C), 163.2 (C); m/z (ESI) 
424.0413 (MNa+. C18H2235Cl3NNaOSi requires 424.0428). 
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(3aS*,8R*,8aS*,8bR*)-5-(Benzyldimethylsilyl)-3a,4,6,7,8a,8b-hexahydro-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (235) 
 
Method A- (3aS*,8R*,8aS*,8bR*)-5-(Benzyldimethylsilyl)-3a,4,6,7,8a,8b-
hexahydro-2-phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (235) was synthesised as described for (3aS*,8R*,8aS*,8bR*)-
3a,4,6,7,8a,8b-hexahydro-5-(4”-methoxyphenyl)-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (210) 
(Method B) using 7-(benzyldimethylsilyl)-3-(2’,2’,2’-
trichloromethylcarbonylamino)hept-1-en-6-yne (233) (0.056 g, 0.14 mmol), except 
that the reaction mixture was stirred with Grubbs second generation catalyst 
(0.0080 g, 0.010 mmol) and 1,7-octadiene (0.083 mL, 0.56 mmol) for 18 h at 90 
°C. Flash column chromatography (petroleum ether/ethyl acetate, 8:2) gave 
(3aS*,8R*,8aS*,8bR*)-5-(benzyldimethylsilyl)-3a,4,6,7,8a,8b-hexahydro-2-phenyl-
8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(235) (0.053 g, 66%) as a yellow oil. νmax/cm−1 (neat) 3313 (NH), 3023 (CH), 2957 
(CH), 1698 (C=O), 1518 (C=C), 1389, 1198, 830, 754; δH (500 MHz, CDCl3) 0.05 
(3H, s, SiCH3), 0.09 (3H, s, SiCH3), 1.73–1.89 (1H, m, 7-HH), 2.06–2.27 (5H, m, 
SiCH2, 4-HH, 6-HH and 7-HH), 2.52 (1H, dd, J 16.5, 7.6 Hz, 6-HH), 2.90–2.96 (1H, 
m, 8a-H), 2.99 (1H, dd, J 14.7, 1.6 Hz, 4-HH), 3.34 (1H, ddd, J 8.9, 6.8, 1.6 Hz, 
3a-H), 3.42 (1H, dd, J 8.9, 6.5 Hz, 8b-H), 4.75–4.88 (1H, m, 8-H), 6.91–6.96 (2H, 
m, 2 × ArH), 7.04–7.10 (1H, m, ArH), 7.14–7.21 (4H, m, 4 × ArH), 7.38–7.50 (3H, 
m, 3 × ArH), 8.91 (1H, d, J 9.5 Hz, NH); δC (126 MHz, CDCl3) −3.2 (CH3), −2.6 
(CH3), 25.2 (CH2), 29.4 (CH2), 29.8 (CH2), 31.9 (CH2), 39.5 (CH), 40.7 (CH), 43.1 
(CH), 52.3 (CH), 92.9 (C), 124.3 (CH), 126.3 (2 × CH), 128.2 (2 × CH), 128.3 (2 × 
CH), 129.0 (C), 129.1 (CH), 129.4 (2 × CH), 131.5 (C), 139.3 (C), 155.7 (C), 162.3 
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(C), 178.4 (C), 179.9 (C); m/z (ESI) 597.0898 (MNa+. C28H2935Cl3N2NaO3Si 
requires 597.0905). 
Method B- (3aS*,8R*,8aS*,8bR*)-5-(Benzyldimethylsilyl)-3a,4,6,7,8a,8b-
hexahydro-2-phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (235) was synthesised as described for (3aS*,8R*,8aS*,8bR*)-
2,5-diphenyl-3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(Method A) using  (2E)-7-(benzyldimethylsilyl)hept-2-en-6-yn-1-ol (232) (0.500 g, 
1.92 mmol), except that the reaction mixture was stirred with N-phenyl maleimide 
(0.500 g, 2.87 mmol) and hydroquinone (0.026 g, 0.24 mmol) at 75 °C for 12 h. 
Purification by flash column chromatography (petroleum ether/diethyl ether, 9:1) 
gave (3aS*,8R*,8aS*,8bR*)-5-(benzyldimethylsilyl)-3a,4,6,7,8a,8b-hexahydro-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (235) (0.631 g, 57%) as a yellow oil. Spectroscopic data was as described 
above. 
(3aS*,8R*,8aS*,8bR*)-4,6,7,8,8a,8b-Hexahydro-2-phenyl-8-(2’,2’,2’- 
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(236)99 
 
To a solution of (3aS*,8R*,8aS*,8bR*)-5-(benzyldimethylsilyl)-3a,4,6,7,8a,8b-
hexahydro-2-phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (235) (0.038 g, 0.066 mmol) in tetrahydrofuran (1 mL) was 
added methanol (2 mL) and 6 M hydrochloric acid (3 mL). The reaction mixture 
was stirred at 60 °C for 18 h. A 20% solution of aqueous sodium carbonate (6 mL) 
was added and the mixture was extracted with ethyl acetate (3 × 10 mL). The 
combined organic layers were dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 7:3) 
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gave (3aS*,8R*,8aS*,8bR*)-4,6,7,8,8a,8b-hexahydro-2-phenyl-8-(2’,2’,2’- 
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (236) 
(0.021 g, 74%) as a white solid. Mp 174‒176 °C; Spectroscopic data was 
consistent with the literature.99 δH (500 MHz, CDCl3) 1.81 (1H, qd, J 12.5, 7.6 Hz, 
7-HH), 2.10‒2.18 (1H, m, 7-HH), 2.19‒2.38 (2H, m, 6-HH and 4-HH), 2.47 (1H, dd, 
J 16.2, 7.6 Hz, 6-HH), 2.85 (1H, ddd, J 15.1, 7.2, 1.1 Hz, 4-HH), 2.89‒2.96 (1H, m, 
8a-H), 3.33 (1H, ddd, J 8.7, 7.2, 1.1 Hz, 3a-H), 3.43 (1H, dd, J 8.7, 6.4 Hz, 8b-H), 
4.80‒4.91 (1H, m, 8-H), 5.75‒5.81 (1H, m, 5-H), 7.15‒7.20 (2H, m, 2 × ArH), 
7.39‒7.51 (3H, m, 3 × ArH), 8.95 (1H, d, J 9.2 Hz, NH); δC (126 MHz, CDCl3) 26.1 
(CH2), 28.6 (CH2), 31.7 (CH2), 39.4 (CH), 41.2 (CH), 41.5 (CH), 52.9 (CH), 92.9 
(C), 117.1 (CH), 126.5 (2 × CH), 129.2 (CH), 129.3 (2 × CH), 131.5 (C), 145.8 (C), 
162.3 (C), 178.6 (C), 179.7 (C); m/z (ESI) 449 (MNa+. 100%). 
(3aS*,5S*,5aR*,8R*,8aR*,8bR*)-5,5a-Dihydroxy-2-phenyl-3a,4,5,5a,6,7,8a,8b-
octahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (237). 
 
(3aS*,5S*,5aR*,8R*,8aR*,8bR*)-5,5a-Dihydroxy-2-phenyl-3a,4,5,5a,6,7,8a,8b-
octahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (237) was synthesised as described for 
(3aS*,5R*,5aR*,8R*,8aR*,8bR*)-5,5a-dihydroxy-2,5-diphenyl-3a,4,5,5a,6,7,8a,8b-
octahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (216) using (3aS*,8R*,8aS*,8bR*)-4,6,7,8,8a,8b-Hexahydro-2-
phenyl-8-(2’,2’,2’- trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (236) (0.029 g, 0.068 mmol). Purification by flash column 
chromatography (dichloromethane/methanol, 19:1) gave  
(3aS*,5S*,5aR*,8R*,8aR*,8bR*)-5,5a-dihydroxy-2-phenyl-3a,4,5,5a,6,7,8a,8b-
octahydro-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
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1,3(2H,3aH)-dione (237) (0.027 g, 86%) as a white solid. Mp 168–170 °C; νmax/cm–
1 (neat) 3471 (OH), 3329 (NH), 2946 (CH), 1698 (C=O), 1515 (C=C), 1386, 1175, 
821, 754; δH (500 MHz, CDCl3) 1.61–1.76 (1H, m, 6-HH), 1.85–2.03 (2H, m, 6-HH 
and 7-HH), 2.09 (1H, dt, J 13.5, 3.7 Hz, 4-HH), 2.18 (1H, ddd, J 13.5, 10.8, 6.7 Hz, 
4-HH), 2.41–2.55 (1H, m, 7-HH), 2.70–2.89 (2H, m, 8a-H and OH), 3.00 (1H, br s, 
OH), 3.22 (1H, dd, J 9.0, 7.1 Hz, 8b-H), 3.35 (1H, ddd, J 9.0, 6.7, 3.7 Hz, 3a-H), 
3.62 (1H, d, J 10.8 Hz, 5-H), 5.04–5.16 (1H, m, 8-H), 7.21–7.25 (2H, m, 2 × ArH), 
7.40–7.56 (3H, m, 3 × ArH), 8.56 (1H, d, J 9.5 Hz, NH); δC (126 MHz, CDCl3) 29.7 
(CH2), 30.3 (CH2), 37.1 (CH2), 38.6 (CH), 39.3 (CH), 48.1 (CH), 51.9 (CH), 70.1 
(CH), 81.9 (C), 92.8 (C), 126.3 (2 × CH), 129.2 (CH), 129.5 (2 × CH), 131.2 (C), 
162.1 (C), 178.0 (C), 178.8 (C); m/z (ESI) 483.0242 (MNa+. C19H1935Cl3N2NaO5 
requires 483.0252). 
(3aS*,5S*,5aR*,8R*,8aR*,8bR*)-5,5a-Epoxy-3a,4,5,5a,6,7,8a,8b-octahydro-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (238) 
 
(3aS*,5S*,5aR*,8R*,8aR*,8bR*)-5,5a-Epoxy-3a,4,5,5a,6,7,8a,8b-octahydro-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (238) was synthesised as described for (3aS*,5R*,5aR*,8R*,8aR*,8bR*)-
5,5a-epoxy-2,5-diphenyl-3a,4,5,5a,6,7,8a,8b-octahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (217) using 
(3aS*,8R*,8aS*,8bR*)-4,6,7,8,8a,8b-hexahydro-2-phenyl-8-(2’,2’,2’- 
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (236) 
(0.032 g, 0.075 mmol). Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave (3aS*,5S*,5aR*,8R*,8aR*,8bR*)-5,5a-epoxy-
3a,4,5,5a,6,7,8a,8b-octahydro-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (238) 
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(0.024 g, 73%) as a light brown solid. Mp 154–156 °C; νmax/cm−1 (neat) 3265 (NH), 
2934 (CH), 1697 (C=O), 1520 (C=C), 1394, 1192, 824, 773; δH (500 MHz, CDCl3) 
1.65−1.72 (1H, m, 6-HH), 1.94−2.11 (2H, m, 6-HH and 7-HH), 2.23 (1H, dd, J 
15.5, 8.5 Hz, 4-HH), 2.26−2.34 (1H, m, 7-HH), 2.77 (1H, dd, J 15.5, 4.1 Hz, 4-HH), 
2.96 (1H, dd, J 11.2, 5.0 Hz, 8a-H), 3.05−3.12 (1H, m, 3a-H), 3.17 (1H, dd, J 9.8, 
5.0 Hz, 8b-H), 3.59 (1H, d, J 4.1 Hz, 5-H), 4.70−4.82 (1H, m, 8-H), 7.27−7.33 (2H, 
m, 2 × ArH), 7.38−7.53 (3H, m, 3 × ArH), 9.33 (1H, d, J 9.8 Hz, NH); δC (126 MHz, 
CDCl3) 25.6 (CH2), 29.1 (CH2), 32.8 (CH2), 38.4 (CH), 40.0 (CH), 40.5 (CH), 50.5 
(CH), 56.5 (CH), 67.9 (C), 92.8 (C), 126.7 (2 × CH), 128.9 (CH), 129.3 (2 × CH), 
132.3 (C), 162.5 (C), 178.9 (C), 180.3 (C); m/z (ESI) 465.0144 (MNa+. 
C19H1735Cl3N2NaO4 requires 465.0146). 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-2-phenyl-8-(2′,2′-
dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (239) 
 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-2-phenyl-8-(2′,2′-
dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (239) was 
synthesised as described for (3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-3a,4,6,7,8a,8b-
hexahydro-8-(2′,2′-dichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (214) using (3aS*,8R*,8aS*,8bR*)-4,6,7,8,8a,8b-hexahydro-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (236) (0.027 g, 0.063 mmol). The mixture was stirred under an atmosphere 
of hydrogen at room temperature for 18 h. The reaction mixture was filtered 
through a short pad of Celite® with diethyl ether (50 mL) and the solvent was 
removed in vacuo. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-2-
phenyl-8-(2′,2′-dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (239) (0.021 g, 85%) as a white solid. Mp 142–144 °C; νmax/cm−1 (neat) 
3327 (NH), 2963 (CH), 1694 (C=O), 1524 (C=C), 1499, 1389, 1201, 1184, 767, 
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753; δH (500 MHz, CDCl3) 1.74–1.85 (1H, m, 7-HH), 2.09 (1H, dt, J 12.1, 7.1 Hz 7-
HH), 2.19–2.35 (2H, m, 4-HH and 6-HH), 2.45 (1H, dd, J 16.1, 7.7 Hz, 6-HH), 
2.81–2.92 (2H, m, 4-HH and 8a-H), 3.31 (1H, td, J 8.8, 1.2 Hz, 3a-H), 3.42 (1H, 
dd, J 8.8, 6.4 Hz, 8b-H), 4.82–4.92 (1H, m, 8-H), 5.74–5.79 (1H, m, 5-H), 5.96 (1H, 
s, CHCl2), 7.16–7.20 (2H, m, 2 × ArH), 7.39–7.51 (3H, m, 3 × ArH), 8.64 (1H, d, J 
9.5 Hz, NH); δC (126 MHz, CDCl3) 26.2 (CH2), 28.6 (CH2), 31.7 (CH2), 39.4 (CH), 
41.2 (CH), 41.5 (CH), 51.6 (CH), 66.7 (CH), 116.9 (CH), 126.5 (2 × CH), 129.0 
(CH), 129.3 (2 × CH), 131.6 (C), 146.0 (C), 164.5 (C), 178.6 (C), 179.6 (C); m/z 
(ESI) 415.0582 (MNa+. C19H1835Cl2N2NaO3 requires 415.0587). 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-iodo-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (240) 
 
To a solution of (3aS*,8R*,8aS*,8bR*)-5-(benzyldimethylsilyl)-3a,4,6,7,8a,8b-
hexahydro-2-phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-
1,3(2H,3aH)-dione (235) (0.470 g, 0.820 mmol) in dichloromethane (10 mL) at −78 
°C was added iodine monochloride (0.0570 mL, 1.14 mmol). The reaction mixture 
was stirred at −78 °C for 3 h, then the excess iodine monochloride was destroyed 
by adding a 10% solution of sodium thiosulfate (20 mL) and the mixture was 
extracted with dichloromethane (3 × 20 mL). The combined organic layers were 
dried (MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 8:2) gave (3aS*,8R*,8aS*,8bR*)-
3a,4,6,7,8a,8b-hexahydro-5-iodo-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (240) 
(0.400 g, 88%) as a white solid. Mp 130−132 °C; νmax/cm−1 (neat) 3309 (NH), 2954 
(CH), 1698 (C=O), 1517 (C=C), 1391, 1200, 823; δH (400 MHz, CDCl3) 1.86 (1H, 
qd, J 12.3, 8.2 Hz, 7-HH), 2.12–2.34 (2H, m, 6-HH and 7-HH), 2.46 (1H, dd, J 
16.9, 8.2 Hz, 6-HH), 2.84–2.94 (1H, m, 4-HH), 3.02–3.08 (1H, m, 8a-H), 3.28 (1H, 
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dd, J 15.7, 1.2 Hz, 4-HH), 3.37 (1H, ddd, J 8.6, 6.7, 1.2 Hz, 3a-H), 3.42 (1H, dd, J 
8.6, 5.8 Hz, 8b-H), 4.86–4.99 (1H, m, 8-H), 7.16–7.21 (2H, m, 2 × ArH), 7.41–7.53 
(3H, m, 3 × ArH), 8.84 (1H, d, J 9.6 Hz, NH); δC (101 MHz, CDCl3) 30.6 (CH2), 
33.6 (CH2), 39.8 (CH2), 40.6 (CH), 41.1 (CH), 44.5 (CH), 53.9 (CH), 82.0 (C), 92.8 
(C), 126.5 (2 × CH), 129.3 (CH), 129.4 (2 × CH), 131.4 (C), 151.0 (C), 162.1 (C), 
177.0 (C), 178.9 (C); m/z (ESI) 574.9151 (MNa+. C19H1635Cl3IN2NaO3 requires 
574.9163). 
(3aS*,8R*,8aS*,8bR*)-5-(4”-Fluorophenyl)-3a,4,6,7,8a,8b-hexahydro-2-phenyl-
8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (241). 
 
(3aS*,8R*,8aS*,8bR*)-5-(4”-Fluorophenyl)-3a,4,6,7,8a,8b-hexahydro-2-phenyl-8-
(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(241) was synthesised as described for 3aS*,8R*,8aS*,8bR*)-2,5-diphenyl-
3a,4,6,7,8a,8b-hexahydro-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (201) 
(Method B) using (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-iodo-2-
phenyl-8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-
dione (240) (0.030 g, 0.054 mmol) and 4-fluorophenylboronic acid (0.019 g, 0.14 
mmol) and performed at 70 °C for 12 h. Flash column chromatography (petroleum 
ether/ethyl acetate, 9:1) gave (3aS*,8R*,8aS*,8bR*)-5-(4”-fluorophenyl)-
3a,4,6,7,8a,8b-hexahydro-2-phenyl-8-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (241) 
(0.013 g, 46%) as a white solid. Mp 124–126 °C; νmax/cm−1 (neat) 3312 (NH), 2926 
(CH), 1700 (C=O), 1510 (C=C), 1500, 1391, 838, 756; δH (500 MHz, CDCl3) 1.69–
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1.82 (1H, m, 7-HH), 2.12–2.20 (1H, m, 7-HH), 2.48–2.66 (3H, m, 4-HH and 6-H2), 
3.12 (1H, dd, J 8.6, 6.6 Hz, 8a-H), 3.25 (1H, dd, J 15.2, 1.2 Hz, 4-HH), 3.45–3.56 
(2H, m, 3a-H and 8b-H), 4.88–4.98 (1H, m, 8-H), 7.00–7.09 (4H, m, 3”-H, 5”-H and 
2 × ArH), 7.19–7.25 (2H, m, 2”-H and 6”-H), 7.37–7.48 (3H, m, 3 × ArH), 8.95 (1H, 
d, J 9.6 Hz, NH); δC (126 MHz, CDCl3) 28.3 (CH2), 31.7 (CH2), 31.7 (CH2), 40.3 
(CH), 41.6 (CH), 43.8 (CH), 52.8 (CH), 92.9 (C), 115.4 (2 × CH, 2JCF 21.4 Hz), 
126.5 (2 × CH), 129.2 (2 × CH, 3JCF 8.0 Hz), 129.2 (CH), 129.4 (2 × CH), 129.4 
(C), 131.4 (C), 134.9 (C, 4JCF 3.2 Hz), 139.6 (C), 161.8 (C, 1JCF 247.3 Hz), 162.3 
(C), 178.5 (C), 179.7 (C); m/z (ESI) 543.0393 (MNa+. C25H20F35Cl3N2NaO3 
requires 543.0416). 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-Hexahydro-5-(phenylethynyl)-2-phenyl-8-
(2’,2’-dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(243) 
 
To a solution of (3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-iodo-2-phenyl-
8-(2’,2’,2’-trichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione 
(240) (0.016 g, 0.029 mmol) in N,N-dimethylformamide (0.5 mL) were added 
copper iodide (0.001 g, 0.006 mmol) and bis(triphenylphosphine)palladium 
dichloride (0.002 g, 0.003 mmol). Phenylacetylene (242) (0.004 mL, 0.037 mmol) 
was dissolved in degassed triethylamine (2 mL) and added to the reaction mixture. 
The solution was briefly heated to 60 °C and then left to stir at room temperature 
for 3 h. The solution was concentrated in vacuo and purified by flash column 
chromatography (petroleum ether/ethyl acetate, 3:2) to give 
(3aS*,8R*,8aS*,8bR*)-3a,4,6,7,8a,8b-hexahydro-5-(phenylethynyl)-2-phenyl-8-
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(2’,2’-dichloromethylcarbonylamino)cyclopent[e]isoindole-1,3(2H,3aH)-dione (243) 
(0.007 g, 48%) as a colourless oil. νmax/cm−1 (neat) 3021 (CH), 2361, 1705 (C=O), 
1522 (C=C), 1393, 1215, 754; δH (400 MHz, CDCl3) 1.78‒1.92 (1H, m, 7-HH), 
2.09‒2.22 (1H, m, 7-HH), 2.35‒2.57 (2H, m, 4-HH and 6-HH), 2.84 (1H, dd, J 
17.6, 7.7 Hz, 6-HH), 2.99‒3.02 (1H, m, 8a-H), 3.06 (1H, dd, J 15.0, 1.3 Hz, 4-HH), 
3.39 (1H, ddd, J 8.8, 7.7, 1.3 Hz, 3a-H), 3.47 (1H, dd, J 8.8, 6.3 Hz, 8b-H), 4.94 
(1H, dtd, J 12.3, 9.8, 7.1 Hz, 8-H), 5.97 (1H, s, CHCl2), 7.18‒7.23 (2H, m, 2 × 
ArH), 7.29‒7.34 (3H, m, 3 × ArH), 7.38‒7.53 (5H, m, 5 × ArH), 8.58 (1H, d, J 9.8 
Hz, NH); δC (101 MHz, CDCl3) 28.7 (CH2), 31.0 (CH2), 31.3 (CH2), 39.4 (CH), 41.1 
(CH), 42.8 (CH), 51.7 (CH), 66.6 (CH), 86.7 (C), 93.5 (C), 111.8 (C), 123.0 (C), 
126.5 (2 × CH), 128.3 (2 × CH), 128.4 (CH), 129.1 (CH), 129.3 (2 × CH), 131.5 (2 
× CH), 131.5 (C), 151.4 (C), 164.5 (C), 177.7 (C), 179.0 (C); m/z (ESI) 515.0875 
(MNa+. C27H2235Cl2N2NaO3 requires 515.0900). 
4-Bromoanisole (250a)206 
 
Method A- N-Bromosuccinimide (165 mg, 0.930 mmol) was added to a solution of 
iron(III) chloride (7.50 mg, 0.0460 mmol) in 1-butyl-3-methylimidazolium 
bis(trifluoromethanesulfonyl)imide ([BMIM]NTf2) (0.30 mL) under an atmosphere of 
air. The mixture was stirred at room temperature for 0.5 h before anisole (101 µL, 
0.930 mmol) in [BMIM]NTf2 (0.10 mL) was added. The reaction mixture was 
heated to 40 °C for 1.5 h. The reaction progress was monitored by 1H NMR 
spectroscopy. The reaction mixture was extracted into 5% ethyl acetate in hexane 
(3 × 50 mL) using sonication in a water bath for 0.1 h. The suspension was 
washed with an aqueous solution of 1 M sodium thiosulfate (10 mL), brine (10 
mL), dried (MgSO4) and then filtered through a pad of Celite®. The solvent was 
removed under reduced pressure. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave 4-bromoanisole (250a) (141 mg, 82%) as 
a pale yellow oil. Spectroscopic data was consistent with the literature.206 δH (400 
MHz, CDCl3) 3.78 (3H, s, OCH3), 6.76–6.81 (2H, m, 2-H and 6-H), 7.35–7.40 (2H, 
m, 3-H and 5-H); δC (101 MHz, CDCl3) 55.4 (CH3), 112.8 (C), 115.8 (2 × CH), 
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132.3 (2 × CH), 158.7 (C); m/z (EI) 186 (M+. 100%), 171 (35), 143 (28). 
Method B- Iron(III) trichloride (4.00 mg, 0.0250 mmol) was dissolved in 
[BMIM]NTf2 (22.0 µL, 0.0750 mmol), pre-stirred for 0.5 h at room temperature and 
then added to a solution of N-bromosuccinimide (178 mg, 1.00 mmol) in toluene 
(1.0 mL). Anisole (108 µL, 1.00 mmol) was then added and the mixture was stirred 
at 40 °C for 4 h. The reaction mixture was then cooled to room temperature, 
diluted with ethyl acetate (10 mL) and washed with a 1 M sodium thiosulfate 
solution (10 mL) and brine (10 mL). The organic phase was dried (MgSO4), filtered 
and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave 4-bromoanisole (250a) (149 mg, 79%) as 
a pale yellow oil. Spectroscopic data was as described above. 
5-Bromo-2-methoxybenzaldehyde (250b)207 
 
5-Bromo-2-methoxybenzaldehyde (250b) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 2-methoxybenzaldehyde (60 mg, 0.44 
mmol) and performing the reaction at 40 °C for 1.5 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 5-bromo-2-
methoxybenzaldehyde (250b) (83 mg, 88%) as a white solid. Mp 112–114 °C 
(lit.207 116–117 °C); δH (400 MHz, CDCl3) 3.93 (3H, s, OCH3), 6.90 (1H, d, J 8.9 
Hz, 3-H), 7.64 (1H, dd, J 8.9, 2.6 Hz, 4-H), 7.92 (1H, d, J 2.6 Hz, 6-H), 10.39 (1H, 
s, CHO); δC (101 MHz, CDCl3) 56.0 (CH3), 113.5 (C), 113.7 (CH), 126.1 (C), 131.1 
(CH), 138.3 (CH), 160.7 (C), 188.3 (CH); m/z (EI) 214 (M+. 100%), 170 (30), 143 
(20), 135 (8), 118 (24), 92 (10), 75 (27), 63 (30), 50 (12). 
 
 
 
1
2
3
4
5
6
Br
MeO
OHC
 171 
3-Bromo-4-ethoxybenzaldehyde (250c) 
 
3-Bromo-4-ethoxybenzaldehyde (250c) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 4-ethoxybenzaldehyde (130 mg, 0.850 
mmol) and performing the reaction at 40 °C for 22 h. Purification by flash column 
chromatography (petroleum ether/diethyl ether, 19:1) gave 3-bromo-4-
ethoxybenzaldehyde (250c) (172 mg, 88%) as a white solid. Mp 70–72 °C; 
νmax/cm−1 (neat) 2977 (CH), 1684 (CO), 1595 (C=C), 1493, 1287, 1049, 813, 667; 
δH (500 MHz, CDCl3) 1.48 (3H, t, J 7.0 Hz, OCH2CH3), 4.15 (2H, q, J 7.0 Hz, 
OCH2CH3), 6.93 (1H, d, J 8.5 Hz, 5-H), 7.74 (1H, dd, J 8.5, 2.0 Hz, 6-H), 8.02 (1H, 
d, J 2.0 Hz, 2-H), 9.78 (1H, s, CHO); δC (126 MHz, CDCl3) 14.5 (CH3), 65.2 (CH2), 
112.3 (CH), 112.8 (C), 130.4 (C), 131.2 (CH), 134.5 (CH), 160.1 (C), 189.6 (CH); 
m/z (ESI) 250.9667 (MNa+. C9H979BrNaO2 requires 250.9678). 
2-Bromo-4-chloroanisole (250d)208 
 
Method A- 2-Bromo-4-chloroanisole (250d) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 4-chloroanisole (62 µL, 0.50 mmol) and 
performing the reaction at 40 °C for 1 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 17:3) gave 2-bromo-4-
chloroanisole (250d) (109 mg, 99%) as a colourless oil. Spectroscopic data was 
consistent with the literature.208 δH (500 MHz, CDCl3) 3.88 (3H, s, OCH3), 6.82 
(1H, d, J 8.8 Hz, 6-H), 7.24 (1H, dd, J 8.8, 2.5 Hz, 5-H), 7.54 (1H, d, J 2.5 Hz, 3-
H); δC (126 MHz, CDCl3) 56.6 (CH3), 112.3 (C), 112.7 (CH), 126.1 (C), 128.4 (CH), 
132.9 (CH), 154.9 (C); m/z (EI) 222 (M+. 100%), 207 (50), 179 (36), 126 (10), 75 
(12), 63 (21). 
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Method B- N-Chlorosuccinimide (140 mg, 1.05 mmol) was added to a solution of 
iron(III) chloride (8.00 mg, 0.0500 mmol) in [BMIM]NTf2 ( (0.30 mL) under an 
atmosphere of air. The mixture was stirred at room temperature for 0.5 h before 
anisole (108 µL, 1.00 mmol) was added. The mixture was stirred at 60 °C for 6 h. 
The reaction mixture was cooled to room temperature and N-bromosuccinimide 
(178 mg, 1.00 mmol) was then added. The reaction mixture was heated to 40 °C 
for 18 h. The reaction mixture was then extracted with 5% ethyl acetate in hexane 
(3 × 50 mL) using sonication in a water bath for 0.1 h. The suspension was 
washed with an aqueous solution of 1 M sodium thiosulfate (10 mL), brine (10 
mL), dried (MgSO4) and then filtered through a pad of Celite®. The solvent was 
removed under reduced pressure. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 17:3) gave 2-bromo-4-chloroanisole (250d) (178 
mg, 81%) as a colourless oil. Spectroscopic data was as described above. 
3-Bromo-4-methoxybenzoic acid (250e)209 
 
N-Bromosuccinimide (89 mg, 0.50 mmol) was added to a solution of iron(III) 
chloride (4.0 mg, 0.025 mmol) in [BMIM]NTf2 (0.15 mL) under an atmosphere of 
air. The mixture was stirred at room temperature for 0.5 h before 4-
methoxybenzoic acid (76 mg, 0.50 mmol) in [BMIM]NTf2 (0.10 mL) was added. 
The reaction mixture was heated to 40 °C for 4 h. The reaction mixture was diluted 
with dichloromethane (20 mL) and extracted with an aqueous solution of 1 M 
sodium hydroxide (10 mL). The aqueous phase was separated and then acidified 
with 1 M hydrochloric acid (10 mL), and extracted into dichloromethane (2 × 50 
mL). The organic phase was dried (MgSO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (dichloromethane/methanol, 19:1) 
gave 3-bromo-4-methoxybenzoic acid (250e) (96 mg, 83%) as a white solid. Mp 
206–208 °C (lit.209 201–206 °C); δH (500 MHz, CDCl3) 3.98 (3H, s, OCH3), 6.95 
(1H, d, J 8.7 Hz, 5-H), 8.06 (1H, dd, J 8.7, 2.1 Hz, 6-H), 8.30 (1H, d, J 2.1 Hz, 2-
H); δC (126 MHz, CDCl3) 56.5 (CH3), 111.1 (CH), 111.6 (C), 122.7 (C), 131.4 (CH), 
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135.5 (CH), 160.2 (C), 169.8 (C); m/z (ESI) 255 (MNa+. 100%). 
5-Bromo-2,4-dimethoxybenzoic acid (250f)210 
 
5-Bromo-2,4-dimethoxybenzoic acid (250f) was synthesised as described for 3-
bromo-4-methoxybenzoic acid (250e) using 2,4-dimethoxybenzoic acid (91 mg, 
0.50 mmol) and performing the reaction at 40 °C for 4 h. Purification by flash 
column chromatography (dichloromethane/methanol, 19:1) gave 2,4-dimethoxy-5-
bromobenzoic acid (250f) (85 mg, 65%) as a white solid. Mp 190–192 °C (lit.210 
192–194 °C); δH (400 MHz, CDCl3) 3.99 (3H, s, OCH3), 4.09 (3H, s, OCH3), 6.51 
(1H, s, 3-H), 8.33 (1H, s, 6-H), 10.38 (1H, s, CO2H); δC (101 MHz, CDCl3) 56.6 
(CH3), 57.0 (CH3), 95.8 (CH), 104.4 (C), 111.2 (C), 137.8 (CH), 159.0 (C), 160.9 
(C), 164.1 (C); m/z (ESI) 283 (MNa+. 100%). 
5-Bromo-2,4-dimethoxybenzaldehyde (250g)211 
 
5-Bromo-2,4-dimethoxybenzaldehyde (250g) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 2,4-dimethoxybenzaldehyde (80 mg, 0.50 
mmol) and performing the reaction at 20 °C for 2.5 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 5:1) gave 5-bromo-2,4-
dimethoxybenzaldehyde (250g) (115 mg, 94%) as a white solid. Mp 134–136 °C 
(lit.211 139–140 °C); δH (500 MHz, CDCl3) 3.93 (3H, s, OCH3), 3.96 (3H, s, OCH3), 
6.42 (1H, s, 3-H), 7.96 (1H, s, 6-H), 10.20 (1H, s, CHO); δC (126 MHz, CDCl3) 56.0 
(CH3), 56.5 (CH3), 95.6 (CH), 103.5 (C), 119.4 (C), 132.8 (CH), 161.7 (C), 163.0 
(C), 187.1 (CH); m/z (ESI) 267 (MNa+. 100%). 
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4-Bromo-2-methylanisole (250h)212 
 
4-Bromo-2-methylanisole (250h) was synthesised as described for 4-bromoanisole 
(250a) (Method A) using 2-methylanisole (62 µL, 0.50 mmol) and performing the 
reaction at 40 °C for 2 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 9:1) gave 4-bromo-2-methylanisole (250h) (90 mg, 90%) as a 
light yellow solid. Mp 64–66 °C (lit.212 66–68 °C); δH (500 MHz, CDCl3) 2.21 (3H, s, 
CH3), 3.82 (3H, s, OCH3), 6.70 (1H, d, J 9.0 Hz, 6-H), 7.24–7.30 (2H, m, 3-H and 
5-H); δC (126 MHz, CDCl3) 16.0 (CH3), 55.5 (CH3), 111.5 (CH), 112.4 (C), 129.0 
(C), 129.4 (CH), 133.2 (CH), 156.9 (C); m/z (EI) 200 (M+. 100%), 185 (47), 149 
(27), 111 (36), 97 (49), 85 (54), 78 (35), 71 (69), 57 (100). 
4-Bromophenol (250i)213 
 
5-Bromophenol (250i) was synthesised as described for 3-bromo-4-
methoxybenzoic acid (250e) using phenol (47 mg, 0.50 mmol) and performing the 
reaction at 20 °C for 0.5 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 9:1) gave 4-bromophenol (250i) (82 mg, 93%) as a 
white solid. Mp 58–60 °C (lit.213 56–59 °C); δH (400 MHz, CDCl3) 5.03 (1H, br s, 
OH), 6.70–6.75 (2H, m, 2-H and 6-H), 7.31–7.36 (2H, m, 3-H and 5-H); δC (101 
MHz, CDCl3) 113.0 (C), 117.2 (2 × CH), 132.5 (2 × CH), 154.6 (C); m/z (ESI) 173 
([M–H]–. 100%). 
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4-Bromo-2-fluorophenol (250j)214 
 
4-Bromo-2-fluorophenol (250j) was synthesised as described for 3-bromo-4-
methoxybenzoic acid (250e) using 2-fluorophenol (44 µL, 0.50 mmol) and 
performing the reaction at 40 °C for 2 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 4-bromo-2-fluorophenol 
(250j)  (77 mg, 82%) as a colourless oil. Spectroscopic data was consistent with 
the literature.214 δH (500 MHz, CDCl3) 5.07 (1H, d, J 4.2 Hz, OH), 6.90 (1H, dd, J 
9.0, 8.8 Hz, 6-H), 7.16 (1H, ddd, J 8.8, 2.2, 1.6 Hz, 5-H), 7.24 (1H, dd, J 9.9, 2.2 
Hz, 3-H); δC (126 MHz, CDCl3) 111.7 (C, d, 3JCF 8.2 Hz), 118.7 (CH, d, 4JCF 2.2 
Hz), 119.2 (CH, d, 2JCF 21.1 Hz), 128.1 (CH, d, 3JCF 3.8 Hz), 143.0 (C, d, 2JCF 14.1 
Hz), 151.0 (C, d, 1JCF 241.8 Hz); m/z (EI) 190 (M+. 100%), 161 (4), 142 (9), 111 
(6), 83 (29), 63 (38), 57 (19). 
5-Bromo-2,4-dimethoxy-6-hydroxybenzaldehyde (250k)  
 
5-Bromo-2,4-dimethoxy-6-hydroxybenzaldehyde (250k) was synthesised as 
described for 3-bromo-4-methoxybenzoic acid (250e) using 2,4-dimethoxy-6-
hydroxybenzaldehyde (92 mg, 0.50 mmol) and performing the reaction at 20 °C for 
6 h. Purification by flash column chromatography (petroleum ether/ethyl acetate, 
7:3) gave 5-bromo-2,4-dimethoxy-6-hydroxybenzaldehyde (250k) (97 mg, 74%) as 
a white solid. Mp 188–190 °C; νmax/cm−1 (neat) 2924 (CH), 1636 (CO), 1615 
(C=C), 1470, 1450, 1427, 1406, 1283, 1233, 1217, 1124, 1089, 981, 772, 723; δH 
(400 MHz, CDCl3) 3.93 (3H, s, OCH3), 3.98 (3H, s, OCH3), 6.01 (1H, s, 3-H), 10.08 
(1H, s, CHO), 12.96 (1H, s, OH); δC (101 MHz, CDCl3) 56.0 (CH3), 56.6 (CH3), 
86.9 (CH), 90.8 (C), 106.4 (C), 161.4 (C), 163.4 (C), 163.8 (C), 191.8 (C); m/z 
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(ESI) 282.9575 (MNa+. C9H979BrNaO4 requires 282.9576). 
4-Bromo-2-trifluoromethylaniline (250l)215 
 
4-Bromo-2-trifluoromethylaniline (250l) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 2-trifluoromethylaniline (63 µL, 0.50 mmol) 
and performing the reaction at 40 °C for 2 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) gave 4-bromo-2-
trifluoromethylaniline (250l) (0.12 g, 99%) as a colourless oil. Spectroscopic data 
was consistent with the literature.215 δH (500 MHz, CDCl3) 4.18 (2H, s, NH2), 6.62 
(1H, d, J 8.7 Hz, 6-H), 7.37 (1H, dd, J 8.7, 2.2 Hz, 5-H), 7.53 (1H, d, J 2.2 Hz, 3-
H); δC (126 MHz, CDCl3) 109.1 (C), 115.3 (C, q, 2JCF 30.7 Hz), 118.9 (CH), 124.1 
(C, q, 1JCF 272.6 Hz), 129.3 (CH, q, 3JCF 5.4 Hz), 135.8 (CH), 143.6 (C); m/z (EI) 
239 (M+. 100%), 219 (51), 192 (37), 160 (8), 140 (12), 132 (11), 113 (15), 70 (14), 
63 (19). 
4-Bromo-2-fluoroaniline (250m)216 
 
4-Bromo-2-fluoroaniline (250m) was synthesised as described for 4-bromoanisole 
(250a) (Method A) using 2-fluoroaniline (56 mg, 0.50 mmol) and performing the 
reaction at 20 °C for 1.5 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 19:1) gave 4-bromo-2-fluoroaniline (250m) (70 mg, 
73%) as a light brown oil. Spectroscopic data was consistent with the literature.216 
δH (500 MHz, CDCl3) 3.72 (2H, s, NH2), 6.65 (1H, dd, J 9.4, 8.5 Hz, 6-H), 7.05 (1H, 
ddd, J 8.5, 2.2, 1.1 Hz, 5-H), 7.14 (1H, dd, J 10.5, 2.2 Hz, 3-H); δC (126 MHz, 
CDCl3) 108.9 (C, d, 3JCF 8.8 Hz), 117.8 (CH, d, 3JCF 4.3 Hz), 118.7 (CH, d, 2JCF 
21.9 Hz), 127.4 (CH, d, 4JCF 3.6 Hz), 133.8 (C, d, 2JCF 12.8 Hz), 151.4 (C, d, 1JCF 
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243.4 Hz); m/z (EI) 189 (M+. 100%), 110 (21), 83 (27), 63 (11). 
2-Bromo-4-nitroaniline (250n)217 
 
2-Bromo-4-nitroaniline (250n) was synthesised as described for 4-bromoanisole 
(250a) (Method A) using 4-nitroaniline (69 mg, 0.50 mmol) and performing the 
reaction at 40 °C for 2 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 7:3) gave 2-bromo-4-nitroaniline (250n) (87 mg, 80%) as a 
yellow solid. Mp 104–106 °C (lit.217 103–104 °C); δH (500 MHz, CDCl3) 4.89 (2H, s, 
NH2), 6.77 (1H, d, J 8.9 Hz, 6-H), 8.04 (1H, dd, J 8.9, 2.4 Hz, 5-H), 8.38 (1H, d, J 
2.4 Hz, 3-H); δC (126 MHz, CDCl3) 107.1 (C), 113.6 (CH), 125.0 (CH), 129.3 (CH), 
139.1 (C), 150.0 (C); m/z (ESI) 239 (MNa+. 99%), 227 (4), 200 (10). 
4-Amino-3-bromobenzonitrile (250o)218  
 
4-Amino-3-bromobenzonitrile (250o) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 4-cyanoaniline (59 mg, 0.50 mmol) and 
performing the reaction at 40 °C for 22 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 7:3) gave 4-amino-3-
bromobenzonitrile (250o) (58 mg, 59%) as a white solid. Mp 110–112 °C (lit.218 
110–112 °C); δH (400 MHz, CDCl3) 4.64 (2H, s, NH2), 6.74 (1H, d, J 8.4 Hz, 6-H), 
7.37 (1H, dd, J 8.4, 1.8 Hz, 5-H), 7.68 (1H, d, J 1.8 Hz, 3-H); δC (101 MHz, CDCl3) 
101.5 (C), 108.0 (C), 114.9 (CH), 118.7 (C), 132.6 (CH), 136.6 (CH), 148.2 (C); 
m/z (ESI) 221 (MNa+. 100%), 199 (26), 171 (3). 
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2-Amino-3-bromo-5-chlorobenzophenone (250p)219 
 
2-Amino-3-bromo-5-chlorobenzophenone (250p) was synthesised as described for 
4-bromoanisole (250a) (Method A) using 2-amino-5-chlorobenzophenone (120 
mg, 0.500 mmol) and performing the reaction at 70 °C for 1 h. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 7:3) gave 2-amino-3-
bromo-5-chlorobenzophenone (250p) (140 mg, 90%) as a yellow solid. Mp 101–
102 °C (lit.219 102–103 °C); δH (500 MHz, CDCl3) 6.60 (2H, s, NH2), 7.41 (1H, d, J 
2.4 Hz, 6-H) 7.46–7.52 (2H, m, 2 × ArH), 7.55–7.65 (4H, m, 4 × ArH); δC (126 
MHz, CDCl3) 111.4 (C), 119.4 (C), 119.7 (C), 128.5 (2 × CH), 129.3 (2 × CH), 
132.0 (CH), 132.9 (CH), 136.6 (CH), 138.9 (C), 146.6 (C), 197.5 (C); m/z (ESI) 
334 (MNa+. 100%). 
4-Bromoacetanilide (250q)220 
 
4-Bromoacetanilide (250q) was synthesised as described for 4-bromoanisole 
(250a) (Method A) using acetanilide (68 mg, 0.50 mmol) and performing the 
reaction at 40 °C for 2.5 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 7:3) gave 4-bromoacetanilide (250q) (0.10 g, 96%) 
as a white solid. Mp 162–164 °C (lit.220 164–166 °C); δH (500 MHz, CDCl3) 2.17 
(3H, s, CH3), 7.30 (1H, br s, NH), 7.37–7.44 (4H, m, 2-H, 3-H, 5-H and 6-H); δC 
(126 MHz, CDCl3) 24.6 (CH3), 116.9 (C), 121.4 (2 × CH), 132.0 (2 × CH), 136.9 
(C), 168.3 (C); m/z (ESI) 236 (MNa+. 100%). 
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N-(4-Bromo-2-chlorophenyl)acetamide (250r)221 
 
N-(4-Bromo-2-chlorophenyl)acetamide (250r) was synthesised as described for 4-
bromoanisole (250a) (Method A) using N-(2-chlorophenyl)acetamide (85 mg, 0.50 
mmol) in a co-solvent system of [BMIM]NTf2 (0.3 mL) and toluene ( 0.1 mL) and 
performing the reaction at 40 °C for 3 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave N-(4-bromo-2-
chlorophenyl)acetamide (250r) (0.12 g, 98%),) as a white solid. Mp 148–150 °C 
(lit.221 151–152 °C); δH (500 MHz, CDCl3) 2.23 (3H, s, CH3), 7.38 (1H, dd, J 8.9, 
2.2 Hz, 5-H), 7.51 (1H, d, J 2.2 Hz, 3-H), 7.57 (1H, s, NH), 8.28 (1H, d, J 8.9 Hz, 6-
H); δC (126 MHz, CDCl3) 24.9 (CH3), 116.2 (C), 122.6 (CH), 123.2 (C), 130.8 (CH), 
131.4 (CH), 133.8 (C), 168.2 (C); m/z (ESI) 272 (MNa+. 100%). 
N-(2-Acetyl-4-bromophenyl)acetamide (250s)222 
 
N-(2-Acetyl-4-bromophenyl)acetamide (250s) was synthesised as described for 4-
bromoanisole (250a) (Method A) using N-(2-acetylphenyl)acetamide (90 mg, 0.50 
mmol)  in a co-solvent system of [BMIM]NTf2 (0.3 mL)  and toluene ( 0.1 mL) and 
performing the reaction at 40 °C for 3.5 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave N-(2-acetyl-4-
bromophenyl)acetamide (250s) (0.13 g, 99%),) as a white solid. Mp 158–160 °C. 
Spectroscopic data was consistent with the literature.222 δH (500 MHz, CDCl3) 2.21 
(3H, s, CH3), 2.64 (3H, s, CH3), 7.61 (1H, dd, J 9.1, 2.3 Hz, 5-H), 7.96 (1H, d, J 2.3 
Hz, 3-H), 8.66 (1H, d, J 9.1 Hz, 6-H), 11.56 (1H, s, NH); δC (126 MHz, CDCl3) 25.5 
(CH3), 28.6 (CH3), 114.4 (C), 122.3 (CH), 123.0 (C), 134.0 (CH), 137.6 (CH), 
139.9 (C), 169.4 (C), 201.6 (C); m/z (ESI) 278 (MNa+. 97%). 
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1-Bromo-4-methoxynaphthalene (250t)223 
 
1-Bromo-4-methoxynaphthalene (250t) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 1-methoxynaphthalene (80 mg, 0.50 mmol) 
and performing the reaction at 40 °C for 2 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-bromo-4-
methoxynaphthalene (250t) (0.11 g, 89%) as a colourless oil. Spectroscopic data 
was consistent with the literature.223 δH (500 MHz, CDCl3) 3.98 (3H, s, OCH3), 6.66 
(1H, d, J 8.3 Hz, 3-H), 7.55 (1H, ddd, J 8.3, 6.9, 1.1 Hz, 7-H), 7.63 (1H, ddd, J 8.4, 
6.9, 1.2 Hz, 6-H), 7.67 (1H, d, J 8.3 Hz, 2-H), 8.21 (1H, br d, J 8.4 Hz, 5-H), 8.31 
(1H, br d, J 8.3 Hz, 8-H); δC (126 MHz, CDCl3) 55.7 (CH3), 104.5 (CH), 113.3 (C), 
122.5 (CH), 126.0 (CH), 126.8 (C), 126.9 (CH), 127.8 (CH), 129.5 (CH), 132.5 (C), 
155.3 (C); m/z (EI) 236 (M+. 100%), 221 (42), 193 (54), 114 (44), 84 (35), 63 (11). 
1-Bromo-2-methoxynaphthalene (250u)224 
 
1-Bromo-2-methoxynaphthalene (250u) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 2-methoxynaphthalene (80 mg, 0.50 mmol) 
and performing the reaction at 40 °C for 2 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-bromo-2-
methoxynaphthalene (250u) (0.11 g, 93%) as a white solid. Mp 80–82 °C (lit.224 82 
°C); δH (500 MHz, CDCl3) 4.03 (3H, s, OCH3), 7.27 (1H, d, J 8.9 Hz, 3-H), 7.40 
(1H, ddd, J 8.1, 6.8, 1.0 Hz, 6-H), 7.57 (1H, ddd, J 8.4, 6.8, 1.2 Hz, 7-H), 7.79 (1H, 
d, J 8.1 Hz, 5-H), 7.82 (1H, d, J 8.9 Hz, 4-H), 8.24 (1H, d, J 8.4 Hz, 8-H); δC (126 
MHz, CDCl3) 57.1 (CH3), 108.7 (C), 113.6 (CH), 124.3 (CH), 126.1 (CH), 127.8 
(CH), 128.1 (CH), 129.0 (CH), 129.8 (C), 133.2 (C), 153.8 (C); m/z (EI) 238 (M+. 
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100%), 195 (70), 175 (32), 149 (29), 127 (27), 114 (39), 84 (91), 69 (33), 55 (60). 
1-Bromo-2-naphthol (250v)225 
 
1-Bromo-2-naphthol (250v) was synthesised as described for 3-bromo-4-
methoxybenzoic acid (250e) using 2-naphthol (70 mg, 0.50 mmol) and performing 
the reaction at 40 °C for 1 h. Purification by flash column chromatography 
(petroleum ether/ethyl acetate, 19:1) gave 1-bromo-2-naphthol (250v) (0.10 g, 
90%) as a pale green solid. Mp 72–74 °C (lit.225 76–78 °C); δH (500 MHz, CDCl3) 
5.95 (1H, s, OH), 7.28 (1H, d, J 8.8 Hz, 3-H), 7.40 (1H, ddd, J 8.0, 6.9, 1.2 Hz, 6-
H), 7.58 (1H, ddd, J 8.5, 6.9, 1.2 Hz, 7-H), 7.74 (1H, d, J 8.8 Hz, 4-H), 7.79 (1H, br 
d, J 8.0 Hz, 5-H), 8.04 (1H, br d, J 8.5 Hz, 8-H); δC (126 MHz, CDCl3) 106.2 (C), 
117.2 (CH), 124.2 (CH), 125.4 (CH), 127.9 (CH), 128.2 (CH), 129.4 (CH), 129.7 
(C), 132.3 (C), 150.6 (C); m/z (EI) 222 (M+. 100%), 144 (12), 114 (38). 
5-Bromo-2,3-dihydrobenzofuran (250w)  
 
5-Bromo-2,3-dihydrobenzofuran (250w) was synthesised as described for 4-
bromoanisole (250a) (Method A) using 2,3-dihydrobenzofuran (56 µL, 0.50 mmol) 
and performing the reaction at 40 °C for 1 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 5-bromo-2,3-
dihydrobenzofuran (250w) (97 mg, 98%) as a white solid. Mp 48–50 °C; νmax/cm−1 
(neat) 2903 (CH), 1478, 1464, 1231, 1155, 1105, 978, 932, 812; δH (500 MHz, 
CDCl3) 3.20 (2H, t, J 8.7 Hz, 3-H2), 4.57 (2H, t, J 8.7 Hz, 2-H2), 6.66 (1H, d, J 8.4 
Hz, 7-H), 7.19 (1H, dd, J 8.4, 1.6 Hz, 6-H), 7.28 (1H, br s, 4-H); δC (126 MHz, 
CDCl3) 29.8 (CH2), 71.7 (CH2), 110.9 (CH), 112.1 (C), 128.0 (CH), 129.6 (C), 
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130.8 (CH), 159.4 (C); m/z (EI) 197.9680 (M+, C8H779BrO requires 197.9680), 118 
(20%), 91 (81), 63 (28). 
3,5-Dibromo-4-hydroxybenzonitrile (250x) 
 
3,5-Dibromo-4-hydroxybenzonitrile (250x) was synthesised as described for 3-
bromo-4-methoxybenzoic acid (250e) using 4-cyanophenol (60.0 mg, 0.500 mmol) 
and N-bromosuccinimide (190 mg, 1.05 mmol) and performing the reaction at 40 
°C for 2.5 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 9:1) gave 3,5-dibromo-4-hydroxybenzonitrile (250x) (126 mg, 91%) as a 
white solid. Mp 190−192; νmax/cm−1 (neat) 3406 (OH), 2926 (CH), 2230, (CN), 
1464, 1325, 1200, 1134, 1055, 893, 800, 745; δH (500 MHz, CDCl3) 6.40 (1H, s, 
OH), 7.77 (2H, s, 2-H and 6-H); δC (126 MHz, CDCl3) 106.6 (C), 110.4 (2 × C), 
116.2 (C), 135.7 (2 × CH), 153.6 (C); m/z (ESI) 275.8499 ([M–H]–. 
C7H2Br79Br81BrNO requires 275.8488). 
1-(4’-Methoxyphenyl)-1H-indole (252a)226  
 
Method A- Iron(III) trichloride (4.00 mg, 0.0250 mmol) was dissolved in 
[BMIM]NTf2 (22.0 µL, 0.0750 mmol), pre-stirred for 0.5 h at room temperature and 
then added to a solution of N-bromosuccinimide (178 mg, 1.00 mmol) in toluene 
(1.0 mL). Anisole (108 µL, 1.00 mmol) was then added and the mixture was stirred 
at 40 °C for 4 h. The reaction mixture was then cooled to room temperature and 
the indole (176 mg, 1.50 mmol), copper(I) iodide (19.0 mg, 0.100 mmol), N,N′-
dimethylethylenediamine (22.0 µL, 0.200 mmol), cesium carbonate (652 mg, 2.00 
mmol) and water (0.70 mL) were added. The reaction mixture was degassed 
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under argon for 0.1 h before heated to 130 °C for 18 h. The reaction mixture was 
then cooled to room temperature, diluted with ethyl acetate (10 mL), washed with 
a 1 M sodium thiosulfate solution (10 mL) and brine (10 mL). The organic phase 
was dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-(4’-
methoxyphenyl)-1H-indole (252a) (175 mg, 78%) as a white solid. Mp 56–58 °C 
(lit.226 57–59 °C); δH (500 MHz, CDCl3) 3.95 (3H, s, OCH3), 6.79 (1H, dd, J 3.2, 0.8 
Hz, 3-H), 7.09–7.14 (2H, m, 3’-H and 5’-H), 7.27–7.36 (2H, m, 5-H and 6-H), 7.39 
(1H, d, J 3.2 Hz, 2-H), 7.47–7.52 (2H, m, 2’-H and 6’-H), 7.59 (1H, dd, J 8.0, 0.8 
Hz, 4-H), 7.82 (1H, br d, J 8.0 Hz, 7-H); δC (126 MHz, CDCl3) 55.7 (CH3), 103.1 
(CH), 110.5 (CH), 114.9 (2 × CH), 120.2 (CH), 121.2 (CH), 122.3 (CH), 126.1 (2 × 
CH), 128.4 (CH), 129.1 (C), 132.9 (C), 136.4 (C), 158.3 (C); m/z (ESI) 224 (MH+. 
100%). 
Method B- Iron(III) trichloride (2.00 mg, 0.0125 mmol) was dissolved in 
[BMIM]NTf2 (11.0 µL, 0.0375 mmol), pre-stirred for 0.5 h at room temperature and 
then added to a solution of N-iodosuccinimide (113 mg, 0.500 mmol) in toluene 
(0.50 mL). Anisole (54.0 µL, 0.500 mmol) was then added and the mixture was 
stirred at 40 °C for 3 h. The reaction mixture was then cooled to room temperature 
and the indole (88.0 mg, 0.750 mmol), copper(I) iodide (10.0 mg, 0.0500 mmol), 
N,N′-dimethylethylenediamine (11.0 µL, 0.100 mmol), cesium carbonate (313 mg, 
1.00 mmol) and water (0.30 mL) were added. The reaction mixture was degassed 
under argon for 0.1 h before heated to 130 °C for 20 h. The reaction mixture was 
then cooled to room temperature, diluted with ethyl acetate (10 mL), washed with 
a 1 M sodium thiosulfate solution (10 mL) and brine (10 mL). The organic phase 
was dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-(4’-
methoxyphenyl)-1H-indole (252a) (0.099 g, 89%) as a white solid. Spectroscopic 
data as described above. 
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1-(4’-Methoxyphenyl)-1H-pyrazole (252b)227 
 
1-(4’-Methoxyphenyl)-1H-pyrazole (252b) was synthesised as described for 1-(4’-
methoxyphenyl)-1H-indole (252a) (Method A) using anisole (1.08 mL, 10.0 mmol) 
and pyrazole (1.02 g, 15.0 mmol). The bromination step was carried out at 40 °C 
for 4 h and the N-arylation step at 150 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-(4’-methoxyphenyl)-
1H-pyrazole (252b) (1.65 g, 95%) as a light brown oil. Spectroscopic data was 
consistent with the literature.227 δH (400 MHz, CDCl3) 3.84 (3H, s, OCH3), 6.44 
(1H, dd, J 2.0, 1.5 Hz, 4-H), 6.94–7.00 (2H, m, 3’-H and 5’-H), 7.56–7.62 (2H, m, 
2’-H and 6’-H), 7.69 (1H, d, J 2.0 Hz, ArH) 7.82 (1H, d, J 2.0 Hz, ArH); δC (101 
MHz, CDCl3) 55.5 (CH3), 107.2 (CH), 114.5 (2 × CH), 120.8 (2 × CH), 126.8 (CH), 
134.0 (C), 140.6 (CH), 158.2 (C); m/z (ESI) 197 (MNa+. 100%). 
1-(4’-Methoxyphenyl)-1H-imidazole (252c)228 
 
1-(4’-Methoxyphenyl)-1H-imidazole (252c) was synthesised as described for 1-(4’-
methoxyphenyl)-1H-indole (252a) (Method A) using anisole (108 µL, 1.00 mmol) 
and imidazole (102 mg, 1.50 mmol). The bromination step was carried out at 40 
°C for 4 h and the N-arylation step at 150 °C for 24 h. Purification by flash column 
chromatography (dichloromethane/methanol 19:1) gave 1-(4’-methoxyphenyl)-1H-
imidazole (252c) (132 mg, 76%) as an off-white solid. Mp 60–62 °C (lit.228 61–63 
°C); δH (500 MHz, CDCl3) 3.79 (3H, s, OCH3), 6.90–6.95 (2H, m, 3’-H and 5’-H), 
7.10–7.20 (2H, br m, 4-H and 5-H), 7.21–7.27 (2H, m, 2’-H and 6’-H), 7.72 (1H, br 
s, 2-H); δC (126 MHz, CDCl3) 55.6 (CH3), 114.9 (2 × CH), 118.8 (CH), 123.1 (2 × 
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CH), 130.1 (CH), 130.7 (C), 135.8 (CH), 158.9 (C); m/z (ESI) 175 (MH+. 100%), 
160 (28), 132 (6). 
1-(4’-Methoxyphenyl)-1H-pyrrole (252d)229 
 
Method A- 1-(4’-Methoxyphenyl)-1H-pyrrole (252d) was synthesised as described 
for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using anisole (108 µL, 1.00 
mmol) and pyrrole (104 µL, 1.50 mmol). The bromination step was carried out at 
40 °C for 4 h and the N-arylation step at 150 °C for 36 h. Purification by flash 
column chromatography (petroleum ether) gave 1-(4’-methoxyphenyl)-1H-pyrrole 
(252d) (88.0 mg, 51%) as a white solid. Mp 98–100 °C (lit.229 104–108 °C); δH 
(500 MHz, CDCl3) 3.85 (3H, s, OCH3), 6.35 (2H, t, J 2.2 Hz, 3-H and 4-H), 6.94–
6.99 (2H, m, 3’-H and 5’-H), 7.02 (2H, t, J 2.2 Hz, 2-H and 5-H), 7.31–7.35 (2H, m, 
2’-H and 6’-H); δC (126 MHz, CDCl3) 55.6 (CH3), 109.9 (2 × CH), 114.6 (2 × CH), 
119.7 (2 × CH), 122.2 (2 × CH), 134.5 (C), 157.7 (C); m/z (ESI) 196 (MNa+. 
100%). 
Method B- 1-(4’-Methoxyphenyl)-1H-pyrrole (252d) was synthesised as described 
for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method B) using anisole (54 µL, 0.50 
mmol) and pyrrole (49 µL, 0.75 mmol). The iodination step was carried out at 40 
°C for 3 h and the N-arylation step at 150 °C for 20 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-(4’-methoxyphenyl)-
1H-pyrrole (252d) (59 mg, 68%) as a white solid. Spectroscopic data as described 
above. 
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1-(4’-Methoxyphenyl)pyrrolidin-2-one (252e)230 
 
1-(4’-Methoxyphenyl)pyrrolidin-2-one (252e) was synthesised as described for 1-
(4’-methoxyphenyl)-1H-indole (252a) (Method A) using anisole (108 µL, 1.00 
mmol) and pyrrolidin-2-one (128 mg, 1.50 mmol). The bromination step was 
carried out at 40 °C for 4 h and the N-arylation step at 150 °C for 20 h. Purification 
by flash column chromatography (dichloromethane/methanol 49:1) gave 1-(4’-
methoxyphenyl)pyrrolidin-2-one (252e) (111 mg, 58%) as an off-white solid. Mp 
112–114 °C (lit.230 113–114  °C); δH (500 MHz, CDCl3) 2.14 (2H, quin, J 7.9 Hz, 4-
H2), 2.58 (2H, t, J 7.9 Hz, 3-H2), 3.79 (3H, s, OMe), 3.81 (2H, t, J 7.9 Hz, 5-H2), 
6.86–6.92 (2H, m, 3’-H and 5’-H), 7.46–7.51 (2H, m, 2’-H and 6’-H); δC (126 MHz, 
CDCl3) 18.0 (CH2), 32.5 (CH2), 49.2 (CH2), 55.5 (CH3), 114.0 (2 × CH), 121.8 (2 × 
CH), 132.6 (C), 156.6 (C), 173.9 (C); m/z (ESI) 214 (MNa+. 100%). 
N-(4’-Methoxyphenyl)benzamide (252f)231  
 
N-(4’-Methoxyphenyl)benzamide (252f) was synthesised as described for 1-(4’-
methoxyphenyl)-1H-indole (252a) (Method A) using anisole (108 µL, 1.00 mmol) 
and benzamide (182 mg, 1.50 mmol). The bromination step was carried out at 40 
°C for 4 h and the N-arylation step at 130 °C for 18 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 8:2) gave N-(4’-
methoxyphenyl)benzamide (252f) (177 mg, 78%) as a white solid. Mp 152–154 °C 
(lit.231 153–155 °C); δH (500 MHz, CDCl3) 3.81 (3H, s, OCH3), 6.87–6.93 (2H, m, 
3’-H and 5’-H), 7.44–7.56 (5H, m, 2’-H, 6’-H and 3 × ArH), 7.80 (1H, br s, NH), 
7.83–7.88 (2H, m, 2 × ArH); δC (126 MHz, CDCl3) 55.5 (CH3), 114.3 (2 × CH), 
122.1 (2 × CH), 127.0 (2 × CH), 128.7 (2 × CH), 131.0 (C), 131.7 (CH), 135.1 (C), 
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156.7 (C), 165.6 (C); m/z (ESI) 250 (MNa+. 100%). 
N-(4’-Methoxyphenyl)-4-methylbenzamide (252g)231 
 
Method A- N-(4’-Methoxyphenyl)-4-methylbenzamide (252g) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using anisole 
(108 µL, 1.00 mmol) and p-toluamide (203 mg, 1.50 mmol). The bromination step 
was carried out at 40 °C for 4 h and the N-arylation step at 130 °C for 18 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 8:2) 
gave N-(4’-methoxyphenyl)-4-methylbenzamide (252g) (213 mg, 88%) as a light 
brown solid. Mp 156–158 °C (lit.231 157–159 °C); δH (500 MHz, CDCl3) 2.40 (3H, s, 
CH3), 3.80 (3H, s, OCH3), 6.85–6.90 (2H, m, 3’-H and 5’-H), 7.24 (2H, d, J 8.0 Hz, 
3-H and 5-H), 7.50–7.55 (2H, m, 2’-H and 6’-H), 7.75 (2H, d, J 8.0 Hz, 2-H and 6-
H), 7.88 (1H, s, NH); δC (126 MHz, CDCl3) 21.5 (CH3), 55.5 (CH3), 114.2 (2 × CH), 
122.2 (2 × CH), 127.0 (2 × CH), 129.4 (2 × CH), 131.2 (C), 132.2 (C), 142.1 (C), 
156.5 (C), 165.7 (C); m/z (ESI) 264 (MNa+. 100%). 
Method B- N-(4’-Methoxyphenyl)-4-methylbenzamide (252g) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method B) using anisole 
(54.0 µL, 0.500 mmol) and p-toluamide (102 mg, 0.750 mmol). The iodination step 
was carried out at 40 °C for 3 h and the N-arylation step at 130 °C for 20 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 8:2) 
gave N-(4’-methoxyphenyl)-4-methylbenzamide (252g) (119 mg, 99%) as a light 
brown solid. Spectroscopic data as described above. 
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N-(4’-Methoxyphenyl)benzenesulfonamide (252h)232  
 
Method A- N-(4’-Methoxyphenyl)benzenesulfonamide (252h) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using anisole 
(108 µL, 1.00 mmol) and benzenesulfonamide (236 mg, 1.50 mmol). The 
bromination step was carried out at 40 °C for 4 h and the N-arylation step at 130 
°C for 18 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 9:1) gave N-(4’-methoxyphenyl)benzenesulfonamide (252h) (231 mg, 
88%) as a brown solid. Mp 90–92 °C. Spectroscopic data was consistent with the 
literature.232 δH (400 MHz, CDCl3) 3.75 (3H, s, OCH3), 6.71–6.78 (3H, m, 3’-H, 5’-H 
and NH), 6.95–7.01 (2H, m, 2’-H and 6’-H), 7.39–7.45 (2H, m, 2 × ArH), 7.53 (1H, 
tt, J 7.6, 1.2 Hz, ArH), 7.70–7.74 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 55.4 
(CH3), 114.5 (2 × CH), 125.3 (2 × CH), 127.3 (2 × CH), 129.0 (2 × CH and C), 
132.9 (CH), 138.9 (C), 157.9 (C); m/z (ESI) 286 (MNa+. 100%). 
Method B- N-(4’-Methoxyphenyl)benzenesulfonamide (252h) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method B) using anisole 
(54.0 µL, 0.500 mmol) and benzenesulfonamide (118 mg, 0.750 mmol). The 
iodination step was carried out at 40 °C for 3 h and the N-arylation step at 130 °C 
for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 9:1) gave N-(4’-methoxyphenyl)benzenesulfonamide (252h) (125 mg, 
95%) as a brown solid. Spectroscopic data as described above. 
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4-Fluoro-N-(4’-methoxyphenyl)benzenesulfonamide (252i) 
 
4-Fluoro-N-(4’-methoxyphenyl)benzenesulfonamide (252i) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using anisole 
(108 µL, 1.00 mmol) and 4-fluorobenzenesulfonamide (263 mg, 1.50 mmol). The 
bromination step was carried out at 40 °C for 4 h and the N-arylation step at 130 
°C for 18 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 8:2) gave 4-fluoro-N-(4’-methoxyphenyl)benzenesulfonamide (252i) (231 
mg, 82%) as a light brown solid. Mp 102–104 °C; νmax/cm−1 (neat) 3262 (NH), 
2937 (CH), 1592 (C=C), 1508, 1495, 1247, 1241, 1165, 1153, 1090, 837, 754; δH 
(500 MHz, CDCl3) 3.76 (3H, s, OCH3), 6.74–6.79 (3H, m, 3’-H, 5’-H and NH), 
6.95–7.00 (2H, m, 2’-H and 6’-H), 7.06–7.12 (2H, m, 3-H and 5-H), 7.69–7.74 (2H, 
m, 2-H and 6-H); δC (126 MHz, CDCl3) 55.4 (CH3), 114.5 (2 × CH), 116.2 (2 × CH, 
d, 2JCF 22.6 Hz), 125.7 (2 × CH), 128.5 (C), 130.1 (2 × CH, d, 3JCF 9.4 Hz), 134.9 
(C, d, 4JCF 3.2 Hz), 158.2 (C), 165.2 (C, d, 1JCF 255.1 Hz); m/z (ESI) 304.0405 
(MNa+. C13H12FNNaO3S requires 304.0414). 
1-(4’-Methoxy-3’-methylphenyl)-1H-pyrazole (253a) 
 
1-(4’-Methoxy-3’-methylphenyl)-1H-pyrazole (253a) was synthesised as described 
for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2-methylanisole (124 
µL, 1.00 mmol) and pyrazole (102 mg, 1.50 mmol). The bromination step was 
carried out at 40 °C for 4 h and the N-arylation step at 150 °C for 20 h. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-(4’-
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methoxy-3’-methylphenyl)-1H-pyrazole (253a) (152 mg, 81%) as a colourless oil. 
νmax/cm−1 (neat) 2928 (CH), 1519 (C=C), 1504, 1239, 1046, 909, 730; δH (500 
MHz, CDCl3) 2.28 (3H, s, CH3), 3.86 (3H, s, OCH3), 6.42 (1H, t, J 2.0 Hz, 4-H), 
6.86 (1H, d, J 8.7 Hz, 5’-H), 7.42 (1H, dd, J 8.7, 2.6 Hz, 6’-H), 7.48 (1H, d, J 2.6 
Hz, 2’-H), 7.68 (1H, d, J 2.0 Hz, ArH), 7.81 (1H, d, J 2.0 Hz, ArH); δC (126 MHz, 
CDCl3) 16.4 (CH3), 55.6 (CH3), 107.0 (CH), 110.2 (CH), 117.8 (CH), 122.3 (CH), 
126.8 (CH), 127.8 (C), 133.5 (C), 140.5 (CH), 156.4 (C); m/z (ESI) 211.0838 
(MNa+. C11H12N2NaO requires 211.0842). 
4’-(1H-Pyrazol-1-yl)phenol (253b)233 
 
Method A- 4’-(1H-Pyrazol-1-yl)phenol (253b) was synthesised as described for 1-
(4’-methoxyphenyl)-1H-indole (252a) (Method A) using phenol (94.0 mg, 1.00 
mmol) and pyrazole (102 mg, 1.50 mmol). The bromination step was carried out at 
room temperature for 1 h and the N-arylation step at 150 °C for 20 h. Purification 
by flash column chromatography (dichloromethane/methanol 49:1) gave 4’-(1H-
pyrazol-1-yl)phenol (253b) (106 mg, 66%) as a light brown oil. Spectroscopic data 
was consistent with the literature.233 δH (500 MHz, CDCl3) 6.45 (1H, t, J 2.0 Hz, 4-
H), 6.80–6.84 (2H, m, 2’-H and 6’-H), 7.40–7.44 (2H, m, 3’-H and 5’-H), 7.72 (1H, 
d, J 2.0 Hz, ArH), 7.78 (1H, d, J 2.0 Hz, ArH); δC (126 MHz, CDCl3) 107.2 (CH), 
116.3 (2 × CH), 122.0 (2 × CH), 128.1 (CH), 132.8 (C), 140.4 (CH), 156.1 (C); m/z 
(ESI) 159 ([M–H]–. 100%). 
Method B- 4’-(1H-Pyrazol-1-yl)phenol (253b) was synthesised as described for 1-
(4’-methoxyphenyl)-1H-indole (252a) (Method B) using phenol (47 mg, 0.50 mmol) 
and pyrazole (51 mg, 0.75 mmol). The iodination step was carried out at 40 °C for 
0.5 h and the N-arylation step at 150 °C for 20 h. Purification by flash column 
chromatography (dichloromethane/methanol 49:1) gave 4’-(1H-pyrazol-1-yl)phenol 
(253b) (57 mg, 71%) as a light brown oil. Spectroscopic data as described above. 
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2’-Fluoro-4’-(1H-pyrazol-1-yl)phenol (253c) 
 
2’-Fluoro-4’-(1H-pyrazol-1-yl)phenol (253c) was synthesised as described for 1-
(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2-fluorophenol (89.0 µL, 
1.00 mmol) and pyrazole (102 mg, 1.50 mmol). The bromination step was carried 
out at 40 °C for 3 h and the N-arylation step at 130 °C for 20 h. Purification by 
flash column chromatography (petroleum ether/ethyl acetate, 9:1) gave 2’-fluoro-
4’-(1H-pyrazol-1-yl)phenol (253c) (104 mg, 64%) as a yellow oil. νmax/cm−1 (neat) 
3123 (OH), 2970 (CH), 1526, 1516, 1401, 1288, 1248, 1186, 1039, 753; δH (500 
MHz, CDCl3) 6.45 (1H, t, J 2.0 Hz, 4-H), 6.49 (1H, s, OH), 7.02 (1H, t, J 8.9 Hz, 6’-
H), 7.28 (1H, ddd, J 8.9, 2.5, 1.4 Hz, 5’-H), 7.44 (1H, dd, J 11.4, 2.5 Hz, 3’-H), 7.71 
(1H, d, J 2.0 Hz, ArH), 7.80 (1H, d, J 2.0 Hz, ArH); δC (126 MHz, CDCl3) 107.6 
(CH), 108.9 (CH, d, 2JCF 22.6 Hz), 116.2 (CH, d, 3JCF 3.3 Hz), 118.1 (CH, d, 4JCF 
3.1 Hz), 127.7 (CH), 133.0 (C, d, 3JCF 8.6 Hz), 140.9 (CH), 143.2 (C, d, 2JCF 13.7 
Hz), 151.3 (C, d, 1JCF 241.2 Hz); m/z (ESI) 177.0465 ([M–H]–. C9H6FN2O requires 
177.0470). 
4’-(1H-Pyrazol-1-yl)-2’-(trifluoromethyl)aniline (253d) 
 
Method A- 4’-(1H-Pyrazol-1-yl)-2’-(trifluoromethyl)aniline (253d) was synthesised 
as described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2-
trifluoromethylaniline (126 µL, 1.00 mmol) and pyrazole (102 mg, 1.50 mmol). The 
bromination step was carried out at 40 °C for 7 h and the N-arylation step at 150 
°C for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 9:1) gave 4’-(1H-pyrazol-1-yl)-2’-(trifluoromethyl)aniline (253d) (148 mg, 
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65%) as a brown oil. νmax/cm−1 (neat) 3365 (NH), 2935 (CH), 1641, 1521, 1506, 
1299, 1142, 1106, 1037, 749; δH (500 MHz, CDCl3) 4.24 (2H, s, NH2), 6.44 (1H, t, 
J 2.0 Hz, 4-H), 6.81 (1H, d, J 8.7 Hz, 6’-H), 7.61 (1H, dd, J 8.7, 2.4 Hz, 5’-H), 7.69 
(1H, d, J 2.0 Hz, ArH), 7.74 (1H, d, J 2.4 Hz, 3’-H), 7.80 (1H, d, J 2.0 Hz, ArH); δC 
(126 MHz, CDCl3) 107.4 (CH), 113.9 (C, q, 2JCF 30.7 Hz), 118.0 (CH), 118.2 (CH, 
q, 3JCF 5.5 Hz), 124.4 (C, q, 1JCF 272.5 Hz), 124.5 (CH), 126.8 (CH), 131.4 (C), 
140.7 (CH), 143.2 (C); m/z (ESI) 250.0556 (MNa+. C10H8F3N3Na requires 
250.0563). 
Method B- 4’-(1H-Pyrazol-1-yl)-2’-(trifluoromethyl)aniline (253d) was synthesised 
as described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method B) using 2-
trifluoromethylaniline (63 µL, 0.50 mmol) and pyrazole (51 mg, 0.75 mmol). The 
iodination step was carried out at 40 °C for 6 h and the N-arylation step at 150 °C 
for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 9:1) gave 4’-(1H-pyrazol-1-yl)-2’-(trifluoromethyl)aniline (253d) (90 mg, 
79%) as a brown oil. Spectroscopic data as described above. 
N-[4’-(1H-Pyrazol-1-yl)phenyl]acetamide (243e) 
 
N-[4’-(1H-Pyrazol-1-yl)phenyl]acetamide (253e) was synthesised as described for 
1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using acetanilide (136 mg, 1.00 
mmol) and pyrazole (102 mg, 1.50 mmol). The bromination step was carried out at 
40 °C for 6 h and the N-arylation step at 150 °C for 20 h. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 7:3) gave N-[4’-(1H-
pyrazol-1-yl)phenyl]acetamide (253e) (152 mg, 76%) as a brown solid. Mp 134–
136 °C; νmax/cm−1 (neat) 3304 (NH), 3062 (CH), 1667 (CO), 1614, 1555, 1525, 
1398, 1330, 1054, 1036, 940, 826; δH (500 MHz, CDCl3) 2.16 (3H, s, CH3), 6.45 
(1H, t, J 2.1 Hz, 4-H), 7.55–7.61 (4H, m, 2’-H, 3’-H, 5’-H and 6’-H), 7.70 (1H, d, J 
2.1 Hz, ArH), 7.80 (1H, br s, NH), 7.86 (1H, d, J 2.1 Hz, ArH); δC (126 MHz, 
CDCl3) 24.4 (CH3), 107.6 (CH), 119.9 (2 × CH), 120.9 (2 × CH), 127.0 (CH), 136.4 
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(C), 136.6 (C), 141.0 (CH), 169.0 (C); m/z (ESI) 224.0791 (MNa+. C11H11N3NaO 
requires 224.0794). 
N-[2’-Chloro-4’-(1H-pyrazol-1’-yl)phenyl]acetamide (253f) 
 
N-[2’-Chloro-4’-(1H-pyrazol-1’-yl)phenyl]acetamide (253f) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using N-(2-
chlorophenyl)acetamide (170 mg, 1.00 mmol) and pyrazole (102 mg, 1.50 mmol). 
The bromination step was carried out at 40 °C for 8 h and the N-arylation step at 
150 °C for 20 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 9:1) gave N-[2’-chloro-4’-(1H-pyrazol-1’-yl)phenyl]acetamide 
(253f) (149 mg, 63%) as a brown solid. Mp 120–122 °C; νmax/cm−1 (neat) 3264 
(NH), 3011 (CH), 1671 (CO), 1522, 1396, 1302, 1053, 944, 757; δH (500 MHz, 
CDCl3) 2.26 (3H, s, CH3), 6.47 (1H, t, J 2.1 Hz, 4-H), 7.53 (1H, dd, J 9.0, 2.5 Hz, 
5’-H), 7.62 (1H, br s, NH), 7.71 (1H, d, J 2.1 Hz, ArH), 7.83 (1H, d, J 2.5 Hz, 3’-H), 
7.87 (1H, d, J 2.1 Hz, ArH), 8.47 (1H, d, J 9.0 Hz, 6’-H); δC (126 MHz, CDCl3) 24.8 
(CH3), 108.0 (CH), 117.8 (CH), 119.9 (CH), 122.3 (CH), 123.6 (C), 126.7 (CH), 
132.9 (C), 136.4 (C), 141.4 (CH), 168.4 (C); m/z (ESI) 258.0401 (MNa+. 
C11H10N3NaO35Cl requires 258.0405). 
N-[2’-Acetyl-4’-(1H-pyrazol-1-yl)phenyl]acetamide (253g) 
 
N-[2’-Acetyl-4’-(1H-pyrazol-1-yl)phenyl]acetamide (253g) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using N-(2-
acetylphenyl)acetamide (178 mg, 1.00 mmol) and pyrazole (102 mg, 1.50 mmol). 
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The bromination step was carried out at 40 °C for 7 h and the N-arylation step at 
130 °C for 20 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 8:2) gave N-[2’-acetyl-4’-(1H-pyrazol-1-yl)phenyl]acetamide 
(253g) (129 mg, 53%) as a yellow solid. Mp 146–148 °C; νmax/cm−1 (neat) 3241 
(NH), 3001 (CH), 1693 (CO), 1655 (CO), 1594, 1527, 1509, 1361, 1224, 1041, 
946, 755; δH (500 MHz, CDCl3) 2.22 (3H, s, CH3), 2.71 (3H, s, CH3), 6.47 (1H, t, J 
2.1 Hz, 4-H), 7.68–7.73 (2H, m, ArH), 7.90 (1H, d, J 2.1 Hz, ArH), 8.29 (1H, d, J 
2.6 Hz, 3’-H), 8.82 (1H, d, J 9.1 Hz, 6’-H), 11.59 (1H, br s, NH); δC (126 MHz, 
CDCl3) 25.5 (CH3), 28.8 (CH3), 108.0 (CH), 121.6 (CH), 122.3 (C), 122.3 (CH), 
124.8 (CH), 126.7 (CH), 134.6 (C), 139.2 (C), 141.3 (CH), 169.5 (C), 202.4 (C); 
m/z (ESI) 266.0904 (MNa+. C13H13N3NaO2 requires 266.0900). 
1-(2’,3’-Dihydrobenzofuran-5’-yl)-1H-pyrazole (253h) 
 
1-(2’,3’-Dihydrobenzofuran-5’-yl)-1H-pyrazole (253h) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2,3-
dihydrobenzofuran (113 µL, 1.00 mmol) and pyrazole (102 mg, 1.50 mmol). The 
bromination step was carried out at 40 °C for 1.5 h and the N-arylation step at 150 
°C for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 19:1) gave 1-(2’,3’-dihydrobenzofuran-5’-yl)-1H-pyrazole (253h) (157 mg, 
84%) as a brown oil. νmax/cm−1 (neat) 2974 (CH), 1516, 1492, 1394, 1228, 1029, 
983, 942, 746; δH (400 MHz, CDCl3) 3.25 (2H, t, J 8.7 Hz, 3’-H2), 4.62 (2H, t, J 8.7 
Hz, 2’-H2), 6.41 (1H, t, J 2.1 Hz, 4-H), 6.81 (1H, d, J 8.5 Hz, 7’-H), 7.35 (1H, dd, J 
8.5, 2.4 Hz, 6’-H), 7.51–7.54 (1H, m, 4’-H), 7.67 (1H, d, J 2.1 Hz, ArH), 7.78 (1H, 
d, J 2.1 Hz, ArH); δC (101 MHz, CDCl3) 29.7 (CH2), 71.7 (CH2), 107.0 (CH), 109.3 
(CH), 117.2 (CH), 119.7 (CH), 126.9 (CH), 128.3 (C), 134.1 (C), 140.4 (CH), 158.8 
(C); m/z (ESI) 209.0682 (MNa+. C11H10N2NaO requires 209.0685). 
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N-(4’-Methoxy-3’-methylphenyl)benzamide (253i)234 
 
N-(4’-Methoxy-3’-methylphenyl)benzamide (253i) was synthesised as described 
for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2-methylanisole (124 
µL, 1.00 mmol) and benzamide (182 mg, 1.50 mmol). The bromination step was 
carried out at 40 °C for 4 h and the N-arylation step at 130 °C for 20 h. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 8:2) gave N-(4’-
methoxy-3’-methylphenyl)benzamide (253i) (156 mg, 65%) as a light purple solid. 
Mp 148–150 °C. Spectroscopic data was consistent with the literature.234 δH (500 
MHz, CDCl3) 2.22 (3H, s, CH3), 3.83 (3H, s, OCH3), 6.80 (1H, d, J 8.7 Hz, 5’-H), 
7.36 (1H, d, J 1.8 Hz, 2’-H), 7.42–7.49 (3H, m, 6’-H and 2 × ArH), 7.53 (1H, tt, J 
7.4, 1.2 Hz, ArH), 7.76 (1H, br s, NH), 7.83–7.88 (2H, m, 2 × ArH); δC (126 MHz, 
CDCl3) 16.3 (CH3), 55.6 (CH3), 110.2 (CH), 119.2 (CH), 123.5 (CH), 127.0 (2 × 
CH), 127.3 (C), 128.7 (2 × CH), 130.5 (C), 131.6 (CH), 135.1 (C), 154.9 (C), 165.6 
(C); m/z (ESI) 264 (MNa+. 100%). 
N-[4’-Amino-3’-(trifluoromethyl)phenyl]benzamide (253j) 
 
N-[4’-Amino-3’-(trifluoromethyl)phenyl]benzamide (253j) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2-
trifluoromethylaniline (126 µL, 1.00 mmol) and benzamide (133 mg, 1.10 mmol). 
The bromination step was carried out at 40 °C for 7 h and the N-arylation step at 
130 °C for 20 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 8:2) gave N-[4’-amino-3’-(trifluoromethyl)phenyl]benzamide 
(253j) (198 mg, 71%) as a light brown solid. Mp 118–120 °C; νmax/cm−1 (neat) 3282 
(NH), 2927 (CH), 1643 (CO), 1508, 1432, 1310, 1225, 1104, 1051, 694; δH (500 
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MHz, CDCl3) 4.13 (2H, s, NH2), 6.77 (1H, d, J 8.7 Hz, 5’-H), 7.46−7.51 (2H, m, 2 × 
ArH), 7.53−7.58 (1H, m, ArH), 7.59−7.67 (2H, m, 2’-H and 6’-H), 7.70 (1H, s, NH), 
7.83−7.87 (2H, m, 2 × ArH); δC (126 MHz, CDCl3) 113.8 (C, q, 2JCF 30.3 Hz), 117.7 
(CH), 119.5 (CH, q, 3JCF 5.1 Hz), 124.5 (C, q, 1JCF 272.2 Hz), 126.4 (CH), 127.0 (2 
× CH), 128.4 (C), 128.7 (2 × CH), 131.8 (CH), 134.6 (C), 141.6 (C), 166.0 (C); m/z 
(ESI) 303.0711 (MNa+. C14H11F3N2NaO requires 303.0716). 
N-(4’-Acetamidophenyl)benzamide (253k)235 
 
N-(4’-Acetamidophenyl)benzamide (253k) was synthesised as described for 1-(4’-
methoxyphenyl)-1H-indole (252a) (Method A) using 2-trifluoromethylaniline (136 
mg, 1.00 mmol) and benzamide (133 mg, 1.10 mmol). The bromination step was 
carried out at 40 °C for 6 h and the N-arylation step at 130 °C for 20 h. Purification 
by flash column chromatography (dichloromethane/methanol, 98:2) gave N-(4’-
acetamidophenyl)benzamide (253k) (176 mg, 77%) as a brown solid. Mp 146–148 
°C. Spectroscopic data was consistent with the literature.235 δH (500 MHz, DMSO-
d6) 2.03 (3H, s, CH3), 7.49−7.60 (5H, m, 5 × ArH), 7.66−7.71 (2H, m, 2 × ArH), 
7.92−7.96 (2H, m, 2 × ArH), 9.91 (1H, s, NH), 10.19 (1H, s, NH); δC (126 MHz, 
DMSO-d6) 24.4 (CH3), 119.7 (2 × CH), 121.3 (2 × CH), 128.0 (2 × CH), 128.8 (2 × 
CH), 131.9 (CH), 134.8 (C), 135.5 (C), 135.7 (C), 165.7 (C), 168.5 (C); m/z (EI) 
254 (M+. 100%), 212 (20), 105 (89), 77 (32). 
N-(2’,3’-Dihydrobenzofuran-5’-yl)benzamide (253l) 
 
N-(2’,3’-Dihydrobenzofuran-5’-yl)benzamide (253l) was synthesised as described 
for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2,3-
dihydrobenzofuran (113 µL, 1.00 mmol) and benzamide (182 mg, 1.50 mmol). The 
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bromination step was carried out at 40 °C for 1.5 h and the N-arylation step at 130 
°C for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 8:2) gave N-(2’,3’-dihydrobenzofuran-5’-yl)benzamide (253l) (162 mg, 
68%) as a brown solid. Mp 156–158 °C; νmax/cm−1 (neat) 3268 (NH), 2895 (CH), 
1641 (CO), 1529, 1491, 1220, 983, 692; δH (500 MHz, CDCl3) 3.21 (2H, t, J 8.7 
Hz, 3’-H2), 4.58 (2H, t, J 8.7 Hz, 2’-H2), 6.74 (1H, d, J 8.4 Hz, 7’-H), 7.14 (1H, dd, J 
8.4, 1.5 Hz, 6’-H), 7.42–7.56 (3H, m, 3 × ArH), 7.63 (1H, br s, 4’-H), 7.78–7.88 
(3H, m, NH and 2 × ArH); δC (126 MHz, CDCl3) 29.9 (CH2), 71.5 (CH2), 109.1 
(CH), 118.6 (CH), 120.8 (CH), 127.0 (2 × CH), 127.8 (C), 128.7 (2 × CH), 130.8 
(C), 131.7 (CH), 135.1 (C), 157.2 (C), 165.7 (C); m/z (ESI) 262.0836 (MNa+. 
C15H13NNaO2 requires 262.0838). 
1-(2’,3’-Dihydrobenzofuran-5’-yl)-1H-indole (253m) 
 
1-(2’,3’-Dihydrobenzofuran-5’-yl)-1H-indole (253m) was synthesised as described 
for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2,3-
dihydrobenzofuran (113 µL, 1.00 mmol) and indole (176 mg, 1.50 mmol). The 
bromination step was carried out at 40 °C for 1.5 h and the N-arylation step at 130 
°C for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 19:1) gave 1-(2’,3’-dihydrobenzofuran-5’-yl)-1H-indole (253m) (146 mg, 
62%) as a colourless oil. νmax/cm−1 (neat) 2979 (CH), 1512 (C=C), 1491, 1458, 
1213, 1094, 739; δH (500 MHz, CDCl3) 3.31 (2H, t, J 8.7 Hz, 3’-H2), 4.68 (2H, t, J 
8.7 Hz, 2’-H2), 6.67 (1H, dd, J 3.2, 0.6 Hz, 3-H), 6.92 (1H, d, J 8.4 Hz, 7’-H), 7.18 
(1H, td, J 7.8, 1.0 Hz, 6-H), 7.21–7.26 (2H, m, 5-H and 6’-H), 7.29 (1H, d, J 3.2 Hz, 
2-H), 7.30–7.33 (1H, m, 4’-H), 7.48 (1H, dd, J 8.2, 0.6 Hz, 4-H), 7.71 (1H, br d, J 
7.8 Hz, 7-H); δC (126 MHz, CDCl3) 29.9 (CH2), 71.8 (CH2), 102.7 (CH), 109.7 
(CH), 110.4 (CH), 120.0 (CH), 121.0 (CH), 122.0 (CH), 122.1 (CH), 124.9 (CH), 
128.4 (C), 128.5 (CH), 128.9 (C), 132.7 (C), 136.5 (C), 158.9 (C); m/z (ESI) 
258.0887 (MNa+. C16H13NNaO requires 258.0889). 
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4’-(1H-Indol-1-yl)-2’-(trifluoromethyl)aniline (253n) 
 
4’-(1H-Indol-1-yl)-2’-(trifluoromethyl)aniline (253n) was synthesised as described 
for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 2-
trifluoromethylaniline (126 µL, 1.00 mmol) and indole (176 mg, 1.50 mmol). The 
bromination step was carried out at 40 °C for 7 h and the N-arylation step at 130 
°C for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 19:1) gave 4’-(1H-indol-1-yl)-2’-(trifluoromethyl)aniline (253n) (146 mg, 
53%) as a colourless oil. νmax/cm−1 (neat) 3403 (NH), 2923 (CH), 1516, 1459, 
1293, 1214, 1105, 772, 741; δH (500 MHz, CDCl3) 4.21 (2H, s, NH2), 6.64 (1H, d, J 
3.2 Hz, 3-H), 6.77 (1H, d, J 8.6 Hz, 6’-H), 7.12−7.24 (3H, m, 2-H, 5-H and 6-H), 
7.34−7.39 (2H, m, 4-H and 5’-H), 7.52 (1H, d, J 2.4 Hz, 3’-H), 7.67 (1H, d, J 7.8 
Hz, 7-H); δC (126 MHz, CDCl3) 103.3 (CH), 110.2 (CH), 114.3 (C, q, 2JCF 30.6 Hz), 
118.1 (CH), 120.3 (CH), 121.2 (CH), 122.4 (CH), 123.3 (CH, q, 3JCF 5.1 Hz), 124.5 
(C, q, 1JCF 272.6 Hz), 128.1 (CH), 129.0 (C), 129.7 (CH), 130.1 (C), 136.4 (C), 
143.3 (C); m/z (ESI) 277.0948 (MH+. C15H12F3N2 requires 277.0947). 
1-(5'-Chloro-2'-methoxyphenyl)-1H-pyrazole (253o) 
 
1-(5'-Chloro-2'-methoxyphenyl)-1H-pyrazole (253o) was synthesised as described 
for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method A) using 4-chloroanisole (123 
µL, 1.00 mmol), iron(III) trichloride (0.0500 mmol), [BMIM]NTf2 (0.150 mmol) and 
pyrazole (102 mg, 1.50 mmol). The bromination step was carried out at 70 °C for 5 
h and the N-arylation step at 150 °C for 20 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 1-(5'-chloro-2'-
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methoxyphenyl)-1H-pyrazole (253o) (110 mg, 53%) as a colourless oil. νmax/cm−1 
(neat) 2943 (CH), 1521 (C=C), 1495, 1244, 1024, 750, 704; δH (500 MHz, CDCl3) 
3.88 (3H, s, OCH3), 6.43 (1H, dd, J 2.4, 2.0 Hz, 4-H), 6.96 (1H, d, J 8.8 Hz, 3’-H), 
7.23 (1H, dd, J 8.8, 2.6 Hz, 4’-H), 7.70 (1H, d, J 2.0 Hz, ArH), 7.81 (1H, d, J 2.6 
Hz, 6’-H), 8.09 (1H, d, J 2.4 Hz, ArH); δC (126 MHz, CDCl3) 56.2 (CH3), 106.7 
(CH), 113.4 (CH), 124.7 (CH), 126.1 (C), 127.2 (CH), 130.3 (C), 131.6 (CH), 140.4 
(CH), 149.5 (C); m/z (ESI) 231.0291 (MNa+. C10H935ClN2NaO requires 231.0296). 
N-(4’-Methoxyphenyl)-4-methylbenzenesulfonamide (252j)236 
 
N-(4’-Methoxyphenyl)-4-methylbenzenesulfonamide (252j) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method B) using anisole 
(54.0 µL, 0.500 mmol) and p-toluenesulfonamide (128 mg, 0.750 mmol). The 
iodination step was carried out at 40 °C for 3 h and the N-arylation step at 130 °C 
for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 8:2) gave N-(4’-methoxyphenyl)-4-methylbenzenesulfonamide (252j) (119 
mg, 86%) as a light yellow solid. Mp 112–114 °C (lit.236 113–114 °C); δH (400 MHz, 
CDCl3) 2.38 (3H, s, CH3), 3.75 (3H, s, OCH3), 6.62 (1H, s, NH), 6.72–6.79 (2H, m, 
3’-H and 5’-H), 7.72–7.79 (2H, m, 2’-H and 6’-H), 7.21 (2H, d, J 8.0 Hz, 3-H and 5-
H), 7.59 (2H, d, J 8.0 Hz, 2-H and 6-H); δC (101 MHz, CDCl3) 21.5 (CH3), 55.4 
(CH3), 114.4 (2 × CH), 125.1 (2 × CH), 127.4 (2 × CH), 129.1 (C), 129.6 (2 × CH), 
136.0 (C), 143.7 (C), 157.8 (C); m/z (EI) 277 (M+. 35%), 228 (11), 122 (100), 92 
(12), 65 (8). 
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4-Chloro-N-(4’-methoxyphenyl)benzenesulfonamide (252k)237 
 
4-Chloro-N-(4’-methoxyphenyl)benzenesulfonamide (252k) was synthesised as 
described for 1-(4’-methoxyphenyl)-1H-indole (252a) (Method B) using anisole 
(54.0 µL, 0.500 mmol) and 4-chlorobenzenesulfonamide (144 mg, 0.750 mmol). 
The iodination step was carried out at 40 °C for 3 h and the N-arylation step at 130 
°C for 20 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 19:1) gave 4-chloro-N-(4’-methoxyphenyl)benzenesulfonamide (252k) 
(124 mg, 83%) as a white solid. Mp 138–140 °C (lit.237 140–144 °C); δH (500 MHz, 
CDCl3) 3.76 (3H, s, OCH3), 6.72–6.81 (3H, m, 3’-H, 5’-H and NH), 6.94–7.02 (2H, 
m, 2’-H and 6’-H), 7.35–7.42 (2H, m, 3-H and 5-H), 7.60–7.66 (2H, m, 2-H and 6-
H); δC (126 MHz, CDCl3) 55.4 (CH3), 114.6 (2 × CH), 125.7 (2 × CH), 128.3 (C), 
128.8 (2 × CH), 129.3 (2 × CH), 137.4 (C), 139.4 (C), 158.2 (C); m/z (EI) 297 (M+. 
73%), 122 (100), 111 (23), 95 (34), 83 (27), 75 (17), 65 (7), 52 (13). 
4’-(1H-Pyrazol-1-yl)aniline (253q)238 
 
4’-(1H-Pyrazol-1-yl)aniline (253q) was synthesised as described for 1-(4’-
methoxyphenyl)-1H-indole (252a) (Method B) using aniline (46.0 µL, 0.500 mmol) 
and pyrazole (51.0 mg, 0.750 mmol). The iodination step was carried out at 20 °C 
for 3 h and the N-arylation step at 130 °C for 20 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 1:1) gave 4’-(1H-pyrazol-1-
yl)aniline (253q) (73.0 mg, 92%) as a brown oil. Spectroscopic data was 
consistent with the literature.238 δH (500 MHz, CDCl3) 3.74 (1H, br s, NH2), 6.41 
(1H, t, J 2.0 Hz, 4-H), 6.70–6.75 (2H, m, 2’-H and 6’-H), 7.42–7.46 (2H, m, 3’-H 
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and 5’-H), 7.67 (1H, d, J 2.0 Hz, ArH), 7.78 (1H, d, J 2.0 Hz, ArH); δC (126 MHz, 
CDCl3) 106.8 (CH), 115.5 (2 × CH), 121.1 (2 × CH), 126.7 (CH), 132.5 (C), 140.2 
(CH), 145.2 (C); m/z (EI) 159 (M+. 100%). 
4’-Nitro-2’-(1H-pyrazol-1-yl)aniline (253p) 
 
4’-Nitro-2’-(1H-pyrazol-1-yl)aniline (253p) was synthesised as described for 1-(4’-
methoxyphenyl)-1H-indole (252a) (Method B) using 4-nitroaniline (69 mg, 0.50 
mmol) and pyrazole (51 mg, 0.75 mmol). The iodination step was carried out at 40 
°C for 4 h and the N-arylation step at 130 °C for 22 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 4’-nitro-2’-(1H-pyrazol-
1-yl)aniline (253p) (78 mg, 76%) as a yellow solid. Mp 136–138 °C; νmax/cm−1 
(neat) 3319 (NH), 3080 (CH), 1633, 1614, 1527 (C=C), 1494, 1333, 1316, 707; δH 
(500 MHz, CDCl3) 5.83 (2H, s, NH2), 6.52 (1H, t, J 2.0 Hz, 4-H), 6.80 (1H, d, J 9.0 
Hz, 3’-H), 7.78 (1H, d, J 2.0 Hz, ArH), 7.87 (1H, d, J 2.0 Hz, ArH), 8.05 (1H, dd, J 
9.0, 2.5 Hz, 4’-H), 8.18 (1H, d, J 2.5 Hz, 6’-H); δC (126 MHz, CDCl3) 107.3 (CH), 
115.8 (CH), 119.4 (CH), 124.2 (C), 124.4 (CH), 129.8 (CH), 138.1 (C), 141.2 (CH), 
146.7 (C); m/z (EI) 204.0654 (M+, C9H8N4O2 requires 204.0647), 174 (20%), 159 
(19), 149 (20), 131 (15), 83 (100), 77 (23), 69 (28). 57 (46). 
4-Chloroanisole (261a)239 
 
Iron(III) chloride (4.00 mg, 0.0250 mmol) was dissolved in [BMIM]NTf2 (22.0 µL, 
0.0750 mmol), stirred for 0.5 h at room temperature and then added to a solution 
of N-chlorosuccinimide (140 mg, 1.05 mmol) in tetrahydrofuran (0.60 mL). Anisole 
(108 µL, 1.00 mmol) was then added and the reaction mixture was stirred at 60 °C 
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for 18 h, under an atmosphere of air. The reaction mixture was cooled to room 
temperature, diluted with ethyl acetate (10 mL) and washed with a 1 M sodium 
thiosulfate solution (10 mL) and brine (10 mL). The organic phase was dried 
(MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 4-chloroanisole (261a) 
(131 mg, 92%) as a colourless oil. Spectroscopic data was consistent with the 
literature.239 δH (500 MHz, CDCl3) 3.77 (3H, s, OCH3), 6.80–6.85 (2H, m, 2-H and 
6-H), 7.21–7.26 (2H, m, 3-H and 5-H); δC (126 MHz, CDCl3) 55.5 (CH3), 115.2 (2 × 
CH), 125.5 (C), 129.3 (2 × CH), 158.2 (C); m/z (EI) 142 (M+. 100%), 127 (46), 99 
(39), 84 (16). 
4-Chloro-2-methylanisole (261b)240 
 
4-Chloro-2-methylanisole (261b) was synthesised as described for 4-chloroanisole 
(261a) using 2-methylanisole (124 µL, 1.00 mmol) and performing the reaction at 
60 °C for 24 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 8:2) gave 4-chloro-2-methylanisole (261b) (133 mg, 85%) as a yellow oil. 
Spectroscopic data was consistent with the literature.240 δH (400 MHz, CDCl3) 2.21 
(3H, s, CH3), 3.81 (3H, s, OCH3), 6.73 (1H, d, J 9.2 Hz, 6-H), 7.09–7.15 (2H, m, 3-
H and 5-H); δC (101 MHz, CDCl3) 16.2 (CH3), 55.6 (CH3), 111.1 (CH), 125.1 (C), 
126.4 (CH), 128.6 (C), 130.5 (CH), 156.5 (C); m/z (EI) 156 (M+. 100%), 141 (63), 
83 (35), 77 (45), 57 (38). 
5-Chloro-2,4-dimethoxybenzaldehyde (261c)241 
 
5-Chloro-2,4-dimethoxybenzaldehyde (261c) was synthesised as described for 4-
chloroanisole (261a) using 2,4-dimethoxybenzaldehyde (166 mg, 1.00 mmol) and 
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performing the reaction at 60 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 10:1) gave 5-chloro-2,4-
dimethoxybenzaldehyde (261c) (154 mg, 77%) as a white solid. Mp 130–132 °C. 
Spectroscopic data was consistent with the literature.241 δH (500 MHz, CDCl3) 3.93 
(3H, s, OCH3), 3.97 (3H, s, OCH3), 6.46 (1H, s, 3-H), 7.81 (1H, s, 6-H), 10.23 (1H, 
s, CHO); δC (126 MHz, CDCl3) 56.0 (CH3), 56.4 (CH3), 95.7 (CH), 115.3 (C), 118.7 
(C), 129.7 (CH), 160.8 (C), 162.4 (C), 187.2 (CH); m/z (ESI) 223 (MNa+. 100%). 
5-Chloro-2,4-dimethoxybenzoic acid (261d) 
 
Iron(III) chloride (4.00 mg, 0.0250 mmol) was dissolved in [BMIM]NTf2 (22.0 µL, 
0.0750 mmol), stirred for 0.5 h at room temperature and then added to a solution 
of N-chlorosuccinimide (140 mg, 1.05 mmol) in tetrahydrofuran (0.60 mL). 2,4-
Dimethoxybenzoic acid (182 mg, 1.00 mmol) was then added and the reaction 
mixture was stirred at 60 °C for 24 h, under an atmosphere of air. The reaction 
mixture was diluted with dichloromethane (20 mL) and extracted with an aqueous 
solution of 1 M sodium hydroxide (10 mL). The aqueous phase was separated and 
then acidified with 1 M hydrochloric acid (10 mL), and extracted into 
dichloromethane (2 × 50 mL). The organic phase was dried (MgSO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography 
(dichloromethane/methanol, 19:1) gave 5-chloro-2,4-dimethoxybenzoic acid 
(261d) (181 mg, 84%) as a white solid. Mp 166–168 °C. νmax/cm−1 (neat) 2970 
(CH), 2569 (OH), 1694 (CO), 1599 (C=C), 1243, 1213, 1021, 904, 820, 727; δH 
(500 MHz, CDCl3) 3.98 (3H, s, OCH3), 4.08 (3H, s, OCH3), 6.53 (1H, s, 3-H), 8.13 
(1H, s, 6-H); δC (126 MHz, CDCl3) 56.6 (CH3), 57.1 (CH3), 96.0 (CH), 110.6 (C), 
116.1 (C), 134.5 (CH), 158.4 (C), 160.0 (C), 164.6 (C); m/z (EI) 218.0167 (M+. 
C9H937ClO4 requires 218.0163), 216 (100%), 199 (47), 169 (42), 142 (22), 78 (27), 
63 (32). 
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5-Chloro-2,4-dimethoxy-6-hydroxybenzaldehyde (261e)  
 
5-Chloro-2,4-dimethoxy-6-hydroxybenzaldehyde (261e) was synthesised as 
described for 5-chloro-2,4-dimethoxybenzoic acid (261d) using 2,4-dimethoxy-6-
hydroxybenzaldehyde (182 mg, 1.00 mmol) and performing the reaction at 60 °C 
for 18 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 7:3) gave 5-chloro-2,4-dimethoxy-6-hydroxybenzaldehyde (261e) (182 
mg, 84%) as a light yellow solid. Mp 184–186 °C; νmax/cm−1 (neat) 2953 (CH), 
1631 (CO), 1595 (C=C), 1470, 1453, 1417, 1410, 1292, 1227, 1186, 1119, 1100, 
790, 731; δH (500 MHz, CDCl3) 3.91 (3H, s, OCH3), 3.97 (3H, s, OCH3), 5.99 (1H, 
s, 3-H), 10.09 (1H, s, CHO), 12.80 (1H, s, OH); δC (126 MHz, CDCl3) 56.0 (CH3), 
56.5 (CH3), 86.7 (CH), 101.4 (C), 106.1 (C), 160.3 (C), 162.5 (C), 162.8 (C), 192.0 
(CH); m/z (ESI) 239.0083 (MNa+. C9H935ClNaO4 requires 239.0082). 
4-Chloroaniline (261f)242 
 
4-Chloroaniline (261f) was synthesised as described for 4-chloroanisole (261a) 
using aniline (91 µL, 1.0 mmol) and performing the reaction at 40 °C for 24 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 19:1) 
gave 4-chloroaniline (261f) (67 mg, 53%) as a yellow solid. Mp 58–60 °C (lit.242 
63–65 °C); δH (400 MHz, CDCl3) 3.64 (2H, br s, NH2), 6.56–6.65 (2H, m, 2H and 
6-H), 7.07–7.14 (2H, m, 3-H and 5-H); δC (101 MHz, CDCl3) 116.3 (2 × CH), 123.3 
(C), 129.2 (2 × CH), 145.1 (C); m/z (EI) 127 (M+. 100%), 92 (16), 84 (19), 64 (19). 
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4-Chloro-2-fluoroaniline (261g)243 
 
4-Chloro-2-fluoroaniline (261g) was synthesised as described for 4-chloroanisole 
(261a) using 2-fluoroaniline (111 mg, 1.00 mmol) and performing the reaction at 
60 °C for 18 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 19:1) gave 4-chloro-2-fluoroaniline (261g) (109 mg, 75%) as a brown oil. 
Spectroscopic data was consistent with the literature.243 δH (500 MHz, CDCl3) 3.70 
(2H, br s, NH2), 6.69 (1H, dd, J 9.4, 8.5 Hz, 6-H), 6.92 (1H, ddd, J 8.5, 2.3, 1.2 Hz, 
5-H), 7.00 (1H, dd, J 10.8, 2.3 Hz, 3-H); δC (126 MHz, CDCl3) 115.9 (CH, d, 2JCF 
22.0 Hz), 117.3 (CH, d, 3JCF 4.4 Hz), 122.5 (C, d, 3JCF 9.2 Hz), 124.5 (CH, d, 4JCF 
3.6 Hz), 133.3 (C, d, 2JCF 13.0 Hz), 151.2 (C, d, 1JCF 242.3 Hz); m/z (EI) 145 (M+. 
32%), 84 (100). 
4-Chloro-2-trifluoromethylaniline (261h)244 
 
4-Chloro-2-trifluoromethylaniline (261h) was synthesised as described for 4-
chloroanisole (261a) using 2-trifluoromethylaniline (126 µL, 1.00 mmol), iron(III) 
chloride (8.00 mg, 0.0500 mmol) and [BMIM]NTf2 (44.0 µL, 0.150 mmol) in 
tetrahydrofuran (0.60 mL). The reaction was performed at 70 °C for 24 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 7:3) 
gave 4-chloro-2-trifluoromethylaniline (261h) (139 mg, 71%) as a pale yellow oil. 
Spectroscopic data was consistent with the literature.244 δH (500 MHz, CDCl3) 4.17 
(2H, br s, NH2), 6.67 (1H, d, J 8.7 Hz, 6-H), 7.24 (1H, dd, J 8.7, 2.4 Hz, 5-H), 7.40 
(1H, d, J 2.4 Hz, 3-H); δC (126 MHz, CDCl3) 114.8 (C, q, 2JCF 30.8 Hz), 118.4 
(CH), 122.4 (C), 124.1 (C, q, 1JCF 272.4 Hz), 126.3 (CH, q, 3JCF 5.5 Hz), 132.8 
(CH), 143.1 (C); m/z (EI) 195 (M+. 59%), 175 (45), 148 (36), 107 (19), 84 (100), 77 
(46). 
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4-Amino-3-chlorobenzonitrile (261i)245 
 
4-Amino-3-chlorobenzonitrile (261i) was synthesised as described for 4-
chloroanisole (261a) using 4-aminobenzonitrile (118 mg, 1.00 mmol), iron(III) 
chloride (8.00 mg, 0.0500 mmol) and [BMIM]NTf2 (44.0 µL, 0.150 mmol) in 
tetrahydrofuran (0.60 mL). The reaction was performed at 70 °C for 24 h. 
Purification by flash column chromatography (petroleum ether/ethyl acetate, 9:1) 
gave 4-amino-3-chlorobenzonitrile (261i) (142 mg, 93%) as a white solid. Mp 102–
104 °C (lit.245 106–108 °C); δH (400 MHz, CDCl3) 4.65 (2H, br s, NH2), 6.75 (1H, d, 
J 8.4 Hz, 5-H), 7.31 (1H, dd, J 8.4, 1.8 Hz, 6-H), 7.50 (1H, d, J 1.8 Hz, 2-H); δC 
(101 MHz, CDCl3) 100.7 (C), 115.1 (CH), 118.5 (C), 119.0 (C), 132.0 (CH), 133.3 
(CH), 147.2 (C); m/z (EI) 152 (M+. 100%), 125 (45), 117 (46), 90 (47), 76 (40), 63 
(45). 
2-Chloro-4-nitroaniline (261j)246 
 
2-Chloro-4-nitroaniline (261j) was synthesised as described for 4-chloroanisole 
(261a) using 4-nitroaniline (138 mg, 1.00 mmol) and performing the reaction at 60 
°C for 24 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 9:1) gave 2-chloro-4-nitroaniline (261j) (153 mg, 89%) as a yellow solid. 
Mp 98–100 °C (lit.246 99–101 °C); δH (500 MHz, CDCl3) 4.85 (2H, br s, NH2), 6.75 
(1H, d, J 8.9 Hz, 6-H), 7.98 (1H, dd, J 8.9, 2.5 Hz, 5-H), 8.19 (1H, d, J 2.5 Hz, 3-
H); δC (126 MHz, CDCl3) 113.7 (CH), 117.7 (C), 124.4 (CH), 126.0 (CH), 138.8 
(C), 148.9 (C); m/z (EI) 172 (M+. 100%), 142 (60), 126 (28), 99 (21), 90 (70), 63 
(29). 
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4-Chloroacetanilide (261k)247 
 
4-Chloroacetanilide (261k) was synthesised as described for 4-chloroanisole 
(261a) using acetanilide (135 mg, 1.00 mmol) and performing the reaction at 60 °C 
for 24 h. The reaction was performed as described in general procedure A using 
acetanilide (135 mg, 1.00 mmol). The reaction mixture was heated to 60 °C for 24 
h. Purification by flash column chromatography (petroleum ether/ethyl acetate, 
8:2) gave 4-chloroacetanilide (261k) (132 g, 78%) as a white solid. Mp 174–176 
°C (lit.247 175–178 °C); δH (500 MHz, CDCl3) 2.17 (3H, s, CH3), 7.21–7.30 (3H, m, 
3-H, 5-H and NH), 7.42–7.48 (2H, m, 2-H and 6-H); δC (126 MHz, CDCl3) 24.6 
(CH3), 121.0 (2 × CH), 129.0 (2 × CH), 129.3 (C), 136.4 (C), 168.2 (C); m/z (ESI) 
192 (MNa+. 100%). 
4-Chlorophenol (261l)248 
 
4-Chlorophenol (261l) was synthesised as described for 5-chloro-2,4-
dimethoxybenzoic acid (261d) using phenol (94 mg, 1.0 mmol) and performing the 
reaction at 60 °C for 18 h. Purification by flash column chromatography (petroleum 
ether/ethyl acetate, 19:1) gave 4-chlorophenol (261l) (96 mg, 75%) as a colourless 
oil. Spectroscopic data was consistent with the literature.248 δH (500 MHz, CDCl3) 
4.77 (1H, br s, OH), 6.74–6.79 (2H, m, 2-H and 6-H), 7.17–7.22 (2H, m, 3-H and 
5-H); δC (126 MHz, CDCl3) 116.7 (2 × CH), 125.7 (C), 129.5 (2 × CH), 154.0 (C); 
m/z (EI) 128 (M+. 100%), 102 (34), 84 (90), 66 (98), 57 (27). 
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2,4-Dichlorophenol (256)249 
 
2,4-Dichlorophenol (256) was synthesised as described for 5-chloro-2,4-
dimethoxybenzoic acid (261d) using phenol (94.0 mg, 1.00 mmol) and NCS (280 
mg, 2.10 mmol) in tetrahydrofuran (1.20 mL). The reaction was performed at 60 °C 
for 48 h. Purification by flash column chromatography (petroleum ether/diethyl 
ether 19:1) gave 2,4-dichlorophenol (256) (131 mg, 81%) as a light orange solid. 
Mp 40–42 °C (lit.249 43–44 °C); δH (400 MHz, CDCl3) 5.49 (1H, s, OH), 6.95 (1H, d, 
J 8.7 Hz, 6-H), 7.15 (1H, dd, J 8.7, 2.5 Hz, 5-H), 7.33 (1H, d, J 2.5 Hz, 3-H); δC 
(101 MHz, CDCl3) 117.3 (CH), 120.6 (C), 125.8 (C), 128.7 (2 × CH), 150.4 (C); 
m/z (EI) 162 (M+. 100%), 153 (21), 136 (18), 107 (46), 89 (38). 
4-Chloro-2-methylphenol (261m)250 
 
4-Chloro-2-methylphenol (261m) was synthesised as described for 5-chloro-2,4-
dimethoxybenzoic acid (261d) using 2-methylphenol (108 mg, 1.00 mmol) and 
performing the reaction at 60 °C for 12 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 4-chloro-2-
methylphenol (261m) (115 mg, 81%) as a yellow solid. Mp 46–48 °C (lit.250 46–47 
°C); δH (500 MHz, CDCl3) 2.22 (3H, s, CH3), 5.02 (1H, br s, OH), 6.69 (1H, d, J 8.5 
Hz, 6-H), 7.03 (1H, dd, J 8.5, 2.7 Hz, 5-H), 7.10 (1H, d, J 2.7 Hz, 3-H); δC (126 
MHz, CDCl3) 15.7 (CH3), 116.1 (CH), 125.3 (C), 125.8 (C), 126.8 (CH), 130.7 
(CH), 152.3 (C); m/z (CI) 143 (MH+. 48%), 113 (45), 97 (40), 85 (68), 71 (100), 69 
(54). 
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4-Chloro-3,5-dimethylphenol (258)251 
 
4-Chloro-3,5-dimethylphenol (258) was synthesised as described for 5-chloro-2,4-
dimethoxybenzoic acid (261d) using 3,5-dimethylphenol (122 mg, 1.00 mmol) and 
performing the reaction at 60 °C for 12 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 4-chloro-3,5-
dimethylphenol (258) (119 mg, 76%) as a white solid. Mp 112–114 °C (lit.251 114–
116 °C); δH (500 MHz, CDCl3) 2.32 (6H, s, 2 × CH3), 4.72 (1H, s, OH), 6.58 (2H, s, 
2H and 6-H); δC (126 MHz, CDCl3) 20.8 (2 × CH3), 115.3 (2 × CH), 126.3 (C), 
137.4 (2 × C), 153.2 (C); m/z (CI) 157 (MH+. 26%), 113 (66), 97 (43), 85 (69), 71 
(100), 69 (53). 
1-Chloro-2-naphthol (261n)252 
 
1-Chloro-2-naphthol (261n) was synthesised as described for 5-chloro-2,4-
dimethoxybenzoic acid (261d) using 2-naphthol (144 mg, 1.00 mmol) and 
performing the reaction at 60 °C for 18 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 1-chloro-2-naphthol 
(261n) (174 mg, 97%) as an off-white solid. Mp 64–66 °C (lit.252 66 °C); δH (500 
MHz, CDCl3) 5.87 (1H, s, OH), 7.26 (1H, d, J 8.9 Hz, 3-H), 7.40 (1H, ddd, J 8.1, 
6.8, 1.1 Hz, 6-H), 7.57 (1H, ddd, J 8.5, 6.8, 1.2 Hz, 7-H), 7.71 (1H, d, J 8.9 Hz, 4-
H), 7.79 (1H, br d, J 8.1 Hz, 5-H), 8.06 (1H, br d, J 8.5 Hz, 8-H); δC (126 MHz, 
CDCl3) 113.4 (C), 117.3 (CH), 122.8 (CH), 124.2 (CH), 127.6 (CH), 128.2 (CH), 
128.5 (CH), 129.5 (C), 131.1 (C), 149.4 (C); m/z (ESI) 177 ([M-H]−. 100%). 
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1-Chloro-4-methoxynaphthalene (261o)253 
 
1-Chloro-4-methoxynaphthalene (261o) was synthesised as described for 4-
chloroanisole (261a) using 1-methoxynaphthalene (144 µL, 1.00 mmol) and 
performing the reaction at 60 °C for 18 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-chloro-4-
methoxynaphthalene (261o) (175 mg, 91%) as a colourless oil. Spectroscopic 
data was consistent with the literature.253 δH (400 MHz, CDCl3) 4.00 (3H, s, OCH3), 
6.73 (1H, d, J 8.3 Hz, 3-H), 7.46 (1H, d, J 8.3 Hz, 2-H), 7.54 (1H, ddd, J 8.3, 6.9, 
1.3 Hz, 7-H), 7.62 (1H, ddd, J 8.4, 6.9, 1.4 Hz, 6-H), 8.20 (1H, br d, J 8.4 Hz, 5-H), 
8.29 (1H, br d, J 8.3 Hz, 8-H); δC (101 MHz, CDCl3) 55.7 (CH3), 103.8 (CH), 122.4 
(CH), 123.2 (C), 124.2 (CH), 125.7 (CH), 125.9 (CH), 126.6 (C), 127.5 (CH), 131.3 
(C), 154.6 (C); m/z (EI) 192 (M+. 100%), 177 (52), 149 (66), 114 (14), 84 (46). 
1-Chloro-2-methoxynaphthalene (261p)254 
 
1-Chloro-2-methoxynaphthalene (261p) was synthesised as described for 4-
chloroanisole (261a) using 2-methoxynaphthalene (158 mg, 1.00 mmol), iron(III) 
chloride (8.00 mg, 0.0500 mmol) and [BMIM]NTf2 (44.0 µL, 0.150 mmol). The 
reaction was performed at 70 °C for 18 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 1-chloro-2-
methoxynaphthalene (261p) (173 mg, 90%) as a white solid. Mp 64–66 °C (lit.254 
68–69 °C); δH (400 MHz, CDCl3) 4.03 (3H, s, OCH3), 7.29 (1H, d, J 9.0 Hz, 3-H), 
7.41 (1H, ddd, J 8.2, 6.8, 1.2 Hz, 6-H), 7.58 (1H, ddd, J 8.4, 6.8, 1.2 Hz, 7-H), 7.77 
(1H, d, J 9.0 Hz, 4-H), 7.80 (1H, br d, J 8.2 Hz, 5-H), 8.21–8.26 (1H, m, 8-H); δC 
(101 MHz, CDCl3) 57.1 (CH3), 113.8 (CH), 117.0 (C), 123.6 (CH), 124.4 (CH), 
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127.6 (CH), 128.1 (2 × CH), 129.6 (C), 132.0 (C), 152.7 (C); m/z (EI) 192 (M+. 
27%), 149 (25), 97 (18), 84 (91), 66 (100), 57 (43). 
5-Chloro-2,3-dihydrobenzofuran (261q)255 
 
5-Chloro-2,3-dihydrobenzofuran (261q) was synthesised as described for 4-
chloroanisole (261a) using 2,3-dihydrobenzofuran (113 µL, 1.00 mmol) and 
performing the reaction at 60 °C for 18 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 9:1) gave 5-chloro-2,3-
dihydrobenzofuran (261q) (133 mg, 86%) as a colourless oil. Spectroscopic data 
was consistent with the literature.255 δH (500 MHz, CDCl3) 3.20 (2H, t, J 8.7 Hz, 3-
H2), 4.58 (2H, t, J 8.7 Hz, 2-H2), 6.69 (1H, d, J 8.4 Hz, 7-H), 7.05 (1H, dd, J 8.4, 
2.2 Hz, 6-H), 7.13–7.16 (1H, m, 4-H); δC (126 MHz, CDCl3) 29.7 (CH2), 71.6 (CH2), 
110.2 (CH), 124.9 (C), 125.0 (CH), 127.8 (CH), 128.9 (C), 158.7 (C); m/z (EI) 154 
(M+. 80%), 91 (41), 84 (100). 
5-Chloro-2-methoxybenzaldehyde (261r)256 
 
N-Chlorosuccinimide (62.0 mg, 0.460 mmol) was added to a solution of iron(III) 
chloride (3.70 mg, 0.0220 mmol) in [BMIM]NTf2 (0.13 mL) under an atmosphere of 
air. The mixture was stirred at room temperature for 0.5 h before 2-
methoxybenzaldehyde (60.0 mg, 0.440 mmol) in [BMIM]NTf2 (0.05 mL) was 
added. The reaction mixture was heated to 70 °C for 18 h. The reaction progress 
was monitored by 1H NMR spectroscopy. The reaction mixture was extracted into 
5% ethyl acetate in hexane (3 × 30 mL) using sonication in a water bath for 0.1 h. 
The suspension was washed with an aqueous solution of 1 M sodium thiosulfate 
(7 mL), brine (7 mL), dried (MgSO4) and then filtered through a pad of Celite®. The 
solvent was removed under reduced pressure. Purification by flash column 
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chromatography (petroleum ether/ethyl acetate, 9:1) gave 5-chloro-2-
methoxybenzaldehyde (261r) (51.0 mg, 68%) as a white solid. Mp 78–79 °C (lit.256 
80–81 °C); δH (400 MHz, CDCl3) 3.93 (3H, s, OCH3), 6.95 (1H, d, J 8.9 Hz, 3-H), 
7.50 (1H, dd, J 8.9, 2.8 Hz, 4-H), 7.79 (1H, d, J 2.8 Hz, 6-H), 10.41 (1H, s, CHO); 
δC (126 MHz, CDCl3) 56.0 (CH3), 113.3 (CH), 125.7 (C), 126.4 (C), 128.0 (CH), 
135.4 (CH), 160.3 (C), 188.5 (CH); m/z (EI) 170 (M+. 17%), 153 (6), 84 (100), 49 
(79), 44 (32). 
3-Chloro-4-ethoxybenzaldehyde (261s)257  
 
3-Chloro-4-ethoxybenzaldehyde (261s) was synthesised as described for 5-
chloro-2-methoxybenzaldehyde (261r) using 4-ethoxybenzaldehyde (70 µL, 0.50 
mmol) and performing the reaction at 70 °C for 24 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 17:3) gave 3-chloro-4-
ethoxybenzaldehyde (261s) (65 mg, 70%) as a white solid. Mp 64–66 °C. 
Spectroscopic data was consistent with the literature.257 δH (400 MHz, CDCl3) 1.51 
(3H, t, J 7.0 Hz, OCH2CH3), 4.19 (2H, q, J 7.0 Hz, OCH2CH3), 7.01 (1H, d, J 8.5 
Hz, 5-H), 7.74 (1H, dd, J 8.5, 2.0 Hz, 6-H), 7.89 (1H, d, J 2.0 Hz, 2-H), 9.83 (1H, s, 
CHO); δC (101 MHz, CDCl3) 14.6 (CH3), 65.3 (CH2), 112.6 (CH), 124.0 (C), 130.2 
(C), 130.6 (CH), 131.4 (CH), 159.5 (C), 189.8 (CH); m/z (EI) 184 (M+. 15%), 157 
(8), 153 (36), 136 (27), 124 (4), 107 (27), 84 (100), 77 (75), 63 (11), 51 (33). 
3-Chloro-4-methoxybenzaldehyde (261t)258 
 
3-Chloro-4-methoxybenzaldehyde (261t) was synthesised as described for 5-
chloro-2-methoxybenzaldehyde (261r) using 4-methoxybenzaldehyde (122 µL, 
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1.00 mmol) and NCS (160 mg, 1.20 mmol). The reaction was performed at 70 °C 
for 18 h. Purification by flash column chromatography (petroleum ether/ethyl 
acetate 19:1) gave 3-chloro-4-methoxybenzaldehyde (261t) (141 mg, 83%) as a 
pale yellow solid. Mp 52–54 °C (lit.258 53–55 °C); δH (400 MHz, CDCl3) 3.99 (3H, s, 
OCH3), 7.04 (1H, d, J 8.5 Hz, 5-H), 7.77 (1H, dd, J 8.5, 2.0 Hz, 6-H), 7.91 (1H, d, J 
2.0 Hz, 2-H), 9.85 (1H, s, CHO); δC (101 MHz, CDCl3) 56.5 (CH3), 111.7 (CH), 
123.7 (C), 130.3 (C), 130.5 (CH), 131.2 (CH), 159.8 (C), 189.6 (CH); m/z (EI) 169 
(M+. 100%), 143 (13), 126 (15), 115 (19), 99 (14), 83 (16), 75 (12), 63 (26). 
3-Chloro-4-methoxybenzoic acid (261u)209 
 
N-Chlorosuccinimide (70.0 mg, 0.525 mmol) was added to a solution of iron(III) 
chloride (4.00 mg, 0.0250 mmol) in [BMIM]NTf2 (0.15 mL) under an atmosphere of 
air. The mixture was stirred at room temperature for 0.5 h before 4-
methoxybenzoic acid (76.0 mg, 0.500 mmol) in [BMIM]NTf2 (0.050 mL) was 
added. The reaction mixture was heated to 70 °C for 24 h. The reaction progress 
was monitored by 1H NMR spectroscopy. The reaction mixture was diluted with 
dichloromethane (10 mL) and extracted with an aqueous solution of 1 M sodium 
hydroxide (5 mL). The aqueous phase was separated and then acidified with 1 M 
hydrochloric acid (5 mL), and extracted into dichloromethane (2 × 25 mL). The 
organic phase was dried (MgSO4), filtered and concentrated in vacuo. Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 17:3) gave 3-
chloro-4-methoxybenzoic acid (261u) (86.0 mg, 92%) as a white solid. Mp 208–
210 °C (lit.209 211–214 °C); δH (400 MHz, CDCl3) 3.99 (3H, s, OCH3), 6.99 (1H, d, 
J 8.7 Hz, 5-H), 8.02 (1H, dd, J 8.7, 2.1 Hz, 6-H), 8.13 (1H, d, J 2.1 Hz, 2-H); δC 
(101 MHz, CDCl3) 56.6 (CH3), 111.5 (CH), 122.4 (C), 122.9 (C), 130.8 (CH), 132.5 
(CH), 159.5 (C), 170.0 (C); m/z (EI) 186 (M+. 83%), 169 (41), 115 (13), 83 (100), 
63 (11). 
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N-(2-Acetyl-4-chlorophenyl)acetamide (261v) 
 
N-(2-Acetyl-4-chlorophenyl)acetamide (261v) was synthesised as described for 5-
chloro-2-methoxybenzaldehyde (261r) using N-(2-acetylphenyl)acetamide (99.0 
mg, 0.500 mmol) and performing the reaction at 70 °C for 48 h. Purification by 
flash column chromatography (petroleum ether/diethyl ether, 9:1) gave N-(2-
acetyl-4-chlorophenyl)acetamide (261v) (101 mg, 95%) as a white solid. Mp 126–
128 °C; νmax/cm−1 (neat) 3218 (NH), 2359, 1685 (CO), 1657 (CO), 1588 (C=C), 
1501, 1400, 1360, 1311, 1286, 1246, 1224, 828, 773, 637; δH (400 MHz, CDCl3) 
2.22 (3H, s, NHCOCH3), 2.65 (3H, s, COCH3), 7.49 (1H, dd, J 9.1, 2.5 Hz, 5-H), 
7.82 (1H, d, J 2.5 Hz, 3-H), 8.72 (1H, d, J 9.1 Hz, 6-H), 11.56 (1H, br s, NH); δC 
(101 MHz, CDCl3) 25.6 (CH3), 28.7 (CH3), 122.4 (CH), 122.9 (C), 127.3 (C), 131.2 
(CH), 135.0 (CH), 139.7 (C), 169.6 (C), 201.9 (C); m/z (EI) 211.0402 (M+. 
C10H1035ClNO2 requires 211.0400), 169 (97), 154 (100). 
2-Chloro-4-nitrophenol (255)259 
 
2-chloro-4-nitrophenol (255) was synthesised as described for 3-chloro-4-
methoxybenzoic acid (261u) using 4-nitrophenol (70 mg, 0.50 mmol) and 
performing the reaction at 70 °C for 48 h. Purification by flash column 
chromatography (petroleum ether/ethyl acetate 3:1) gave 2-chloro-4-nitrophenol 
(255) (64 mg, 74%) as a yellow solid. Mp 108–110 °C (lit.259 110–112 °C); δH (400 
MHz, CDCl3) 6.34 (1H, s, OH), 7.13 (1H, d, J 9.0 Hz, 6-H), 8.12 (1H, dd, J 9.0, 2.7 
Hz, 5-H), 8.29 (1H, d, J 2.7 Hz, 3-H); δC (101 MHz, CDCl3) 116.4 (CH), 120.5 (C), 
124.7 (CH), 125.5 (CH), 141.7 (C), 157.0 (C); m/z (EI) 173 (M+. 100%), 143 (39), 
107 (21), 99 (37), 84 (65), 63 (36). 
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3,5-Dichloro-4-hydroxybenzonitrile (259)  
 
3,5-dichloro-4-hydroxybenzonitrile (259) was synthesised as described for 3-
chloro-4-methoxybenzoic acid (261u) using 4-hydroxybenzonitrile (60.0 mg, 0.500 
mmol) and NCS (147 mg, 1.10 mmol). The reaction was performed at 70 °C for 36 
h. Purification by flash column chromatography (petroleum ether/ethyl acetate, 
7:3) gave 3,5-dichloro-4-hydroxybenzonitrile (259) (68.0 mg, 73%) as a white 
solid. Mp 128–130 °C; νmax/cm−1 (neat) 3255 (OH), 2924 (CH), 2243 (CN), 1483, 
1302, 1150, 909; δH (400 MHz, CDCl3) 6.48 (1H, br s, OH), 7.59 (2H, s, 2-H and 6-
H); δC (101 MHz, CDCl3) 105.4 (C), 116.7 (C), 122.3 (2 × C), 132.2 (2 × CH), 
152.3 (C); m/z (EI) 186.9583 (M+. C7H335Cl2NO requires 186.9592). 
4-Bromo-2-chloroanisole (262)260 
 
N-Bromosuccinimide (178 mg, 1.00 mmol) was added to a solution of iron(III) 
chloride (8.00 mg, 0.0500 mmol) in [BMIM]NTf2 (0.400 mL) under an atmosphere 
of air. The mixture was stirred at room temperature for 0.5 h before anisole (108 
µL, 1.00 mmol) in acetonitrile (0.10 mL) was added. The reaction mixture was 
heated to 40 °C for 1.5 h. The reaction mixture was cooled to room temperature 
and N-chlorosuccinimide (160 mg, 1.20 mmol) was then added. The reaction 
mixture was heated to 70 °C for 24 h. The reaction mixture was then extracted 
with 5% ethyl acetate in hexane (3 × 50 mL) using sonication in a water bath for 
0.1 h. The suspension was washed with an aqueous solution of 1 M sodium 
thiosulfate (10 mL), brine (10 mL), dried (MgSO4) and then filtered through a pad 
of Celite®. The solvent was removed under reduced pressure. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 19:1) gave 4-bromo-2-
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chloroanisole (262) (197 mg, 89%) as a pale yellow solid. Mp 66–68 °C (lit.260 66–
68 °C); δH (400 MHz, CDCl3) 3.88 (3H, s, OCH3), 6.79 (1H, d, J 8.8 Hz, 6-H), 7.33 
(1H, dd, J 8.8, 2.4 Hz, 5-H), 7.50 (1H, d, J 2.4 Hz, 3-H); δC (101 MHz, CDCl3) 56.3 
(CH3), 112.5 (C), 113.3 (CH), 123.7 (C), 130.5 (CH), 132.7 (CH), 154.4 (C); m/z 
(EI) 222 (M+. 86%), 179 (100), 126 (36). 
4-Chloro-N-(5’-chloro-2’-methoxyphenyl)benzenesulfonamide (263)191 
 
To a solution of 2-bromo-4-chloroanisole (250d) (110 mg, 0.500 mmol) in toluene 
(0.50 mL) were added 4-chlorobenzenesulfonamide (115 mg, 0.600 mmol), 
copper(I) iodide (10.0 mg, 0.0500 mmol), N,N′-dimethylethylenediamine (11.0 µL, 
0.100 mmol), cesium carbonate (326 mg, 1.00 mmol) and water (0.30 mL). The 
reaction mixture was degassed under argon for 0.1 h and then heated to 150 °C 
for 24 h. The reaction mixture was then cooled to room temperature, diluted with 
ethyl acetate (10 mL), washed with 1 M sodium thiosulfate solution (10 mL) and 
brine (10 mL). The organic phase was dried (MgSO4), filtered and concentrated in 
vacuo. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 8:2) gave 4-chloro-N-(5’-chloro-2’-methoxyphenyl)benzenesulfonamide 
(263) (107 mg, 65%) as a white solid. Mp 142–144 °C (lit.191 144–146 °C); δH (400 
MHz, CDCl3) 3.66 (3H, s, OCH3), 6.67 (1H, d, J 8.7 Hz, 3’-H), 7.01 (1H, dd, J 8.7, 
2.5 Hz, 4’-H), 7.03 (1H, br s, NH), 7.38–7.42 (2H, m, 3-H and 5-H), 7.53 (1H, d, J 
2.5 Hz, 6’-H), 7.69–7.74 (2H, m, 2-H and 6-H); δC (101 MHz, CDCl3) 56.0 (CH3), 
111.6 (CH), 121.0 (CH), 125.3 (CH), 126.2 (C), 126.5 (C), 128.6 (2 × CH), 129.2 
(2 × CH), 137.4 (C), 139.7 (C), 148.0 (C); m/z (EI) 331 (M+. 100%), 296 (52), 262 
(18), 158 (32), 156 (100), 126 (19), 111 (27), 93 (48), 75 (16). 
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N-(5’-Chloro-2’-methoxyphenyl)benzenesulfonamide (264)187 
 
The reaction was performed as described for 4-chloro-N-(5’-chloro-2’-
methoxyphenyl)benzenesulfonamide (263) using 2-bromo-4-chloroanisole (250d) 
(221 mg, 1.00 mmol) and benzenesulfonamide (189 mg, 1.20 mmol). Purification 
by flash column chromatography (petroleum ether/ethyl acetate, 7:3) gave N-(5’-
chloro-2’-methoxyphenyl)benzenesulfonamide (264) (199 mg, 67%) as a white 
solid. Mp 140–142 °C (lit.187 140–142 °C); δH (400 MHz, CDCl3) 3.63 (3H, s, 
OCH3), 6.64 (1H, d, J 8.7 Hz, 3’-H), 6.98 (1H, dd, J 8.7, 2.6 Hz, 4’-H), 7.02 (1H, br 
s, NH), 7.40–7.47 (2H, m, 2 × ArH), 7.50–7.53 (1H, m, ArH), 7.55 (1H, d, J 2.6 Hz, 
6’-H), 7.76–7.82 (2H, m, 2 × ArH); δC (101 MHz, CDCl3) 56.0 (CH3), 111.5 (CH), 
120.8 (CH), 124.9 (CH), 126.1 (C), 126.9 (C), 127.2 (2 × CH), 128.9 (2 × CH), 
133.1 (CH), 139.0 (C), 148.0 (C); m/z (EI) 297 (M+. 79%), 156 (100), 93 (70), 77 
(40), 51 (27). 
N-(5’-Chloro-2’-methoxyphenyl)-N-methylbenzenesulfonamide (260)187 
 
To a solution of N-(5’-chloro-2’-methoxyphenyl)benzenesulfonamide (264) (38 mg, 
0.13 mmol) in DMF (0.7 mL) were added potassium carbonate (53 mg, 0.38 mmol) 
and iodomethane (24 µL, 0.38 mmol). The reaction mixture was stirred at room 
temperature for 2 h. The reaction mixture was then quenched with water (2 mL) 
and extracted with diethyl ether (3 × 3 mL). The organic layers were combined, 
dried (MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 8:2) gave N-(5’-chloro-2’-
methoxyphenyl)-N-methylbenzenesulfonamide (260) (37 mg, 93%) as a colourless 
oil. Spectroscopic data was consistent with the literature.187 δH (500 MHz, CDCl3) 
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3.18 (3H, s, NCH3), 3.36 (3H, s, OCH3), 6.71 (1H, d, J 8.8 Hz, 3’-H), 7.23 (1H, dd, 
J 8.8, 2.7 Hz, 4’-H), 7.29 (1H, d, J 2.7 Hz, 6’-H), 7.44–7.50 (2H, m, 2 × ArH), 7.53–
7.59 (1H, m, ArH), 7.66–7.71 (2H, m, 2 × ArH); δC (126 MHz, CDCl3) 37.8 (CH3), 
55.3 (CH3), 112.6 (CH), 125.1 (C), 127.5 (2 × CH), 128.6 (2 × CH), 129.4 (CH), 
129.9 (C), 131.8 (CH), 132.4 (CH), 139.2 (C), 155.2 (C); m/z (EI) 311 (M+. 41%), 
170 (100), 155 (39), 84 (15), 77 (19). 
2-(5-Acetylthien-2-yl)-4-chloroanisole (266) 
 
To a solution of 2-bromo-4-chloroanisole (250d) (160 mg, 0.730 mmol) in 1,4-
dioxane (8 mL) were added 5-acetylthiophene-2-boronic acid (265) (148 mg, 0.870 
mmol), potassium carbonate (303 mg, 2.19 mmol) and water (6.0 mL). The 
reaction mixture was degassed with argon for 0.1 h. 
Bis(triphenylphosphine)palladium(II) dichloride (51.0 mg, 0.0730 mmol) was added 
and the reaction mixture was heated to 80 °C for 4 h. The reaction mixture was 
cooled to room temperature and the organic solvent was removed under reduced 
pressure. The residue was dissolved in ethyl acetate (15 mL), extracted with water 
(10 mL) and washed with brine (10 mL). The combined organic layers were dried 
(MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (petroleum ether/ethyl acetate, 19:1) gave 2-(5-acetylthien-2-yl)-
4-chloroanisole (266) (154 mg, 79%) as a yellow solid. Mp 128–130 °C; νmax/cm−1 
2941 (CH), 1653 (C=O), 1436, 1277, 1259, 1021, 807, 677; δH (500 MHz, CDCl3) 
2.57 (3H, s, COCH3), 3.95 (3H, s, OCH3), 6.93 (1H, d, J 8.8 Hz, 6-H), 7.27 (1H, 
dd, J 8.8, 2.6 Hz, 5-H), 7.47 (1H, d, J 4.1 Hz, 3’-H), 7.64–7.67 (2H, m, 3-H and 4’-
H); δC (126 MHz, CDCl3) 26.8 (CH3), 55.9 (CH3), 112.9 (CH), 123.6 (C), 126.0 (C), 
126.2 (CH), 128.0 (CH), 129.3 (CH), 132.1 (CH), 143.8 (C), 146.1 (C), 154.6 (C), 
191.1 (C); m/z (ESI) 289.0052 (MNa+. C13H1135ClNaO2S requires 289.0060). 
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2-(5-Acetylthien-2-yl)-4-chlorophenol (257)182 
 
2-(5-Acetylthien-2-yl)-4-chloroanisole (266) (50.0 mg, 0.190 mmol) was dissolved 
in dichloromethane (3.0 mL) and cooled to −78 °C. Boron tribromide (374 µL, 
0.370 mmol, 1 M in dichloromethane) was added dropwise and the reaction 
mixture was stirred at −78 °C for 1 h, before warming to room temperature over 5 
h. The reaction mixture was quenched by the addition of a saturated solution of 
sodium bicarbonate (2 mL) and then extracted with dichloromethane (4 × 3 mL). 
The organic layers were combined, dried (MgSO4), filtered and concentrated in 
vacuo. Purification by flash column chromatography (petroleum ether/ethyl 
acetate, 8:2) gave 2-(5-acetylthien-2-yl)-4-chlorophenol (257) (41.0 mg, 87%) as a 
yellow solid. Mp 212–214 °C (lit.182 218 °C); δH (500 MHz, DMSO-d6) 2.53 (3H, s, 
COCH3), 7.00 (1H, d, J 8.7 Hz, 6-H), 7.25 (1H, dd, J 8.7, 2.6 Hz, 5-H), 7.79 (1H, d, 
J 4.1 Hz, 3’-H), 7.84 (1H, d, J 2.6 Hz, 3-H), 7.89 (1H, d, J 4.1 Hz, 4’-H), 11.00 (1H, 
br s, OH); δC (126 MHz, DMSO-d6) 27.0 (CH3), 118.5 (CH), 121.7 (C), 123.7 (C), 
126.7 (CH), 127.3 (CH), 129.8 (CH), 133.8 (CH), 143.5 (C), 146.0 (C), 153.4 (C), 
191.5 (C); m/z (ESI) 251 ([M−H]−. 100%). 
4-Methoxybiphenyl (267)261 
 
Iron(III) chloride (8.00 mg, 0.050 mmol), 1,3-bis-(2,6-
diisopropylphenyl)imidazolinium chloride (SIPr.HCl) (64.0 mg, 0.150 mmol) and 
sodium tert-butoxide (17.0 mg, 0.180 mmol) were dissolved in THF (1.50 mL) and 
stirred at room temperature for 1 h, under an atmosphere of argon. To the 
solution, 4-chloroanisole (261a) (122 µL, 1.00 mmol) and phenylmagnesium 
bromide (2.00 mL, 2.00 mmol, 1 M in THF) were added and the reaction mixture 
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was stirred at 60 °C for 18 h. The reaction was quenched by addition of brine (10 
mL) and then exacted with dichloromethane (3 × 10 mL). The organic layers were 
combined, dried (MgSO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography (petroleum ether/ethyl acetate, 18:2) gave 4-
methoxybiphenyl (267) (148 mg, 80%) as a white solid. Mp 86–88 °C (lit.261 88–89  
°C); δH (400 MHz, CDCl3) 3.86 (3H, s, OCH3), 6.97–7.02 (2H, m, 3-H and 5-H), 
7.29–7.34 (1H, m, ArH), 7.40–7.46 (2H, m, 2 × ArH), 7.52–7.59 (4H, m, 2-H, 6-H 
and 2 × ArH); δC (101 MHz, CDCl3) 55.4 (CH3), 114.3 (2 × CH), 126.7 (CH), 126.8 
(2 × CH), 128.2 (2 × CH), 128.8 (2 × CH), 133.8 (C), 140.9 (C), 159.2 (C); m/z (EI) 
184 (M+. 100%), 169 (34), 167 (41), 141 (31). 
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5.0 Appendices 
Appendix 1: NOE data 
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Appendix 2: X-ray data 
Crystal data and structure refinement for 216 
 
Identification code 216 
Empirical formula  C25H23Cl3N2O5 
Formula weight  537.82 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 11.7084 (4) Å α = 90.096 (3)°. 
 b = 14.1127 (6) Å β = 95.408 (3)°. 
 c = 15.5928 (6) Å γ = 91.971 (3)°. 
 237 
Volume  2563.48 (17)  Å3 
Z 4 
Density (calculated)  1.477 Mg/m3 
Absorption coefficient  0.40 mm−1 
F(000)  1184 
Theta range for data collection  4.4 to 50° 
Index ranges                                                          −15<=h<=15, −18<=k<=18, 
−20<=l<=20 
Reflections collected  34139 
Independent reflections  9008 [Rint = 0.073] 
Completeness to theta = 25°  99.9% 
Refinement method Full-matrix least-squares on F2 0.054 
Data / restraints / parameters  9008/ 0 /675 
Goodness-of-fit on F2  1.01 
Final R indices [I>2sigma(I)]  0.054 (6437) 
R indices (all data)  0.136 
Largest diff. peak and hole  0.42 and −0.37 e Å−3 
Fractional atomic coordinates and isotropic or equivalent isotropic 
displacement parameters (Å2) 
         X        Y         Z  Uiso*/Ueq 
Cl1 0.56318 (7) 0.41697 (6) 0.12159 (6) 0.0325 (2) 
Cl2 0.70717 (7) 0.47561 (6) –0.01123 (6) 0.0287 (2) 
Cl3 0.50893 (7) 0.35127 (6) –0.05247 (6) 0.0297 (2) 
O1 0.69807 (18) 0.29606 (16) 0.28775 (14) 0.0239 (5) 
O3 1.01209 (18) 0.36148 (16) 0.47674 (15) 0.0258 (5) 
O5 1.13042 (17) 0.15698 (15) 0.23986 (13) 0.0205 (5) 
H5 1.1885 0.1734 0.2705 0.031* 
O1' 0.73834 (19) 0.26330 (16) –0.02584 (14) 0.0289 (6) 
O5A 0.95893 (17) 0.04964 (15) 0.15894 (13) 0.0202 (5) 
 238 
H5A 1.0181 0.0677 0.1388 0.030* 
N1 0.7174 (2) 0.26103 (18) 0.11762 (16) 0.0183 (6) 
H1 0.6842 0.2876 0.1578 0.022* 
N2 0.8391 (2) 0.33875 (18) 0.39405 (16) 0.0182 (6) 
C1 0.7996 (3) 0.3039 (2) 0.3126 (2) 0.0193 (7) 
C3 0.9585 (3) 0.3353 (2) 0.4103 (2) 0.0189 (7) 
C4 1.0308 (3) 0.1850 (2) 0.3660 (2) 0.0178 (7) 
H4A 1.1001 0.1879 0.4053 0.021* 
H4B 0.9688 0.1600 0.3973 0.021* 
C5 1.0477 (2) 0.1178 (2) 0.2918 (2) 0.0174 (7) 
C6 0.8261 (2) 0.0702 (2) 0.2602 (2) 0.0181 (7) 
H6A 0.8144 0.0957 0.3164 0.022* 
H6B 0.8264 0.0016 0.2636 0.022* 
C7 0.7318 (3) 0.1026 (2) 0.1911 (2) 0.0211 (7) 
H7A 0.7042 0.0502 0.1535 0.025* 
H7B 0.6674 0.1273 0.2180 0.025* 
C8 0.7907 (3) 0.1812 (2) 0.1400 (2) 0.0200 (7) 
H8 0.8100 0.1528 0.0860 0.024* 
C101 0.7661 (3) 0.3812 (2) 0.4522 (2) 0.0188 (7) 
C102 0.7950 (3) 0.4702 (2) 0.4852 (2) 0.0223 (8) 
H102 0.8614 0.5023 0.4712 0.027* 
C103 0.7239 (3) 0.5114 (2) 0.5395 (2) 0.0269 (8) 
H103 0.7431 0.5713 0.5626 0.032* 
C104 0.6256 (3) 0.4647 (2) 0.5595 (2) 0.0293 (8) 
H104 0.5779 0.4930 0.5958 0.035* 
C105 0.5969 (3) 0.3752 (3) 0.5258 (2) 0.0295 (8) 
H105 0.5299 0.3436 0.5393 0.035* 
C106 0.6679 (3) 0.3325 (2) 0.4721 (2) 0.0232 (8) 
H106 0.6497 0.2721 0.4499 0.028* 
C111 1.0837 (3) 0.0214 (2) 0.3272 (2) 0.0190 (7) 
C112 1.1817 (3) -0.0200 (2) 0.3024 (2) 0.0240 (8) 
H112 1.2247 0.0110 0.2631 0.029* 
C113 1.2160 (3) –0.1064 (3) 0.3353 (2) 0.0311 (9) 
H113 1.2816 –0.1329 0.3177 0.037* 
C114 1.1542 (3) –0.1535 (3) 0.3936 (2) 0.0341 (9) 
H114 1.1782 –0.2113 0.4159 0.041* 
C115 1.0558 (3) –0.1141 (2) 0.4190 (2) 0.0288 (8) 
 239 
H115 1.0127 –0.1461 0.4576 0.035* 
C116 1.0221 (3) –0.0275 (2) 0.3867 (2) 0.0215 (7) 
H116 0.9568 –0.0010 0.4050 0.026* 
C1' 0.6997 (3) 0.2943 (2) 0.0386 (2) 0.0218 (8) 
C2' 0.6223 (3) 0.3815 (2) 0.0261 (2) 0.0241 (8) 
C3A 1.0031 (2) 0.2852 (2) 0.33510 (19) 0.0175 (7) 
H3A 1.0716 0.3185 0.3171 0.021* 
C5A 0.9384 (2) 0.1102 (2) 0.22924 (19) 0.0160 (7) 
C8A 0.9039 (2) 0.2080 (2) 0.19353 (19) 0.0168 (7) 
H8A 0.9596 0.2279 0.1534 0.020* 
C8B 0.9034 (2) 0.2871 (2) 0.2633 (2) 0.0192 (7) 
H8B 0.9159 0.3464 0.2325 0.023* 
Cl21 0.42396 (7) 0.06289 (6) 0.68326 (5) 0.0292 (2) 
Cl22 0.28103 (7) 0.02545 (6) 0.52534 (6) 0.0287 (2) 
Cl23 0.49942 (7) 0.12707 (6) 0.52317 (6) 0.0306 (2) 
O21 0.30895 (18) 0.20125 (17) 0.83235 (14) 0.0268 (6) 
O23 –0.00657 (18) 0.13584 (16) 0.97481 (14) 0.0264 (5) 
O25 –0.12130 (17) 0.34204 (16) 0.72273 (14) 0.0230 (5) 
H25 –0.1794 0.3257 0.7451 0.035* 
O21' 0.2880 (2) 0.24170 (17) 0.51339 (15) 0.0296 (6) 
O25A 0.04980 (17) 0.44734 (15) 0.66487 (13) 0.0217 (5) 
H25A –0.0108 0.4300 0.6378 0.033* 
N21 0.2894 (2) 0.23331 (18) 0.65891 (16) 0.0204 (6) 
H21 0.3166 0.2034 0.7039 0.025* 
N22 0.1672 (2) 0.15851 (18) 0.91785 (16) 0.0198 (6) 
C21 0.2079 (3) 0.1937 (2) 0.8427 (2) 0.0202 (7) 
C23 0.0471 (3) 0.1623 (2) 0.9161 (2) 0.0218 (7) 
C24 –0.0212 (3) 0.3136 (2) 0.8627 (2) 0.0192 (7) 
H24A –0.0900 0.3115 0.8928 0.023* 
H24B 0.0417 0.3379 0.9025 0.023* 
C25 –0.0381 (3) 0.3812 (2) 0.7868 (2) 0.0186 (7) 
C26 0.1845 (2) 0.4278 (2) 0.7844 (2) 0.0198 (7) 
H26A 0.1965 0.4034 0.8426 0.024* 
H26B 0.1851 0.4965 0.7870 0.024* 
C27 0.2779 (3) 0.3938 (2) 0.7290 (2) 0.0235 (8) 
H27A 0.3421 0.3692 0.7651 0.028* 
H27B 0.3059 0.4455 0.6948 0.028* 
 240 
C28 0.2185 (3) 0.3147 (2) 0.6701 (2) 0.0204 (7) 
H28 0.1993 0.3422 0.6131 0.024* 
C201 0.2390 (3) 0.1156 (2) 0.9859 (2) 0.0213 (7) 
C202 0.2108 (3) 0.0255 (2) 1.0127 (2) 0.0251 (8) 
H202 0.1442 –0.0059 0.9887 0.030* 
C203 0.2822 (3) –0.0181 (3) 1.0756 (2) 0.0334 (9) 
H203 0.2629 –0.0785 1.0946 0.040* 
C204 0.3816 (3) 0.0281 (3) 1.1098 (3) 0.0430 (10) 
H204 0.4311 –0.0018 1.1505 0.052* 
C205 0.4076 (3) 0.1193 (3) 1.0833 (3) 0.0473 (11) 
H205 0.4740 0.1510 1.1073 0.057* 
C206 0.3363 (3) 0.1636 (3) 1.0218 (2) 0.0358 (9) 
H206 0.3536 0.2251 1.0047 0.043* 
C211 –0.0742 (3) 0.4776 (2) 0.8173 (2) 0.0195 (7) 
C212 –0.1736 (3) 0.5178 (2) 0.7803 (2) 0.0276 (8) 
H212 –0.2168 0.4869 0.7348 0.033* 
C213 –0.2093 (3) 0.6034 (3) 0.8104 (2) 0.0344 (9) 
H213 –0.2765 0.6290 0.7854 0.041* 
C214 –0.1464 (3) 0.6506 (3) 0.8768 (2) 0.0361 (10) 
H214 –0.1707 0.7079 0.8967 0.043* 
C215 –0.0461 (3) 0.6122 (2) 0.9141 (2) 0.0320 (9) 
H215 –0.0023 0.6444 0.9585 0.038* 
C216 –0.0114 (3) 0.5259 (2) 0.8851 (2) 0.0245 (8) 
H216 0.0548 0.4999 0.9114 0.029* 
C21' 0.3136 (3) 0.2037 (2) 0.5818 (2) 0.0203 (7) 
C22' 0.3774 (3) 0.1090 (2) 0.5805 (2) 0.0211 (7) 
C23A 0.0046 (3) 0.2129 (2) 0.8353 (2) 0.0193 (7) 
H23A –0.0644 0.1806 0.8070 0.023* 
C25A 0.0713 (3) 0.3882 (2) 0.73877 (19) 0.0182 (7) 
C28A 0.1047 (3) 0.2891 (2) 0.7085 (2) 0.0181 (7) 
H28A 0.0485 0.2693 0.6607 0.022* 
C28B 0.1047 (2) 0.2105 (2) 0.7781 (2) 0.0194 (7) 
H28B 0.0922 0.1510 0.7455 0.023* 
O1M 0.31816 (19) 0.2291 (2) 0.33926 (15) 0.0357 (6) 
H1M 0.3227 0.2289 0.3921 0.053* 
C1M 0.4282 (3) 0.2283 (4) 0.3119 (3) 0.0593 (14) 
H1MA 0.4231 0.2312 0.2501 0.089* 
 241 
H1MB 0.4645 0.1711 0.3309 0.089* 
H1MC 0.4727 0.2821 0.3357 0.089* 
O2M –0.30712 (19) 0.26944 (19) 0.79678 (15) 0.0322 (6) 
H2M –0.3069 0.2802 0.8485 0.048* 
C2M –0.4126 (3) 0.2935 (3) 0.7546 (3) 0.0466 (11) 
H2MA –0.4734 0.2590 0.7794 0.070* 
H2MB –0.4144 0.2777 0.6946 0.070* 
H2MC –0.4225 0.3603 0.7608 0.070* 
Bond-length (Å) for 216 
Cl1–C2' 1.778 (3) O25–H25 0.8200 
Cl2–C2' 1.764 (3) O25–C25 1.425 (4) 
Cl3–C2' 1.760 (3) O21'–C21' 1.212 (4) 
O1–C1 1.216 (4) O25A–H25A 0.8200 
O3–C3 1.210 (4) O25A–C25A 1.432 (4) 
O5–H5 0.8200 N21–H21 0.8600 
O5–C5 1.419 (3) N21–C28 1.460 (4) 
O1'–C1' 1.226 (4) N21–C21' 1.331 (4) 
O5A–H5A 0.8200 N22–C21 1.393 (4) 
O5A–C5A 1.432 (3) N22–C23 1.407 (4) 
N1–H1 0.8600 N22–C201 1.438 (4) 
N1–C8 1.463 (4) C21–C28B 1.524 (4) 
N1–C1' 1.320 (4) C23–C23A 1.501 (5) 
N2–C1 1.393 (4) C24–H24A 0.9700 
N2–C3 1.400 (4) C24–H24B 0.9700 
N2–C101 1.445 (4) C24–C25 1.524 (4) 
C1–C8B 1.523 (4) C24–C23A 1.532 (4) 
C3–C3A 1.512 (4) C25–C211 1.527 (4) 
C4–H4A 0.9700 C25–C25A 1.543 (4) 
C4–H4B 0.9700 C26–H26A 0.9700 
C4–C5 1.526 (4) C26–H26B 0.9700 
C4–C3A 1.530 (4) C26–C27 1.545 (4) 
C5–C111 1.526 (4) C26–C25A 1.532 (4) 
C5–C5A 1.535 (4) C27–H27A 0.9700 
C6–H6A 0.9700 C27–H27B 0.9700 
C6–H6B 0.9700 C27–C28 1.548 (4) 
C6–C7 1.550 (4) C28–H28 0.9800 
 242 
C6–C5A 1.533 (4) C28–C28A 1.543 (4) 
C7–H7A 0.9700 C201–C202 1.378 (5) 
C7–H7B 0.9700 C201–C206 1.377 (5) 
C7–C8 1.547 (4) C202–H202 0.9300 
C8–H8 0.9800 C202–C203 1.386 (5) 
C8–C8A 1.533 (4) C203–H203 0.9300 
C101–C102 1.377 (4) C203–C204 1.377 (5) 
C101–C106 1.379 (4) C204–H204 0.9300 
C102–H102 0.9300 C204–C205 1.386 (6) 
C102–C103 1.382 (4) C205–H205 0.9300 
C103–H103 0.9300 C205–C206 1.376 (5) 
C103–C104 1.369 (5) C206–H206 0.9300 
C104–H104 0.9300 C211–C212 1.389 (5) 
C104–C105 1.386 (5) C211–C216 1.393 (5) 
C105–H105 0.9300 C212–H212 0.9300 
C105–C106 1.385 (4) C212–C213 1.388 (5) 
C106–H106 0.9300 C213–H213 0.9300 
C111–C112 1.391 (4) C213–C214 1.369 (5) 
C111–C116 1.398 (4) C214–H214 0.9300 
C112–H112 0.9300 C214–C215 1.388 (5) 
C112–C113 1.382 (5) C215–H215 0.9300 
C113–H113 0.9300 C215–C216 1.385 (5) 
C113–C114 1.373 (5) C216–H216 0.9300 
C114–H114 0.9300 C21'–C22' 1.554 (4) 
C114–C115 1.386 (5) C23A–H23A 0.9800 
C115–H115 0.9300 C23A–C28B 1.540 (4) 
C115–C116 1.379 (5) C25A–C28A 1.550 (4) 
C116–H116 0.9300 C28A–H28A 0.9800 
C1'–C2' 1.555 (4) C28A–C28B 1.553 (4) 
C3A–H3A 0.9800 C28B–H28B 0.9800 
C3A–C8B 1.540 (4) O1M–H1M 0.8200 
C5A–C8A 1.542 (4) O1M–C1M 1.396 (4) 
C8A–H8A 0.9800 C1M–H1MA 0.9600 
C8A–C8B 1.558 (4) C1M–H1MB 0.9600 
C8B–H8B 0.9800 C1M–H1MC 0.9600 
Cl21–C22' 1.775 (3) O2M–H2M 0.8200 
Cl22–C22' 1.768 (3) O2M–C2M 1.396 (4) 
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Cl23–C22' 1.766 (3) C2M–H2MA 0.9600 
O21–C21 1.210 (4) C2M–H2MB 0.9600 
O23–C23 1.211 (4) C2M–H2MC 0.9600 
Bond Angle (°) for 216 
C5–O5–H5 109.5 C23–N22–C201 124.0 (3) 
C5A–O5A—H5A 109.5 O21–C21–N22 123.2 (3) 
C8–N1–H1 118.5 O21–C21–C28B 128.8 (3) 
C1'–N1–H1 118.5 N22–C21–C28B 107.9 (3) 
C1'–N1–C8 123.1 (3) O23–C23–N22 123.5 (3) 
C1–N2–C3 112.4 (3) O23–C23–C23A 128.5 (3) 
C1–N2–C101 123.7 (3) N22–C23–C23A 107.7 (3) 
C3–N2–C101 123.7 (3) H24A–C24–H24B 107.8 
O1–C1–N2 122.7 (3) C25–C24–H24A 109.0 
O1–C1–C8B 129.1 (3) C25–C24–H24B 109.0 
N2–C1–C8B 108.1 (3) C25–C24–C23A 112.8 (3) 
O3–C3–N2 124.3 (3) C23A–C24–H24A 109.0 
O3–C3–C3A 127.7 (3) C23A–C24–H24B 109.0 
N2–C3–C3A 107.8 (3) O25–C25–C24 110.2 (3) 
H4A–C4–H4B 107.8 O25–C25–C211 110.8 (3) 
C5–C4–H4A 109.1 O25–C25–C25A 102.5 (2) 
C5–C4–H4B 109.1 C24–C25–C211 110.2 (2) 
C5–C4–C3A 112.5 (3) C24–C25–C25A 110.3 (3) 
C3A–C4–H4A 109.1 C211–C25–C25A 112.6 (3) 
C3A–C4–H4B 109.1 H26A–C26–H26B 108.9 
O5–C5–C4 110.3 (2) C27–C26–H26A 110.8 
O5–C5–C111 110.9 (2) C27–C26–H26B 110.8 
O5–C5–C5A 103.0 (2) C25A–C26–H26A 110.8 
C4–C5–C111 109.9 (3) C25A–C26–H26B 110.8 
C4–C5–C5A 110.3 (2) C25A–C26–C27 104.7 (2) 
C111–C5–C5A 112.2 (2) C26–C27–H27A 110.7 
H6A–C6–H6B 108.9 C26–C27–H27B 110.7 
C7–C6–H6A 110.9 C26–C27–C28 105.4 (2) 
C7—C6—H6B 110.9 H27A–C27–H27B 108.8 
C5A–C6–H6A 110.9 C28–C27–H27A 110.7 
C5A–C6–H6B 110.9 C28–C27–H27B 110.7 
C5A–C6–C7 104.3 (2) N21–C28–C27 114.2 (2) 
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C6–C7–H7A 110.7 N21–C28–H28 107.6 
C6–C7–H7B 110.7 N21–C28–C28A 113.8 (3) 
H7A–C7–H7B 108.8 C27–C28–H28 107.6 
C8–C7–C6 105.1 (2) C28A–C28–C27 105.7 (2) 
C8–C7–H7A 110.7 C28A–C28–H28 107.6 
C8–C7–H7B 110.7 C202–C201–N22 119.3 (3) 
N1–C8–C7 113.5 (2) C206–C201–N22 119.9 (3) 
N1–C8–H8 107.5 C206–C201–C202 120.9 (3) 
N1–C8–C8A 114.6 (2) C201–C202–H202 120.2 
C7–C8–H8 107.5 C201–C202–C203 119.7 (3) 
C8A–C8–C7 106.0 (2) C203–C202–H202 120.2 
C8A–C8–H8 107.5 C202–C203–H203 120.0 
C102–C101–N2 119.2 (3) C204–C203–C202 119.9 (4) 
C102–C101–C106 121.3 (3) C204–C203–H203 120.0 
C106–C101–N2 119.4 (3) C203–C204–H204 120.2 
C101–C102–H102 120.4 C203–C204–C205 119.6 (4) 
C101–C102–C103 119.1 (3) C205–C204–H204 120.2 
C103–C102–H102 120.4 C204–C205–H205 119.6 
C102–C103–H103 119.8 C206–C205–C204 120.7 (4) 
C104–C103–C102 120.5 (3) C206–C205–H205 119.6 
C104–C103–H103 119.8 C201–C206–H206 120.4 
C103–C104–H104 120.0 C205–C206–C201 119.1 (4) 
C103–C104–C105 120.1 (3) C205–C206–H206 120.4 
C105–C104–H104 120.0 C212–C211–C25 120.7 (3) 
C104–C105–H105 119.9 C212–C211–C216 118.0 (3) 
C106–C105–C104 120.1 (3) C216–C211–C25 121.2 (3) 
C106–C105–H105 119.9 C211–C212–H212 119.6 
C101–C106–C105 118.9 (3) C213–C212–C211 120.8 (3) 
C101–C106–H106 120.6 C213–C212–H212 119.6 
C105–C106–H106 120.6 C212–C213–H213 119.7 
C112–C111–C5 120.6 (3) C214–C213–C212 120.6 (4) 
C112–C111–C116 117.5 (3) C214–C213–H213 119.7 
C116–C111–C5 121.9 (3) C213–C214–H214 120.2 
C111–C112–H112 119.5 C213–C214–C215 119.6 (3) 
C113–C112–C111 121.0 (3) C215–C214–H214 120.2 
C113–C112–H112 119.5 C214–C215دH215 120.0 
C112–C113–H113 119.6 C216–C215–C214 119.9 (3) 
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C114–C113–C112 120.7 (3) C216–C215–H215 120.0 
C114–C113–H113 119.6 C211–C216–H216 119.5 
C113–C114–H114 120.3 C215–C216–C211 121.0 (3) 
C113–C114–C115 119.5 (3) C215–C216–H216 119.5 
C115–C114–H114 120.3 O21'–C21'–N21 126.4 (3) 
C114–C115–H115 120.1 O21'–C21'–C22' 117.7 (3) 
C116–C115–C114 119.9 (3) N21–C21'–C22' 115.8 (3) 
C116–C115–H115 120.1 Cl22–C22'–Cl21 108.81 (18) 
C111–C116–H116 119.3 Cl23–C22'–Cl21 107.90 (17) 
C115–C116–C111 121.5 (3) Cl23–C22'–Cl22 109.80 (17) 
C115–C116–H116 119.3 C21'–C22'–Cl21 115.3 (2) 
O1'–C1'–N1 126.5 (3) C21'–C22'–Cl22 106.6 (2) 
O1'–C1'–C2' 116.9 (3) C21'–C22'–Cl23 108.4 (2) 
N1–C1'–C2' 116.6 (3) C23–C23A–C24 106.3 (2) 
Cl2–C2'–Cl1 109.67 (18) C23–C23A–H23A 111.0 
Cl3–C2'–Cl1 108.61 (17) C23–C23A–C28B 104.6 (2) 
Cl3–C2'–Cl2 109.79 (18) C24–C23A–H23A 111.0 
C1'–C2'–Cl1 113.7 (2) C24–C23A–C28B 112.7 (3) 
C1'–C2'–Cl2 107.3 (2) C28B–C23A–H23A 111.0 
C1'–C2'–Cl3 107.7 (2) O25A–C25A–C25 108.7 (2) 
C3–C3A–C4 106.3 (2) O25A–C25A–C26 104.8 (2) 
C3–C3A–H3A 110.9 O25A–C25A–C28A 108.8 (2) 
C3–C3A–C8B 104.4 (2) C25–C25A–C28A 111.0 (2) 
C4–C3A–H3A 110.9 C26–C25A–C25 120.5 (2) 
C4–C3A–C8B 113.2 (2) C26–C25A–C28A 102.4 (2) 
C8B–C3A–H3A 110.9 C28–C28A–C25A 100.6 (2) 
O5A–C5A–C5 108.7 (2) C28–C28A–H28A 107.4 
O5A–C5A–C6 104.4 (2) C28–C28A–C28B 118.3 (3) 
O5A–C5A–C8A 108.9 (2) C25A–C28A–H28A 107.4 
C5–C5A–C8A 111.5 (2) C25A–C28A–C28B 115.0 (2) 
C6–C5A–C5 120.1 (3) C28B–C28A–H28A 107.4 
C6–C5A–C8A 102.6 (2) C21–C28B–C23A 103.0 (2) 
C8–C8A–C5A 100.6 (2) C21–C28B–C28A 122.7 (3) 
C8–C8A–H8A 107.6 C21–C28B–H28B 104.9 
C8–C8A–C8B 118.3 (2) C23A–C28B–C28A 114.9 (3) 
C5A–C8A–H8A 107.6 C23A–C28B–H28B 104.9 
C5A–C8A–C8B 114.4 (2) C28A–C28B–H28B 104.9 
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C8B–C8A–H8A 107.6 C1M–O1M–H1M 109.5 
C1–C8B–C3A 103.1 (2) O1M–C1M–H1MA 109.5 
C1–C8B–C8A 122.6 (3) O1M–C1M–H1MB 109.5 
C1–C8B–H8B 104.8 O1M–C1M–H1MC 109.5 
C3A–C8B–C8A 115.0 (2) H1MA–C1M–H1MB 109.5 
C3A–C8B–H8B 104.8 H1MA–C1M–H1MC 109.5 
C8A–C8B–H8B 104.8 H1MB–C1M–H1MC 109.5 
C25–O25–H25 109.5 C2M–O2M–H2M 109.5 
C25A–O25A–H25A 109.5 O2M–C2M–H2MA 109.5 
C28–N21–H21 118.7 O2M–C2M–H2MB 109.5 
C21'–N21–H21 118.7 O2M–C2M–H2MC 109.5 
C21'–N21–C28 122.6 (3) H2MA–C2M–H2MB 109.5 
C21–N22–C23 112.3 (3) H2MA–C2M–H2MC 109.5 
C21–N22–C201 123.5 (3) H2MB–C2M–H2MC 109.5 
Atomic displacement parameters (Å2 × 103) for 216 
 U11 U22 U33 U12 U13 U23 
Cl1 45.6 (5) 29.5 (5) 25.2 (5) 15.3 (4) 12.1 (4) 9.8 (4) 
Cl2 33.4 (4) 20.8 (5) 32.3 (5) –2.4 (4) 5.2 (4) 9.8 (4) 
Cl3 28.4 (4) 29.6 (5) 30.0 (5) 0.5 (4) –2.4 (4) 8.4 (4) 
O1 25.8 (12) 30.7 (14) 15.1 (12) 1.3 (10) 1.7 (10) 5.2 (10) 
O3 33.0 (12) 22.1 (13) 21.2 (14) –1.7 (10) –1.9 (11) –3.9 (11) 
O5 22.1 (11) 22.9 (13) 16.0 (12) –4.9 (10) 1.8 (9) 4.4 (10) 
O1' 42.8 (14) 28.6 (14) 17.1 (13) 13.2 (11) 7.2 (11) 10.0 (11) 
O5A 29.0 (12) 17.6 (12) 14.1 (12) 0.9 (10) 2.2 (10) 1.0 (10) 
N1 29.7 (14) 15.1 (14) 10.2 (14) 4.7 (11) 0.3 (11) 4.9 (11) 
N2 25.6 (14) 13.0 (14) 15.8 (15) –3.0 (11) 2.2 (11) 2.2 (11) 
C1 29.0 (18) 12.1 (17) 16.9 (18) –0.2 (14) 2.6 (14) 8.7 (14) 
C3 25.2 (16) 9.1 (16) 22.0 (2) –1.7 (13) 1.9 (15) 6.7 (14) 
C4 24.3 (16) 13.8 (17) 15.0 (17) –2.9 (13) 1.8 (13) 3.9 (13) 
C5 21.4 (15) 15.1 (17) 15.9 (18) –4.1 (13) 4.5 (13) 4.9 (14) 
C6 25.8 (16) 13.6 (17) 14.4 (17) –2.3 (13) 0.0 (14) 4.7 (14) 
C7 26.4 (17) 17.8 (18) 18.5 (18) –1.0 (14) 0.2 (14) 1.8 (14) 
C8 31.0 (17) 14.5 (17) 14.6 (18) 5.0 (14) 0.7 (14) 4.7 (14) 
C101 28.4 (17) 16.5 (18) 11.5 (17) 1.5 (14) 1.9 (14) 3.3 (14) 
C102 33.6 (18) 16.7 (18) 16.9 (18) –5.1 (15) 5.0 (15) 5.2 (14) 
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C103 44.0 (2) 18.0 (19) 18.8 (19) 0.8 (16) 2.0 (16) 0.3 (15) 
C104 43.0 (2) 29.0 (2) 18.3 (19) 11.0 (17) 9.2 (16) 4.2 (16) 
C105 31.2 (18) 29.0 (2) 29.0 (2) –3.9 (16) 8.9 (16) 1.9 (17) 
C106 30.6 (18) 16.9 (18) 21.4 (19) –2.6 (14) 0.8 (15) 0.7 (15) 
C111 28.1 (17) 16.3 (18) 10.8 (17) –3.9 (14) –6.0 (13) 0.8 (14) 
C112 28.3 (17) 22.1 (19) 20.7 (19) –2.1 (15) –1.8 (15) –4.5 (15) 
C113 37.0 (2) 24.0 (2) 31.0 (2) 6.2 (16) –10.5 (17) –7.8 (17) 
C114 54.0 (2) 19.0 (2) 25.0 (2) 6.5 (18) –22.2 (18) –0.9 (17) 
C115 52.0 (2) 20.0 (2) 12.7 (18) –6.6 (17) –7.0 (16) 2.4 (15) 
C116 31.8 (18) 16.6 (18) 15.4 (18) –0.9 (14) –1.4 (14) 1.9 (14) 
C1' 24.5 (17) 19.2 (19) 0.022 (2) –0.1 (14) 2.3 (15) 3.1 (15) 
C2' 30.6 (18) 23.0 (19) 19.5 (19) 3.1 (15) 5.6 (15) 8.7 (15) 
C3A 21.7 (16) 14.6 (17) 16.2 (18) –1.9 (13) 3.8 (13) 4.7 (14) 
C5A 26.6 (16) 12.3 (16) 9.0 (16) 1.3 (13) 1.5 (13) 3.2 (13) 
C8A 24.1 (16) 13.4 (17) 12.8 (17) –2.1 (13) 2.9 (13) 3.5 (13) 
C8B 23.8 (16) 17.0 (18) 17.3 (18) –1.9 (13) 4.4 (14) 8.3 (14) 
Cl21 39.0 (5) 23.8 (5) 24.2 (5) 5.1 (4) –0.9 (4) 7.4 (4) 
Cl22 31.3 (4) 24.8 (5) 29.6 (5) –2.9 (4) 1.9 (4) –5.7 (4) 
Cl23 30.0 (4) 24.2 (5) 40.1 (6) 2.6 (4) 15.4 (4) 6.1 (4) 
O21 24.9 (12) 38.2 (15) 17.3 (13) –0.3 (11) 2.6 (10) 6.8 (11) 
O23 35.2 (13) 21.3 (13) 23.9 (14) –1.2 (10) 10.1 (11) 8.5 (11) 
O25 24.2 (12) 27.8 (14) 16.8 (12) –2.4 (10) 1.6 (10) 0.4 (11) 
O21' 46.7 (14) 30.2 (14) 13.3 (13) 16.2 (12) 4.9 (11) 4.9 (11) 
O25A 29.4 (12) 21.5 (13) 14.1 (12) –0.3 (10) 1.2 (10) 6.7 (10) 
N21 28.9 (14) 21.0 (15) 11.8 (15) 4.0 (12) 2.7 (11) 3.4 (12) 
N22 27.8 (14) 19.8 (15) 11.6 (14) –2.8 (12) 1.7 (11) 2.8 (12) 
C21 29.9 (18) 15.7 (18) 14.9 (18) –0.4 (14) 1.8 (14) 0.4 (14) 
C23 34.9 (18) 9.0 (17) 21.9 (19) –2.5 (14) 6.5 (16) –1.8 (14) 
C24 24.6 (16) 17.0 (18) 16.4 (18) –1.8 (14) 5.0 (14) 4.8 (14) 
C25 25.7 (16) 15.9 (17) 13.2 (17) –3.3 (14) –1.0 (14) 2.4 (14) 
C26 27.7 (17) 15.4 (17) 15.8 (18) –3.8 (14) 1.1 (14) 1.0 (14) 
C27 29.5 (17) 21.0 (19) 20.5 (19) 1.1 (15) 4.7 (15) 2.2 (15) 
C28 29.4 (17) 18.6 (18) 13.6 (17) 2.9 (14) 3.8 (14) 2.3 (14) 
C201 7.4 (17) 24.5 (19) 11.4 (17) –3.0 (15) –0.4 (14) 3.6 (14) 
C202 37.4 (19) 20.4 (19) 17.7 (19) 0.3 (15) 3.5 (15) 0.0 (15) 
C203 49.0 (2) 30.0 (2) 21.0 (2) 1.6 (18) 2.4 (17) 10.9 (17) 
C204 49.0 (2) 51.0 (3) 27.0 (2) 1.0 (2) –7.7 (19) 18.0 (2) 
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C205 44.0 (2) 63.0 (3) 30.0 (2) –16.0 (2) –13.8 (19) 19.0 (2) 
C206 44.0 (2) 37.0 (2) 24.0 (2) –14.4 (18) –5.8 (17) 12.7 (18) 
C211 29.6 (17) 17.1 (18) 12.4 (18) –3.5 (14) 6.6 (14) 3.8 (14) 
C212 35.3 (19) 23.0 (2) 26.0 (2) 2.0 (16) 9.2 (16) 9.3 (16) 
C213 42.0 (2) 24.0 (2) 40.0 (2) 8.4 (17) 17.5 (19) 14.5 (19) 
C214 59.0 (2) 18.0 (2) 37.0 (2) 1.9 (18) 32.0 (2) 5.3 (18) 
C215 61.0 (2) 16.1 (19) 22.0 (2) –7.8 (18) 20.0 (18) 2.9 (16) 
C216 38.6 (19) 19.9 (19) 16.6 (19) 0.3 (15) 11.4 (15) 6.8 (15) 
C21' 22.8 (16) 19.4 (18) 18.9 (19) 1.3 (14) 1.7 (14) 2.5 (15) 
C22' 26.1 (16) 20.8 (19) 16.1 (18) –2.2 (14) 1.3 (14) 5.5 (14) 
C23A 24.0 (16) 16.5 (18) 17.1 (18) –5.0 (13) 2.0 (14) 2.1 (14) 
C25A 26.4 (16) 18.0 (18) 10.1 (17) 1.3 (14) 1.2 (13) 1.6 (14) 
C28A 24.3 (16) 17.6 (18) 11.8 (17) –2.1 (13) 0.0 (13) –0.3 (14) 
C28B 25.6 (16) 13.4 (17) 18.5 (18) –3.8 (13) 1.1 (14) –0.2 (14) 
O1M 30.2 (13) 58.6 (18) 17.7 (14) –9.4 (12) 3.3 (10) 0.9 (14) 
C1M 38.0 (2) 110.0 (4) 31.0 (3) 11.0 (2) 4.6 (19) 15.0 (3) 
O2M 32.8 (13) 44.2 (16) 19.8 (14) –1.5 (12) 4.8 (11) –0.1 (12) 
C2M 43.0 (2) 64.0 (3) 32.0 (2) 2.0 (2) 0.3 (19) –1.0 (2) 
 
 
 
 
 
 
